WO2021020928A2 - Polycyclic compound and organic light-emitting element comprising same - Google Patents

Polycyclic compound and organic light-emitting element comprising same Download PDF

Info

Publication number
WO2021020928A2
WO2021020928A2 PCT/KR2020/010123 KR2020010123W WO2021020928A2 WO 2021020928 A2 WO2021020928 A2 WO 2021020928A2 KR 2020010123 W KR2020010123 W KR 2020010123W WO 2021020928 A2 WO2021020928 A2 WO 2021020928A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
substituted
unsubstituted
carbon atoms
formula
Prior art date
Application number
PCT/KR2020/010123
Other languages
French (fr)
Korean (ko)
Other versions
WO2021020928A3 (en
Inventor
김명곤
금수정
김경희
홍완표
Original Assignee
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200065269A external-priority patent/KR102239440B1/en
Application filed by 주식회사 엘지화학 filed Critical 주식회사 엘지화학
Priority to EP20847289.4A priority Critical patent/EP3901158A4/en
Priority to US17/423,185 priority patent/US20230077439A1/en
Priority to JP2021540053A priority patent/JP7248229B2/en
Priority to CN202080010225.9A priority patent/CN113396151B/en
Publication of WO2021020928A2 publication Critical patent/WO2021020928A2/en
Publication of WO2021020928A3 publication Critical patent/WO2021020928A3/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers

Definitions

  • the present specification relates to a polycyclic compound and an organic light emitting device including the same.
  • an organic light-emitting device is a light-emitting device using an organic semiconductor material, and requires an exchange of holes and/or electrons between an electrode and an organic semiconductor material.
  • the organic light emitting device can be divided into two types as follows according to the operating principle. First, excitons are formed in the organic material layer by photons introduced into the device from an external light source, and the excitons are separated into electrons and holes, and these electrons and holes are transferred to different electrodes, and used as a current source (voltage source). It is a type of light emitting device.
  • the second is a light emitting device in which holes and/or electrons are injected into an organic semiconductor material layer that forms an interface with the electrode by applying voltage or current to two or more electrodes, and operates by the injected electrons and holes.
  • the organic light emission phenomenon refers to a phenomenon in which electrical energy is converted into light energy using an organic material.
  • An organic light emitting device using the organic light emitting phenomenon has a structure including an anode, a cathode, and an organic material layer therebetween.
  • the organic material layer is often made of a multi-layered structure composed of different materials in order to increase the efficiency and stability of the organic light emitting device.
  • the organic material layer is composed of a hole injection layer, a hole transport layer, a light emitting layer, an electron blocking layer, an electron transport layer, an electron injection layer, etc. I can lose.
  • organic light-emitting device when a voltage is applied between the two electrodes, holes are injected from the anode and electrons from the cathode are injected into the organic material layer, and excitons are formed when the injected holes and electrons meet. It glows when it falls back to the ground.
  • organic light emitting devices are known to have characteristics such as self-luminescence, high brightness, high efficiency, low driving voltage, wide viewing angle, and high contrast.
  • Materials used as the organic material layer in the organic light-emitting device may be classified into light-emitting materials and charge transport materials, such as hole injection materials, hole transport materials, electron suppression materials, electron transport materials, electron injection materials, and the like, according to their functions.
  • the light-emitting material includes blue, green, and red light-emitting materials and yellow and orange light-emitting materials necessary to realize better natural colors according to the light-emitting color.
  • a host/dopant system may be used as a light emitting material.
  • the principle is that when a small amount of a dopant having an energy band gap smaller than that of a host that mainly constitutes the light emitting layer is mixed with the light emitting layer, excitons generated from the host are transported as a dopant to emit light with high efficiency. At this time, since the wavelength of the host moves to the wavelength of the dopant, light having a desired wavelength can be obtained according to the type of dopant used.
  • materials that form the organic material layer in the device such as hole injection materials, hole transport materials, light-emitting materials, electron suppression materials, electron transport materials, electron injection materials, etc., are stable and efficient materials. As it is supported by, the development of new materials is continuously required.
  • Patent Literature 1 International Patent Publication No. 2017-126443
  • R1 and R301 are the same as or different from each other, and each independently deuterium; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • x101 is 1 or 2
  • Cy3 and Cy4 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
  • R302 is hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • n1 is an integer of 1 to 3
  • n301 is an integer of 1 to 4
  • n302 is an integer of 0 to 10
  • n1, n301 and n302 are each 2 or more, the substituents in parentheses are the same as or different from each other,
  • At least one of Cy3 and Cy4 is one selected from Formulas A-1 to A-3,
  • the dotted line is the position connected to Formula 100,
  • Q1 is O; S; Or C(R118)(R119),
  • R101 to R104, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • x11 is 1 or 2
  • n101 is an integer from 0 to 7
  • n102 is an integer from 0 to 11
  • n103 is an integer from 0 to 4
  • n104 is an integer from 0 to 5
  • n101 to n104 are each 2 or more, the substituents in parentheses are the same as or different from each other,
  • At least one of the aliphatic rings contained in Formula 100 is selected from the following structures,
  • the dotted double line is the condensed position
  • R105 to R114 are the same as or different from each other, and each independently, a substituted or unsubstituted alkyl group,
  • R115 to R117 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • n115 is an integer of 0 to 2
  • n116 and n117 are each an integer of 0 to 4
  • n115 to n117 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  • the first electrode A second electrode provided to face the first electrode; And one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the aforementioned polycyclic compound.
  • the compound of the present invention can be used as a material for an organic material layer of an organic light emitting device.
  • an organic light emitting device including the compound of the present invention an organic light emitting device having high efficiency, low voltage and long life characteristics can be obtained, and when the compound of the present invention is included in the light emitting layer of the organic light emitting device, a high color gamut is achieved.
  • Eggplant can manufacture an organic light emitting device.
  • FIG 1 and 2 show an example of an organic light emitting device according to the present invention.
  • 3 to 7 show systems of Examples 2-1 to 2-5, respectively.
  • the present specification provides a compound represented by the following formula (100).
  • the compound represented by the following Chemical Formula 100 is used in the organic material layer of the organic light-emitting device, the efficiency and lifetime characteristics of the organic light-emitting device are improved.
  • conventional compounds having a high sublimation temperature have low stability of the compound, resulting in a problem that the efficiency and life of the device decrease when applied to a device, but the compound represented by the following formula 100 is an aliphatic hydrocarbon ring substituted with an alkyl group in the molecule ( Specifically, by including a cycloalkene ring), it has a low sublimation temperature and thus has high stability, so that when applied to a device, a device having excellent efficiency and long life characteristics can be obtained.
  • the compound represented by the following formula (100) contains a cycloalkene ring in the molecule, so that the solubility is increased and thus can be applied to a solution process.
  • substituted means that the hydrogen atom bonded to the carbon atom of the compound is replaced with another substituent, and the position to be substituted is not limited as long as the position at which the hydrogen atom is substituted, that is, the position where the substituent can be substituted, and when two or more are substituted , Two or more substituents may be the same or different from each other.
  • substituted or unsubstituted refers to deuterium; Halogen group; Cyano group (-CN); Silyl group; Boron group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted aryl group; And a substituted or unsubstituted heterocyclic group, substituted with one or two or more substituents selected from the group consisting of, or two or more of the substituents exemplified above are substituted with a connected substituent, or no substituent.
  • a substituent to which two or more substituents are connected may be a biphenyl group. That is, the biphenyl group may be an aryl group, or may be interpreted as a substituent to which two phenyl groups are connected.
  • connection of two or more substituents means that hydrogen of any one substituent is substituted with another substituent.
  • an isopropyl group and a phenyl group are connected or It may be a substituent of.
  • connection of three substituents is not only that (substituent 1)-(substituent 2)-(substituent 3) is continuously connected, but also (substituent 2) and (substituent 3) are Includes connections.
  • two phenyl groups and isopropyl groups are connected or It may be a substituent of. The same applies to those in which four or more substituents are connected.
  • the dotted line means a site bonded or condensed to another substituent or bonding portion.
  • examples of the halogen group include fluorine (F), chlorine (Cl), bromine (Br), or iodine (I).
  • the silyl group may be represented by the formula of -SiY1Y2Y3, wherein Y1, Y2 and Y3 are each hydrogen; A substituted or unsubstituted alkyl group; Or it may be a substituted or unsubstituted aryl group.
  • the silyl group specifically includes a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, a phenylsilyl group, etc., but is not limited thereto. Does not.
  • the boron group may be represented by the formula of -BY4Y5, wherein Y4 and Y5 are each hydrogen; A substituted or unsubstituted alkyl group; Or it may be a substituted or unsubstituted aryl group.
  • the boron group specifically includes a trimethyl boron group, a triethyl boron group, a t-butyldimethyl boron group, a triphenyl boron group, and a phenyl boron group, but is not limited thereto.
  • the alkyl group may be a linear or branched chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 60. According to an exemplary embodiment, the alkyl group has 1 to 30 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 20 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 10 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 6 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 4 carbon atoms.
  • alkyl group examples include, but are not limited to, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, and the like.
  • the amine group is -NH 2 ; Alkylamine group; Alkylarylamine group; Arylamine group; Arylheteroarylamine group; It may be selected from the group consisting of an alkylheteroarylamine group and a heteroarylamine group, and the number of carbon atoms is not particularly limited, but is preferably 1 to 60. In the case of an arylamine group, the number of carbon atoms is 6 to 60. According to another exemplary embodiment, the arylamine group has 6 to 40 carbon atoms.
  • amine group examples include methylamine group; Dimethylamine group; Ethylamine group; Diethylamine group; Phenylamine group; Naphthylamine group; Biphenylamine group; Anthracenylamine group; 9-methylanthracenylamine group; Diphenylamine group; N-phenylnaphthylamine group; Ditolylamine group; N-phenyltolylamine group; Triphenylamine group; N-phenylbiphenylamine group; N-phenylnaphthylamine group; N-biphenylnaphthylamine group; N-naphthylfluorenylamine group; N-phenylphenanthrenylamine group; N-biphenylphenanthrenylamine group; N-phenylfluorenylamine group; N-phenylterphenylamine group; N-phenanthrenylfluorenylamine group; N-phenant
  • the alkylarylamine group means an amine group in which an alkyl group and an aryl group are substituted with N of the amine group.
  • the arylheteroarylamine group refers to an amine group in which an aryl group and a heteroaryl group are substituted with N of the amine group.
  • the alkylheteroarylamine group refers to an amine group in which an alkyl group and a heteroaryl group are substituted with N of the amine group.
  • the alkyl group in the alkylamine group, the arylalkylamine group, the alkylthioxy group, the alkylsulfoxy group, and the alkylheteroarylamine group is the same as the example of the alkyl group described above.
  • the alkyl thioxy group is a methyl thioxy group; Ethyl thioxy group; tert-butyl thioxy group; Hexylthioxy group; Octylthioxy group and the like
  • examples of the alkyl sulfoxy group include mesyl; Ethyl sulfoxy group; Propyl sulfoxy group; Butyl sulfoxy group and the like, but are not limited thereto.
  • the cycloalkyl group is not particularly limited, but is preferably 3 to 60 carbon atoms, and according to an exemplary embodiment, the cycloalkyl group has 3 to 30 carbon atoms. According to another exemplary embodiment, the cycloalkyl group has 3 to 20 carbon atoms. According to another exemplary embodiment, the cycloalkyl group has 3 to 6 carbon atoms.
  • Cychloroalkyl groups include monocyclic groups as well as bicyclic groups such as bridgeheads, fused rings, and spiro rings.
  • a cyclopropyl group a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, and the like, but is not limited thereto.
  • cycloalkene is a cyclic group that has a double bond in a hydrocarbon ring, but is not aromatic, and the number of carbons is not particularly limited, but may be 3 to 60 carbon atoms, and according to an exemplary embodiment, 3 to May be 30.
  • Cycloalkene includes not only monocyclic groups, but also bicyclic groups such as bridgehead, fused ring, and spiro. Examples of the cycloalkene include cyclopropene, cyclobutene, cyclopentene, and cyclohexene, but are not limited thereto.
  • the aryl group is not particularly limited, but is preferably 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to an exemplary embodiment, the aryl group has 6 to 30 carbon atoms. According to an exemplary embodiment, the aryl group has 6 to 20 carbon atoms.
  • the aryl group may be a phenyl group, a biphenyl group, or a terphenyl group, but the monocyclic aryl group is not limited thereto.
  • the polycyclic aryl group may be a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, a perylenyl group, a triphenyl group, a chrysenyl group, a fluorenyl group, and the like, but is not limited thereto.
  • the substituted aryl group includes a form in which an aliphatic ring is condensed with an aryl group.
  • the alkylaryl group refers to an aryl group substituted with an alkyl group, and a substituent other than the alkyl group may be further connected.
  • arylalkyl group refers to an alkyl group substituted with an aryl group, and a substituent other than the alkyl group may be further connected.
  • the heterocyclic group is a cyclic group including at least one of N, O, P, S, Si, and Se as a hetero atom, and the number of carbons is not particularly limited, but is preferably 2 to 60 carbon atoms. According to an exemplary embodiment, the number of carbon atoms of the heterocyclic group is 2 to 30. According to an exemplary embodiment, the number of carbon atoms of the heterocyclic group is 2 to 20.
  • heterocyclic group examples include a pyridine group, a pyrrole group, a pyrimidine group, a pyridazinyl group, a furan group, a thiophene group, an imidazole group, a pyrazole group, a dibenzofuran group, a dibenzothiophene group, a carbazole group, and a hexa Hydrocarbazole group and the like, but are not limited to these.
  • the heterocyclic group may be monocyclic or polycyclic, and may be aromatic, aliphatic, or condensed rings of aromatic and aliphatic, and may be selected from examples of the heterocyclic group.
  • the aromatic hydrocarbon ring refers to a hydrocarbon ring in which pi electrons are completely conjugated and planar, and the description of the aryl group may be applied except that it is divalent.
  • the aliphatic hydrocarbon ring is a structure bonded in a ring shape, and refers to a ring that is not aromatic.
  • the aliphatic hydrocarbon ring include cycloalkyl or cycloalkane, and the description of the cycloalkyl group or cycloalkenyl group described above may be applied except for divalent.
  • the substituted aliphatic hydrocarbon ring also includes an aliphatic hydrocarbon ring condensed with an aromatic ring.
  • the condensed ring of an aromatic hydrocarbon ring and an aliphatic hydrocarbon ring means that an aromatic hydrocarbon ring and an aliphatic hydrocarbon ring form a condensed ring.
  • the "adjacent" group means a substituent substituted on an atom directly connected to the atom where the corresponding substituent is substituted, a substituent positioned three-dimensionally closest to the corresponding substituent, or another substituent substituted on the atom where the corresponding substituent is substituted.
  • I can.
  • two substituents substituted at an ortho position in a benzene ring and two substituents substituted at the same carbon in an aliphatic ring may be interpreted as “adjacent" groups to each other.
  • substituent groups (total of 4) connected to two consecutive carbons in the aliphatic ring can also be interpreted as "adjacent" groups.
  • adjacent groups bonded to each other to form a ring refers to a substituted or unsubstituted hydrocarbon ring by bonding with adjacent groups to each other; Or it means to form a substituted or unsubstituted heterocycle.
  • the condensed hydrocarbon ring may be monovalent or divalent. Specifically, when Cy3 and Cy4 are condensed hydrocarbon rings in the present formula, the condensed hydrocarbon ring corresponds to a monovalent group.
  • Chemical Formula 100 is selected from the following structures.
  • the dotted double line is the condensed position
  • R105 to R114 are the same as or different from each other, and each independently, a substituted or unsubstituted alkyl group,
  • R115 to R117 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • n115 is an integer of 0 to 2
  • n116 and n117 are each an integer of 0 to 4
  • n115 to n117 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  • n115 When n115 is 2, R115 is the same as or different from each other. When n116 is 2 or more, R116 is the same as or different from each other. When n117 is 2 or more, R117 is the same as or different from each other.
  • the aliphatic ring included in Formula 100 is 1) an aliphatic hydrocarbon ring formed by bonding of two R301s to each other, 2) a cyclopentene ring when x101 is 1, 3) a cyclopentene ring when x101 is 2 It means at least one of the hexene ring, 4) an aliphatic hydrocarbon ring included in Cy3, and 5) an aliphatic hydrocarbon ring included in Cy5.
  • R105 to R114 are the same as or different from each other, and each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms.
  • R105 to R114 are the same as or different from each other, and are each independently a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms.
  • R105 to R114 are methyl groups.
  • R115 and R116 are the same as or different from each other, and each independently, hydrogen; Or deuterium.
  • R117 is hydrogen or deuterium, or four adjacent R117s combine with each other to form a substituted or unsubstituted benzene ring.
  • R117 is hydrogen or deuterium, or four adjacent R117s combine with each other to form a benzene ring unsubstituted or substituted with an alkyl group having 1 to 10 carbon atoms.
  • R117 is hydrogen or deuterium, or four adjacent R117s are bonded to each other to form a benzene ring.
  • Chemical Formula 100 is selected from the following structures.
  • R301 is the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, and two adjacent R301s are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
  • R301 is deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms, and two adjacent R301s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 30 carbon atoms.
  • R301 is deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted aryl group having 6 to 20 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 20 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 40 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 40 carbon atoms, and two adjacent R301s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
  • R301 is deuterium; An alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; An aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted substituted or unsubstituted C6-C30 hetero with one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group Cyclic group; Substituted or un
  • R301 is a methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Dimethylfluorenyl group; Dibenzofuran group; Dibenzothiophene group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group substituted or unsubstituted with a methyl group or a tert-butyl group and condensed or non-condensed with a cyclohexene; N-phenyl-N-
  • R302 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
  • R302 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
  • R302 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
  • R302 is hydrogen; heavy hydrogen; Or a methyl group.
  • n302 is 2 or more, and two or four of the plurality of R302s are methyl groups.
  • Chemical Formula 100 is represented by any one of Chemical Formulas 1 to 3.
  • R1, Cy3, Cy4 and n1 are as defined in Chemical Formula 100,
  • R3 and R4 are the same as or different from each other, and each independently, deuterium; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • R2, R5, R6, and R8 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • n3 and n4 are each an integer of 1 to 4
  • n2, n5 and n6 are each an integer of 0 to 10
  • n8 is an integer of 0 to 8
  • n2 to n6 and n8 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  • Cy3 and Cy4 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
  • At least one of Cy3 and Cy4 is one selected from Formulas A-1 to A-3 below.
  • the dotted line is the position connected to Formula 100,
  • Q1 is O; S; Or C(R118)(R119),
  • R101 to R104, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • x11 is 1 or 2
  • n101 is an integer from 0 to 7
  • n102 is an integer from 0 to 11
  • n103 is an integer from 0 to 4
  • n104 is an integer from 0 to 5
  • n101 to n104 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest are substituted or unsubstituted aromatic hydrocarbon rings.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the remainder is a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 60 carbon atoms.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest are substituted or unsubstituted aromatic hydrocarbon rings having 6 to 30 carbon atoms.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest is a substituted or unsubstituted monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest is from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms. It is an aromatic hydrocarbon ring having 6 to 30 carbon atoms substituted or unsubstituted with one or more selected substituents or a substituent to which two or more groups selected from the group are connected.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest are from the group consisting of deuterium, an alkyl group having 1 to 6 carbon atoms, and an aryl group having 6 to 20 carbon atoms. It is a monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms, which is substituted or unsubstituted with one or more selected substituents or a substituent to which two or more groups selected from the group are connected.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest is substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, or an arylalkyl group having 7 to 50 carbon atoms. Or an unsubstituted monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms.
  • At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the remainder is a phenyl group, a biphenyl group, or a terphenyl group, and the phenyl group, biphenyl group, or terphenyl group is a methyl group , Isopropyl group, tert-butyl group, or 2-phenylpropan-2-yl group (2-phenylpropan-2-yl) substituted or unsubstituted.
  • Cy3 and Cy4 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3.
  • R118 and R119 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R118 and R119 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
  • R118 and R119 are methyl groups.
  • R101 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R101 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
  • R101 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
  • R101 is hydrogen; heavy hydrogen; Or tert-butyl group.
  • R102 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or four adjacent R102 bonded to each other to form a substituted or unsubstituted aromatic hydrocarbon ring.
  • R102 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or four adjacent R 102 bonds to each other to form a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 30 carbon atoms.
  • R102 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or four adjacent R102s are bonded to each other to form a substituted or unsubstituted benzene ring.
  • R102 is hydrogen; heavy hydrogen; Or it is a methyl group, or four adjacent R102 combine with each other to form a benzene ring.
  • n102 is 2 or more, and two or four of the plurality of R102s are methyl groups.
  • R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, adjacent two R103; Or two adjacent R104s are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
  • R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or two adjacent R103; Or two adjacent R104s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 30 carbon atoms.
  • R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C 1 to C 6 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or two adjacent R103; Or two adjacent R104s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
  • the alkyl group or aryl group of R103 and R104 includes one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
  • the alkyl group or aryl group of R103 and R104 may be substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, an arylalkyl group having 7 to 50 carbon atoms, or an aryl group having 6 to 30 carbon atoms.
  • two adjacent R103; Or the aliphatic hydrocarbon ring formed by bonding of two adjacent R104s to each other is at least one substituent selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
  • R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; Or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms, or two adjacent R103; Or two adjacent R104s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
  • R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R103; Alternatively, two adjacent R104s are bonded to each other to form a cyclopentene ring substituted or unsubstituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
  • R103 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group.
  • R104 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R104s are bonded to each other to form a cyclopentene ring unsubstituted or substituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
  • n101 is 2 or more.
  • R101 is the same as or different from each other.
  • n102 is 2 or more, R102 is the same as or different from each other.
  • n103 is 2 or more.
  • R103 is the same as or different from each other.
  • n104 is 2 or more, R104 is the same as or different from each other.
  • Cy3 and Cy4 are the same as or different from each other, and each independently, is selected from the following groups A-11 to A-14, and at least one of Cy3 and Cy4 is the following groups A-11 to A It is selected from -13.
  • the dotted line is the position connected to Formula 100,
  • Q1 is O; S; Or C(R118)(R119),
  • R41 to R43, R46 to R50, R53 to R55, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • R45, R51 and R52 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group,
  • n41, n43 and n44 are each an integer of 0 to 7
  • n42, n49 and n50 are each an integer of 0 to 5
  • n41 to n44, n49 and n50 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  • R41 may be applied to the description of R101 described above.
  • R41 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R41 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
  • R41 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
  • R41 is hydrogen; heavy hydrogen; Or tert-butyl group.
  • R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
  • R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
  • R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a methyl group.
  • R44 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or four adjacent R44 bonded to each other to form a substituted or unsubstituted aromatic hydrocarbon ring.
  • R44 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or four adjacent R 44 bonds to each other to form a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 30 carbon atoms.
  • R44 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or four adjacent R44s are bonded to each other to form a substituted or unsubstituted benzene ring.
  • R44 is hydrogen; heavy hydrogen; Or a methyl group, or four adjacent R44s are bonded to each other to form a benzene ring.
  • R103 and R104 described above may be applied to R45 to R49.
  • R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or is bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring.
  • R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted hydrocarbon ring having 5 to 30 carbon atoms.
  • R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C 1 to C 6 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
  • the alkyl group or aryl group of R46 to R50 is one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
  • the alkyl group or aryl group of R46 to R50 may be substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, an arylalkyl group having 7 to 50 carbon atoms, or an aryl group having 6 to 30 carbon atoms.
  • the aliphatic hydrocarbon ring formed by bonding of two adjacent R49 or two adjacent R50 to each other is at least one substituent selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
  • R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; Or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms, or two adjacent R49; Or two adjacent R50s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
  • R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R49; Alternatively, two adjacent R50s are bonded to each other to form a cyclopentene ring unsubstituted or substituted with a methyl group or a cyclohexene ring unsubstituted or substituted with a methyl group.
  • R45 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
  • R45 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
  • R45 is hydrogen; heavy hydrogen; Or deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms, or an alkyl group having 1 to 10 carbon atoms substituted with a substituent to which two or more groups selected from the group are connected.
  • R45 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; Or 2-phenylpropan-2-yl group (2-phenylpropan-2-yl).
  • R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
  • R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
  • R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms, or an alkyl group having 1 to 10 carbon atoms substituted with a substituent to which two or more groups selected from the group are connected.
  • R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; Or 2-phenylpropan-2-yl group (2-phenylpropan-2-yl).
  • the group A-12 is selected from the following group A-12-1.
  • R42 to R44 is as defined in group A-12,
  • n421, n431 and n441 are each an integer of 0 to 3, and when n421, n431 and n441 are each 2 or more, the substituents in parentheses are the same or different from each other.
  • n41 is 2 or more, R41 is the same as or different from each other.
  • n42 is 2 or more, R42 is the same as or different from each other.
  • n43 is 2 or more, R43 is the same as or different from each other.
  • n44 is 2 or more, R44 is the same as or different from each other.
  • n49 is 2 or more, R49 is the same as or different from each other.
  • n50 is 2 or more, R50 is the same as or different from each other.
  • R1 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group.
  • R1 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or -N(R211)(R212).
  • R1 is deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted N-containing heterocyclic group having 2 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
  • R1 is deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted C 2 to C 20 N-containing heterocyclic group; A substituted or unsubstituted arylamine group having 6 to 40 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 40 carbon atoms.
  • R1 is deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted N-containing heterocyclic group having 2 to 30 carbon atoms; Or -N(R211)(R212).
  • R1 is deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted C 2 to C 20 N-containing heterocyclic group; Or -N(R211)(R212).
  • R1 is deuterium; An alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Deuterium, an N-containing heterocyclic group having 2 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent to which two or more groups selected from the group are connected, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 carbon atoms Arylamine group of to 60; Or an arylheteroarylamine group having 6 to 60 carbon atoms substituted or
  • R1 is deuterium; An alkyl group having 1 to 6 carbon atoms substituted or unsubstituted with deuterium; An N-containing heterocyclic group having 2 to 20 carbon atoms unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an alkylaryl group having 7 to 30 carbon atoms; An arylamine group having 6 to 40 carbon atoms, unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms and condensed or uncondensed with an aliphatic hydrocarbon ring having 5 or 6 carbon atoms; Or an arylheteroarylamine group having 6 to 40 carbon atoms substituted or unsubstituted with deuterium.
  • R1 is a methyl group unsubstituted or substituted with deuterium; Isopropyl group; tert-butyl group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group in which a methyl group, an isopropyl group, or a tert-butyl group is substituted or unsubstituted, and a cyclopentene or cyclohexene is condensed or non-condensed; N-phenyl-N-dibenzofuranamine group; Or N-phenyl-N-dibenzothiophenamine group.
  • R211 and R212 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
  • R211 and R212 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted C2 to C30 heterocyclic group.
  • R211 and R212 are the same as or different from each other, each independently substituted or unsubstituted with deuterium or an alkyl group having 1 to 10 carbon atoms, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or non-condensed An aryl group having 6 to 30 carbon atoms; Or a C2 to C30 heterocyclic group unsubstituted or substituted with deuterium or a C1 to C10 alkyl group.
  • R211 and R212 are the same as or different from each other, each independently substituted or unsubstituted with deuterium or an alkyl group having 1 to 6 carbon atoms, and an aliphatic hydrocarbon ring having 5 or 6 carbon atoms is condensed or non-condensed An aryl group having 6 to 20 carbon atoms; Or it is a C6-C20 heterocyclic group substituted or unsubstituted with deuterium or a C1-C6 alkyl group.
  • R211 and R212 are the same as or different from each other, and each independently a phenyl group unsubstituted or substituted with deuterium, a methyl group, or a tert-butyl group; A tetrahydronaphthalene group unsubstituted or substituted with a methyl group; Dibenzofuran group; Or a dibenzothiophene group.
  • R1 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 Arylamine group of to 60; Arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Or the following formula Het1.
  • the dotted line is the position connected to Chemical Formula 100,
  • R203 to R205 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; An alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Or an aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group,
  • n205 is an integer from 0 to 12, and when n205 is 2 or more, R205 is the same as or different from each other.
  • R203 and R204 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
  • R203 and R204 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
  • R203 and R204 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
  • R203 and R204 are methyl groups.
  • R205 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R205 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
  • R205 is hydrogen; heavy hydrogen; An alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Or an aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms, or a substituent connected with two or more groups selected from the group.
  • R205 is hydrogen; heavy hydrogen; An alkyl group having 1 to 6 carbon atoms substituted or unsubstituted with deuterium; Or deuterium or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
  • the substituted aryl group of R205 also includes an aliphatic hydrocarbon ring condensed.
  • R205 is hydrogen; heavy hydrogen; Methyl group, tert-butyl group; A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Or a tetrahydronaphthalene group unsubstituted or substituted with a methyl group.
  • R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group.
  • R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
  • R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted aryl group having 6 to 20 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 20 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 40 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 40 carbon atoms.
  • R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; Or -N(R211)(R212).
  • R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted aryl group having 6 to 20 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 20 carbon atoms; Or -N(R211)(R212).
  • R3 and R4 are the same as or different from each other, and each independently, deuterium;
  • R3 and R4 are the same as or different from each other, and each independently, deuterium; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; An arylamine group having 6 to 40 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; Or an arylheteroarylamine group having 2 to 40 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon carbon atoms;
  • R3 and R4 are the same as or different from each other, and each independently, a methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Dimethylfluorenyl group; Dibenzofuran group; Dibenzothiophene group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group substituted or unsubstituted with a methyl group or a tert-butyl group and condensed or non-condensed with a
  • two adjacent R3s combine with each other to form a substituted or unsubstituted aliphatic hydrocarbon ring.
  • two adjacent R3s are bonded to each other to form an aliphatic hydrocarbon ring having 5 to 30 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 10 carbon atoms.
  • two adjacent R3s are bonded to each other to form an aliphatic hydrocarbon ring having 5 to 20 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
  • two adjacent R3s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms unsubstituted or substituted with a methyl group.
  • R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
  • R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted hydrocarbon ring having 5 to 30 carbon atoms.
  • R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or two adjacent substituents bonded to each other to form a substituted or unsubstituted hydrocarbon ring having 5 to 20 carbon atoms.
  • R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a methyl group, adjacent two R2; Two adjacent R5s; Or, two adjacent R6 bonds to each other to form a benzene ring.
  • n2 is 4 or more, and 4 of the plurality of R2s are methyl groups.
  • n5 is 4 or more, and 4 of the plurality of R5 are methyl groups.
  • n6 is 4 or more, and 4 of the plurality of R6 are methyl groups.
  • n8 is 2 or more, and two or four of the plurality of R8s are methyl groups.
  • n1 is 1.
  • n3 is 1.
  • n4 is 1.
  • n2 is 2 or more
  • R2 is the same as or different from each other.
  • n5 is 2 or more
  • r5 is the same as or different from each other.
  • R6 is the same as or different from each other.
  • Chemical Formula 100 is represented by any one of Chemical Formulas 101 to 109 below.
  • Cy3 and Cy4 are as defined in Chemical Formula 100,
  • R22, R31, G1, G2 and Y1 to Y6 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
  • At least one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
  • n22 and n31 are each an integer of 0 to 2
  • y1 and y5 are each an integer of 0 to 4
  • y2 to y4 and y6 are each an integer of 0 to 6
  • n22, n31 and y1 to y6 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  • R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group.
  • R21 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or -N(R211)(R212).
  • R21 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; A substituted or unsubstituted N-containing heterocyclic group having 2 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
  • R21 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Deuterium, an N-containing heterocyclic group having 2 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent to which two or more groups selected from the group are connected, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 carbon atoms Arylamine group of to 60; Or an arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstit
  • R21 is an alkyl group having 1 to 6 carbon atoms substituted or unsubstituted with deuterium;
  • R21 is a methyl group unsubstituted or substituted with deuterium; Isopropyl group; tert-butyl group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group in which a methyl group, an isopropyl group, or a tert-butyl group is substituted or unsubstituted, and a cyclopentene or cyclohexene is condensed or non-condensed; N-phenyl-N-dibenzofuranamine group; Or N-phenyl-N-dibenzothiophenamine group.
  • R21 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Deuterium, an N-containing heterocyclic group having 2 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; Or -N(R211)(R212).
  • R21 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 Arylamine group of to 60; Arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Or the above formula Het1.
  • R22 is hydrogen; Or deuterium.
  • R31 is hydrogen; Or deuterium.
  • At least one of G1 and G2 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
  • At least one of G1 and G2 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or -N(R211)(R212).
  • At least one of G1 and G2 is one or more substituents selected from the group consisting of deuterium and an aryl group having 6 to 30 carbon atoms, or 1 carbon number unsubstituted or substituted with a substituent to which two or more groups selected from the group are connected.
  • At least one of G1 and G2 is an alkyl group having 1 to 6 carbon atoms unsubstituted or substituted with deuterium or an aryl group having 6 to 20 carbon atoms; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; An arylamine group having 6 to 40 carbon atoms, unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms and condensed or uncondensed with an aliphatic hydrocarbon ring having 5 or 6 carbon atoms; Or an arylheteroarylamine group having 6 to 40 carbon atoms substituted or unsub
  • At least one of G1 and G2 is a methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Dimethylfluorenyl group; Dibenzofuran group; Dibenzothiophene group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group in which a methyl group, an isopropyl group, or a tert-butyl group is substituted or unsubstituted, and a cyclopentene or
  • At least one of G1 and G2 is one or more substituents selected from the group consisting of deuterium and an aryl group having 6 to 30 carbon atoms, or 1 carbon number unsubstituted or substituted with a substituent to which two or more groups selected from the group are connected.
  • any one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, and the other is hydrogen or deuterium.
  • any one of G1 and G2 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms, and the other is hydrogen or deuterium.
  • any one of G1 and G2 is an alkyl group having 1 to 6 carbon atoms unsubstituted or substituted with deuterium or an aryl group having 6 to 20 carbon atoms; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; An arylamine group having 6 to 40 carbon atoms, unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms and condensed or uncondensed with an aliphatic hydrocarbon ring having 5 or 6 carbon atoms; Or an arylheteroarylamine group having 6 to 40 carbon atoms substituted or unsubsti
  • any one of G1 and G2 is an alkyl group having 1 to 6 carbon atoms unsubstituted or substituted with deuterium or an aryl group having 6 to 20 carbon atoms; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; Or -N(R211)(R212), and the other is hydrogen or deuterium.
  • Y1 to Y6 are the same as or different from each other, and each independently, hydrogen; Or deuterium, or four adjacent Y3; Or, four adjacent Y6s are bonded to each other to form a benzene ring.
  • Y1 to Y6 are the same as or different from each other, and each independently, hydrogen; Or deuterium, or four adjacent Y3; Or, four adjacent Y6s are bonded to each other to form a benzene ring.
  • Chemical Formula 103 is represented by Chemical Formula 103-1 or 103-2 below.
  • G1, G2, Cy3, Cy4, R21, R22, R31, n22 and n31 are as defined in Chemical Formula 103.
  • Chemical Formula 107 is represented by Chemical Formula 107-1 or 107-2 below.
  • Y5, Cy3, Cy4, R21, R22, n22 and y5 are as defined in Chemical Formula 107.
  • Chemical Formula 108 is represented by Chemical Formula 108-1 or 108-2 below.
  • Y4, Cy3, Cy4, R21, R22, n22 and y4 are as defined in Chemical Formula 108.
  • Chemical Formula 109 is represented by any one of Chemical Formulas 109-1 to 109-3 below.
  • Cy3, Cy4, R21, R22 and n22 are as defined in Chemical Formula 109.
  • Chemical Formula 100 is represented by any one of Chemical Formulas 201 to 209 below.
  • Cy5 to Cy7 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
  • R22, R31 to R38, G1 and G2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
  • At least one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
  • x1 to x3 are each 1 or 2
  • n22, n31, n36 and n37 are each an integer of 0 to 2
  • n32 and n35 are each an integer of 0 to 4
  • n33 is an integer of 0 to 5
  • n34 and n38 are each an integer of 0 to 3
  • n22 and n31 to n38 are each 2 or more, the substituents in parentheses are the same as or different from each other,
  • Cy11 to Cy13 are the same as or different from each other, and each independently, is selected from the following structures,
  • the dotted double line is the condensed position
  • R121 to R123 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
  • n121 is an integer of 0 to 2
  • n122 and n123 are each an integer of 0 to 4, when n121 to n123 are each 2 or more.
  • the substituents in parentheses are the same as or different from each other.
  • R115 to R117 described above is applied to R121 to R123.
  • R121 and R122 are the same as or different from each other, and each independently, hydrogen; Or deuterium.
  • R123 is hydrogen or deuterium, or four adjacent R117s combine with each other to form a substituted or unsubstituted benzene ring.
  • R123 is hydrogen or deuterium, or four adjacent R117s are bonded to each other to form a benzene ring unsubstituted or substituted with an alkyl group having 1 to 10 carbon atoms.
  • R123 is hydrogen or deuterium, or four adjacent R117s are bonded to each other to form a benzene ring.
  • Cy11 to Cy13 are the same as or different from each other, and each independently, is selected from the following structures.
  • R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or two adjacent R32; Or two adjacent R33s are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
  • R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or two adjacent R32; Or, two adjacent R33s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 30 carbon atoms.
  • R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C 1 to C 6 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or two adjacent R32; Or two adjacent R33s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
  • the alkyl group or aryl group of R32 and R33 includes at least one substituent selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
  • the alkyl group or aryl group of R32 and R33 may be substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, an arylalkyl group having 7 to 50 carbon atoms, or an aryl group having 6 to 30 carbon atoms.
  • two adjacent R32; Or the aliphatic hydrocarbon ring formed by bonding of two adjacent R 33 to each other is at least one substituent selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
  • R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; Or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms, or two adjacent R32; Or two adjacent R33s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
  • R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R32; Alternatively, two adjacent R33s are bonded to each other to form a cyclopentene ring substituted or unsubstituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
  • R32 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group.
  • R33 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R33s are bonded to each other to form a cyclopentene ring unsubstituted or substituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
  • R101 described above may be applied to R34 and R35.
  • R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
  • R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
  • R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or tert-butyl group.
  • R36 and R37 are the same as or different from each other, and each independently hydrogen; Or deuterium.
  • R38 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
  • R38 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
  • R38 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
  • R38 is hydrogen; heavy hydrogen; Or a methyl group.
  • Cy5 to Cy7 are the same as or different from each other, and each independently is a substituted or unsubstituted aromatic hydrocarbon ring selected from Formulas A-1 to A-3.
  • Cy5 to Cy7 are the same as or different from each other, and each independently is a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 30 carbon atoms selected from Formulas A-1 to A-3.
  • Cy5 to Cy7 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms selected from Formulas A-1 to A-3 to be.
  • Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from the above Chemical Formulas A-1 to A-3, or deuterium, an alkyl group having 1 to 6 carbon atoms, and having 6 to 20 carbon atoms It is a monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms, which is unsubstituted or substituted with one or more substituents selected from the group consisting of aryl groups or a substituent connected with two or more groups selected from the group.
  • Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3, or deuterium, an alkyl group having 1 to 10 carbon atoms, or 7 to 50 carbon atoms It is a monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms unsubstituted or substituted with an arylalkyl group of.
  • Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3, or is a phenyl group, a biphenyl group, or a terphenyl group, and the phenyl group, biphenyl group Or the terphenyl group is substituted or unsubstituted with a methyl group, isopropyl group, tert-butyl group, or 2-phenylpropan-2-yl group.
  • Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3.
  • Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from the groups A-11 to A-14.
  • Cy4 is And R44 is hydrogen or deuterium
  • G2 is a tert-butyl group
  • R21 is a methyl group
  • Cy3 is a substituted phenyl group
  • Cy11 and Cy13 are each And, when G2 is a tert-butyl group, R21 is a methyl group, and Cy7 is a substituted phenyl group,
  • Chemical Formula 103 excludes the case of including two tert-butyl groups as a substituent included in G2 or/and Cy3. That is, when G2 in Formula 103 is a tert-butyl group, it may be included, and when there is one tert-butyl group among the substituents connected to Cy3 in Formula 103, it may be included, and among the substituents connected to Cy3 in Formula 103, Cases with three tert-butyl groups may also be included. However, the case where G2 in Formula 103 is a tert-butyl group and one tert-butyl group among the substituents connected to Cy3 is excluded. In addition, the case of having two tert-butyl groups among the substituents connected to Cy3 of Chemical Formula 103 is also excluded.
  • Chemical Formula 205 is excluded from the case of including two tert-butyl groups as a substituent included in G2 or/and Cy7. That is, when G2 in Formula 205 is a tert-butyl group, it may be included, and when there is one tert-butyl group among the substituents connected to Cy7 in Formula 205, it may be included, and among the substituents connected to Cy7 in Formula 205, Cases with three tert-butyl groups may also be included. However, the case where G2 in Formula 205 is a tert-butyl group and one tert-butyl group among the substituents connected to Cy7 is excluded. In addition, the case of having two tert-butyl groups among the substituents connected to Cy7 of Formula 205 is also excluded.
  • the above-described chemical formula excludes the following compounds.
  • Chemical Formula 1 may be represented by any one of the following structures.
  • the substituent of the compound of Formula 1 may be bonded by a method known in the art, and the type, position, or number of the substituent may be changed according to techniques known in the art.
  • the conjugation length and the energy band gap of the compound are closely related. Specifically, the longer the conjugation length of the compound, the smaller the energy band gap.
  • compounds having various energy band gaps can be synthesized by introducing various substituents into the core structure as described above.
  • the HOMO and LUMO energy levels of the compound can be adjusted by introducing various substituents to the core structure of the above structure.
  • a compound having the inherent characteristics of the introduced substituent can be synthesized.
  • a substituent mainly used for the hole injection layer material, the hole transport material, the light emitting layer material and the electron transport layer material used in the manufacture of the organic light emitting device into the core structure, it is possible to synthesize a material that satisfies the conditions required by each organic material layer. I can.
  • the organic light emitting device includes a first electrode; A second electrode provided to face the first electrode; And one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the above-described compound.
  • the organic light-emitting device of the present invention may be manufactured by a conventional method and material of an organic light-emitting device, except that one or more organic material layers are formed by using the above-described compound.
  • the compound may be formed as an organic material layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light emitting device.
  • the solution coating method refers to spin coating, dip coating, inkjet printing, screen printing, spray method, roll coating, etc., but is not limited thereto.
  • the organic material layer of the organic light emitting device of the present invention may have a single-layer structure, but may have a multilayer structure in which two or more organic material layers are stacked.
  • the organic light-emitting device of the present invention may have a structure including a hole injection layer, a hole transport layer, a layer that simultaneously injects and transports holes, a light emitting layer, an electron transport layer, an electron injection layer, and the like as an organic material layer.
  • the structure of the organic light emitting device is not limited thereto, and may include a smaller number of organic material layers or a greater number of organic material layers.
  • the organic material layer may include at least one of an electron transport layer, an electron injection layer, and a layer that simultaneously injects and transports electrons, and at least one of the layers is represented by Formula 1 above. It may contain a compound.
  • the organic material layer may include an electron transport layer or an electron injection layer, and the electron transport layer or the electron injection layer may include a compound represented by Formula 1 above.
  • the organic material layer may include at least one of a hole injection layer, a hole transport layer, and a layer that simultaneously injects and transports holes, and at least one of the layers is represented by Formula 1 above. It may contain a compound.
  • the organic material layer may include a hole injection layer or a hole transport layer, and the hole transport layer or the hole injection layer may include a compound represented by Formula 1 above.
  • the organic material layer includes an emission layer
  • the emission layer includes a compound represented by Formula 1 above.
  • the compound represented by Formula 1 may be included as a dopant of the emission layer.
  • the organic light-emitting device is a green organic light-emitting device in which the emission layer includes the compound represented by Formula 1 as a dopant.
  • the organic light-emitting device is a red organic light-emitting device in which the emission layer includes the compound represented by Formula 1 as a dopant.
  • the organic light-emitting device is a blue organic light-emitting device in which the emission layer includes the compound represented by Formula 1 as a dopant.
  • the organic material layer including the compound represented by Formula 1 may include the compound represented by Formula 1 as a dopant, and may include an organic compound such as an anthracene compound as a host.
  • the organic material layer including the heterocyclic compound represented by Formula 1 may include the compound represented by Formula 1 as a dopant, and may include a fluorescent host or a phosphorescent host.
  • the organic material layer comprising the heterocyclic compound represented by Formula 1 includes the compound represented by Formula 1 as a dopant, includes a fluorescent host or a phosphorescent host, and other organic compounds, metals, or A metal compound may be included as a dopant.
  • the organic material layer including the compound represented by Formula 1 includes the compound represented by Formula 1 as a dopant, includes a fluorescent host or a phosphorescent host, and can be used together with an iridium-based (Ir) dopant. have.
  • the organic material layer includes an emission layer
  • the emission layer includes the polycyclic compound described above as a dopant of the emission layer, and a compound represented by the following Formula H as a host of the emission layer.
  • L21 and L22 are the same as or different from each other, and each independently, a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group,
  • Ar21 and Ar22 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
  • R201 and R202 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
  • n202 is an integer from 0 to 7, and when n202 is 2 or more, R202 is the same as or different from each other.
  • L21 and L22 are the same as or different from each other, and each independently, a direct bond; A monocyclic or polycyclic arylene group having 6 to 30 carbon atoms; Or a monocyclic or polycyclic heteroarylene group having 2 to 30 carbon atoms.
  • L21 and L22 are the same as or different from each other, and each independently, a direct bond; A monocyclic or polycyclic arylene group having 6 to 20 carbon atoms; Or a monocyclic or polycyclic heteroarylene group having 2 to 20 carbon atoms.
  • L21 and L22 are the same as or different from each other, and each independently, a direct bond; A phenylene group unsubstituted or substituted with deuterium; Biphenylylene group unsubstituted or substituted with deuterium; A naphthylene group unsubstituted or substituted with deuterium; Divalent dibenzofuran group; Or a divalent dibenzothiophene group.
  • Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
  • Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 20 carbon atoms.
  • Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic to 4 ring aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic to 4 ring heterocyclic group having 6 to 20 carbon atoms.
  • Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted phenyl group; A substituted or unsubstituted biphenyl group; A substituted or unsubstituted terphenyl group; A substituted or unsubstituted naphthyl group; A substituted or unsubstituted anthracene group; A substituted or unsubstituted phenanthrene group; A substituted or unsubstituted phenalene group; A substituted or unsubstituted fluorene group; A substituted or unsubstituted benzofluorene group; A substituted or unsubstituted furan group; A substituted or unsubstituted thiophene group; A substituted or unsubstituted dibenzofuran group; A substituted or unsubstituted naphthobenzofuran group; A substituted or unsubsti
  • Ar21 and Ar22 are the same as or different from each other, and each independently, a phenyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A biphenyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthyl group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthobenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzothiophene group unsubstituted or substituted with a
  • Ar21 and Ar22 are the same as or different from each other, and each independently, a phenyl group unsubstituted or substituted with deuterium; Biphenyl group unsubstituted or substituted with deuterium; Terphenyl group; A naphthyl group unsubstituted or substituted with deuterium; Phenanthrene group; Dibenzofuran group; Naphthobenzofuran group; Dibenzothiophene group; Or a naphthobenzothiophene group.
  • any one of Ar21 and Ar22 is a substituted or unsubstituted aryl group, and the other is a substituted or unsubstituted heterocyclic group.
  • Ar21 is a substituted or unsubstituted aryl group
  • Ar22 is a substituted or unsubstituted substituted or unsubstituted heterocyclic group.
  • Ar21 is a substituted or unsubstituted heterocyclic group
  • Ar22 is a substituted or unsubstituted aryl group.
  • R201 is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C 1 to C 30 linear or branched alkyl group; A substituted or unsubstituted monocyclic or polycyclic cycloalkyl group having 3 to 30 carbon atoms; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
  • R201 is hydrogen; heavy hydrogen; Fluorine; A substituted or unsubstituted C 1 to C 10 linear or branched alkyl group; A substituted or unsubstituted monocyclic or polycyclic cycloalkyl group having 3 to 10 carbon atoms; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
  • R201 is hydrogen; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
  • R201 is hydrogen; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 20 carbon atoms.
  • R201 is hydrogen; A substituted or unsubstituted monocyclic to 4 ring aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic to 4 ring heterocyclic group having 6 to 20 carbon atoms.
  • R201 is hydrogen; A substituted or unsubstituted phenyl group; A substituted or unsubstituted biphenyl group; A substituted or unsubstituted terphenyl group; A substituted or unsubstituted naphthyl group; A substituted or unsubstituted anthracene group; A substituted or unsubstituted phenanthrene group; A substituted or unsubstituted phenalene group; A substituted or unsubstituted fluorene group; A substituted or unsubstituted benzofluorene group; A substituted or unsubstituted furan group; A substituted or unsubstituted thiophene group; A substituted or unsubstituted dibenzofuran group; A substituted or unsubstituted naphthobenzofuran group; A substituted or unsubstituted dibenzothiophene group; Or a
  • R201 is hydrogen; heavy hydrogen; A phenyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A biphenyl group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthobenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzothiophene group unsubstituted or substituted with a monocyclic or polycyclic aryl group having
  • R201 is hydrogen; heavy hydrogen; A phenyl group unsubstituted or substituted with deuterium, a phenyl group, or a naphthyl group; Biphenyl group; A naphthyl group unsubstituted or substituted with deuterium, a phenyl group, or a naphthyl group; Dibenzofuran group; Naphthobenzofuran group; Dibenzothiophene group; Or a naphthobenzothiophene group.
  • R202 is hydrogen; Or deuterium.
  • R202 are deuterium.
  • R202 is hydrogen
  • R202 is deuterium
  • the compound represented by Formula H is any one selected from the following compounds.
  • the emission layer includes the polycyclic compound described above as a dopant of the emission layer, and the compound represented by Formula H as a host of the emission layer.
  • the content of the dopant may be selected from 0.01 to 10 parts by weight based on 100 parts by weight of the emission layer, but is not limited thereto.
  • the emission layer includes a host and a dopant, and the host and the dopant are 99:1 to 1:99 weight ratio, preferably 99:1 to 70:30 weight ratio, even more preferably 99 It includes in a weight ratio of :1 to 90:10.
  • the light emitting layer may further include a host material, and the host may include a condensed aromatic ring derivative or a heterocyclic compound.
  • condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, and fluoranthene compounds
  • heterocycle-containing compounds include carbazole derivatives, dibenzofuran derivatives, ladder type Furan compounds, pyrimidine derivatives, triazine derivatives, and the like, and may be a mixture of two or more thereof, but are not limited thereto.
  • the organic material layer includes an emission layer, and the emission layer includes at least one dopant and a host.
  • the organic material layer includes an emission layer, and the emission layer includes two or more mixed dopants and a host.
  • At least one of the two or more mixed dopants includes Formula 1, and the host includes a compound represented by Formula H. At least one of the two or more mixed dopants includes Formula 1, and the other may use a conventionally known dopant material, but is not limited thereto.
  • At least one of the two or more mixed dopants includes the formula 1, and the rest of the boron-based compounds, pyrene-based compounds, and delayed fluorescent compounds different from those of the formula 1 are used.
  • the rest of the boron-based compounds, pyrene-based compounds, and delayed fluorescent compounds different from those of the formula 1 are used.
  • the organic material layer includes an emission layer, and the emission layer includes one or more types of hosts.
  • the organic material layer includes an emission layer, and the emission layer includes two or more mixed hosts.
  • At least one of the two or more mixed hosts is a compound represented by Formula H.
  • the two or more kinds of mixed hosts are different from each other, and each independently, is a compound represented by Formula H.
  • the organic material layer includes an emission layer, and the emission layer includes two kinds of mixed hosts.
  • the organic material layer includes an emission layer
  • the emission layer includes a mixed host of two types
  • the two types of mixed hosts are different from each other
  • the two types of hosts are represented by Formula H. It is a compound that becomes.
  • the organic material layer includes a first host including an emission layer and represented by Chemical Formula H; And a second host represented by Formula H, wherein the first host and the second host are different from each other.
  • the first host the second host is included in a weight ratio of 95:5 to 5:95, and preferably is included in a weight ratio of 70:30 to 30:70.
  • the organic material layer includes an emission layer, and the emission layer includes at least one host and a dopant.
  • the organic material layer includes an emission layer, the emission layer includes at least one host and a dopant, the host includes a compound represented by Formula H, and the dopant is the formula It includes the compound represented by 1.
  • the organic material layer includes an emission layer, and the emission layer includes two or more mixed hosts and a dopant.
  • At least one of the two or more mixed hosts includes the compound represented by Formula H, and the dopant includes the compound represented by Formula 1 above.
  • the two or more kinds of mixed hosts are different from each other.
  • the organic material layer includes an emission layer, and the emission layer includes two kinds of mixed hosts and a dopant.
  • the two kinds of mixed hosts are different from each other, and each independently includes a compound represented by Chemical Formula H, and the dopant includes a compound represented by Chemical Formula 1.
  • the organic material layer includes a first host including an emission layer and represented by Chemical Formula H; A second host represented by Formula H; And a dopant represented by Formula 1, wherein the first host and the second host are different from each other.
  • the organic material layer uses at least one host and at least one dopant, the at least one host comprises a compound represented by Formula H, and the at least one dopant is the It includes a compound represented by Formula 1.
  • the organic material layer may use two or more types of mixed hosts and two or more types of mixed dopants, and the two or more types of mixed hosts may use the same material as described above, and the two or more types of mixed host may be used.
  • the dopant may use the same material as described above.
  • the maximum emission peak of the emission layer including the polycyclic compound represented by Chemical Formula 100 is 380 nm to 500 nm. That is, the light emitting layer containing the polycyclic compound described above is a blue light emitting layer.
  • the first electrode is an anode
  • the second electrode is a cathode
  • the first electrode is a cathode
  • the second electrode is an anode
  • the structure of the organic light-emitting device of the present invention may have the following structures (1) to (18), but is not limited thereto.
  • the structure of the organic light-emitting device of the present invention may have a structure as shown in FIGS. 1 and 2, but is not limited thereto.
  • FIG. 1 illustrates a structure of an organic light-emitting device in which a light emitting layer 3 and a cathode 4 are sequentially stacked on a substrate 1 and an anode 2.
  • the compound represented by Formula 1 may be included in the emission layer 3.
  • the organic light-emitting device uses a PVD (physical vapor deposition) method such as sputtering or e-beam evaporation, and uses a metal or conductive metal oxide or alloy thereof on a substrate. Is deposited to form an anode, and on it After forming an organic material layer including one or more selected layers, it can be prepared by depositing a material that can be used as a cathode thereon. In addition to this method, an organic light-emitting device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.
  • PVD physical vapor deposition
  • the organic material layer may have a multilayer structure including a hole injection layer, a hole transport layer, an emission layer, an electron transport layer, etc., but is not limited thereto and may have a single layer structure.
  • the organic material layer is made of a variety of polymer materials, and is used in a smaller number of solvent processes, such as spin coating, dip coating, doctor blading, screen printing, inkjet printing, or thermal transfer. It can be made in layers.
  • the anode is an electrode for injecting holes, and a material having a large work function is preferably used as the anode material to facilitate hole injection into an organic material layer.
  • the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), conductive polymers such as polypyrrole and polyaniline, and the like, but are not limited thereto.
  • the cathode is an electrode for injecting electrons
  • the cathode material is usually a material having a small work function to facilitate electron injection into the organic material layer.
  • the negative electrode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; There are multilayered materials such as LiF/Al or LiO 2 /Al, but are not limited thereto.
  • the hole injection layer is a layer that facilitates injection of holes from the anode to the light emitting layer, and may have a single-layer or multi-layer structure.
  • the hole injection material is a material capable of injecting holes well from the anode at a low voltage, It is preferable that the HOMO (highest occupied molecular orbital) of the hole injection material is between the work function of the positive electrode material and the HOMO of the surrounding organic material layer.
  • Specific examples of hole injection materials include metal porphyrine, oligothiophene, arylamine-based organic substances, hexanitrile hexaazatriphenylene-based organic substances, quinacridone-based organic substances, and perylene-based organic substances.
  • the thickness of the hole injection layer may be 1 to 150 nm.
  • the thickness of the hole injection layer is 1 nm or more, there is an advantage of preventing deterioration of the hole injection characteristics, and when the thickness of the hole injection layer is 150 nm or less, the thickness of the hole injection layer is too thick to increase the driving voltage to improve the movement of holes. There is an advantage that can prevent it.
  • the hole injection layer has a multilayer structure of two or more layers.
  • the hole transport layer may serve to facilitate transport of holes.
  • the hole transport material a material capable of transporting holes from the anode or the hole injection layer and transferring them to the emission layer, and a material having high mobility for holes is suitable. Specific examples include an arylamine-based organic material, a conductive polymer, and a block copolymer including a conjugated portion and a non-conjugated portion, but are not limited thereto.
  • a hole buffer layer may be additionally provided between the hole injection layer and the hole transport layer, and may include a hole injection or transport material known in the art.
  • An electron blocking layer may be provided between the hole transport layer and the light emitting layer.
  • the electron blocking layer the aforementioned spiro compound or a material known in the art may be used.
  • the emission layer may emit red, green, or blue light, and may be made of a phosphorescent material or a fluorescent material.
  • the light-emitting material is a material capable of emitting light in a visible light region by transporting and bonding holes and electrons from the hole transport layer and the electron transport layer, respectively, and a material having good quantum efficiency for fluorescence or phosphorescence is preferable.
  • Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ); Carbazole-based compounds; Dimerized styryl compounds; BAlq; 10-hydroxybenzo quinoline-metal compound; Benzoxazole, benzthiazole, and benzimidazole-based compounds; Poly(p-phenylenevinylene) (PPV)-based polymer; Spiro compounds; Polyfluorene, rubrene, and the like, but are not limited thereto.
  • Alq 3 8-hydroxy-quinoline aluminum complex
  • Carbazole-based compounds Dimerized styryl compounds
  • BAlq 10-hydroxybenzo quinoline-metal compound
  • Benzoxazole, benzthiazole, and benzimidazole-based compounds include Poly(p-phenylenevinylene) (PPV)-based polymer; Spiro compounds; Polyfluorene, rubrene, and the like, but are not limited thereto.
  • Examples of the host material for the light emitting layer include a condensed aromatic ring derivative or a heterocyclic compound.
  • condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, and fluoranthene compounds
  • heterocycle-containing compounds include carbazole derivatives, dibenzofuran derivatives, ladder type Furan compounds, pyrimidine derivatives, and the like, but are not limited thereto.
  • the emission dopants include PIQIr(acac)(bis(1-phenylisoquinoline)acetylacetonateiridium), PQIr(acac)(bis(1-phenylquinoline)acetylacetonate iridium), PQIr(tris(1-phenylquinoline)iridium). ), a phosphorescent material such as octaethylporphyrin platinum (PtOEP), or a fluorescent material such as Alq 3 (tris(8-hydroxyquinolino)aluminum), but is not limited thereto.
  • a phosphor such as Ir(ppy) 3 (fac tris(2-phenylpyridine)iridium) or a fluorescent material such as Alq3 (tris(8-hydroxyquinolino)aluminum) may be used as the emission dopant.
  • a fluorescent material such as Alq3 (tris(8-hydroxyquinolino)aluminum)
  • Alq3 tris(8-hydroxyquinolino)aluminum
  • the light emitting dopant is a phosphorescent material such as (4,6-F2ppy) 2 Irpic, spiro-DPVBi, spiro-6P, distillbenzene (DSB), distrylarylene (DSA),
  • a fluorescent material such as a PFO-based polymer or a PPV-based polymer may be used, but is not limited thereto.
  • a hole blocking layer may be provided between the electron transport layer and the light emitting layer, and materials known in the art may be used.
  • the electron transport layer serves to facilitate transport of electrons, and may have a single layer or multilayer structure.
  • the electron transport material a material capable of receiving electrons from the cathode and transferring them to the light emitting layer, and a material having high mobility for electrons is suitable. Specific examples include Al complex of 8-hydroxyquinoline; Complexes containing Alq 3 ; Organic radical compounds; Hydroxyflavone-metal complexes and the like, but are not limited thereto.
  • the thickness of the electron transport layer may be 1 to 50 nm.
  • the thickness of the electron transport layer is 1 nm or more, there is an advantage of preventing deterioration of the electron transport characteristics, and if the thickness of the electron transport layer is 50 nm or less, the thickness of the electron transport layer is too thick to prevent an increase in the driving voltage to improve the movement of electrons. There is an advantage to be able to.
  • the electron transport layer has a multilayer structure of two or more layers, and the electron transport layer adjacent to the cathode includes an n-type dopant.
  • the electron injection layer may play a role of smoothly injecting electrons.
  • the electron injection material has the ability to transport electrons, has an electron injection effect from the cathode, an excellent electron injection effect for the light emitting layer or the light emitting material, prevents the movement of excitons generated in the light emitting layer to the hole injection layer, ,
  • a compound having excellent thin film forming ability is preferable. Specifically, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylene tetracarboxylic acid, preorenylidene methane, anthrone, etc. Complex compounds and nitrogen-containing 5-membered ring derivatives, but are not limited thereto.
  • the metal complex compound examples include lithium 8-hydroxyquinolinato, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, Tris(8-hydroxyquinolinato)aluminum, tris(2-methyl-8-hydroxyquinolinato)aluminum, tris(8-hydroxyquinolinato)gallium, bis(10-hydroxybenzo[h] Quinolinato)beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)( o-cresolato)gallium, bis(2-methyl-8-quinolinato)(1-naphtholato)aluminum, bis(2-methyl-8-quinolinato)(2-naphtholato)gallium, etc. It is not limited to this.
  • the hole blocking layer is a layer that prevents holes from reaching the cathode, and may be generally formed under the same conditions as the hole injection layer. Specifically, there are oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, BCP, aluminum complexes, etc., but are not limited thereto.
  • the organic light emitting device may be a top emission type, a bottom emission type, or a double-sided emission type depending on the material used.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present specification relates to a polycyclic compound and an organic light-emitting element comprising same.

Description

다환 화합물 및 이를 포함하는 유기 발광 소자Polycyclic compound and organic light-emitting device comprising the same
본 명세서는 다환 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present specification relates to a polycyclic compound and an organic light emitting device including the same.
본 출원은 2019년 7월 31일 한국특허청에 제출된 한국 특허 출원 제10-2019-0093157호, 2019년 11월 29일 한국특허청에 제출된 한국 특허 출원 제10-2019-0156836호, 및 2020년 5월 29일 한국특허청에 제출된 한국 특허 출원 제10-2020-0065269호의 출원일의 이익을 주장하며, 그 내용 전부는 본 명세서에 포함된다.This application is for Korean Patent Application No. 10-2019-0093157 filed with the Korean Intellectual Property Office on July 31, 2019, Korean Patent Application No. 10-2019-0156836 filed with the Korean Intellectual Property Office on November 29, 2019, and 2020. It claims the interest of the filing date of the Korean Patent Application No. 10-2020-0065269 filed with the Korean Intellectual Property Office on May 29, the entire contents of which are incorporated herein.
본 명세서에서, 유기 발광 소자란 유기 반도체 물질을 이용한 발광 소자로서, 전극과 유기 반도체 물질 사이에서의 정공 및/또는 전자의 교류를 필요로 한다. 유기 발광 소자는 동작 원리에 따라 하기와 같이 크게 두 가지로 나눌 수 있다. 첫째는 외부의 광원으로부터 소자로 유입된 광자에 의하여 유기물층에서 엑시톤(exiton)이 형성되고, 이 엑시톤이 전자와 정공으로 분리되고, 이 전자와 정공이 각각 다른 전극으로 전달되어 전류원(전압원)으로 사용되는 형태의 발광 소자이다. 둘째는 2개 이상의 전극에 전압 또는 전류를 가하여 전극과 계면을 이루는 유기 반도체 물질층에 정공 및/또는 전자를 주입하고, 주입된 전자와 정공에 의하여 작동하는 형태의 발광 소자이다.In the present specification, an organic light-emitting device is a light-emitting device using an organic semiconductor material, and requires an exchange of holes and/or electrons between an electrode and an organic semiconductor material. The organic light emitting device can be divided into two types as follows according to the operating principle. First, excitons are formed in the organic material layer by photons introduced into the device from an external light source, and the excitons are separated into electrons and holes, and these electrons and holes are transferred to different electrodes, and used as a current source (voltage source). It is a type of light emitting device. The second is a light emitting device in which holes and/or electrons are injected into an organic semiconductor material layer that forms an interface with the electrode by applying voltage or current to two or more electrodes, and operates by the injected electrons and holes.
일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자차단층, 전자수송층, 전자주입층 등으로 이루어 질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. 이러한 유기 발광 소자는 자발광, 고휘도, 고효율, 낮은 구동 전압, 넓은 시야각, 높은 콘트라스트 등의 특성을 갖는 것으로 알려져 있다.In general, the organic light emission phenomenon refers to a phenomenon in which electrical energy is converted into light energy using an organic material. An organic light emitting device using the organic light emitting phenomenon has a structure including an anode, a cathode, and an organic material layer therebetween. Here, the organic material layer is often made of a multi-layered structure composed of different materials in order to increase the efficiency and stability of the organic light emitting device.For example, the organic material layer is composed of a hole injection layer, a hole transport layer, a light emitting layer, an electron blocking layer, an electron transport layer, an electron injection layer, etc. I can lose. In the structure of such an organic light-emitting device, when a voltage is applied between the two electrodes, holes are injected from the anode and electrons from the cathode are injected into the organic material layer, and excitons are formed when the injected holes and electrons meet. It glows when it falls back to the ground. These organic light emitting devices are known to have characteristics such as self-luminescence, high brightness, high efficiency, low driving voltage, wide viewing angle, and high contrast.
유기 발광 소자에서 유기물층으로 사용되는 재료는 기능에 따라, 발광 재료와 전하 수송 재료, 예컨대 정공 주입 재료, 정공 수송 재료, 전자 억제 물질, 전자 수송 재료, 전자 주입 재료 등으로 분류될 수 있다. 발광 재료는 발광색에 따라 청색, 녹색, 적색 발광 재료와 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 재료가 있다.Materials used as the organic material layer in the organic light-emitting device may be classified into light-emitting materials and charge transport materials, such as hole injection materials, hole transport materials, electron suppression materials, electron transport materials, electron injection materials, and the like, according to their functions. The light-emitting material includes blue, green, and red light-emitting materials and yellow and orange light-emitting materials necessary to realize better natural colors according to the light-emitting color.
또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 재료로서 호스트/도펀트 계를 사용할 수 있다. 그 원리는 발광층을 주로 구성하는 호스트보다 에너지 대역 간극이 작고 발광 효율이 우수한 도펀트를 발광층에 소량 혼합하면, 호스트에서 발생한 엑시톤이 도펀트로 수송되어 효율이 높은 빛을 내는 것이다. 이 때 호스트의 파장이 도펀트의 파장대로 이동하므로, 이용하는 도펀트의 종류에 따라 원하는 파장의 빛을 얻을 수 있다.In addition, in order to increase color purity and increase luminous efficiency through energy transfer, a host/dopant system may be used as a light emitting material. The principle is that when a small amount of a dopant having an energy band gap smaller than that of a host that mainly constitutes the light emitting layer is mixed with the light emitting layer, excitons generated from the host are transported as a dopant to emit light with high efficiency. At this time, since the wavelength of the host moves to the wavelength of the dopant, light having a desired wavelength can be obtained according to the type of dopant used.
전술한 유기 발광 소자가 갖는 우수한 특징들을 충분히 발휘하기 위해서는 소자 내 유기물층을 이루는 물질, 예컨대 정공 주입 물질, 정공 수송 물질, 발광 물질, 전자 억제 물질, 전자 수송 물질, 전자 주입 물질 등이 안정하고 효율적인 재료에 의하여 뒷받침되므로 새로운 재료의 개발이 계속 요구되고 있다.In order to fully exhibit the excellent characteristics of the organic light emitting device described above, materials that form the organic material layer in the device, such as hole injection materials, hole transport materials, light-emitting materials, electron suppression materials, electron transport materials, electron injection materials, etc., are stable and efficient materials. As it is supported by, the development of new materials is continuously required.
[선행기술문헌] (특허문헌 1) 국제 특허 공개 공보 제2017-126443호[Prior Technical Literature] (Patent Literature 1) International Patent Publication No. 2017-126443
본 명세서에는 화합물 및 이를 포함하는 유기 발광 소자가 기재된다. In the present specification, a compound and an organic light emitting device including the same are described.
본 명세서는 하기 화학식 100으로 표시되는 다환 화합물을 제공한다.The present specification provides a polycyclic compound represented by the following formula (100).
[화학식 100][Chemical Formula 100]
Figure PCTKR2020010123-appb-I000001
Figure PCTKR2020010123-appb-I000001
상기 화학식 100에 있어서, In Formula 100,
R1 및 R301은 서로 같거나 상이하고, 각각 독립적으로, 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R1 and R301 are the same as or different from each other, and each independently deuterium; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
x101은 1 또는 2이고,x101 is 1 or 2,
Cy3 및 Cy4는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 방향족 탄화수소고리; 치환 또는 비치환된 지방족 탄화수소고리; 및 치환 또는 비치환된 방향족 헤테로고리로 이루어진 군에서 선택된 하나이거나, 상기 군에서 선택된 2 이상의 고리가 축합된 고리이고,Cy3 and Cy4 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
R302은 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R302 is hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
n1는 1 내지 3의 정수이고, n301는 1 내지 4의 정수이고, n302는 0 내지 10의 정수이고,n1 is an integer of 1 to 3, n301 is an integer of 1 to 4, n302 is an integer of 0 to 10,
n1, n301 및 n302가 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하고,When n1, n301 and n302 are each 2 or more, the substituents in parentheses are the same as or different from each other,
상기 Cy3 및 Cy4 중 적어도 하나는 하기 화학식 A-1 내지 A-3에서 선택된 하나이고,At least one of Cy3 and Cy4 is one selected from Formulas A-1 to A-3,
Figure PCTKR2020010123-appb-I000002
Figure PCTKR2020010123-appb-I000002
상기 화학식 A-1 내지 A-3에 있어서,In the formulas A-1 to A-3,
점선은 화학식 100에 연결되는 위치이며,The dotted line is the position connected to Formula 100,
Q1은 O; S; 또는 C(R118)(R119)이고,Q1 is O; S; Or C(R118)(R119),
R101 내지 R104, R118 및 R119는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R101 to R104, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
x11은 1 또는 2이고, x11 is 1 or 2,
n101은 0 내지 7의 정수이고, n102는 0 내지 11의 정수이고, n103은 0 내지 4의 정수이고, n104는 0 내지 5의 정수이고,n101 is an integer from 0 to 7, n102 is an integer from 0 to 11, n103 is an integer from 0 to 4, n104 is an integer from 0 to 5,
n101 내지 n104이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하고,When n101 to n104 are each 2 or more, the substituents in parentheses are the same as or different from each other,
상기 화학식 100에 포함된 지방족 고리 중 1 이상은 하기 구조에서 선택되고,At least one of the aliphatic rings contained in Formula 100 is selected from the following structures,
Figure PCTKR2020010123-appb-I000003
Figure PCTKR2020010123-appb-I000003
상기 구조에 있어서,In the above structure,
점선 이중선은 축합되는 위치이고, The dotted double line is the condensed position,
R105 내지 R114는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 알킬기이고,R105 to R114 are the same as or different from each other, and each independently, a substituted or unsubstituted alkyl group,
R115 내지 R117는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R115 to R117 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
n115은 0 내지 2의 정수이고, n116 및 n117은 각각 0 내지 4의 정수이고, n115 is an integer of 0 to 2, n116 and n117 are each an integer of 0 to 4,
n115 내지 n117이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n115 to n117 are each 2 or more, the substituents in parentheses are the same as or different from each other.
또한, 본 발명의 일 실시상태에 따르면, 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상이 전술한 다환 화합물을 포함하는 유기 발광 소자를 제공한다.Further, according to an exemplary embodiment of the present invention, the first electrode; A second electrode provided to face the first electrode; And one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the aforementioned polycyclic compound.
본 발명의 화합물은 유기 발광 소자의 유기물층의 재료로서 사용될 수 있다. 본 발명의 화합물을 포함하여 유기 발광 소자를 제조하는 경우, 고효율, 저전압 및 장수명 특성을 갖는 유기 발광 소자를 얻을 수 있으며, 본 발명의 화합물을 유기 발광 소자의 발광층에 포함하는 경우, 높은 색재현율을 가지는 유기 발광 소자를 제조할 수 있다.The compound of the present invention can be used as a material for an organic material layer of an organic light emitting device. In the case of manufacturing an organic light emitting device including the compound of the present invention, an organic light emitting device having high efficiency, low voltage and long life characteristics can be obtained, and when the compound of the present invention is included in the light emitting layer of the organic light emitting device, a high color gamut is achieved. Eggplant can manufacture an organic light emitting device.
도 1 및 2는 본 발명에 따른 유기 발광 소자의 예를 도시한 것이다.1 and 2 show an example of an organic light emitting device according to the present invention.
도 3 내지 7은 각각 실시예 2-1 내지 2-5의 시스템을 도시한 것이다.3 to 7 show systems of Examples 2-1 to 2-5, respectively.
도 8 및 9는 각각 비교예 2-1 및 2-2의 시스템을 도시한 것이다.8 and 9 show systems of Comparative Examples 2-1 and 2-2, respectively.
[부호의 설명][Explanation of code]
1: 기판1: substrate
2: 양극2: anode
3: 발광층3: light emitting layer
4: 음극4: cathode
5: 제1 정공주입층5: first hole injection layer
6: 제2 정공주입층6: second hole injection layer
7: 정공수송층7: hole transport layer
8: 전자차단층8: electron blocking layer
9: 제1 전자수송층9: first electron transport layer
10: 제2 전자수송층10: second electron transport layer
11: 전자주입층11: Electron injection layer
이하 본 명세서에 대하여 더욱 상세히 설명한다. Hereinafter, the present specification will be described in more detail.
본 명세서는 하기 화학식 100로 표시되는 화합물을 제공한다. 하기 화학식 100로 표시되는 화합물을 유기 발광 소자의 유기물층에 사용하는 경우, 유기 발광 소자의 효율 및 수명 특성이 향상된다. 특히, 기존의 높은 승화온도를 갖는 화합물은 화합물의 안정성이 낮아, 소자에 적용시 소자의 효율 및 수명이 떨어지는 문제점이 있었으나, 하기 화학식 100로 표시되는 화합물은 분자 내에 알킬기로 치환된 지방족 탄화수소고리(구체적으로 사이클로알켄고리)를 포함함으로써, 낮은 승화온도를 가져 안정성이 높으며, 이로 인하여 소자에 적용시 우수한 효율 및 장수명 특성을 갖는 소자를 얻을 수 있다.The present specification provides a compound represented by the following formula (100). When the compound represented by the following Chemical Formula 100 is used in the organic material layer of the organic light-emitting device, the efficiency and lifetime characteristics of the organic light-emitting device are improved. In particular, conventional compounds having a high sublimation temperature have low stability of the compound, resulting in a problem that the efficiency and life of the device decrease when applied to a device, but the compound represented by the following formula 100 is an aliphatic hydrocarbon ring substituted with an alkyl group in the molecule ( Specifically, by including a cycloalkene ring), it has a low sublimation temperature and thus has high stability, so that when applied to a device, a device having excellent efficiency and long life characteristics can be obtained.
또한, 하기 화학식 100로 표시되는 화합물은 분자 내에 사이클로알켄고리를 포함함으로써, 용해도가 증가하여 용액 공정용으로도 적용될 수 있다.In addition, the compound represented by the following formula (100) contains a cycloalkene ring in the molecule, so that the solubility is increased and thus can be applied to a solution process.
본 명세서에 있어서, 어떤 부분이 어떤 구성요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.In the present specification, when a part "includes" a certain component, it means that other components may be further included rather than excluding other components unless otherwise stated.
본 명세서에 있어서, 어떤 부재가 다른 부재 "상에" 위치하고 있다고 할 때, 이는 어떤 부재가 다른 부재에 접해 있는 경우뿐 아니라 두 부재 사이에 또 다른 부재가 존재하는 경우도 포함한다.In the present specification, when a member is said to be located "on" another member, this includes not only the case where the member is in contact with the other member, but also the case where another member exists between the two members.
본 명세서에서 치환기의 예시들은 아래에서 설명하나, 이에 한정되는 것은 아니다.Examples of the substituent in the present specification are described below, but are not limited thereto.
상기 "치환" 이라는 용어는 화합물의 탄소 원자에 결합된 수소 원자가 다른 치환기로 바뀌는 것을 의미하며, 치환되는 위치는 수소 원자가 치환되는 위치 즉, 치환기가 치환 가능한 위치라면 한정하지 않으며, 2 이상 치환되는 경우, 2 이상의 치환기는 서로 같거나 상이할 수 있다.The term "substituted" means that the hydrogen atom bonded to the carbon atom of the compound is replaced with another substituent, and the position to be substituted is not limited as long as the position at which the hydrogen atom is substituted, that is, the position where the substituent can be substituted, and when two or more are substituted , Two or more substituents may be the same or different from each other.
본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 시아노기(-CN); 실릴기; 붕소기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 사이클로알킬기; 치환 또는 비치환된 아릴기; 및 치환 또는 비치환된 헤테로고리기로 이루어진 군에서 선택된 1 또는 2 이상의 치환기로 치환되었거나 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환기로 치환되거나, 또는 어떠한 치환기도 갖지 않는 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 바이페닐기일 수 있다. 즉, 바이페닐기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수 도 있다.In the present specification, the term "substituted or unsubstituted" refers to deuterium; Halogen group; Cyano group (-CN); Silyl group; Boron group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted aryl group; And a substituted or unsubstituted heterocyclic group, substituted with one or two or more substituents selected from the group consisting of, or two or more of the substituents exemplified above are substituted with a connected substituent, or no substituent. For example, "a substituent to which two or more substituents are connected" may be a biphenyl group. That is, the biphenyl group may be an aryl group, or may be interpreted as a substituent to which two phenyl groups are connected.
본 명세서에 있어서, 2 이상의 치환기가 연결된다는 것은 어느 하나의 치환기의 수소가 다른 치환기로 치환된 것을 말한다. 예를 들어, 이소프로필기와 페닐기가 연결되어
Figure PCTKR2020010123-appb-I000004
또는
Figure PCTKR2020010123-appb-I000005
의 치환기가 될 수 있다.
In the present specification, the connection of two or more substituents means that hydrogen of any one substituent is substituted with another substituent. For example, an isopropyl group and a phenyl group are connected
Figure PCTKR2020010123-appb-I000004
or
Figure PCTKR2020010123-appb-I000005
It may be a substituent of.
본 명세서에 있어서, 3개의 치환기가 연결되는 것은 (치환기 1)-(치환기 2)-(치환기 3)이 연속하여 연결되는 것뿐만 아니라, (치환기 1)에 (치환기 2) 및 (치환기 3)이 연결되는 것도 포함한다. 예를 들어, 2개의 페닐기 및 이소프로필기가 연결되어
Figure PCTKR2020010123-appb-I000006
또는
Figure PCTKR2020010123-appb-I000007
의 치환기가 될 수 있다. 4 이상의 치환기가 연결되는 것에도 전술한 것과 동일하게 적용된다.
In the present specification, the connection of three substituents is not only that (substituent 1)-(substituent 2)-(substituent 3) is continuously connected, but also (substituent 2) and (substituent 3) are Includes connections. For example, two phenyl groups and isopropyl groups are connected
Figure PCTKR2020010123-appb-I000006
or
Figure PCTKR2020010123-appb-I000007
It may be a substituent of. The same applies to those in which four or more substituents are connected.
본 명세서에 있어서, 점선은 다른 치환기 또는 결합부에 결합 또는 축합되는 부위를 의미한다.In the present specification, the dotted line means a site bonded or condensed to another substituent or bonding portion.
상기 치환기들의 예시들은 아래에서 설명하나, 이에 한정되는 것은 아니다. Examples of the substituents are described below, but are not limited thereto.
본 명세서에 있어서, 할로겐기의 예로는 불소(F), 염소(Cl), 브롬(Br) 또는 요오드(I)가 있다.In the present specification, examples of the halogen group include fluorine (F), chlorine (Cl), bromine (Br), or iodine (I).
본 명세서에 있어서, 실릴기는 -SiY1Y2Y3의 화학식으로 표시될 수 있고, 상기 Y1, Y2 및 Y3는 각각 수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기일 수 있다. 상기 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다. In the present specification, the silyl group may be represented by the formula of -SiY1Y2Y3, wherein Y1, Y2 and Y3 are each hydrogen; A substituted or unsubstituted alkyl group; Or it may be a substituted or unsubstituted aryl group. The silyl group specifically includes a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, a phenylsilyl group, etc., but is not limited thereto. Does not.
본 명세서에 있어서, 붕소기는 -BY4Y5의 화학식으로 표시될 수 있고, 상기 Y4 및Y5는 각각 수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기일 수 있다. 상기 붕소기는 구체적으로 트리메틸붕소기, 트리에틸붕소기, t-부틸디메틸붕소기, 트리페닐붕소기, 페닐붕소기 등이 있으나 이에 한정되지 않는다.In the present specification, the boron group may be represented by the formula of -BY4Y5, wherein Y4 and Y5 are each hydrogen; A substituted or unsubstituted alkyl group; Or it may be a substituted or unsubstituted aryl group. The boron group specifically includes a trimethyl boron group, a triethyl boron group, a t-butyldimethyl boron group, a triphenyl boron group, and a phenyl boron group, but is not limited thereto.
본 명세서에 있어서, 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 60인 것이 바람직하다. 일 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 30이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 10이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 6이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 4이다. 알킬기의 구체적인 예로는 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, tert-부틸기, 펜틸기, 헥실기, 헵틸기, 옥틸기 등이 있으나, 이들에 한정되지 않는다.In the present specification, the alkyl group may be a linear or branched chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 60. According to an exemplary embodiment, the alkyl group has 1 to 30 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 20 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 10 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 6 carbon atoms. According to another exemplary embodiment, the alkyl group has 1 to 4 carbon atoms. Specific examples of the alkyl group include, but are not limited to, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, and the like.
본 명세서에 있어서, 아민기는 -NH2; 알킬아민기; 알킬아릴아민기; 아릴아민기; 아릴헤테로아릴아민기; 알킬헤테로아릴아민기 및 헤테로아릴아민기로 이루어진 군으로부터 선택될 수 있으며, 탄소수는 특별히 한정되지 않으나, 1 내지 60인 것이 바람직하다. 아릴아민기의 경우 탄소수는 6 내지 60이다. 또 하나의 일 실시상태에 따르면, 아릴아민기의 탄소수는 6 내지 40이다. 아민기의 구체적인 예로는 메틸아민기; 디메틸아민기; 에틸아민기; 디에틸아민기; 페닐아민기; 나프틸아민기; 바이페닐아민기; 안트라세닐아민기; 9-메틸안트라세닐아민기; 디페닐아민기; N-페닐나프틸아민기; 디톨릴아민기; N-페닐톨릴아민기; 트리페닐아민기; N-페닐바이페닐아민기; N-페닐나프틸아민기; N-바이페닐나프틸아민기; N-나프틸플루오레닐아민기; N-페닐페난트레닐아민기; N-바이페닐페난트레닐아민기; N-페닐플루오레닐아민기; N-페닐터페닐아민기; N-페난트레닐플루오레닐아민기; N-바이페닐플루오레닐아민기; N-(4-(tert-부틸)페닐)-N-페닐아민기; N,N-비스(4-(tert-부틸)페닐)아민기; N,N-비스(3-(tert-부틸)페닐)아민기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the amine group is -NH 2 ; Alkylamine group; Alkylarylamine group; Arylamine group; Arylheteroarylamine group; It may be selected from the group consisting of an alkylheteroarylamine group and a heteroarylamine group, and the number of carbon atoms is not particularly limited, but is preferably 1 to 60. In the case of an arylamine group, the number of carbon atoms is 6 to 60. According to another exemplary embodiment, the arylamine group has 6 to 40 carbon atoms. Specific examples of the amine group include methylamine group; Dimethylamine group; Ethylamine group; Diethylamine group; Phenylamine group; Naphthylamine group; Biphenylamine group; Anthracenylamine group; 9-methylanthracenylamine group; Diphenylamine group; N-phenylnaphthylamine group; Ditolylamine group; N-phenyltolylamine group; Triphenylamine group; N-phenylbiphenylamine group; N-phenylnaphthylamine group; N-biphenylnaphthylamine group; N-naphthylfluorenylamine group; N-phenylphenanthrenylamine group; N-biphenylphenanthrenylamine group; N-phenylfluorenylamine group; N-phenylterphenylamine group; N-phenanthrenylfluorenylamine group; N-biphenylfluorenylamine group; N-(4-(tert-butyl)phenyl)-N-phenylamine group; N,N-bis(4-(tert-butyl)phenyl)amine group; N,N-bis(3-(tert-butyl)phenyl)amine group, and the like, but are not limited thereto.
본 명세서에 있어서, 알킬아릴아민기는 아민기의 N에 알킬기 및 아릴기가 치환된 아민기를 의미한다.In the present specification, the alkylarylamine group means an amine group in which an alkyl group and an aryl group are substituted with N of the amine group.
본 명세서에 있어서, 아릴헤테로아릴아민기는 아민기의 N에 아릴기 및 헤테로아릴기가 치환된 아민기를 의미한다.In the present specification, the arylheteroarylamine group refers to an amine group in which an aryl group and a heteroaryl group are substituted with N of the amine group.
본 명세서에 있어서, 알킬헤테로아릴아민기는 아민기의 N에 알킬기 및 헤테로아릴기가 치환된 아민기를 의미한다.In the present specification, the alkylheteroarylamine group refers to an amine group in which an alkyl group and a heteroaryl group are substituted with N of the amine group.
본 명세서에 있어서, 알킬아민기, 아릴알킬아민기, 알킬티옥시기, 알킬술폭시기, 알킬헤테로아릴아민기 중의 알킬기는 전술한 알킬기의 예시와 같다. 구체적으로 알킬티옥시기로는 메틸티옥시기; 에틸티옥시기; tert-부틸티옥시기; 헥실티옥시기; 옥틸티옥시기 등이 있고, 알킬술폭시기로는 메실; 에틸술폭시기; 프로필술폭시기; 부틸술폭시기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the alkyl group in the alkylamine group, the arylalkylamine group, the alkylthioxy group, the alkylsulfoxy group, and the alkylheteroarylamine group is the same as the example of the alkyl group described above. Specifically, the alkyl thioxy group is a methyl thioxy group; Ethyl thioxy group; tert-butyl thioxy group; Hexylthioxy group; Octylthioxy group and the like, and examples of the alkyl sulfoxy group include mesyl; Ethyl sulfoxy group; Propyl sulfoxy group; Butyl sulfoxy group and the like, but are not limited thereto.
본 명세서에 있어서, 사이클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 일 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 30이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 20이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 6이다. 사이클로로알킬기는 단일고리기뿐만 아니라 다리목(bridgehead), 접합고리(fused ring), 스피로고리(spiro)와 같은 이중고리기를 포함한다. 구체적으로 사이클로프로필기, 사이클로부틸기, 사이클로펜틸기, 사이클로헥실기, 사이클로헵틸기, 사이클로옥틸기 등이 있으나, 이에 한정되지 않는다. In the present specification, the cycloalkyl group is not particularly limited, but is preferably 3 to 60 carbon atoms, and according to an exemplary embodiment, the cycloalkyl group has 3 to 30 carbon atoms. According to another exemplary embodiment, the cycloalkyl group has 3 to 20 carbon atoms. According to another exemplary embodiment, the cycloalkyl group has 3 to 6 carbon atoms. Cychloroalkyl groups include monocyclic groups as well as bicyclic groups such as bridgeheads, fused rings, and spiro rings. Specifically, there are a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, and the like, but is not limited thereto.
본 명세서에 있어서, 사이클로알켄(cycloalkene)은 탄화수소고리 내에 이중결합이 존재하나, 방향족이 아닌 고리기로서, 탄소수는 특별히 한정되지 않으나, 탄소수 3 내지 60일 수 있으며, 일 실시상태에 따르면, 3 내지 30일 수 있다. 사이클로알켄는 단일고리기 뿐만 아니라 다리목(bridgehead), 접합고리(fused ring), 스피로고리(spiro)와 같은 이중고리기를 포함한다. 상기 사이클로알켄의 예로는 사이클로프로펜, 사이클로뷰텐, 사이클로펜텐, 사이클로헥센등이 있으나, 이들에만 한정되는 것은 아니다.In the present specification, cycloalkene is a cyclic group that has a double bond in a hydrocarbon ring, but is not aromatic, and the number of carbons is not particularly limited, but may be 3 to 60 carbon atoms, and according to an exemplary embodiment, 3 to May be 30. Cycloalkene includes not only monocyclic groups, but also bicyclic groups such as bridgehead, fused ring, and spiro. Examples of the cycloalkene include cyclopropene, cyclobutene, cyclopentene, and cyclohexene, but are not limited thereto.
본 명세서에 있어서, 아릴기는 특별히 한정되지 않으나 탄소수 6 내지 60인 것이 바람직하며, 단환식 아릴기 또는 다환식 아릴기일 수 있다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 30이다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 20이다. 상기 아릴기가 단환식 아릴기로는 페닐기, 바이페닐기, 터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. 상기 다환식 아릴기로는 나프틸기, 안트라세닐기, 페난트레닐기, 파이레닐기, 페릴레닐기, 트리페닐기, 크라이세닐기, 플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. 본 명세서에 있어서, 치환된 아릴기에는 아릴기에 지방족 고리가 축합된 형태도 포함된다.In the present specification, the aryl group is not particularly limited, but is preferably 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to an exemplary embodiment, the aryl group has 6 to 30 carbon atoms. According to an exemplary embodiment, the aryl group has 6 to 20 carbon atoms. The aryl group may be a phenyl group, a biphenyl group, or a terphenyl group, but the monocyclic aryl group is not limited thereto. The polycyclic aryl group may be a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, a perylenyl group, a triphenyl group, a chrysenyl group, a fluorenyl group, and the like, but is not limited thereto. In the present specification, the substituted aryl group includes a form in which an aliphatic ring is condensed with an aryl group.
본 명세서에 있어서, 알킬아릴기는 알킬기로 치환된 아릴기를 의미하며, 알킬기 외의 치환기가 추가로 연결될 수 있다. In the present specification, the alkylaryl group refers to an aryl group substituted with an alkyl group, and a substituent other than the alkyl group may be further connected.
본 명세서에 있어서, 아릴알킬기는 아릴기로 치환된 알킬기를 의미하며, 알킬기 외의 치환기가 추가로 연결될 수 있다. In the present specification, the arylalkyl group refers to an alkyl group substituted with an aryl group, and a substituent other than the alkyl group may be further connected.
본 명세서에 있어서, 헤테로고리기는 이종원자로 N, O, P, S, Si 및 Se 중 1개 이상을 포함하는 고리기로서, 탄소수는 특별히 한정되지 않으나 탄소수 2 내지 60인 것이 바람직하다. 일 실시상태에 따르면, 상기 헤테로고리기의 탄소수는 2 내지 30이다. 일 실시상태에 따르면, 상기 헤테로고리기의 탄소수는 2 내지 20이다. 헤테로고리기의 예로는 피리딘기, 피롤기, 피리미딘기, 피리다지닐기, 퓨란기, 티오펜기, 이미다졸기, 피라졸기, 디벤조퓨란기, 디벤조티오펜기, 카바졸기, 헥사하이드로카바졸기 등이 있으나, 이들에만 한정되는 것은 아니다. 본 명세서에 있어서, 헤테로고리기는 단환 또는 다환일 수 있으며, 방향족, 지방족 또는 방향족과 지방족의 축합고리일 수 있으며, 상기 헤테로고리기의 예시 중에서 선택될 수 있다.In the present specification, the heterocyclic group is a cyclic group including at least one of N, O, P, S, Si, and Se as a hetero atom, and the number of carbons is not particularly limited, but is preferably 2 to 60 carbon atoms. According to an exemplary embodiment, the number of carbon atoms of the heterocyclic group is 2 to 30. According to an exemplary embodiment, the number of carbon atoms of the heterocyclic group is 2 to 20. Examples of the heterocyclic group include a pyridine group, a pyrrole group, a pyrimidine group, a pyridazinyl group, a furan group, a thiophene group, an imidazole group, a pyrazole group, a dibenzofuran group, a dibenzothiophene group, a carbazole group, and a hexa Hydrocarbazole group and the like, but are not limited to these. In the present specification, the heterocyclic group may be monocyclic or polycyclic, and may be aromatic, aliphatic, or condensed rings of aromatic and aliphatic, and may be selected from examples of the heterocyclic group.
본 명세서에 있어서, 방향족 탄화수소고리는 pi 전자가 완전히 컨쥬게이션되고 평면인 탄화수소고리를 의미하는 것으로, 2가인 것을 제외하고는 상기 아릴기에 관한 설명이 적용될 수 있다.In the present specification, the aromatic hydrocarbon ring refers to a hydrocarbon ring in which pi electrons are completely conjugated and planar, and the description of the aryl group may be applied except that it is divalent.
본 명세서에 있어서, 지방족 탄화수소고리는 고리모양으로 결합된 구조이며, 방향족이 아닌 고리를 의미한다. 지방족 탄화수소고리의 예로 사이클로알킬 또는 사이클로알켄(cycloalkane)을 들 수 있으며, 2가인 것을 제외하고는 전술한 상기 사이클로알킬기 또는 사이클로알케닐기에 관한 설명이 적용될 수 있다. 또한, 치환된 지방족 탄화수소 고리에는 방향족 고리가 축합된 지방족 탄화수소 고리도 포함된다.In the present specification, the aliphatic hydrocarbon ring is a structure bonded in a ring shape, and refers to a ring that is not aromatic. Examples of the aliphatic hydrocarbon ring include cycloalkyl or cycloalkane, and the description of the cycloalkyl group or cycloalkenyl group described above may be applied except for divalent. Further, the substituted aliphatic hydrocarbon ring also includes an aliphatic hydrocarbon ring condensed with an aromatic ring.
본 명세서에 있어서, 방향족 탄화수소고리 및 지방족 탄화수소고리의 축합고리는 방향족 탄화수소고리와 지방족 탄화수소고리가 축합고리를 형성하는 것을 의미한다.In the present specification, the condensed ring of an aromatic hydrocarbon ring and an aliphatic hydrocarbon ring means that an aromatic hydrocarbon ring and an aliphatic hydrocarbon ring form a condensed ring.
본 명세서에 있어서, "인접한" 기는 해당 치환기가 치환된 원자와 직접 연결된 원자에 치환된 치환기, 해당 치환기와 입체구조적으로 가장 가깝게 위치한 치환기, 또는 해당 치환기가 치환된 원자에 치환된 다른 치환기를 의미할 수 있다. 예컨대, 벤젠고리에서 오르토(ortho)위치로 치환된 2개의 치환기 및 지방족 고리에서 동일 탄소에 치환된 2개의 치환기는 서로 "인접한" 기로 해석될 수 있다. 또한, 지방족고리에서의 연속한 2개 탄소에 연결된 치환기 (총 4개) 또한 "인접한" 기로 해석될 수 있다.In the present specification, the "adjacent" group means a substituent substituted on an atom directly connected to the atom where the corresponding substituent is substituted, a substituent positioned three-dimensionally closest to the corresponding substituent, or another substituent substituted on the atom where the corresponding substituent is substituted. I can. For example, two substituents substituted at an ortho position in a benzene ring and two substituents substituted at the same carbon in an aliphatic ring may be interpreted as "adjacent" groups to each other. In addition, substituent groups (total of 4) connected to two consecutive carbons in the aliphatic ring can also be interpreted as "adjacent" groups.
본 명세서에 있어서, 치환기 중 "인접한 기는 서로 결합하여 고리를 형성한다"는 의미는 인접한 기와 서로 결합하여 치환 또는 비치환된 탄화수소고리; 또는 치환 또는 비치환된 헤테로고리를 형성하는 것을 의미한다.In the present specification, the meaning of "adjacent groups bonded to each other to form a ring" among substituents refers to a substituted or unsubstituted hydrocarbon ring by bonding with adjacent groups to each other; Or it means to form a substituted or unsubstituted heterocycle.
본 명세서에 있어서, 축합 탄화수소고리는 1가 또는 2가일 수 있다. 구체적으로, 본원 화학식에서 Cy3 및 Cy4가 축합 탄화수소고리인 경우, 상기 축합 탄화수소고리는 1가기에 해당한다.In the present specification, the condensed hydrocarbon ring may be monovalent or divalent. Specifically, when Cy3 and Cy4 are condensed hydrocarbon rings in the present formula, the condensed hydrocarbon ring corresponds to a monovalent group.
본 명세서는 하기 화학식 100으로 표시되는 다환 화합물을 제공한다.The present specification provides a polycyclic compound represented by the following formula (100).
[화학식 100][Chemical Formula 100]
Figure PCTKR2020010123-appb-I000008
Figure PCTKR2020010123-appb-I000008
본 명세서의 일 실시상태에 있어서, 화학식 100에 포함된 지방족 고리는 하기 구조에서 선택된다.In an exemplary embodiment of the present specification, the aliphatic ring contained in Chemical Formula 100 is selected from the following structures.
Figure PCTKR2020010123-appb-I000009
Figure PCTKR2020010123-appb-I000009
상기 구조에 있어서,In the above structure,
점선 이중선은 축합되는 위치이고, The dotted double line is the condensed position,
R105 내지 R114는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 알킬기이고,R105 to R114 are the same as or different from each other, and each independently, a substituted or unsubstituted alkyl group,
R115 내지 R117는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R115 to R117 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
n115은 0 내지 2의 정수이고, n116 및 n117은 각각 0 내지 4의 정수이고, n115 is an integer of 0 to 2, n116 and n117 are each an integer of 0 to 4,
n115 내지 n117이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n115 to n117 are each 2 or more, the substituents in parentheses are the same as or different from each other.
n115가 2일 때, R115는 서로 같거나 상이하다. n116가 2 이상일 때, R116는 서로 같거나 상이하다. n117가 2 이상일 때, R117은 서로 같거나 상이하다.When n115 is 2, R115 is the same as or different from each other. When n116 is 2 or more, R116 is the same as or different from each other. When n117 is 2 or more, R117 is the same as or different from each other.
본 명세서에 있어서, 화학식 100에 포함된 지방족 고리란, 1) 2개의 R301이 서로 결합하여 형성한 지방족 탄화수소고리, 2) x101이 1 인 경우의 사이클로펜텐고리, 3) x101이 2인 경우의 사이클로헥센고리, 4) Cy3에 포함된 지방족 탄화수소고리, 및 5) Cy5에 포함된 지방족 탄화수소고리 중 하나 이상의 고리를 의미한다.In the present specification, the aliphatic ring included in Formula 100 is 1) an aliphatic hydrocarbon ring formed by bonding of two R301s to each other, 2) a cyclopentene ring when x101 is 1, 3) a cyclopentene ring when x101 is 2 It means at least one of the hexene ring, 4) an aliphatic hydrocarbon ring included in Cy3, and 5) an aliphatic hydrocarbon ring included in Cy5.
본 명세서의 일 실시상태에 있어서, R105 내지 R114는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 탄소수 1 내지 10의 알킬기이다.In the exemplary embodiment of the present specification, R105 to R114 are the same as or different from each other, and each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms.
본 명세서의 일 실시상태에 있어서, R105 내지 R114는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In the exemplary embodiment of the present specification, R105 to R114 are the same as or different from each other, and are each independently a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms.
본 명세서의 일 실시상태에 있어서, R105 내지 R114는 메틸기이다.In an exemplary embodiment of the present specification, R105 to R114 are methyl groups.
본 명세서의 일 실시상태에 있어서, R115 및 R116은 서로 같거나 상이하고, 각각 독립적으로, 수소; 또는 중수소이다.In the exemplary embodiment of the present specification, R115 and R116 are the same as or different from each other, and each independently, hydrogen; Or deuterium.
본 명세서의 일 실시상태에 있어서, R117은 수소, 또는 중수소이거나, 인접한 4개의 R117이 서로 결합하여 치환 또는 비치환된 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, R117 is hydrogen or deuterium, or four adjacent R117s combine with each other to form a substituted or unsubstituted benzene ring.
본 명세서의 일 실시상태에 있어서, R117은 수소, 또는 중수소이거나, 인접한 4개의 R117이 서로 결합하여 탄소수 1 내지 10의 알킬기로 치환 또는 비치환된 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, R117 is hydrogen or deuterium, or four adjacent R117s combine with each other to form a benzene ring unsubstituted or substituted with an alkyl group having 1 to 10 carbon atoms.
본 명세서의 일 실시상태에 있어서, R117은 수소, 또는 중수소이거나, 인접한 4개의 R117이 서로 결합하여 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, R117 is hydrogen or deuterium, or four adjacent R117s are bonded to each other to form a benzene ring.
본 명세서의 일 실시상태에 있어서, 화학식 100에 포함된 모든 지방족 고리는 상기 구조에서 선택된다,In an exemplary embodiment of the present specification, all aliphatic rings included in Chemical Formula 100 are selected from the above structures,
본 명세서의 일 실시상태에 있어서, 화학식 100에 포함된 지방족 고리는 하기 구조에서 선택된다.In an exemplary embodiment of the present specification, the aliphatic ring contained in Chemical Formula 100 is selected from the following structures.
Figure PCTKR2020010123-appb-I000010
Figure PCTKR2020010123-appb-I000010
본 명세서의 일 실시상태에 있어서, R301은 서로 같거나 상이하고, 각각 독립적으로, 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고, 인접한 2개의 R301이 서로 결합하여 치환 또는 비치환된 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R301 is the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, and two adjacent R301s are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, R301은 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 60의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이고, 인접한 2개의 R301이 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 30의 지방족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, R301 is deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms, and two adjacent R301s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R301은 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 40의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 40의 아릴헤테로아릴아민기이고, 인접한 2개의 R301이 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 20의 지방족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, R301 is deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted aryl group having 6 to 20 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 20 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 40 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 40 carbon atoms, and two adjacent R301s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, R301은 중수소; 중수소 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환되고, 탄소수 5 또는 6의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 60의 아릴아민기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이고, 인접한 2개의 R301이 서로 결합하여 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 5 내지 30의 지방족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, R301 is deuterium; An alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; An aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted substituted or unsubstituted C6-C30 hetero with one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group Cyclic group; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent to which two or more groups selected from the group are connected, and an aliphatic hydrocarbon ring having 5 or 6 carbon atoms is condensed or uncondensed, 6 carbon atoms Arylamine group of to 60; Or an arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group, and two adjacent R301s are An aliphatic hydrocarbon ring having 5 to 30 carbon atoms, unsubstituted or substituted with one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms, or a substituent connected with two or more groups selected from the group. To form.
본 명세서의 일 실시상태에 있어서, R301은 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 메틸기 또는 tert-부틸기로 치환 또는 비치환된 페닐기; 디메틸플루오레닐기; 디벤조퓨란기; 디벤조티오펜기; 메틸기, tert-부틸기, 페닐기, 톨릴기, tert-부틸페닐기 또는 테트라메틸테트라하이드로나프탈렌기로 치환 또는 비치환된 헥사하이드로카바졸기; 메틸기 또는 tert-부틸기로 치환 또는 비치환되고, 시클로헥센이 축합 또는 비축합된, 다이페닐아민기; 메틸기 또는 tert-부틸기로 치환 또는 비치환된 N-페닐-N-디벤조퓨란아민기; 또는 메틸기 또는 tert-부틸기로 치환 또는 비치환된 N-페닐-N-디벤조티오펜아민기이다.In an exemplary embodiment of the present specification, R301 is a methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Dimethylfluorenyl group; Dibenzofuran group; Dibenzothiophene group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group substituted or unsubstituted with a methyl group or a tert-butyl group and condensed or non-condensed with a cyclohexene; N-phenyl-N-dibenzofuranamine group unsubstituted or substituted with a methyl group or a tert-butyl group; Or N-phenyl-N-dibenzothiophenamine group unsubstituted or substituted with a methyl group or a tert-butyl group.
본 명세서의 일 실시상태에 있어서, R302는 수소; 중수소; 또는 치환 또는 비치환된 알킬기이다.In an exemplary embodiment of the present specification, R302 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
본 명세서의 일 실시상태에 있어서, R302는 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 10의 알킬기이다.In an exemplary embodiment of the present specification, R302 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
본 명세서의 일 실시상태에 있어서, R302는 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In an exemplary embodiment of the present specification, R302 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R302는 수소; 중수소; 또는 메틸기이다.In an exemplary embodiment of the present specification, R302 is hydrogen; heavy hydrogen; Or a methyl group.
본 명세서의 일 실시상태에 있어서, n302는 2 이상이고, 복수 개의 R302 중 2개 또는 4개는 메틸기이다.In an exemplary embodiment of the present specification, n302 is 2 or more, and two or four of the plurality of R302s are methyl groups.
본 명세서의 일 실시상태에 있어서, 상기 화학식 100은 하기 화학식 1 내지 3 중 어느 하나로 표시된다.In an exemplary embodiment of the present specification, Chemical Formula 100 is represented by any one of Chemical Formulas 1 to 3.
[화학식 1][Formula 1]
Figure PCTKR2020010123-appb-I000011
Figure PCTKR2020010123-appb-I000011
[화학식 2][Formula 2]
Figure PCTKR2020010123-appb-I000012
Figure PCTKR2020010123-appb-I000012
[화학식 3][Formula 3]
Figure PCTKR2020010123-appb-I000013
Figure PCTKR2020010123-appb-I000013
상기 화학식 1 내지 3에 있어서,In Formulas 1 to 3,
R1, Cy3, Cy4 및 n1은 상기 화학식 100에서 정의한 바와 같고,R1, Cy3, Cy4 and n1 are as defined in Chemical Formula 100,
R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R3 and R4 are the same as or different from each other, and each independently, deuterium; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
R2, R5, R6, 및 R8은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R2, R5, R6, and R8 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
n3 및 n4는 각각 1 내지 4의 정수이고, n2, n5 및 n6은 각각 0 내지 10의 정수이고, n8은 0 내지 8의 정수이고,n3 and n4 are each an integer of 1 to 4, n2, n5 and n6 are each an integer of 0 to 10, n8 is an integer of 0 to 8,
n2 내지 n6 및 n8이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n2 to n6 and n8 are each 2 or more, the substituents in parentheses are the same as or different from each other.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 방향족 탄화수소고리; 치환 또는 비치환된 지방족 탄화수소고리; 및 치환 또는 비치환된 방향족 헤테로고리로 이루어진 군에서 선택된 하나이거나, 상기 군에서 선택된 2 이상의 고리가 축합된 고리이고,In the exemplary embodiment of the present specification, Cy3 and Cy4 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
상기 Cy3 및 Cy4 중 적어도 하나는 하기 화학식 A-1 내지 A-3에서 선택된 하나이다.At least one of Cy3 and Cy4 is one selected from Formulas A-1 to A-3 below.
Figure PCTKR2020010123-appb-I000014
Figure PCTKR2020010123-appb-I000014
상기 화학식 A-1 내지 A-3에 있어서,In the formulas A-1 to A-3,
점선은 화학식 100에 연결되는 위치이며,The dotted line is the position connected to Formula 100,
Q1은 O; S; 또는 C(R118)(R119)이고,Q1 is O; S; Or C(R118)(R119),
R101 내지 R104, R118 및 R119는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R101 to R104, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
x11은 1 또는 2이고, x11 is 1 or 2,
n101은 0 내지 7의 정수이고, n102는 0 내지 11의 정수이고, n103은 0 내지 4의 정수이고, n104는 0 내지 5의 정수이고,n101 is an integer from 0 to 7, n102 is an integer from 0 to 11, n103 is an integer from 0 to 4, n104 is an integer from 0 to 5,
n101 내지 n104이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n101 to n104 are each 2 or more, the substituents in parentheses are the same as or different from each other.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 치환 또는 비치환된 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest are substituted or unsubstituted aromatic hydrocarbon rings.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 치환 또는 비치환된 탄소수 6 내지 60의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the remainder is a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 60 carbon atoms.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 치환 또는 비치환된 탄소수 6 내지 30의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest are substituted or unsubstituted aromatic hydrocarbon rings having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 치환 또는 비치환된 탄소수 6 내지 20의 단환의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest is a substituted or unsubstituted monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest is from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms. It is an aromatic hydrocarbon ring having 6 to 30 carbon atoms substituted or unsubstituted with one or more selected substituents or a substituent to which two or more groups selected from the group are connected.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 중수소, 탄소수 1 내지 6의 알킬기 및 탄소수 6 내지 20의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 20의 단환의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest are from the group consisting of deuterium, an alkyl group having 1 to 6 carbon atoms, and an aryl group having 6 to 20 carbon atoms. It is a monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms, which is substituted or unsubstituted with one or more selected substituents or a substituent to which two or more groups selected from the group are connected.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 중수소, 탄소수 1 내지 10의 알킬기, 또는 탄소수 7 내지 50의 아릴알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 단환의 방향족 탄화수소고리이다.In an exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest is substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, or an arylalkyl group having 7 to 50 carbon atoms. Or an unsubstituted monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 페닐기, 바이페닐기 또는 터페닐기이고, 상기 페닐기, 바이페닐기 또는 터페닐기는 메틸기, 이소프로필기, tert-부틸기, 또는 2-페닐프로판-2-일기(2-phenylpropan-2-yl)로 치환 또는 비치환된다.In an exemplary embodiment of the present specification, at least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the remainder is a phenyl group, a biphenyl group, or a terphenyl group, and the phenyl group, biphenyl group, or terphenyl group is a methyl group , Isopropyl group, tert-butyl group, or 2-phenylpropan-2-yl group (2-phenylpropan-2-yl) substituted or unsubstituted.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택된다.In the exemplary embodiment of the present specification, Cy3 and Cy4 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3.
본 명세서의 일 실시상태에 있어서, R118 및 R119는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In the exemplary embodiment of the present specification, R118 and R119 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R118 및 R119는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In the exemplary embodiment of the present specification, R118 and R119 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R118 및 R119는 메틸기이다.In an exemplary embodiment of the present specification, R118 and R119 are methyl groups.
본 명세서의 일 실시상태에 있어서, R101은 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In an exemplary embodiment of the present specification, R101 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R101은 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In an exemplary embodiment of the present specification, R101 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R101은 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In an exemplary embodiment of the present specification, R101 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R101은 수소; 중수소; 또는 tert-부틸기이다.In an exemplary embodiment of the present specification, R101 is hydrogen; heavy hydrogen; Or tert-butyl group.
본 명세서의 일 실시상태에 있어서, R102는 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이거나, 인접한 4개의 R102가 서로 결합하여 치환 또는 비치환된 방향족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, R102 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or four adjacent R102 bonded to each other to form a substituted or unsubstituted aromatic hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, R102는 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이거나, 인접한 4개의 R102가 서로 결합하여 치환 또는 비치환된 탄소수 6 내지 30의 방향족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, R102 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or four adjacent R 102 bonds to each other to form a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R102는 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이거나, 인접한 4개의 R102가 서로 결합하여 치환 또는 비치환된 벤젠고리를 형성한다.In an exemplary embodiment of the present specification, R102 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or four adjacent R102s are bonded to each other to form a substituted or unsubstituted benzene ring.
본 명세서의 일 실시상태에 있어서, R102는 수소; 중수소; 또는 메틸기이거나, 인접한 4개의 R102가 서로 결합하여 벤젠고리를 형성한다.In an exemplary embodiment of the present specification, R102 is hydrogen; heavy hydrogen; Or it is a methyl group, or four adjacent R102 combine with each other to form a benzene ring.
본 명세서의 일 실시상태에 있어서, n102는 2 이상이고, 복수 개의 R102 중 2개 또는 4개는 메틸기이다.In an exemplary embodiment of the present specification, n102 is 2 or more, and two or four of the plurality of R102s are methyl groups.
본 명세서의 일 실시상태에 있어서, R103 및 R104는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이거나, 인접한 2개의 R103; 또는 인접한 2개의 R104가 서로 결합하여 치환 또는 비치환된 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, adjacent two R103; Or two adjacent R104s are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, R103 및 R104는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이거나, 인접한 2개의 R103; 또는 인접한 2개의 R104가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 30의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or two adjacent R103; Or two adjacent R104s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R103 및 R104는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 20의 아릴기이거나, 인접한 2개의 R103; 또는 인접한 2개의 R104가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 20의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C 1 to C 6 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or two adjacent R103; Or two adjacent R104s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, R103 및 R104의 알킬기 또는 아릴기는 중수소, 탄소수 1 내지 10의 알킬기, 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기; 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In an exemplary embodiment of the present specification, the alkyl group or aryl group of R103 and R104 includes one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
본 명세서의 일 실시상태에 있어서, R103 및 R104의 알킬기 또는 아릴기는 중수소, 탄소수 1 내지 10의 알킬기, 탄소수 7 내지 50의 아릴알킬기, 또는 탄소수 6 내지 30의 아릴기로 치환될 수 있다.In the exemplary embodiment of the present specification, the alkyl group or aryl group of R103 and R104 may be substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, an arylalkyl group having 7 to 50 carbon atoms, or an aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 인접한 2개의 R103; 또는 인접한 2개의 R104가 서로 결합하여 형성한 지방족 탄화수소고리는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기; 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In the exemplary embodiment of the present specification, two adjacent R103; Or the aliphatic hydrocarbon ring formed by bonding of two adjacent R104s to each other is at least one substituent selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
본 명세서의 일 실시상태에 있어서, R103 및 R104는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 또는 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기이거나, 인접한 2개의 R103; 또는 인접한 2개의 R104가 서로 결합하여 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 5 또는 6의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; Or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms, or two adjacent R103; Or two adjacent R104s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
본 명세서의 일 실시상태에 있어서, R103 및 R104는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 또는 tert-부틸기로 치환 또는 비치환된 페닐기이거나, 인접한 2개의 R103; 또는 인접한 2개의 R104가 서로 결합하여 메틸기로 치환 또는 비치환된 사이클로펜텐고리, 또는 메틸기로 치환 또는 비치환된 사이클로헥센고리를 형성한다.In the exemplary embodiment of the present specification, R103 and R104 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R103; Alternatively, two adjacent R104s are bonded to each other to form a cyclopentene ring substituted or unsubstituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
본 명세서의 일 실시상태에 있어서, R103은 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 또는 tert-부틸기로 치환 또는 비치환된 페닐기이다.In an exemplary embodiment of the present specification, R103 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group.
본 명세서의 일 실시상태에 있어서, R104는 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 또는 tert-부틸기로 치환 또는 비치환된 페닐기이거나, 인접한 2개의 R104가 서로 결합하여 메틸기로 치환 또는 비치환된 사이클로펜텐고리, 또는 메틸기로 치환 또는 비치환된 사이클로헥센고리를 형성한다.In an exemplary embodiment of the present specification, R104 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R104s are bonded to each other to form a cyclopentene ring unsubstituted or substituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
n101이 2 이상일 때. R101은 서로 같거나 상이하다. n102가 2 이상일 때, R102는 서로 같거나 상이하다. n103이 2 이상일 때. R103은 서로 같거나 상이하다. n104이 2 이상일 때, R104는 서로 같거나 상이하다.When n101 is 2 or more. R101 is the same as or different from each other. When n102 is 2 or more, R102 is the same as or different from each other. When n103 is 2 or more. R103 is the same as or different from each other. When n104 is 2 or more, R104 is the same as or different from each other.
본 명세서의 일 실시상태에 있어서, Cy3 및 Cy4는 서로 같거나 상이하고, 각각 독립적으로, 하기 그룹 A-11 내지 A-14에서 선택되고, Cy3 및 Cy4 중 적어도 하나는 하기 그룹 A-11 내지 A-13 에서 선택된다.In the exemplary embodiment of the present specification, Cy3 and Cy4 are the same as or different from each other, and each independently, is selected from the following groups A-11 to A-14, and at least one of Cy3 and Cy4 is the following groups A-11 to A It is selected from -13.
[그룹 A-11][Group A-11]
Figure PCTKR2020010123-appb-I000015
Figure PCTKR2020010123-appb-I000015
[그룹 A-12][Group A-12]
Figure PCTKR2020010123-appb-I000016
Figure PCTKR2020010123-appb-I000016
[그룹 A-13][Group A-13]
Figure PCTKR2020010123-appb-I000017
Figure PCTKR2020010123-appb-I000017
[그룹 A-14][Group A-14]
Figure PCTKR2020010123-appb-I000018
Figure PCTKR2020010123-appb-I000018
상기 그룹 A-11 내지 A-14에 있어서,In the above groups A-11 to A-14,
점선은 화학식 100에 연결되는 위치이며,The dotted line is the position connected to Formula 100,
Q1은 O; S; 또는 C(R118)(R119)이고,Q1 is O; S; Or C(R118)(R119),
R41 내지 R43, R46 내지 R50, R53 내지 R55, R118 및 R119는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R41 to R43, R46 to R50, R53 to R55, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
R45, R51 및 R52는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 알킬기이고,R45, R51 and R52 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group,
n41, n43 및 n44는 각각 0 내지 7의 정수이고, n42, n49 및 n50은 각각 0 내지 5의 정수이고, n41, n43 and n44 are each an integer of 0 to 7, n42, n49 and n50 are each an integer of 0 to 5,
n41 내지 n44, n49 및 n50이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n41 to n44, n49 and n50 are each 2 or more, the substituents in parentheses are the same as or different from each other.
본 명세서의 일 실시상태에 있어서, R41에는 전술한 R101에 관한 설명에 적용될 수 있다.In the exemplary embodiment of the present specification, R41 may be applied to the description of R101 described above.
본 명세서의 일 실시상태에 있어서, R41은 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In an exemplary embodiment of the present specification, R41 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R41은 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In an exemplary embodiment of the present specification, R41 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R41은 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In an exemplary embodiment of the present specification, R41 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R41은 수소; 중수소; 또는 tert-부틸기이다.In an exemplary embodiment of the present specification, R41 is hydrogen; heavy hydrogen; Or tert-butyl group.
본 명세서의 일 실시상태에 있어서, R42 내지 R44에는 전술한 R102에 관한 설명이 적용될 수 있다.In the exemplary embodiment of the present specification, the description of R102 described above may be applied to R42 to R44.
본 명세서의 일 실시상태에 있어서, R42 및 R43은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In the exemplary embodiment of the present specification, R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R42 및 R43은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In the exemplary embodiment of the present specification, R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R42 및 R43은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In the exemplary embodiment of the present specification, R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R42 및 R43은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 메틸기이다.In the exemplary embodiment of the present specification, R42 and R43 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a methyl group.
본 명세서의 일 실시상태에 있어서, R44는 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이거나, 인접한 4개의 R44가 서로 결합하여 치환 또는 비치환된 방향족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, R44 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or four adjacent R44 bonded to each other to form a substituted or unsubstituted aromatic hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, R44는 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이거나, 인접한 4개의 R44가 서로 결합하여 치환 또는 비치환된 탄소수 6 내지 30의 방향족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, R44 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or four adjacent R 44 bonds to each other to form a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R44는 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이거나, 인접한 4개의 R44가 서로 결합하여 치환 또는 비치환된 벤젠고리를 형성한다.In an exemplary embodiment of the present specification, R44 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or four adjacent R44s are bonded to each other to form a substituted or unsubstituted benzene ring.
본 명세서의 일 실시상태에 있어서, R44는 수소; 중수소; 또는 메틸기이거나, 인접한 4개의 R44가 서로 결합하여 벤젠고리를 형성한다.In an exemplary embodiment of the present specification, R44 is hydrogen; heavy hydrogen; Or a methyl group, or four adjacent R44s are bonded to each other to form a benzene ring.
본 명세서의 일 실시상태에 있어서, R45 내지 R49에는 전술한 R103 및 R104의 설명이 적용될 수 있다,In one embodiment of the present specification, the descriptions of R103 and R104 described above may be applied to R45 to R49.
본 명세서의 일 실시상태에 있어서, R46 내지 R50은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성한다.In the exemplary embodiment of the present specification, R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or is bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring.
본 명세서의 일 실시상태에 있어서, R46 내지 R50은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이거나, 인접한 2개의 치환기가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 30의 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted hydrocarbon ring having 5 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R46 내지 R50은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 20의 아릴기이거나, 인접한 2개의 치환기가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 20의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C 1 to C 6 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, R46 내지 R50의 알킬기 또는 아릴기는 중수소, 탄소수 1 내지 10의 알킬기, 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기; 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In an exemplary embodiment of the present specification, the alkyl group or aryl group of R46 to R50 is one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
본 명세서의 일 실시상태에 있어서, R46 내지 R50의 알킬기 또는 아릴기는 중수소, 탄소수 1 내지 10의 알킬기, 탄소수 7 내지 50의 아릴알킬기, 또는 탄소수 6 내지 30의 아릴기로 치환될 수 있다.In the exemplary embodiment of the present specification, the alkyl group or aryl group of R46 to R50 may be substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, an arylalkyl group having 7 to 50 carbon atoms, or an aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 인접한 2개의 R49 또는 인접한 2개의 R50이 서로 결합하여 형성한 지방족 탄화수소고리는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기; 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In the exemplary embodiment of the present specification, the aliphatic hydrocarbon ring formed by bonding of two adjacent R49 or two adjacent R50 to each other is at least one substituent selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
본 명세서의 일 실시상태에 있어서, R46 내지 R50은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 또는 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기이거나, 인접한 2개의 R49; 또는 인접한 2개의 R50이 서로 결합하여 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 5 또는 6의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; Or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms, or two adjacent R49; Or two adjacent R50s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
본 명세서의 일 실시상태에 있어서, R46 내지 R50은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 또는 tert-부틸기로 치환 또는 비치환된 페닐기이거나, 인접한 2개의 R49; 또는 인접한 2개의 R50이 서로 결합하여 메틸기로 치환 또는 비치환된 사이클로펜텐고리, 또는 메틸기로 치환 또는 비치환된 사이클로헥센고리를 형성한다.In the exemplary embodiment of the present specification, R46 to R50 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R49; Alternatively, two adjacent R50s are bonded to each other to form a cyclopentene ring unsubstituted or substituted with a methyl group or a cyclohexene ring unsubstituted or substituted with a methyl group.
본 명세서의 일 실시상태에 있어서, R45는 수소; 중수소; 또는 치환 또는 비치환된 알킬기이다.In an exemplary embodiment of the present specification, R45 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
본 명세서의 일 실시상태에 있어서, R45는 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 10의 알킬기이다.In an exemplary embodiment of the present specification, R45 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
본 명세서의 일 실시상태에 있어서, R45는 수소; 중수소; 또는 중수소, 탄소수 1 내지 10의 알킬기, 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기, 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환된 탄소수 1 내지 10의 알킬기이다.In an exemplary embodiment of the present specification, R45 is hydrogen; heavy hydrogen; Or deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms, or an alkyl group having 1 to 10 carbon atoms substituted with a substituent to which two or more groups selected from the group are connected.
본 명세서의 일 실시상태에 있어서, R45는 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 또는 2-페닐프로판-2-일기(2-phenylpropan-2-yl)이다.In an exemplary embodiment of the present specification, R45 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; Or 2-phenylpropan-2-yl group (2-phenylpropan-2-yl).
본 명세서의 일 실시상태에 있어서, R51 및 R52는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 알킬기이다.In the exemplary embodiment of the present specification, R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
본 명세서의 일 실시상태에 있어서, R51 및 R52는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 10의 알킬기이다.In the exemplary embodiment of the present specification, R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
본 명세서의 일 실시상태에 있어서, R51 및 R52는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 중수소, 탄소수 1 내지 10의 알킬기, 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기, 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환된 탄소수 1 내지 10의 알킬기이다.In the exemplary embodiment of the present specification, R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms, or an alkyl group having 1 to 10 carbon atoms substituted with a substituent to which two or more groups selected from the group are connected.
본 명세서의 일 실시상태에 있어서, R51 및 R52는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 또는 2-페닐프로판-2-일기(2-phenylpropan-2-yl)이다.In the exemplary embodiment of the present specification, R51 and R52 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; Or 2-phenylpropan-2-yl group (2-phenylpropan-2-yl).
본 명세서의 일 실시상태에 있어서, 상기 그룹 A-12은 하기 그룹 A-12-1에서 선택된다.In the exemplary embodiment of the present specification, the group A-12 is selected from the following group A-12-1.
[그룹 A-12-1][Group A-12-1]
Figure PCTKR2020010123-appb-I000019
Figure PCTKR2020010123-appb-I000019
상기 그룹 A-12-1에 있어서,In the above group A-12-1,
R42 내지 R44의 정의는 그룹 A-12에서 정의한 바와 같고,The definition of R42 to R44 is as defined in group A-12,
n421, n431 및 n441은 각각 0 내지 3의 정수이고, n421, n431 및 n441가 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.n421, n431 and n441 are each an integer of 0 to 3, and when n421, n431 and n441 are each 2 or more, the substituents in parentheses are the same or different from each other.
n41이 2 이상일 때, R41은 서로 같거나 상이하다. n42이 2 이상일 때, R42는 서로 같거나 상이하다. n43이 2 이상일 때, R43은 서로 같거나 상이하다. n44이 2 이상일 때, R44는 서로 같거나 상이하다. n49는 2 이상일 때, R49는 서로 같거나 상이하다. n50이 2 이상일 때, R50은 서로 같거나 상이하다. When n41 is 2 or more, R41 is the same as or different from each other. When n42 is 2 or more, R42 is the same as or different from each other. When n43 is 2 or more, R43 is the same as or different from each other. When n44 is 2 or more, R44 is the same as or different from each other. When n49 is 2 or more, R49 is the same as or different from each other. When n50 is 2 or more, R50 is the same as or different from each other.
본 명세서의 일 실시상태에 있어서, R1은 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이다.In an exemplary embodiment of the present specification, R1 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group.
본 명세서의 일 실시상태에 있어서, R1은 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 헤테로고리기; 또는 -N(R211)(R212)이다.In an exemplary embodiment of the present specification, R1 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, R1은 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 2 내지 30의 N함유 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 60의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In an exemplary embodiment of the present specification, R1 is deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted N-containing heterocyclic group having 2 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
본 명세서의 일 실시상태에 있어서, R1은 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 치환 또는 비치환된 탄소수 2 내지 20의 N함유 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 40의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 40의 아릴헤테로아릴아민기이다.In an exemplary embodiment of the present specification, R1 is deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted C 2 to C 20 N-containing heterocyclic group; A substituted or unsubstituted arylamine group having 6 to 40 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 40 carbon atoms.
본 명세서의 일 실시상태에 있어서, R1은 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 2 내지 30의 N함유 헤테로고리기; 또는 -N(R211)(R212)이다.In an exemplary embodiment of the present specification, R1 is deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted N-containing heterocyclic group having 2 to 30 carbon atoms; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, R1은 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 치환 또는 비치환된 탄소수 2 내지 20의 N함유 헤테로고리기; 또는 -N(R211)(R212)이다.In an exemplary embodiment of the present specification, R1 is deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted C 2 to C 20 N-containing heterocyclic group; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, R1은 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 2 내지 30의 N함유 헤테로고리기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환되고, 탄소수 5 내지 30의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 60의 아릴아민기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In an exemplary embodiment of the present specification, R1 is deuterium; An alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Deuterium, an N-containing heterocyclic group having 2 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent to which two or more groups selected from the group are connected, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 carbon atoms Arylamine group of to 60; Or an arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, R1은 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 탄소수 1 내지 6의 알킬기, 탄소수 6 내지 20의 아릴기 또는 탄소수 7 내지 30의 알킬아릴기로 치환 또는 비치환된 탄소수 2 내지 20의 N함유 헤테로고리기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환되고, 탄소수 5 또는 6의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 40의 아릴아민기; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 40의 아릴헤테로아릴아민기이다.In an exemplary embodiment of the present specification, R1 is deuterium; An alkyl group having 1 to 6 carbon atoms substituted or unsubstituted with deuterium; An N-containing heterocyclic group having 2 to 20 carbon atoms unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an alkylaryl group having 7 to 30 carbon atoms; An arylamine group having 6 to 40 carbon atoms, unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms and condensed or uncondensed with an aliphatic hydrocarbon ring having 5 or 6 carbon atoms; Or an arylheteroarylamine group having 6 to 40 carbon atoms substituted or unsubstituted with deuterium.
본 명세서의 일 실시상태에 있어서, R1은 중수소로 치환 또는 비치환된 메틸기; 이소프로필기; tert-부틸기; 메틸기, tert-부틸기, 페닐기, 톨릴기, tert-부틸페닐기 또는 테트라메틸테트라하이드로나프탈렌기로 치환 또는 비치환된 헥사하이드로카바졸기; 메틸기, 이소프로필기 또는 tert-부틸기로 치환 또는 비치환되고, 사이클로펜텐 또는 사이클로헥센이 축합 또는 비축합된, 다이페닐아민기; N-페닐-N-디벤조퓨란아민기; 또는 N-페닐-N-디벤조티오펜아민기이다.In the exemplary embodiment of the present specification, R1 is a methyl group unsubstituted or substituted with deuterium; Isopropyl group; tert-butyl group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group in which a methyl group, an isopropyl group, or a tert-butyl group is substituted or unsubstituted, and a cyclopentene or cyclohexene is condensed or non-condensed; N-phenyl-N-dibenzofuranamine group; Or N-phenyl-N-dibenzothiophenamine group.
본 명세서의 일 실시상태에 있어서, R211 및 R212는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이다.In the exemplary embodiment of the present specification, R211 and R212 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group.
본 명세서의 일 실시상태에 있어서, R211 및 R212는 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 30의 헤테로고리기이다.In the exemplary embodiment of the present specification, R211 and R212 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted C2 to C30 heterocyclic group.
본 명세서의 일 실시상태에 있어서, R211 및 R212는 서로 같거나 상이하고, 각각 독립적으로 중수소 또는 탄소수 1 내지 10의 알킬기로 치환 또는 비치환되고, 탄소수 5 내지 30의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 30의 아릴기; 또는 중수소 또는 탄소수 1 내지 10의 알킬기로 치환 또는 비치환된 탄소수 2 내지 30의 헤테로고리기이다.In the exemplary embodiment of the present specification, R211 and R212 are the same as or different from each other, each independently substituted or unsubstituted with deuterium or an alkyl group having 1 to 10 carbon atoms, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or non-condensed An aryl group having 6 to 30 carbon atoms; Or a C2 to C30 heterocyclic group unsubstituted or substituted with deuterium or a C1 to C10 alkyl group.
본 명세서의 일 실시상태에 있어서, R211 및 R212는 서로 같거나 상이하고, 각각 독립적으로 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환되고, 탄소수 5 또는 6의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 20의 아릴기; 또는 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기이다.In the exemplary embodiment of the present specification, R211 and R212 are the same as or different from each other, each independently substituted or unsubstituted with deuterium or an alkyl group having 1 to 6 carbon atoms, and an aliphatic hydrocarbon ring having 5 or 6 carbon atoms is condensed or non-condensed An aryl group having 6 to 20 carbon atoms; Or it is a C6-C20 heterocyclic group substituted or unsubstituted with deuterium or a C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R211 및 R212는 서로 같거나 상이하고, 각각 독립적으로 중수소, 메틸기 또는 tert-부틸기로 치환 또는 비치환된 페닐기; 메틸기로 치환 또는 비치환된 테트라하이드로나프탈렌기; 디벤조퓨란기; 또는 디벤조티오펜기이다.In the exemplary embodiment of the present specification, R211 and R212 are the same as or different from each other, and each independently a phenyl group unsubstituted or substituted with deuterium, a methyl group, or a tert-butyl group; A tetrahydronaphthalene group unsubstituted or substituted with a methyl group; Dibenzofuran group; Or a dibenzothiophene group.
본 명세서의 일 실시상태에 있어서, R1은 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환되고, 탄소수 5 내지 30의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 60의 아릴아민기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기; 또는 하기 화학식 Het1이다.In the exemplary embodiment of the present specification, R1 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 Arylamine group of to 60; Arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Or the following formula Het1.
[화학식 Het1][Chemical Formula Het1]
Figure PCTKR2020010123-appb-I000020
Figure PCTKR2020010123-appb-I000020
상기 화학식 Het1에 있어서,In the formula Het1,
점선은 화학식 100에 연결되는 위치이고,The dotted line is the position connected to Chemical Formula 100,
R203 내지 R205는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이고,R203 to R205 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; An alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Or an aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group,
n205는 0 내지 12의 정수이고, n205가 2 이상일 때 R205는 서로 같거나 상이하다.n205 is an integer from 0 to 12, and when n205 is 2 or more, R205 is the same as or different from each other.
본 명세서의 일 실시상태에 있어서, R203 및 R204는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 알킬기이다.In the exemplary embodiment of the present specification, R203 and R204 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
본 명세서의 일 실시상태에 있어서, R203 및 R204는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 10의 알킬기이다.In the exemplary embodiment of the present specification, R203 and R204 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C10 alkyl group.
본 명세서의 일 실시상태에 있어서, R203 및 R204는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In the exemplary embodiment of the present specification, R203 and R204 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R203 및 R204는 메틸기이다.In an exemplary embodiment of the present specification, R203 and R204 are methyl groups.
본 명세서의 일 실시상태에 있어서, R205는 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In an exemplary embodiment of the present specification, R205 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R205는 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In an exemplary embodiment of the present specification, R205 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R205는 수소; 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In an exemplary embodiment of the present specification, R205 is hydrogen; heavy hydrogen; An alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Or an aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms, or a substituent connected with two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, R205는 수소; 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 또는 중수소, 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기이다.In an exemplary embodiment of the present specification, R205 is hydrogen; heavy hydrogen; An alkyl group having 1 to 6 carbon atoms substituted or unsubstituted with deuterium; Or deuterium or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
상기 R205의 치환된 아릴기에는 지방족 탄화수소고리가 축합된 형태도 포함된다.The substituted aryl group of R205 also includes an aliphatic hydrocarbon ring condensed.
본 명세서의 일 실시상태에 있어서, R205는 수소; 중수소; 메틸기, tert-부틸기; 메틸기 또는 tert-부틸기로 치환 또는 비치환된 페닐기; 또는 메틸기로 치환 또는 비치환된 테트라하이드로나프탈렌기이다.In an exemplary embodiment of the present specification, R205 is hydrogen; heavy hydrogen; Methyl group, tert-butyl group; A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Or a tetrahydronaphthalene group unsubstituted or substituted with a methyl group.
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group.
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 60의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 40의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 40의 아릴헤테로아릴아민기이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted aryl group having 6 to 20 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 20 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 40 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 40 carbon atoms.
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 또는 -N(R211)(R212)이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C1-C10 alkyl group; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 또는 -N(R211)(R212)이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, deuterium; A substituted or unsubstituted C 1 to C 6 alkyl group; A substituted or unsubstituted aryl group having 6 to 20 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 20 carbon atoms; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 중수소 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환되고, 탄소수 5 내지 30의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 60의 아릴아민기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, deuterium; An alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; An aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted substituted or unsubstituted C6-C30 hetero with one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group Cyclic group; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent to which two or more groups selected from the group are connected, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 carbon atoms Arylamine group of to 60; Or an arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 탄소수 1 내지 6의 알킬기, 탄소수 6 내지 20의 아릴기 또는 탄소수 7 내지 30의 알킬아릴기로 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 40의 아릴아민기; 또는 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 2 내지 40의 아릴헤테로아릴아민기이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, deuterium; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; An arylamine group having 6 to 40 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; Or an arylheteroarylamine group having 2 to 40 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms.
본 명세서의 일 실시상태에 있어서, R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 메틸기 또는 tert-부틸기로 치환 또는 비치환된 페닐기; 디메틸플루오레닐기; 디벤조퓨란기; 디벤조티오펜기; 메틸기, tert-부틸기, 페닐기, 톨릴기, tert-부틸페닐기 또는 테트라메틸테트라하이드로나프탈렌기로 치환 또는 비치환된 헥사하이드로카바졸기; 메틸기 또는 tert-부틸기로 치환 또는 비치환되고, 시클로헥센이 축합 또는 비축합된, 다이페닐아민기; 메틸기 또는 tert-부틸기로 치환 또는 비치환된 N-페닐-N-디벤조퓨란아민기; 또는 메틸기 또는 tert-부틸기로 치환 또는 비치환된 N-페닐-N-디벤조티오펜아민기이다.In the exemplary embodiment of the present specification, R3 and R4 are the same as or different from each other, and each independently, a methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Dimethylfluorenyl group; Dibenzofuran group; Dibenzothiophene group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group substituted or unsubstituted with a methyl group or a tert-butyl group and condensed or non-condensed with a cyclohexene; N-phenyl-N-dibenzofuranamine group unsubstituted or substituted with a methyl group or a tert-butyl group; Or N-phenyl-N-dibenzothiophenamine group unsubstituted or substituted with a methyl group or a tert-butyl group.
본 명세서의 일 실시상태에 있어서, 인접한 2개의 R3는 서로 결합하여 치환 또는 비치환된 지방족 탄화수소고리를 형성한다.In an exemplary embodiment of the present specification, two adjacent R3s combine with each other to form a substituted or unsubstituted aliphatic hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, 인접한 2개의 R3는 서로 결합하여 탄소수 1 내지 10의 알킬기로 치환 또는 비치환된 탄소수 5 내지 30의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, two adjacent R3s are bonded to each other to form an aliphatic hydrocarbon ring having 5 to 30 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 10 carbon atoms.
본 명세서의 일 실시상태에 있어서, 인접한 2개의 R3는 서로 결합하여 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 5 내지 20의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, two adjacent R3s are bonded to each other to form an aliphatic hydrocarbon ring having 5 to 20 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
본 명세서의 일 실시상태에 있어서, 인접한 2개의 R3는 서로 결합하여 메틸기로 치환 또는 비치환된 탄소수 5 또는 6의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, two adjacent R3s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms unsubstituted or substituted with a methyl group.
본 명세서의 일 실시상태에 있어서, R2, R5, R6 및 R8은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 알킬기이거나, 인접한 2개의 치환기가 서로 결합하여 치환 또는 비치환된 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, R2, R5, R6 및 R8은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 10의 알킬기이거나, 인접한 2개의 치환기가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 30의 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, or two adjacent substituents are bonded to each other to form a substituted or unsubstituted hydrocarbon ring having 5 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R2, R5, R6 및 R8은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이거나, 인접한 2개의 치환기가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 20의 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, or two adjacent substituents bonded to each other to form a substituted or unsubstituted hydrocarbon ring having 5 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, R2, R5, R6 및 R8은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 메틸기이거나, 인접한 2개의 R2; 인접한 2개의 R5; 또는 인접한 2개의 R6이 서로 결합하여 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, R2, R5, R6 and R8 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a methyl group, adjacent two R2; Two adjacent R5s; Or, two adjacent R6 bonds to each other to form a benzene ring.
본 명세서의 일 실시상태에 있어서, n2는 4 이상이고, 복수 개의 R2 중 4개는 메틸기이다.In an exemplary embodiment of the present specification, n2 is 4 or more, and 4 of the plurality of R2s are methyl groups.
본 명세서의 일 실시상태에 있어서, n5는 4 이상이고, 복수 개의 R5 중 4개는 메틸기이다.In an exemplary embodiment of the present specification, n5 is 4 or more, and 4 of the plurality of R5 are methyl groups.
본 명세서의 일 실시상태에 있어서, n6은 4 이상이고, 복수 개의 R6 중 4개는 메틸기이다.In an exemplary embodiment of the present specification, n6 is 4 or more, and 4 of the plurality of R6 are methyl groups.
본 명세서의 일 실시상태에 있어서, n8은 2 이상이고, 복수 개의 R8 중 2개 또는 4개는 메틸기이다.In an exemplary embodiment of the present specification, n8 is 2 or more, and two or four of the plurality of R8s are methyl groups.
본 명세서의 일 실시상태에 있어서, n1은 1 이다.In an exemplary embodiment of the present specification, n1 is 1.
본 명세서의 일 실시상태에 있어서, n3은 1 이다.In an exemplary embodiment of the present specification, n3 is 1.
본 명세서의 일 실시상태에 있어서, n4은 1 이다.In an exemplary embodiment of the present specification, n4 is 1.
n2가 2 이상일 때, R2는 서로 같거나 상이하다. n5가 2 이상일 때, r5는 서로 같거나 상이하다. n6이 2 이상일 때, R6은 서로 같거나 상이하다.When n2 is 2 or more, R2 is the same as or different from each other. When n5 is 2 or more, r5 is the same as or different from each other. When n6 is 2 or more, R6 is the same as or different from each other.
본 명세서의 일 실시상태에 있어서, 상기 화학식 100은 하기 화학식 101 내지 109 중 어느 하나로 표시된다.In an exemplary embodiment of the present specification, Chemical Formula 100 is represented by any one of Chemical Formulas 101 to 109 below.
[화학식 101][Formula 101]
Figure PCTKR2020010123-appb-I000021
Figure PCTKR2020010123-appb-I000021
[화학식 102][Formula 102]
Figure PCTKR2020010123-appb-I000022
Figure PCTKR2020010123-appb-I000022
[화학식 103][Chemical Formula 103]
Figure PCTKR2020010123-appb-I000023
Figure PCTKR2020010123-appb-I000023
[화학식 104][Formula 104]
Figure PCTKR2020010123-appb-I000024
Figure PCTKR2020010123-appb-I000024
[화학식 105][Chemical Formula 105]
Figure PCTKR2020010123-appb-I000025
Figure PCTKR2020010123-appb-I000025
[화학식 106][Chemical Formula 106]
Figure PCTKR2020010123-appb-I000026
Figure PCTKR2020010123-appb-I000026
[화학식 107][Chemical Formula 107]
Figure PCTKR2020010123-appb-I000027
Figure PCTKR2020010123-appb-I000027
[화학식 108][Formula 108]
Figure PCTKR2020010123-appb-I000028
Figure PCTKR2020010123-appb-I000028
[화학식 109][Formula 109]
Figure PCTKR2020010123-appb-I000029
Figure PCTKR2020010123-appb-I000029
상기 화학식 101 내지 109에 있어서,In Formulas 101 to 109,
Cy3 및 Cy4는 상기 화학식 100에서 정의한 바와 같고,Cy3 and Cy4 are as defined in Chemical Formula 100,
R22, R31, G1, G2 및 Y1 내지 Y6은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R22, R31, G1, G2 and Y1 to Y6 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
R21은 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
G1 및 G2 중 적어도 하나는 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,At least one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
n22 및 n31은 각각 0 내지 2의 정수이고, y1 및 y5은 각각 0 내지 4의 정수이고, y2 내지 y4 및 y6은 각각 0 내지 6의 정수이고,n22 and n31 are each an integer of 0 to 2, y1 and y5 are each an integer of 0 to 4, y2 to y4 and y6 are each an integer of 0 to 6,
n22, n31 및 y1 내지 y6가 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n22, n31 and y1 to y6 are each 2 or more, the substituents in parentheses are the same as or different from each other.
본 명세서의 일 실시상태에 있어서, R21에는 전술한 R1에 관한 설명이 적용될 수 있다.In the exemplary embodiment of the present specification, the description of R1 described above may be applied to R21.
본 명세서의 일 실시상태에 있어서, R21은 치환 또는 비치환된 알킬기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이다.In the exemplary embodiment of the present specification, R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group.
본 명세서의 일 실시상태에 있어서, R21은 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 헤테로고리기; 또는 -N(R211)(R212)이다.In an exemplary embodiment of the present specification, R21 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, R21은 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 2 내지 30의 N함유 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 60의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In the exemplary embodiment of the present specification, R21 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; A substituted or unsubstituted N-containing heterocyclic group having 2 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
본 명세서의 일 실시상태에 있어서, R21은 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 2 내지 30의 N함유 헤테로고리기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환되고, 탄소수 5 내지 30의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 60의 아릴아민기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In the exemplary embodiment of the present specification, R21 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Deuterium, an N-containing heterocyclic group having 2 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent to which two or more groups selected from the group are connected, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 carbon atoms Arylamine group of to 60; Or an arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, R21은 중수소로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 탄소수 1 내지 6의 알킬기, 탄소수 6 내지 20의 아릴기 또는 탄소수 7 내지 30의 알킬아릴기로 치환 또는 비치환된 탄소수 2 내지 20의 N함유 헤테로고리기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환되고, 탄소수 5 또는 6의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 40의 아릴아민기; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 40의 아릴헤테로아릴아민기이다.In the exemplary embodiment of the present specification, R21 is an alkyl group having 1 to 6 carbon atoms substituted or unsubstituted with deuterium; An N-containing heterocyclic group having 2 to 20 carbon atoms unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms, an aryl group having 6 to 20 carbon atoms, or an alkylaryl group having 7 to 30 carbon atoms; An arylamine group having 6 to 40 carbon atoms, unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms and condensed or uncondensed with an aliphatic hydrocarbon ring having 5 or 6 carbon atoms; Or an arylheteroarylamine group having 6 to 40 carbon atoms substituted or unsubstituted with deuterium.
본 명세서의 일 실시상태에 있어서, R21은 중수소로 치환 또는 비치환된 메틸기; 이소프로필기; tert-부틸기; 메틸기, tert-부틸기, 페닐기, 톨릴기, tert-부틸페닐기 또는 테트라메틸테트라하이드로나프탈렌기로 치환 또는 비치환된 헥사하이드로카바졸기; 메틸기, 이소프로필기 또는 tert-부틸기로 치환 또는 비치환되고, 사이클로펜텐 또는 사이클로헥센이 축합 또는 비축합된, 다이페닐아민기; N-페닐-N-디벤조퓨란아민기; 또는 N-페닐-N-디벤조티오펜아민기이다.In the exemplary embodiment of the present specification, R21 is a methyl group unsubstituted or substituted with deuterium; Isopropyl group; tert-butyl group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group in which a methyl group, an isopropyl group, or a tert-butyl group is substituted or unsubstituted, and a cyclopentene or cyclohexene is condensed or non-condensed; N-phenyl-N-dibenzofuranamine group; Or N-phenyl-N-dibenzothiophenamine group.
본 명세서의 일 실시상태에 있어서, R21은 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 2 내지 30의 N함유 헤테로고리기; 또는 -N(R211)(R212)이다.In the exemplary embodiment of the present specification, R21 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Deuterium, an N-containing heterocyclic group having 2 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, R21은 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환되고, 탄소수 5 내지 30의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 60의 아릴아민기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기; 또는 상기 화학식 Het1이다.In the exemplary embodiment of the present specification, R21 is an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with deuterium; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 Arylamine group of to 60; Arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Or the above formula Het1.
본 명세서의 일 실시상태에 있어서, R22는 수소; 또는 중수소이다.In an exemplary embodiment of the present specification, R22 is hydrogen; Or deuterium.
본 명세서의 일 실시상태에 있어서, R31은 수소; 또는 중수소이다.In an exemplary embodiment of the present specification, R31 is hydrogen; Or deuterium.
본 명세서의 일 실시상태에 있어서, G1 및 G2에는 전술한 R3 및 R4에 관한 설명이 적용될 수 있다. In the exemplary embodiment of the present specification, the description of R3 and R4 described above may be applied to G1 and G2.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 적어도 하나는 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 치환 또는 비치환된 탄소수 6 내지 60의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In an exemplary embodiment of the present specification, at least one of G1 and G2 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 적어도 하나는 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 헤테로고리기; 또는 -N(R211)(R212)이다.In an exemplary embodiment of the present specification, at least one of G1 and G2 is deuterium; A substituted or unsubstituted alkyl group; A substituted or unsubstituted heterocyclic group; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 적어도 하나는 중수소 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환되고, 탄소수 5 내지 30의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 60의 아릴아민기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이다.In an exemplary embodiment of the present specification, at least one of G1 and G2 is one or more substituents selected from the group consisting of deuterium and an aryl group having 6 to 30 carbon atoms, or 1 carbon number unsubstituted or substituted with a substituent to which two or more groups selected from the group are connected. An alkyl group of to 10; An aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted substituted or unsubstituted C6-C30 hetero with one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group Cyclic group; Substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent to which two or more groups selected from the group are connected, and an aliphatic hydrocarbon ring having 5 to 30 carbon atoms is condensed or uncondensed, 6 carbon atoms Arylamine group of to 60; Or an arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 적어도 하나는 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 탄소수 1 내지 6의 알킬기, 탄소수 6 내지 20의 아릴기 또는 탄소수 7 내지 30의 알킬아릴기로 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환되고, 탄소수 5 또는 6의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 40의 아릴아민기; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 40의 아릴헤테로아릴아민기이다.In an exemplary embodiment of the present specification, at least one of G1 and G2 is an alkyl group having 1 to 6 carbon atoms unsubstituted or substituted with deuterium or an aryl group having 6 to 20 carbon atoms; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; An arylamine group having 6 to 40 carbon atoms, unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms and condensed or uncondensed with an aliphatic hydrocarbon ring having 5 or 6 carbon atoms; Or an arylheteroarylamine group having 6 to 40 carbon atoms substituted or unsubstituted with deuterium.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 적어도 하나는 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 메틸기 또는 tert-부틸기로 치환 또는 비치환된 페닐기; 디메틸플루오레닐기; 디벤조퓨란기; 디벤조티오펜기; 메틸기, tert-부틸기, 페닐기, 톨릴기, tert-부틸페닐기 또는 테트라메틸테트라하이드로나프탈렌기로 치환 또는 비치환된 헥사하이드로카바졸기; 메틸기, 이소프로필기 또는 tert-부틸기로 치환 또는 비치환되고, 사이클로펜텐 또는 사이클로헥센이 축합 또는 비축합된, 다이페닐아민기; N-페닐-N-디벤조퓨란아민기; 또는 N-페닐-N-디벤조티오펜아민기이다.In an exemplary embodiment of the present specification, at least one of G1 and G2 is a methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); A phenyl group unsubstituted or substituted with a methyl group or a tert-butyl group; Dimethylfluorenyl group; Dibenzofuran group; Dibenzothiophene group; A hexahydrocarbazole group unsubstituted or substituted with a methyl group, tert-butyl group, phenyl group, tolyl group, tert-butylphenyl group or tetramethyltetrahydronaphthalene group; A diphenylamine group in which a methyl group, an isopropyl group, or a tert-butyl group is substituted or unsubstituted, and a cyclopentene or cyclohexene is condensed or non-condensed; N-phenyl-N-dibenzofuranamine group; Or N-phenyl-N-dibenzothiophenamine group.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 적어도 하나는 중수소 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 또는 -N(R211)(R212)이다.In an exemplary embodiment of the present specification, at least one of G1 and G2 is one or more substituents selected from the group consisting of deuterium and an aryl group having 6 to 30 carbon atoms, or 1 carbon number unsubstituted or substituted with a substituent to which two or more groups selected from the group are connected. An alkyl group of to 10; An aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Substituted or unsubstituted substituted or unsubstituted C6-C30 hetero with one or more substituents selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group Cyclic group; Or -N(R211)(R212).
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 어느 하나는 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고, 다른 하나는 수소 또는 중수소이다.In an exemplary embodiment of the present specification, any one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, and the other is hydrogen or deuterium.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 어느 하나는 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 치환 또는 비치환된 탄소수 6 내지 30의 헤테로고리기; 치환 또는 비치환된 탄소수 6 내지 60의 아릴아민기; 또는 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기이고, 다른 하나는 수소 또는 중수소이다.In an exemplary embodiment of the present specification, any one of G1 and G2 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; A substituted or unsubstituted aryl group having 6 to 30 carbon atoms; A substituted or unsubstituted heterocyclic group having 6 to 30 carbon atoms; A substituted or unsubstituted arylamine group having 6 to 60 carbon atoms; Or a substituted or unsubstituted arylheteroarylamine group having 6 to 60 carbon atoms, and the other is hydrogen or deuterium.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 어느 하나는 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 탄소수 1 내지 6의 알킬기, 탄소수 6 내지 20의 아릴기 또는 탄소수 7 내지 30의 알킬아릴기로 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환되고, 탄소수 5 또는 6의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 40의 아릴아민기; 또는 중수소로 치환 또는 비치환된 탄소수 6 내지 40의 아릴헤테로아릴아민기이고, 다른 하나는 수소 또는 중수소이다.In the exemplary embodiment of the present specification, any one of G1 and G2 is an alkyl group having 1 to 6 carbon atoms unsubstituted or substituted with deuterium or an aryl group having 6 to 20 carbon atoms; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; An arylamine group having 6 to 40 carbon atoms, unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms and condensed or uncondensed with an aliphatic hydrocarbon ring having 5 or 6 carbon atoms; Or an arylheteroarylamine group having 6 to 40 carbon atoms substituted or unsubstituted with deuterium, and the other is hydrogen or deuterium.
본 명세서의 일 실시상태에 있어서, G1 및 G2 중 어느 하나는 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 탄소수 1 내지 6의 알킬기, 탄소수 6 내지 20의 아릴기 또는 탄소수 7 내지 30의 알킬아릴기로 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 또는 -N(R211)(R212)이고, 다른 하나는 수소 또는 중수소이다.In the exemplary embodiment of the present specification, any one of G1 and G2 is an alkyl group having 1 to 6 carbon atoms unsubstituted or substituted with deuterium or an aryl group having 6 to 20 carbon atoms; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; Or -N(R211)(R212), and the other is hydrogen or deuterium.
본 명세서의 일 실시상태에 있어서, Y1 내지 Y6은 서로 같거나 상이하고, 각각 독립적으로, 수소; 또는 중수소이거나, 인접한 4개의 Y3; 또는 인접한 4개의 Y6는 서로 결합하여 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, Y1 to Y6 are the same as or different from each other, and each independently, hydrogen; Or deuterium, or four adjacent Y3; Or, four adjacent Y6s are bonded to each other to form a benzene ring.
본 명세서의 일 실시상태에 있어서, Y1 내지 Y6은 서로 같거나 상이하고, 각각 독립적으로, 수소; 또는 중수소이거나, 인접한 4개의 Y3; 또는 인접한 4개의 Y6는 서로 결합하여 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, Y1 to Y6 are the same as or different from each other, and each independently, hydrogen; Or deuterium, or four adjacent Y3; Or, four adjacent Y6s are bonded to each other to form a benzene ring.
본 명세서의 일 실시상태에 있어서, 상기 화학식 103은 하기 화학식 103-1 또는 103-2로 표시된다.In an exemplary embodiment of the present specification, Chemical Formula 103 is represented by Chemical Formula 103-1 or 103-2 below.
Figure PCTKR2020010123-appb-I000030
Figure PCTKR2020010123-appb-I000030
상기 화학식 103-1 및 103-2에 있어서,In Formulas 103-1 and 103-2,
G1, G2, Cy3, Cy4, R21, R22, R31, n22 및 n31의 정의는 화학식 103에서 정의한 바와 같다.The definitions of G1, G2, Cy3, Cy4, R21, R22, R31, n22 and n31 are as defined in Chemical Formula 103.
본 명세서의 일 실시상태에 있어서, 상기 화학식 107은 하기 화학식 107-1 또는 107-2로 표시된다.In the exemplary embodiment of the present specification, Chemical Formula 107 is represented by Chemical Formula 107-1 or 107-2 below.
Figure PCTKR2020010123-appb-I000031
Figure PCTKR2020010123-appb-I000031
상기 화학식 107-1 및 107-2에 있어서,In Formulas 107-1 and 107-2,
Y5, Cy3, Cy4, R21, R22, n22 및 y5의 정의는 화학식 107에서 정의한 바와 같다.The definitions of Y5, Cy3, Cy4, R21, R22, n22 and y5 are as defined in Chemical Formula 107.
본 명세서의 일 실시상태에 있어서, 상기 화학식 108은 하기 화학식 108-1 또는 108-2로 표시된다.In the exemplary embodiment of the present specification, Chemical Formula 108 is represented by Chemical Formula 108-1 or 108-2 below.
Figure PCTKR2020010123-appb-I000032
Figure PCTKR2020010123-appb-I000032
상기 화학식 108-1 및 108-2에 있어서,In Formulas 108-1 and 108-2,
Y4, Cy3, Cy4, R21, R22, n22 및 y4의 정의는 화학식 108에서 정의한 바와 같다.The definitions of Y4, Cy3, Cy4, R21, R22, n22 and y4 are as defined in Chemical Formula 108.
본 명세서의 일 실시상태에 있어서, 상기 화학식 109는 하기 화학식 109-1 내지 109-3 중 어느 하나로 표시된다.In the exemplary embodiment of the present specification, Chemical Formula 109 is represented by any one of Chemical Formulas 109-1 to 109-3 below.
Figure PCTKR2020010123-appb-I000033
Figure PCTKR2020010123-appb-I000033
상기 화학식 109-1 내지 109-3에 있어서,In Formulas 109-1 to 109-3,
Cy3, Cy4, R21, R22 및 n22의 정의는 화학식 109에서 정의한 바와 같다.The definitions of Cy3, Cy4, R21, R22 and n22 are as defined in Chemical Formula 109.
본 명세서의 일 실시상태에 있어서, 상기 화학식 100은 하기 화학식 201 내지 209 중 어느 하나로 표시된다.In an exemplary embodiment of the present specification, Chemical Formula 100 is represented by any one of Chemical Formulas 201 to 209 below.
[화학식 201][Formula 201]
Figure PCTKR2020010123-appb-I000034
Figure PCTKR2020010123-appb-I000034
[화학식 202][Formula 202]
Figure PCTKR2020010123-appb-I000035
Figure PCTKR2020010123-appb-I000035
[화학식 203][Formula 203]
Figure PCTKR2020010123-appb-I000036
Figure PCTKR2020010123-appb-I000036
[화학식 204][Formula 204]
Figure PCTKR2020010123-appb-I000037
Figure PCTKR2020010123-appb-I000037
[화학식 205][Formula 205]
Figure PCTKR2020010123-appb-I000038
Figure PCTKR2020010123-appb-I000038
[화학식 206][Formula 206]
Figure PCTKR2020010123-appb-I000039
Figure PCTKR2020010123-appb-I000039
[화학식 207][Formula 207]
Figure PCTKR2020010123-appb-I000040
Figure PCTKR2020010123-appb-I000040
[화학식 208][Chemical Formula 208]
Figure PCTKR2020010123-appb-I000041
Figure PCTKR2020010123-appb-I000041
[화학식 209][Chemical Formula 209]
Figure PCTKR2020010123-appb-I000042
Figure PCTKR2020010123-appb-I000042
상기 화학식 201 내지 209에 있어서,In Formulas 201 to 209,
Q1는 상기 화학식 100에서 정의한 바와 같고,Q1 is as defined in Chemical Formula 100,
Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 방향족 탄화수소고리; 치환 또는 비치환된 지방족 탄화수소고리; 및 치환 또는 비치환된 방향족 헤테로고리로 이루어진 군에서 선택된 하나이거나, 상기 군에서 선택된 2 이상의 고리가 축합된 고리이고,Cy5 to Cy7 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
R22, R31 내지 R38, G1 및 G2는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R22, R31 to R38, G1 and G2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
R21은 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
G1 및 G2 중 적어도 하나는 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,At least one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
x1 내지 x3은 각각 1 또는 2이고,x1 to x3 are each 1 or 2,
n22, n31, n36 및 n37은 각각 0 내지 2의 정수이고, n32 및 n35는 각각 0 내지 4의 정수이고, n33은 0 내지 5의 정수이고, n34 및 n38은 각각 0 내지 3의 정수이고,n22, n31, n36 and n37 are each an integer of 0 to 2, n32 and n35 are each an integer of 0 to 4, n33 is an integer of 0 to 5, n34 and n38 are each an integer of 0 to 3,
n22 및 n31 내지 n38이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하고,When n22 and n31 to n38 are each 2 or more, the substituents in parentheses are the same as or different from each other,
Cy11 내지 Cy13은 서로 같거나 상이하고, 각각 독립적으로, 하기 구조에서 선택되고,Cy11 to Cy13 are the same as or different from each other, and each independently, is selected from the following structures,
Figure PCTKR2020010123-appb-I000043
Figure PCTKR2020010123-appb-I000043
상기 구조에 있어서,In the above structure,
점선 이중선은 축합되는 위치이고,The dotted double line is the condensed position,
R121 내지 R123은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R121 to R123 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
n121은 0 내지 2의 정수이고, n122 및 n123은 각각 0 내지 4의 정수이고, n121 내지 n123이 각각 2 이상일 때. 괄호 내의 치환기는 서로 같거나 상이하다.n121 is an integer of 0 to 2, n122 and n123 are each an integer of 0 to 4, when n121 to n123 are each 2 or more. The substituents in parentheses are the same as or different from each other.
본 명세서의 일 실시상태에 있어서, R121 내지 R123에는 전술한 R115 내지 R117에 관한 설명이 적용된다.In one embodiment of the present specification, the description of R115 to R117 described above is applied to R121 to R123.
본 명세서의 일 실시상태에 있어서, R121 및 R122는 서로 같거나 상이하고, 각각 독립적으로, 수소; 또는 중수소이다.In the exemplary embodiment of the present specification, R121 and R122 are the same as or different from each other, and each independently, hydrogen; Or deuterium.
본 명세서의 일 실시상태에 있어서, R123은 수소, 또는 중수소이거나, 인접한 4개의 R117이 서로 결합하여 치환 또는 비치환된 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, R123 is hydrogen or deuterium, or four adjacent R117s combine with each other to form a substituted or unsubstituted benzene ring.
본 명세서의 일 실시상태에 있어서, R123은 수소, 또는 중수소이거나, 인접한 4개의 R117이 서로 결합하여 탄소수 1 내지 10의 알킬기로 치환 또는 비치환된 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, R123 is hydrogen or deuterium, or four adjacent R117s are bonded to each other to form a benzene ring unsubstituted or substituted with an alkyl group having 1 to 10 carbon atoms.
본 명세서의 일 실시상태에 있어서, R123은 수소, 또는 중수소이거나, 인접한 4개의 R117이 서로 결합하여 벤젠고리를 형성한다.In the exemplary embodiment of the present specification, R123 is hydrogen or deuterium, or four adjacent R117s are bonded to each other to form a benzene ring.
본 명세서의 일 실시상태에 있어서, Cy11 내지 Cy13은 서로 같거나 상이하고, 각각 독립적으로, 하기 구조에서 선택된다.In the exemplary embodiment of the present specification, Cy11 to Cy13 are the same as or different from each other, and each independently, is selected from the following structures.
Figure PCTKR2020010123-appb-I000044
Figure PCTKR2020010123-appb-I000044
본 명세서의 일 실시상태에 있어서, R32에는 전술한 R103에 관한 설명이 적용될 수 있다.In the exemplary embodiment of the present specification, the description of R103 described above may be applied to R32.
본 명세서의 일 실시상태에 있어서, R33에는 전술한 R104에 관한 설명이 적용될 수 있다.In the exemplary embodiment of the present specification, the description of R104 described above may be applied to R33.
본 명세서의 일 실시상태에 있어서, R32 및 R33은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이거나, 인접한 2개의 R32; 또는 인접한 2개의 R33가 서로 결합하여 치환 또는 비치환된 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group, or two adjacent R32; Or two adjacent R33s are bonded to each other to form a substituted or unsubstituted hydrocarbon ring.
본 명세서의 일 실시상태에 있어서, R32 및 R33은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이거나, 인접한 2개의 R32; 또는 인접한 2개의 R33가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 30의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or two adjacent R32; Or, two adjacent R33s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R32 및 R33은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 20의 아릴기이거나, 인접한 2개의 R32; 또는 인접한 2개의 R33가 서로 결합하여 치환 또는 비치환된 탄소수 5 내지 20의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C 1 to C 6 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or two adjacent R32; Or two adjacent R33s are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring having 5 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, R32 및 R33의 알킬기 또는 아릴기는 중수소, 탄소수 1 내지 10의 알킬기, 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기; 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In an exemplary embodiment of the present specification, the alkyl group or aryl group of R32 and R33 includes at least one substituent selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
본 명세서의 일 실시상태에 있어서, R32 및 R33의 알킬기 또는 아릴기는 중수소, 탄소수 1 내지 10의 알킬기, 탄소수 7 내지 50의 아릴알킬기, 또는 탄소수 6 내지 30의 아릴기로 치환될 수 있다.In the exemplary embodiment of the present specification, the alkyl group or aryl group of R32 and R33 may be substituted with deuterium, an alkyl group having 1 to 10 carbon atoms, an arylalkyl group having 7 to 50 carbon atoms, or an aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 인접한 2개의 R32; 또는 인접한 2개의 R33가 서로 결합하여 형성한 지방족 탄화수소고리는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기; 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환될 수 있다.In an exemplary embodiment of the present specification, two adjacent R32; Or the aliphatic hydrocarbon ring formed by bonding of two adjacent R 33 to each other is at least one substituent selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms; Alternatively, two or more groups selected from the group may be substituted with a linked substituent.
본 명세서의 일 실시상태에 있어서, R32 및 R33은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 또는 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기이거나, 인접한 2개의 R32; 또는 인접한 2개의 R33가 서로 결합하여 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 5 또는 6의 지방족 탄화수소고리를 형성한다.In the exemplary embodiment of the present specification, R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A C 1 to C 6 alkyl group unsubstituted or substituted with deuterium or a C 6 to C 20 aryl group; Or an aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms, or two adjacent R32; Or two adjacent R33s are bonded to each other to form an aliphatic hydrocarbon ring having 5 or 6 carbon atoms, which is unsubstituted or substituted with an alkyl group having 1 to 6 carbon atoms.
본 명세서의 일 실시상태에 있어서, R32 및 R33은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 또는 tert-부틸기로 치환 또는 비치환된 페닐기이거나, 인접한 2개의 R32; 또는 인접한 2개의 R33가 서로 결합하여 메틸기로 치환 또는 비치환된 사이클로펜텐고리, 또는 메틸기로 치환 또는 비치환된 사이클로헥센고리를 형성한다.In the exemplary embodiment of the present specification, R32 and R33 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R32; Alternatively, two adjacent R33s are bonded to each other to form a cyclopentene ring substituted or unsubstituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
본 명세서의 일 실시상태에 있어서, R32은 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 또는 tert-부틸기로 치환 또는 비치환된 페닐기이다.In an exemplary embodiment of the present specification, R32 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group.
본 명세서의 일 실시상태에 있어서, R33는 수소; 중수소; 메틸기; 이소프로필기; tert-부틸기; 2-페닐프로판-2-일기(2-phenylpropan-2-yl); 또는 tert-부틸기로 치환 또는 비치환된 페닐기이거나, 인접한 2개의 R33가 서로 결합하여 메틸기로 치환 또는 비치환된 사이클로펜텐고리, 또는 메틸기로 치환 또는 비치환된 사이클로헥센고리를 형성한다.In an exemplary embodiment of the present specification, R33 is hydrogen; heavy hydrogen; Methyl group; Isopropyl group; tert-butyl group; 2-phenylpropan-2-yl group (2-phenylpropan-2-yl); Or a phenyl group unsubstituted or substituted with a tert-butyl group, or two adjacent R33s are bonded to each other to form a cyclopentene ring unsubstituted or substituted with a methyl group, or a cyclohexene ring unsubstituted or substituted with a methyl group.
본 명세서의 일 실시상태에 있어서, R34 및 R35에는 전술한 R101에 관한 설명이 적용될 수 있다.In the exemplary embodiment of the present specification, the description of R101 described above may be applied to R34 and R35.
본 명세서의 일 실시상태에 있어서, R34 및 R35은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In the exemplary embodiment of the present specification, R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R34 및 R35은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In the exemplary embodiment of the present specification, R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R34 및 R35은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In the exemplary embodiment of the present specification, R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R34 및 R35은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 tert-부틸기이다.In the exemplary embodiment of the present specification, R34 and R35 are the same as or different from each other, and each independently, hydrogen; heavy hydrogen; Or tert-butyl group.
본 명세서의 일 실시상태에 있어서, R36 및 R37은 서로 같거나 상이하고, 각각 독립적으로 수소; 또는 중수소이다.In the exemplary embodiment of the present specification, R36 and R37 are the same as or different from each other, and each independently hydrogen; Or deuterium.
본 명세서의 일 실시상태에 있어서, R38은 전술한 R102에 관한 설명이 적용될 수 있다.In the exemplary embodiment of the present specification, the description of R102 described above may be applied to R38.
본 명세서의 일 실시상태에 있어서, R38은 수소; 중수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.In an exemplary embodiment of the present specification, R38 is hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, R38은 수소; 중수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In an exemplary embodiment of the present specification, R38 is hydrogen; heavy hydrogen; A substituted or unsubstituted C1-C10 alkyl group; Or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, R38은 수소; 중수소; 또는 치환 또는 비치환된 탄소수 1 내지 6의 알킬기이다.In an exemplary embodiment of the present specification, R38 is hydrogen; heavy hydrogen; Or a substituted or unsubstituted C1-C6 alkyl group.
본 명세서의 일 실시상태에 있어서, R38은 수소; 중수소; 또는 메틸기이다.In an exemplary embodiment of the present specification, R38 is hydrogen; heavy hydrogen; Or a methyl group.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7에는 전술한 Cy3 및 Cy4에 관한 설명이 적용될 수 있다. In the exemplary embodiment of the present specification, the description of Cy3 and Cy4 described above may be applied to Cy5 to Cy7.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택되거나 치환 또는 비치환된 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently is a substituted or unsubstituted aromatic hydrocarbon ring selected from Formulas A-1 to A-3.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택되거나 치환 또는 비치환된 탄소수 6 내지 30의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently is a substituted or unsubstituted aromatic hydrocarbon ring having 6 to 30 carbon atoms selected from Formulas A-1 to A-3.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택되거나 치환 또는 비치환된 탄소수 6 내지 20의 단환의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms selected from Formulas A-1 to A-3 to be.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택되거나, 중수소, 탄소수 1 내지 6의 알킬기 및 탄소수 6 내지 20의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 20의 단환의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from the above Chemical Formulas A-1 to A-3, or deuterium, an alkyl group having 1 to 6 carbon atoms, and having 6 to 20 carbon atoms It is a monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms, which is unsubstituted or substituted with one or more substituents selected from the group consisting of aryl groups or a substituent connected with two or more groups selected from the group.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택되거나, 중수소, 탄소수 1 내지 10의 알킬기, 또는 탄소수 7 내지 50의 아릴알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 단환의 방향족 탄화수소고리이다.In the exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3, or deuterium, an alkyl group having 1 to 10 carbon atoms, or 7 to 50 carbon atoms It is a monocyclic aromatic hydrocarbon ring having 6 to 20 carbon atoms unsubstituted or substituted with an arylalkyl group of.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택되거나, 페닐기, 바이페닐기 또는 터페닐기이고, 상기 페닐기, 바이페닐기 또는 터페닐기는 메틸기, 이소프로필기, tert-부틸기, 또는 2-페닐프로판-2-일기(2-phenylpropan-2-yl)로 치환 또는 비치환된다.In an exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3, or is a phenyl group, a biphenyl group, or a terphenyl group, and the phenyl group, biphenyl group Or the terphenyl group is substituted or unsubstituted with a methyl group, isopropyl group, tert-butyl group, or 2-phenylpropan-2-yl group.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 화학식 A-1 내지 A-3에서 선택된다.In the exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from Formulas A-1 to A-3.
본 명세서의 일 실시상태에 있어서, Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 상기 그룹 A-11 내지 A-14에서 선택된다.In the exemplary embodiment of the present specification, Cy5 to Cy7 are the same as or different from each other, and each independently, is selected from the groups A-11 to A-14.
본 명세서의 일 실시상태에 있어서, 상기 화학식 103에 있어서, 상기 Cy4가
Figure PCTKR2020010123-appb-I000045
이고, R44가 수소 또는 중수소이고, G2가 tert-부틸기이고, R21이 메틸기이고, Cy3이 치환된 페닐기인 경우,
In the exemplary embodiment of the present specification, in Chemical Formula 103, Cy4 is
Figure PCTKR2020010123-appb-I000045
And R44 is hydrogen or deuterium, G2 is a tert-butyl group, R21 is a methyl group, and Cy3 is a substituted phenyl group,
Cy3의 페닐기에 연결된 치환기는 2개 이상이다.There are two or more substituents linked to the phenyl group of Cy3.
본 명세서의 일 실시상태에 있어서, 상기 화학식 205에 있어서, 상기 Cy11 및 Cy13이 각각
Figure PCTKR2020010123-appb-I000046
이고, G2가 tert-부틸기이고, R21이 메틸기이고, Cy7이 치환된 페닐기인 경우,
In the exemplary embodiment of the present specification, in Chemical Formula 205, Cy11 and Cy13 are each
Figure PCTKR2020010123-appb-I000046
And, when G2 is a tert-butyl group, R21 is a methyl group, and Cy7 is a substituted phenyl group,
Cy7의 페닐기에 연결된 치환기는 2개 이상이다.There are two or more substituents linked to the phenyl group of Cy7.
본 명세서의 일 실시상태에 있어서, 상기 화학식 103는 G2, 또는/및 Cy3에 포함되는 치환기로서 tert-부틸기를 2개 포함하는 경우는 제외한다. 즉, 상기 화학식 103의 G2가 tert-부틸기인 경우는 포함될 수 있으며, 상기 화학식 103의 Cy3에 연결되는 치환기 중 tert-부틸기가 하나인 경우는 포함될 수 있으며, 상기 화학식 103의 Cy3에 연결되는 치환기 중 tert-부틸기가 세개인 경우도 포함될 수 있다. 그러나, 상기 화학식 103의 G2가 tert-부틸기이면서, Cy3에 연결되는 치환기 중 tert-부틸기가 하나인 경우는 제외된다. 또한, 상기 화학식 103의 Cy3에 연결되는 치환기중 tert-부틸기가 두개인 경우도 제외된다.In the exemplary embodiment of the present specification, Chemical Formula 103 excludes the case of including two tert-butyl groups as a substituent included in G2 or/and Cy3. That is, when G2 in Formula 103 is a tert-butyl group, it may be included, and when there is one tert-butyl group among the substituents connected to Cy3 in Formula 103, it may be included, and among the substituents connected to Cy3 in Formula 103, Cases with three tert-butyl groups may also be included. However, the case where G2 in Formula 103 is a tert-butyl group and one tert-butyl group among the substituents connected to Cy3 is excluded. In addition, the case of having two tert-butyl groups among the substituents connected to Cy3 of Chemical Formula 103 is also excluded.
본 명세서의 일 실시상태에 있어서, 상기 화학식 205는 G2 또는/및 Cy7에 포함되는 치환기로서 tert-부틸기를 2개 포함하는 경우는 제외한다. 즉, 상기 화학식 205의 G2가 tert-부틸기인 경우는 포함될 수 있으며, 상기 화학식 205의 Cy7에 연결되는 치환기 중 tert-부틸기가 하나인 경우는 포함될 수 있으며, 상기 화학식 205의 Cy7에 연결되는 치환기 중 tert-부틸기가 세개인 경우도 포함될 수 있다. 그러나, 상기 화학식 205의 G2가 tert-부틸기이면서, Cy7에 연결되는 치환기중 tert-부틸기가 하나인 경우는 제외된다. 또한, 상기 화학식 205의 Cy7에 연결되는 치환기중 tert-부틸기가 두개인 경우도 제외된다.In the exemplary embodiment of the present specification, Chemical Formula 205 is excluded from the case of including two tert-butyl groups as a substituent included in G2 or/and Cy7. That is, when G2 in Formula 205 is a tert-butyl group, it may be included, and when there is one tert-butyl group among the substituents connected to Cy7 in Formula 205, it may be included, and among the substituents connected to Cy7 in Formula 205, Cases with three tert-butyl groups may also be included. However, the case where G2 in Formula 205 is a tert-butyl group and one tert-butyl group among the substituents connected to Cy7 is excluded. In addition, the case of having two tert-butyl groups among the substituents connected to Cy7 of Formula 205 is also excluded.
본 명세서의 일 실시상태에 있어서, 전술한 화학식은 하기 화합물을 제외한다.In an exemplary embodiment of the present specification, the above-described chemical formula excludes the following compounds.
Figure PCTKR2020010123-appb-I000047
Figure PCTKR2020010123-appb-I000047
Figure PCTKR2020010123-appb-I000048
Figure PCTKR2020010123-appb-I000048
Figure PCTKR2020010123-appb-I000049
Figure PCTKR2020010123-appb-I000049
Figure PCTKR2020010123-appb-I000050
Figure PCTKR2020010123-appb-I000050
본 명세서의 일 실시상태에 있어서, 상기 화학식 1은 하기 구조들 중 어느 하나로 표시될 수 있다.In the exemplary embodiment of the present specification, Chemical Formula 1 may be represented by any one of the following structures.
Figure PCTKR2020010123-appb-I000051
Figure PCTKR2020010123-appb-I000051
Figure PCTKR2020010123-appb-I000052
Figure PCTKR2020010123-appb-I000052
Figure PCTKR2020010123-appb-I000053
Figure PCTKR2020010123-appb-I000053
Figure PCTKR2020010123-appb-I000054
Figure PCTKR2020010123-appb-I000054
Figure PCTKR2020010123-appb-I000055
Figure PCTKR2020010123-appb-I000055
Figure PCTKR2020010123-appb-I000056
Figure PCTKR2020010123-appb-I000056
Figure PCTKR2020010123-appb-I000057
Figure PCTKR2020010123-appb-I000057
Figure PCTKR2020010123-appb-I000058
Figure PCTKR2020010123-appb-I000058
Figure PCTKR2020010123-appb-I000059
Figure PCTKR2020010123-appb-I000059
Figure PCTKR2020010123-appb-I000060
Figure PCTKR2020010123-appb-I000060
Figure PCTKR2020010123-appb-I000061
Figure PCTKR2020010123-appb-I000061
Figure PCTKR2020010123-appb-I000062
Figure PCTKR2020010123-appb-I000062
Figure PCTKR2020010123-appb-I000063
Figure PCTKR2020010123-appb-I000063
Figure PCTKR2020010123-appb-I000064
Figure PCTKR2020010123-appb-I000064
Figure PCTKR2020010123-appb-I000065
Figure PCTKR2020010123-appb-I000065
Figure PCTKR2020010123-appb-I000066
Figure PCTKR2020010123-appb-I000066
Figure PCTKR2020010123-appb-I000067
Figure PCTKR2020010123-appb-I000067
Figure PCTKR2020010123-appb-I000068
Figure PCTKR2020010123-appb-I000068
Figure PCTKR2020010123-appb-I000069
Figure PCTKR2020010123-appb-I000069
Figure PCTKR2020010123-appb-I000070
Figure PCTKR2020010123-appb-I000070
Figure PCTKR2020010123-appb-I000071
Figure PCTKR2020010123-appb-I000071
Figure PCTKR2020010123-appb-I000072
Figure PCTKR2020010123-appb-I000072
Figure PCTKR2020010123-appb-I000073
Figure PCTKR2020010123-appb-I000073
Figure PCTKR2020010123-appb-I000074
Figure PCTKR2020010123-appb-I000074
Figure PCTKR2020010123-appb-I000075
Figure PCTKR2020010123-appb-I000075
Figure PCTKR2020010123-appb-I000076
Figure PCTKR2020010123-appb-I000076
Figure PCTKR2020010123-appb-I000077
Figure PCTKR2020010123-appb-I000077
Figure PCTKR2020010123-appb-I000078
Figure PCTKR2020010123-appb-I000078
Figure PCTKR2020010123-appb-I000079
Figure PCTKR2020010123-appb-I000079
Figure PCTKR2020010123-appb-I000080
Figure PCTKR2020010123-appb-I000080
Figure PCTKR2020010123-appb-I000081
Figure PCTKR2020010123-appb-I000081
Figure PCTKR2020010123-appb-I000082
Figure PCTKR2020010123-appb-I000082
Figure PCTKR2020010123-appb-I000083
Figure PCTKR2020010123-appb-I000083
Figure PCTKR2020010123-appb-I000084
Figure PCTKR2020010123-appb-I000084
Figure PCTKR2020010123-appb-I000085
Figure PCTKR2020010123-appb-I000085
Figure PCTKR2020010123-appb-I000086
Figure PCTKR2020010123-appb-I000086
Figure PCTKR2020010123-appb-I000087
Figure PCTKR2020010123-appb-I000087
Figure PCTKR2020010123-appb-I000088
Figure PCTKR2020010123-appb-I000088
Figure PCTKR2020010123-appb-I000089
Figure PCTKR2020010123-appb-I000089
Figure PCTKR2020010123-appb-I000090
Figure PCTKR2020010123-appb-I000090
Figure PCTKR2020010123-appb-I000091
Figure PCTKR2020010123-appb-I000091
Figure PCTKR2020010123-appb-I000092
Figure PCTKR2020010123-appb-I000092
Figure PCTKR2020010123-appb-I000093
Figure PCTKR2020010123-appb-I000093
Figure PCTKR2020010123-appb-I000094
Figure PCTKR2020010123-appb-I000094
Figure PCTKR2020010123-appb-I000095
Figure PCTKR2020010123-appb-I000095
Figure PCTKR2020010123-appb-I000096
Figure PCTKR2020010123-appb-I000096
Figure PCTKR2020010123-appb-I000097
Figure PCTKR2020010123-appb-I000097
Figure PCTKR2020010123-appb-I000098
Figure PCTKR2020010123-appb-I000098
Figure PCTKR2020010123-appb-I000099
Figure PCTKR2020010123-appb-I000099
Figure PCTKR2020010123-appb-I000100
Figure PCTKR2020010123-appb-I000100
Figure PCTKR2020010123-appb-I000101
Figure PCTKR2020010123-appb-I000101
Figure PCTKR2020010123-appb-I000102
Figure PCTKR2020010123-appb-I000102
Figure PCTKR2020010123-appb-I000103
Figure PCTKR2020010123-appb-I000103
Figure PCTKR2020010123-appb-I000104
Figure PCTKR2020010123-appb-I000104
Figure PCTKR2020010123-appb-I000105
Figure PCTKR2020010123-appb-I000105
Figure PCTKR2020010123-appb-I000106
Figure PCTKR2020010123-appb-I000106
Figure PCTKR2020010123-appb-I000107
Figure PCTKR2020010123-appb-I000107
Figure PCTKR2020010123-appb-I000108
Figure PCTKR2020010123-appb-I000108
Figure PCTKR2020010123-appb-I000109
Figure PCTKR2020010123-appb-I000109
Figure PCTKR2020010123-appb-I000110
Figure PCTKR2020010123-appb-I000110
Figure PCTKR2020010123-appb-I000111
Figure PCTKR2020010123-appb-I000111
Figure PCTKR2020010123-appb-I000112
Figure PCTKR2020010123-appb-I000112
Figure PCTKR2020010123-appb-I000113
Figure PCTKR2020010123-appb-I000113
Figure PCTKR2020010123-appb-I000114
Figure PCTKR2020010123-appb-I000114
Figure PCTKR2020010123-appb-I000115
Figure PCTKR2020010123-appb-I000115
Figure PCTKR2020010123-appb-I000116
Figure PCTKR2020010123-appb-I000116
Figure PCTKR2020010123-appb-I000117
Figure PCTKR2020010123-appb-I000117
Figure PCTKR2020010123-appb-I000118
Figure PCTKR2020010123-appb-I000118
Figure PCTKR2020010123-appb-I000119
Figure PCTKR2020010123-appb-I000119
Figure PCTKR2020010123-appb-I000120
Figure PCTKR2020010123-appb-I000120
Figure PCTKR2020010123-appb-I000121
Figure PCTKR2020010123-appb-I000121
Figure PCTKR2020010123-appb-I000122
Figure PCTKR2020010123-appb-I000122
Figure PCTKR2020010123-appb-I000123
Figure PCTKR2020010123-appb-I000123
Figure PCTKR2020010123-appb-I000124
Figure PCTKR2020010123-appb-I000124
Figure PCTKR2020010123-appb-I000125
Figure PCTKR2020010123-appb-I000125
Figure PCTKR2020010123-appb-I000126
Figure PCTKR2020010123-appb-I000126
Figure PCTKR2020010123-appb-I000127
Figure PCTKR2020010123-appb-I000127
Figure PCTKR2020010123-appb-I000128
Figure PCTKR2020010123-appb-I000128
Figure PCTKR2020010123-appb-I000129
Figure PCTKR2020010123-appb-I000129
Figure PCTKR2020010123-appb-I000130
Figure PCTKR2020010123-appb-I000130
Figure PCTKR2020010123-appb-I000131
Figure PCTKR2020010123-appb-I000131
Figure PCTKR2020010123-appb-I000132
Figure PCTKR2020010123-appb-I000132
Figure PCTKR2020010123-appb-I000133
Figure PCTKR2020010123-appb-I000133
Figure PCTKR2020010123-appb-I000134
Figure PCTKR2020010123-appb-I000134
Figure PCTKR2020010123-appb-I000135
Figure PCTKR2020010123-appb-I000135
Figure PCTKR2020010123-appb-I000136
Figure PCTKR2020010123-appb-I000136
Figure PCTKR2020010123-appb-I000137
Figure PCTKR2020010123-appb-I000137
Figure PCTKR2020010123-appb-I000138
Figure PCTKR2020010123-appb-I000138
Figure PCTKR2020010123-appb-I000139
Figure PCTKR2020010123-appb-I000139
Figure PCTKR2020010123-appb-I000140
Figure PCTKR2020010123-appb-I000140
Figure PCTKR2020010123-appb-I000141
Figure PCTKR2020010123-appb-I000141
Figure PCTKR2020010123-appb-I000142
Figure PCTKR2020010123-appb-I000142
Figure PCTKR2020010123-appb-I000143
Figure PCTKR2020010123-appb-I000143
Figure PCTKR2020010123-appb-I000144
Figure PCTKR2020010123-appb-I000144
Figure PCTKR2020010123-appb-I000145
Figure PCTKR2020010123-appb-I000145
Figure PCTKR2020010123-appb-I000146
Figure PCTKR2020010123-appb-I000146
Figure PCTKR2020010123-appb-I000147
Figure PCTKR2020010123-appb-I000147
Figure PCTKR2020010123-appb-I000148
Figure PCTKR2020010123-appb-I000148
Figure PCTKR2020010123-appb-I000149
Figure PCTKR2020010123-appb-I000149
Figure PCTKR2020010123-appb-I000150
Figure PCTKR2020010123-appb-I000150
Figure PCTKR2020010123-appb-I000151
Figure PCTKR2020010123-appb-I000151
Figure PCTKR2020010123-appb-I000152
Figure PCTKR2020010123-appb-I000152
Figure PCTKR2020010123-appb-I000153
Figure PCTKR2020010123-appb-I000153
Figure PCTKR2020010123-appb-I000154
Figure PCTKR2020010123-appb-I000154
Figure PCTKR2020010123-appb-I000155
Figure PCTKR2020010123-appb-I000155
Figure PCTKR2020010123-appb-I000156
Figure PCTKR2020010123-appb-I000156
Figure PCTKR2020010123-appb-I000157
Figure PCTKR2020010123-appb-I000157
Figure PCTKR2020010123-appb-I000158
Figure PCTKR2020010123-appb-I000158
Figure PCTKR2020010123-appb-I000159
Figure PCTKR2020010123-appb-I000159
Figure PCTKR2020010123-appb-I000160
Figure PCTKR2020010123-appb-I000160
Figure PCTKR2020010123-appb-I000161
Figure PCTKR2020010123-appb-I000161
Figure PCTKR2020010123-appb-I000162
Figure PCTKR2020010123-appb-I000162
Figure PCTKR2020010123-appb-I000163
Figure PCTKR2020010123-appb-I000163
Figure PCTKR2020010123-appb-I000164
Figure PCTKR2020010123-appb-I000164
Figure PCTKR2020010123-appb-I000165
Figure PCTKR2020010123-appb-I000165
Figure PCTKR2020010123-appb-I000166
Figure PCTKR2020010123-appb-I000166
Figure PCTKR2020010123-appb-I000167
Figure PCTKR2020010123-appb-I000167
Figure PCTKR2020010123-appb-I000168
Figure PCTKR2020010123-appb-I000168
Figure PCTKR2020010123-appb-I000169
Figure PCTKR2020010123-appb-I000169
Figure PCTKR2020010123-appb-I000170
Figure PCTKR2020010123-appb-I000170
Figure PCTKR2020010123-appb-I000171
Figure PCTKR2020010123-appb-I000171
Figure PCTKR2020010123-appb-I000172
Figure PCTKR2020010123-appb-I000172
Figure PCTKR2020010123-appb-I000173
Figure PCTKR2020010123-appb-I000173
Figure PCTKR2020010123-appb-I000174
Figure PCTKR2020010123-appb-I000174
Figure PCTKR2020010123-appb-I000175
Figure PCTKR2020010123-appb-I000175
Figure PCTKR2020010123-appb-I000176
Figure PCTKR2020010123-appb-I000176
Figure PCTKR2020010123-appb-I000177
Figure PCTKR2020010123-appb-I000177
Figure PCTKR2020010123-appb-I000178
Figure PCTKR2020010123-appb-I000178
Figure PCTKR2020010123-appb-I000179
Figure PCTKR2020010123-appb-I000179
Figure PCTKR2020010123-appb-I000180
Figure PCTKR2020010123-appb-I000180
Figure PCTKR2020010123-appb-I000181
Figure PCTKR2020010123-appb-I000181
Figure PCTKR2020010123-appb-I000182
Figure PCTKR2020010123-appb-I000182
Figure PCTKR2020010123-appb-I000183
Figure PCTKR2020010123-appb-I000183
Figure PCTKR2020010123-appb-I000184
Figure PCTKR2020010123-appb-I000184
Figure PCTKR2020010123-appb-I000185
Figure PCTKR2020010123-appb-I000185
Figure PCTKR2020010123-appb-I000186
Figure PCTKR2020010123-appb-I000186
Figure PCTKR2020010123-appb-I000187
Figure PCTKR2020010123-appb-I000187
Figure PCTKR2020010123-appb-I000188
Figure PCTKR2020010123-appb-I000188
Figure PCTKR2020010123-appb-I000189
Figure PCTKR2020010123-appb-I000189
Figure PCTKR2020010123-appb-I000190
Figure PCTKR2020010123-appb-I000190
Figure PCTKR2020010123-appb-I000191
Figure PCTKR2020010123-appb-I000191
Figure PCTKR2020010123-appb-I000192
Figure PCTKR2020010123-appb-I000192
Figure PCTKR2020010123-appb-I000193
Figure PCTKR2020010123-appb-I000193
Figure PCTKR2020010123-appb-I000194
Figure PCTKR2020010123-appb-I000194
Figure PCTKR2020010123-appb-I000195
Figure PCTKR2020010123-appb-I000195
Figure PCTKR2020010123-appb-I000196
Figure PCTKR2020010123-appb-I000196
Figure PCTKR2020010123-appb-I000197
Figure PCTKR2020010123-appb-I000197
Figure PCTKR2020010123-appb-I000198
Figure PCTKR2020010123-appb-I000198
Figure PCTKR2020010123-appb-I000199
Figure PCTKR2020010123-appb-I000199
Figure PCTKR2020010123-appb-I000200
Figure PCTKR2020010123-appb-I000200
Figure PCTKR2020010123-appb-I000201
Figure PCTKR2020010123-appb-I000201
Figure PCTKR2020010123-appb-I000202
Figure PCTKR2020010123-appb-I000202
Figure PCTKR2020010123-appb-I000203
Figure PCTKR2020010123-appb-I000203
Figure PCTKR2020010123-appb-I000204
Figure PCTKR2020010123-appb-I000204
Figure PCTKR2020010123-appb-I000205
Figure PCTKR2020010123-appb-I000205
Figure PCTKR2020010123-appb-I000206
Figure PCTKR2020010123-appb-I000206
Figure PCTKR2020010123-appb-I000207
Figure PCTKR2020010123-appb-I000207
Figure PCTKR2020010123-appb-I000208
Figure PCTKR2020010123-appb-I000208
Figure PCTKR2020010123-appb-I000209
Figure PCTKR2020010123-appb-I000209
Figure PCTKR2020010123-appb-I000210
Figure PCTKR2020010123-appb-I000210
Figure PCTKR2020010123-appb-I000211
Figure PCTKR2020010123-appb-I000211
Figure PCTKR2020010123-appb-I000212
Figure PCTKR2020010123-appb-I000212
Figure PCTKR2020010123-appb-I000213
Figure PCTKR2020010123-appb-I000213
Figure PCTKR2020010123-appb-I000214
Figure PCTKR2020010123-appb-I000214
Figure PCTKR2020010123-appb-I000215
Figure PCTKR2020010123-appb-I000215
Figure PCTKR2020010123-appb-I000216
Figure PCTKR2020010123-appb-I000216
Figure PCTKR2020010123-appb-I000217
Figure PCTKR2020010123-appb-I000217
Figure PCTKR2020010123-appb-I000218
Figure PCTKR2020010123-appb-I000218
Figure PCTKR2020010123-appb-I000219
Figure PCTKR2020010123-appb-I000219
Figure PCTKR2020010123-appb-I000220
Figure PCTKR2020010123-appb-I000220
Figure PCTKR2020010123-appb-I000221
Figure PCTKR2020010123-appb-I000221
Figure PCTKR2020010123-appb-I000222
Figure PCTKR2020010123-appb-I000222
Figure PCTKR2020010123-appb-I000223
Figure PCTKR2020010123-appb-I000223
Figure PCTKR2020010123-appb-I000224
Figure PCTKR2020010123-appb-I000224
Figure PCTKR2020010123-appb-I000225
Figure PCTKR2020010123-appb-I000225
Figure PCTKR2020010123-appb-I000226
Figure PCTKR2020010123-appb-I000226
Figure PCTKR2020010123-appb-I000227
Figure PCTKR2020010123-appb-I000227
Figure PCTKR2020010123-appb-I000228
Figure PCTKR2020010123-appb-I000228
Figure PCTKR2020010123-appb-I000229
Figure PCTKR2020010123-appb-I000229
Figure PCTKR2020010123-appb-I000230
Figure PCTKR2020010123-appb-I000230
Figure PCTKR2020010123-appb-I000231
Figure PCTKR2020010123-appb-I000231
Figure PCTKR2020010123-appb-I000232
Figure PCTKR2020010123-appb-I000232
Figure PCTKR2020010123-appb-I000233
Figure PCTKR2020010123-appb-I000233
Figure PCTKR2020010123-appb-I000234
Figure PCTKR2020010123-appb-I000234
Figure PCTKR2020010123-appb-I000235
Figure PCTKR2020010123-appb-I000235
Figure PCTKR2020010123-appb-I000236
Figure PCTKR2020010123-appb-I000236
Figure PCTKR2020010123-appb-I000237
Figure PCTKR2020010123-appb-I000237
Figure PCTKR2020010123-appb-I000238
Figure PCTKR2020010123-appb-I000238
Figure PCTKR2020010123-appb-I000239
Figure PCTKR2020010123-appb-I000239
Figure PCTKR2020010123-appb-I000240
Figure PCTKR2020010123-appb-I000240
Figure PCTKR2020010123-appb-I000241
Figure PCTKR2020010123-appb-I000241
Figure PCTKR2020010123-appb-I000242
Figure PCTKR2020010123-appb-I000242
Figure PCTKR2020010123-appb-I000243
Figure PCTKR2020010123-appb-I000243
Figure PCTKR2020010123-appb-I000244
Figure PCTKR2020010123-appb-I000244
Figure PCTKR2020010123-appb-I000245
Figure PCTKR2020010123-appb-I000245
Figure PCTKR2020010123-appb-I000246
Figure PCTKR2020010123-appb-I000246
Figure PCTKR2020010123-appb-I000247
Figure PCTKR2020010123-appb-I000247
Figure PCTKR2020010123-appb-I000248
Figure PCTKR2020010123-appb-I000248
Figure PCTKR2020010123-appb-I000249
Figure PCTKR2020010123-appb-I000249
Figure PCTKR2020010123-appb-I000250
Figure PCTKR2020010123-appb-I000250
Figure PCTKR2020010123-appb-I000251
Figure PCTKR2020010123-appb-I000251
Figure PCTKR2020010123-appb-I000252
Figure PCTKR2020010123-appb-I000252
Figure PCTKR2020010123-appb-I000253
Figure PCTKR2020010123-appb-I000253
Figure PCTKR2020010123-appb-I000254
Figure PCTKR2020010123-appb-I000254
Figure PCTKR2020010123-appb-I000255
Figure PCTKR2020010123-appb-I000255
Figure PCTKR2020010123-appb-I000256
Figure PCTKR2020010123-appb-I000256
Figure PCTKR2020010123-appb-I000257
Figure PCTKR2020010123-appb-I000257
Figure PCTKR2020010123-appb-I000258
Figure PCTKR2020010123-appb-I000258
Figure PCTKR2020010123-appb-I000259
Figure PCTKR2020010123-appb-I000259
Figure PCTKR2020010123-appb-I000260
Figure PCTKR2020010123-appb-I000260
Figure PCTKR2020010123-appb-I000261
Figure PCTKR2020010123-appb-I000261
Figure PCTKR2020010123-appb-I000262
Figure PCTKR2020010123-appb-I000262
Figure PCTKR2020010123-appb-I000263
Figure PCTKR2020010123-appb-I000263
Figure PCTKR2020010123-appb-I000264
Figure PCTKR2020010123-appb-I000264
Figure PCTKR2020010123-appb-I000265
Figure PCTKR2020010123-appb-I000265
Figure PCTKR2020010123-appb-I000266
Figure PCTKR2020010123-appb-I000266
Figure PCTKR2020010123-appb-I000267
Figure PCTKR2020010123-appb-I000267
Figure PCTKR2020010123-appb-I000268
Figure PCTKR2020010123-appb-I000268
Figure PCTKR2020010123-appb-I000269
Figure PCTKR2020010123-appb-I000269
Figure PCTKR2020010123-appb-I000270
Figure PCTKR2020010123-appb-I000270
Figure PCTKR2020010123-appb-I000271
Figure PCTKR2020010123-appb-I000271
Figure PCTKR2020010123-appb-I000272
Figure PCTKR2020010123-appb-I000272
Figure PCTKR2020010123-appb-I000273
Figure PCTKR2020010123-appb-I000273
Figure PCTKR2020010123-appb-I000274
Figure PCTKR2020010123-appb-I000274
Figure PCTKR2020010123-appb-I000275
Figure PCTKR2020010123-appb-I000275
Figure PCTKR2020010123-appb-I000276
Figure PCTKR2020010123-appb-I000276
Figure PCTKR2020010123-appb-I000277
Figure PCTKR2020010123-appb-I000277
Figure PCTKR2020010123-appb-I000278
Figure PCTKR2020010123-appb-I000278
Figure PCTKR2020010123-appb-I000279
Figure PCTKR2020010123-appb-I000279
Figure PCTKR2020010123-appb-I000280
Figure PCTKR2020010123-appb-I000280
Figure PCTKR2020010123-appb-I000281
Figure PCTKR2020010123-appb-I000281
Figure PCTKR2020010123-appb-I000282
Figure PCTKR2020010123-appb-I000282
Figure PCTKR2020010123-appb-I000283
Figure PCTKR2020010123-appb-I000283
Figure PCTKR2020010123-appb-I000284
Figure PCTKR2020010123-appb-I000284
Figure PCTKR2020010123-appb-I000285
Figure PCTKR2020010123-appb-I000285
Figure PCTKR2020010123-appb-I000286
Figure PCTKR2020010123-appb-I000286
Figure PCTKR2020010123-appb-I000287
Figure PCTKR2020010123-appb-I000287
Figure PCTKR2020010123-appb-I000288
Figure PCTKR2020010123-appb-I000288
상기 화학식 1의 화합물의 치환기는 당 기술분야에 알려져 있는 방법에 의하여 결합될 수 있으며, 치환기의 종류, 위치 또는 개수는 당 기술분야에 알려져 있는 기술에 따라 변경될 수 있다.The substituent of the compound of Formula 1 may be bonded by a method known in the art, and the type, position, or number of the substituent may be changed according to techniques known in the art.
상기 화합물의 컨쥬게이션 길이와 에너지 밴드갭은 밀접한 관계가 있다. 구체적으로, 화합물의 컨쥬게이션 길이가 길수록 에너지 밴드갭이 작아진다. The conjugation length and the energy band gap of the compound are closely related. Specifically, the longer the conjugation length of the compound, the smaller the energy band gap.
본 발명에서는 상기와 같이 코어 구조에 다양한 치환기를 도입함으로써 다양한 에너지 밴드갭을 갖는 화합물을 합성할 수 있다. 또한, 본 발명에서는 상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 화합물의 HOMO 및 LUMO 에너지 준위도 조절할 수 있다.In the present invention, compounds having various energy band gaps can be synthesized by introducing various substituents into the core structure as described above. In addition, in the present invention, the HOMO and LUMO energy levels of the compound can be adjusted by introducing various substituents to the core structure of the above structure.
또한, 상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 도입된 치환기의 고유 특성을 갖는 화합물을 합성할 수 있다. 예컨대, 유기 발광 소자 제조시 사용되는 정공 주입층 물질, 정공 수송용 물질, 발광층 물질 및 전자 수송층 물질에 주로 사용되는 치환기를 상기 코어 구조에 도입함으로써 각 유기물층에서 요구하는 조건들을 충족시키는 물질을 합성할 수 있다.In addition, by introducing various substituents into the core structure of the above-described structure, a compound having the inherent characteristics of the introduced substituent can be synthesized. For example, by introducing a substituent mainly used for the hole injection layer material, the hole transport material, the light emitting layer material and the electron transport layer material used in the manufacture of the organic light emitting device into the core structure, it is possible to synthesize a material that satisfies the conditions required by each organic material layer. I can.
또한, 본 발명에 따른 유기 발광 소자는 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상은 상기 전술한 화합물을 포함하는 것을 특징으로 한다.In addition, the organic light emitting device according to the present invention includes a first electrode; A second electrode provided to face the first electrode; And one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the above-described compound.
본 발명의 유기 발광 소자는 전술한 화합물을 이용하여 한 층 이상의 유기물층을 형성하는 것을 제외하고는, 통상의 유기 발광 소자의 제조방법 및 재료에 의하여 제조될 수 있다.The organic light-emitting device of the present invention may be manufactured by a conventional method and material of an organic light-emitting device, except that one or more organic material layers are formed by using the above-described compound.
상기 화합물은 유기 발광 소자의 제조시 진공 증착법 뿐만 아니라 용액 도포법에 의하여 유기물층으로 형성될 수 있다. 여기서, 용액 도포법이라 함은 스핀 코팅, 딥 코팅, 잉크젯 프린팅, 스크린 프린팅, 스프레이법, 롤 코팅 등을 의미하지만, 이들만으로 한정되는 것은 아니다.The compound may be formed as an organic material layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light emitting device. Here, the solution coating method refers to spin coating, dip coating, inkjet printing, screen printing, spray method, roll coating, etc., but is not limited thereto.
본 발명의 유기 발광 소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 본 발명의 유기 발광 소자는 유기물층으로서 정공주입층, 정공수송층, 정공주입 및 정공수송을 동시에 하는 층, 발광층, 전자수송층, 전자주입층 등을 포함하는 구조를 가질 수 있다. 그러나, 유기 발광 소자의 구조는 이에 한정되지 않고 더 적은 수의 유기물층 또는 더 많은 수의 유기물층을 포함할 수 있다.The organic material layer of the organic light emitting device of the present invention may have a single-layer structure, but may have a multilayer structure in which two or more organic material layers are stacked. For example, the organic light-emitting device of the present invention may have a structure including a hole injection layer, a hole transport layer, a layer that simultaneously injects and transports holes, a light emitting layer, an electron transport layer, an electron injection layer, and the like as an organic material layer. However, the structure of the organic light emitting device is not limited thereto, and may include a smaller number of organic material layers or a greater number of organic material layers.
본 발명의 유기 발광 소자에서, 상기 유기물층은 전자수송층, 전자주입층 및 전자주입과 전자수송을 동시에 하는 층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다.In the organic light emitting device of the present invention, the organic material layer may include at least one of an electron transport layer, an electron injection layer, and a layer that simultaneously injects and transports electrons, and at least one of the layers is represented by Formula 1 above. It may contain a compound.
또 하나의 유기 발광 소자에서, 상기 유기물층은 전자수송층 또는 전자주입층을 포함할 수 있고, 상기 전자수송층 또는 전자주입층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다.In another organic light emitting device, the organic material layer may include an electron transport layer or an electron injection layer, and the electron transport layer or the electron injection layer may include a compound represented by Formula 1 above.
본 발명의 유기 발광 소자에서, 상기 유기물층은 정공주입층, 정공수송층 및 정공주입과 정공수송을 동시에 하는 층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다.In the organic light emitting device of the present invention, the organic material layer may include at least one of a hole injection layer, a hole transport layer, and a layer that simultaneously injects and transports holes, and at least one of the layers is represented by Formula 1 above. It may contain a compound.
또 하나의 유기 발광 소자에서, 상기 유기물층은 정공주입층 또는 정공수송층을 포함할 수 있고, 상기 정공수송층 또는 정공주입층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다.In another organic light emitting device, the organic material layer may include a hole injection layer or a hole transport layer, and the hole transport layer or the hole injection layer may include a compound represented by Formula 1 above.
또 하나의 일 실시 상태에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층이 상기 화학식 1로 표시되는 화합물을 포함한다. 하나의 예로서, 상기 화학식 1로 표시되는 화합물은 발광층의 도펀트로서 포함될 수 있다. In another exemplary embodiment, the organic material layer includes an emission layer, and the emission layer includes a compound represented by Formula 1 above. As an example, the compound represented by Formula 1 may be included as a dopant of the emission layer.
본 명세서의 일 실시상태에 있어서, 상기 유기 발광 소자는 상기 발광층이 상기 화학식 1로 표시되는 화합물을 도펀트로서 포함하는 녹색 유기 발광 소자이다.In the exemplary embodiment of the present specification, the organic light-emitting device is a green organic light-emitting device in which the emission layer includes the compound represented by Formula 1 as a dopant.
본 명세서의 일 실시상태에 따르면, 상기 유기 발광 소자는 상기 발광층이 상기 화학식 1로 표시되는 화합물을 도펀트로서 포함하는 적색 유기 발광 소자이다.According to the exemplary embodiment of the present specification, the organic light-emitting device is a red organic light-emitting device in which the emission layer includes the compound represented by Formula 1 as a dopant.
또 하나의 일 실시상태에 있어서, 상기 유기 발광 소자는 상기 발광층이 상기 화학식 1로 표시되는 화합물을 도펀트로서 포함하는 청색 유기 발광 소자이다.In another exemplary embodiment, the organic light-emitting device is a blue organic light-emitting device in which the emission layer includes the compound represented by Formula 1 as a dopant.
또 하나의 예로서, 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 상기 화학식 1로 표시되는 화합물을 도펀트로서 포함하고, 안트라센계 화합물 등의 유기화합물을 호스트로 포함할 수 있다. As another example, the organic material layer including the compound represented by Formula 1 may include the compound represented by Formula 1 as a dopant, and may include an organic compound such as an anthracene compound as a host.
또 하나의 예로서, 상기 화학식 1로 표시되는 헤테로고리 화합물을 포함하는 유기물층은 상기 화학식 1로 표시되는 화합물을 도펀트로서 포함하고, 형광 호스트 또는 인광 호스트를 포함할 수 있다. As another example, the organic material layer including the heterocyclic compound represented by Formula 1 may include the compound represented by Formula 1 as a dopant, and may include a fluorescent host or a phosphorescent host.
또 하나의 실시상태에 있어서, 상기 화학식 1로 표시되는 헤테로고리 화합물을 포함하는 유기물층은 상기 화학식 1로 표시되는 화합물을 도펀트로서 포함하고, 형광 호스트 또는 인광 호스트를 포함하며, 다른 유기화합물, 금속 또는 금속화합물을 도펀트로 포함할 수 있다.In another exemplary embodiment, the organic material layer comprising the heterocyclic compound represented by Formula 1 includes the compound represented by Formula 1 as a dopant, includes a fluorescent host or a phosphorescent host, and other organic compounds, metals, or A metal compound may be included as a dopant.
또 하나의 예로서, 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 상기 화학식 1로 표시되는 화합물을 도펀트로서 포함하고, 형광 호스트 또는 인광 호스트를 포함하며, 이리듐계(Ir) 도펀트와 함께 사용할 수 있다.As another example, the organic material layer including the compound represented by Formula 1 includes the compound represented by Formula 1 as a dopant, includes a fluorescent host or a phosphorescent host, and can be used together with an iridium-based (Ir) dopant. have.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 전술한 다환 화합물을 발광층의 도펀트로 포함하고, 하기 화학식 H로 표시되는 화합물을 발광층의 호스트로 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, the emission layer includes the polycyclic compound described above as a dopant of the emission layer, and a compound represented by the following Formula H as a host of the emission layer.
[화학식 H][Formula H]
Figure PCTKR2020010123-appb-I000289
Figure PCTKR2020010123-appb-I000289
상기 화학식 H에 있어서,In the formula H,
L21 및 L22는 서로 같거나 상이하고, 각각 독립적으로, 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 헤테로아릴렌기이고,L21 and L22 are the same as or different from each other, and each independently, a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group,
Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고, Ar21 and Ar22 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
R201 및 R202는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고,R201 and R202 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
n202는 0 내지 7의 정수이고, n202가 2 이상일 때 R202는 서로 같거나 상이하다.n202 is an integer from 0 to 7, and when n202 is 2 or more, R202 is the same as or different from each other.
본 명세서의 일 실시상태에 있어서, 상기 L21 및 L22는 서로 같거나 상이하고, 각각 독립적으로, 직접결합; 탄소수 6 내지 30의 단환 또는 다환의 아릴렌기; 또는 탄소수 2 내지 30의 단환 또는 다환의 헤테로아릴렌기이다.In the exemplary embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently, a direct bond; A monocyclic or polycyclic arylene group having 6 to 30 carbon atoms; Or a monocyclic or polycyclic heteroarylene group having 2 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 L21 및 L22는 서로 같거나 상이하고, 각각 독립적으로, 직접결합; 탄소수 6 내지 20의 단환 또는 다환의 아릴렌기; 또는 탄소수 2 내지 20의 단환 또는 다환의 헤테로아릴렌기이다.In the exemplary embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently, a direct bond; A monocyclic or polycyclic arylene group having 6 to 20 carbon atoms; Or a monocyclic or polycyclic heteroarylene group having 2 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 L21 및 L22는 서로 같거나 상이하고, 각각 독립적으로, 직접결합; 중수소로 치환 또는 비치환된 페닐렌기; 중수소로 치환 또는 비치환된 바이페닐릴렌기; 중수소로 치환 또는 비치환된 나프틸렌기; 2가의 디벤조퓨란기; 또는 2가의 디벤조티오펜기이다.In the exemplary embodiment of the present specification, L21 and L22 are the same as or different from each other, and each independently, a direct bond; A phenylene group unsubstituted or substituted with deuterium; Biphenylylene group unsubstituted or substituted with deuterium; A naphthylene group unsubstituted or substituted with deuterium; Divalent dibenzofuran group; Or a divalent dibenzothiophene group.
본 명세서의 일 실시상태에 있어서, 상기 Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 탄소수 6 내지 30의 단환 또는 다환의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 30의 단환 또는 다환의 헤테로고리기다.In the exemplary embodiment of the present specification, Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 탄소수 6 내지 20의 단환 또는 다환의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 20의 단환 또는 다환의 헤테로고리기다.In the exemplary embodiment of the present specification, Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 탄소수 6 내지 20의 단환 내지 4환의 아릴기; 또는 치환 또는 비치환된 탄소수 6 내지 20의 단환 내지 4환의 헤테로고리기다.In the exemplary embodiment of the present specification, Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted monocyclic to 4 ring aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic to 4 ring heterocyclic group having 6 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 페닐기; 치환 또는 비치환된 바이페닐기; 치환 또는 비치환된 터페닐기; 치환 또는 비치환된 나프틸기; 치환 또는 비치환된 안트라센기; 치환 또는 비치환된 페난트렌기; 치환 또는 비치환된 페날렌기; 치환 또는 비치환된 플루오렌기; 치환 또는 비치환된 벤조플루오렌기; 치환 또는 비치환된 퓨란기; 치환 또는 비치환된 티오펜기; 치환 또는 비치환된 디벤조퓨란기; 치환 또는 비치환된 나프토벤조퓨란기; 치환 또는 비치환된 디벤조티오펜기; 또는 치환 또는 비치환된 나프토벤조티오펜기이다.In the exemplary embodiment of the present specification, Ar21 and Ar22 are the same as or different from each other, and each independently, a substituted or unsubstituted phenyl group; A substituted or unsubstituted biphenyl group; A substituted or unsubstituted terphenyl group; A substituted or unsubstituted naphthyl group; A substituted or unsubstituted anthracene group; A substituted or unsubstituted phenanthrene group; A substituted or unsubstituted phenalene group; A substituted or unsubstituted fluorene group; A substituted or unsubstituted benzofluorene group; A substituted or unsubstituted furan group; A substituted or unsubstituted thiophene group; A substituted or unsubstituted dibenzofuran group; A substituted or unsubstituted naphthobenzofuran group; A substituted or unsubstituted dibenzothiophene group; Or a substituted or unsubstituted naphthobenzothiophene group.
본 명세서의 일 실시상태에 있어서, 상기 Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 중수소, 또는 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 페닐기; 중수소, 또는 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 바이페닐기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 나프틸기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 디벤조퓨란기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 나프토벤조퓨란기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 디벤조티오펜기; 또는 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 나프토벤조티오펜기이다.In the exemplary embodiment of the present specification, Ar21 and Ar22 are the same as or different from each other, and each independently, a phenyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A biphenyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthyl group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthobenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzothiophene group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; Or a naphthobenzothiophene group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 중수소로 치환 또는 비치환된 페닐기; 중수소로 치환 또는 비치환된 바이페닐기; 터페닐기; 중수소로 치환 또는 비치환된 나프틸기; 페난트렌기; 디벤조퓨란기; 나프토벤조퓨란기; 디벤조티오펜기; 또는 나프토벤조티오펜기이다.In the exemplary embodiment of the present specification, Ar21 and Ar22 are the same as or different from each other, and each independently, a phenyl group unsubstituted or substituted with deuterium; Biphenyl group unsubstituted or substituted with deuterium; Terphenyl group; A naphthyl group unsubstituted or substituted with deuterium; Phenanthrene group; Dibenzofuran group; Naphthobenzofuran group; Dibenzothiophene group; Or a naphthobenzothiophene group.
본 명세서의 일 실시상태에 있어서, 상기 Ar21 및 Ar22 중 어느 하나는 치환 또는 비치환된 아릴기이고, 다른 하나는 치환 또는 비치환된 헤테로고리기다.In the exemplary embodiment of the present specification, any one of Ar21 and Ar22 is a substituted or unsubstituted aryl group, and the other is a substituted or unsubstituted heterocyclic group.
본 명세서의 일 실시상태에 있어서, 상기 Ar21은 치환 또는 비치환된 아릴기이고, 상기 Ar22은 치환 또는 비치환된 치환 또는 비치환된 헤테로고리기다.In the exemplary embodiment of the present specification, Ar21 is a substituted or unsubstituted aryl group, and Ar22 is a substituted or unsubstituted substituted or unsubstituted heterocyclic group.
본 명세서의 일 실시상태에 있어서, 상기 Ar21은 치환 또는 비치환된 헤테로고리기이고, 상기 Ar22은 치환 또는 비치환된 아릴기이다.In the exemplary embodiment of the present specification, Ar21 is a substituted or unsubstituted heterocyclic group, and Ar22 is a substituted or unsubstituted aryl group.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 중수소; 할로겐기; 치환 또는 비치환된 탄소수 1 내지 30의 직쇄 또는 분지쇄의 알킬기; 치환 또는 비치환된 탄소수 3 내지 30의 단환 또는 다환의 시클로알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 단환 또는 다환의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 30의 단환 또는 다환의 헤테로고리기다.In the exemplary embodiment of the present specification, R201 is hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted C 1 to C 30 linear or branched alkyl group; A substituted or unsubstituted monocyclic or polycyclic cycloalkyl group having 3 to 30 carbon atoms; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 중수소; 불소; 치환 또는 비치환된 탄소수 1 내지 10의 직쇄 또는 분지쇄의 알킬기; 치환 또는 비치환된 탄소수 3 내지 10의 단환 또는 다환의 시클로알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 단환 또는 다환의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 30의 단환 또는 다환의 헤테로고리기다.In the exemplary embodiment of the present specification, R201 is hydrogen; heavy hydrogen; Fluorine; A substituted or unsubstituted C 1 to C 10 linear or branched alkyl group; A substituted or unsubstituted monocyclic or polycyclic cycloalkyl group having 3 to 10 carbon atoms; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 치환 또는 비치환된 탄소수 6 내지 30의 단환 또는 다환의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 30의 단환 또는 다환의 헤테로고리기다.In the exemplary embodiment of the present specification, R201 is hydrogen; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 30 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 치환 또는 비치환된 탄소수 6 내지 20의 단환 또는 다환의 아릴기; 또는 치환 또는 비치환된 탄소수 2 내지 20의 단환 또는 다환의 헤테로고리기다.In the exemplary embodiment of the present specification, R201 is hydrogen; A substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic or polycyclic heterocyclic group having 2 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 치환 또는 비치환된 탄소수 6 내지 20의 단환 내지 4환의 아릴기; 또는 치환 또는 비치환된 탄소수 6 내지 20의 단환 내지 4환의 헤테로고리기다.In the exemplary embodiment of the present specification, R201 is hydrogen; A substituted or unsubstituted monocyclic to 4 ring aryl group having 6 to 20 carbon atoms; Or a substituted or unsubstituted monocyclic to 4 ring heterocyclic group having 6 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 치환 또는 비치환된 페닐기; 치환 또는 비치환된 바이페닐기; 치환 또는 비치환된 터페닐기; 치환 또는 비치환된 나프틸기; 치환 또는 비치환된 안트라센기; 치환 또는 비치환된 페난트렌기; 치환 또는 비치환된 페날렌기; 치환 또는 비치환된 플루오렌기; 치환 또는 비치환된 벤조플루오렌기; 치환 또는 비치환된 퓨란기; 치환 또는 비치환된 티오펜기; 치환 또는 비치환된 디벤조퓨란기; 치환 또는 비치환된 나프토벤조퓨란기; 치환 또는 비치환된 디벤조티오펜기; 또는 치환 또는 비치환된 나프토벤조티오펜기이다.In the exemplary embodiment of the present specification, R201 is hydrogen; A substituted or unsubstituted phenyl group; A substituted or unsubstituted biphenyl group; A substituted or unsubstituted terphenyl group; A substituted or unsubstituted naphthyl group; A substituted or unsubstituted anthracene group; A substituted or unsubstituted phenanthrene group; A substituted or unsubstituted phenalene group; A substituted or unsubstituted fluorene group; A substituted or unsubstituted benzofluorene group; A substituted or unsubstituted furan group; A substituted or unsubstituted thiophene group; A substituted or unsubstituted dibenzofuran group; A substituted or unsubstituted naphthobenzofuran group; A substituted or unsubstituted dibenzothiophene group; Or a substituted or unsubstituted naphthobenzothiophene group.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 중수소; 중수소, 또는 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 페닐기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 바이페닐기; 중수소, 또는 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 나프틸기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 디벤조퓨란기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 나프토벤조퓨란기; 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 디벤조티오펜기; 또는 탄소수 6 내지 20의 단환 또는 다환의 아릴기로 치환 또는 비치환된 나프토벤조티오펜기이다.In the exemplary embodiment of the present specification, R201 is hydrogen; heavy hydrogen; A phenyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A biphenyl group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthyl group unsubstituted or substituted with deuterium or a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A naphthobenzofuran group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; A dibenzothiophene group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms; Or a naphthobenzothiophene group unsubstituted or substituted with a monocyclic or polycyclic aryl group having 6 to 20 carbon atoms.
본 명세서의 일 실시상태에 있어서, 상기 R201은 수소; 중수소; 중수소, 페닐기, 또는 나프틸기로 치환 또는 비치환된 페닐기; 바이페닐기; 중수소, 페닐기, 또는 나프틸기로 치환 또는 비치환된 나프틸기; 디벤조퓨란기; 나프토벤조퓨란기; 디벤조티오펜기; 또는 나프토벤조티오펜기이다.In the exemplary embodiment of the present specification, R201 is hydrogen; heavy hydrogen; A phenyl group unsubstituted or substituted with deuterium, a phenyl group, or a naphthyl group; Biphenyl group; A naphthyl group unsubstituted or substituted with deuterium, a phenyl group, or a naphthyl group; Dibenzofuran group; Naphthobenzofuran group; Dibenzothiophene group; Or a naphthobenzothiophene group.
본 명세서의 일 실시상태에 따르면, 상기 R202은 수소; 또는 중수소이다.[0366] According to an exemplary embodiment of the present specification, R202 is hydrogen; Or deuterium.
본 명세서의 일 실시상태에 따르면, 상기 R202 중 4개 이상은 중수소이다.According to an exemplary embodiment of the present specification, four or more of R202 are deuterium.
본 명세서의 일 실시상태에 따르면, 상기 R202은 수소이다.According to an exemplary embodiment of the present specification, R202 is hydrogen.
본 명세서의 일 실시상태에 따르면, 상기 R202은 중수소이다.According to an exemplary embodiment of the present specification, R202 is deuterium.
본 명세서의 일 실시상태에 있어서, 상기 화학식 H로 표시되는 화합물이 중수소로 치환된 경우, 치환 가능한 위치의 수소가 중수소로 30% 이상 치환된다. 또 다른 일 실시상태에 있어서, 상기 화학식 H의 구조는 치환 가능한 위치의 수소가 중수소로 40% 이상 치환된다. 또 다른 일 실시상태에 있어서, 상기 화학식 H의 구조는 치환 가능한 위치의 수소가 중수소로 60% 이상 치환된다. In the exemplary embodiment of the present specification, when the compound represented by Formula H is substituted with deuterium, hydrogen at a position where it can be substituted is substituted with deuterium by 30% or more. In another exemplary embodiment, in the structure of Formula H, 40% or more of hydrogen at a replaceable position is substituted with deuterium. In another exemplary embodiment, in the structure of Formula H, hydrogen at a position where it can be substituted is substituted by at least 60% of deuterium.
또 다른 일 실시상태에 있어서, 상기 화학식 H의 구조는 치환 가능한 위치의 수소가 중수소로 80% 이상 치환된다. 또 다른 일 실시상태에 있어서, 상기 화학식 H의 구조는 치환 가능한 위치의 수소가 중수소로 100% 치환된다.In another exemplary embodiment, in the structure of Formula H, at least 80% of hydrogen at a replaceable position is substituted with deuterium. In another exemplary embodiment, in the structure of Formula H, 100% of hydrogen at a replaceable position is substituted with deuterium.
본 명세서의 일 실시상태에 있어서, 상기 화학식 H로 표시되는 화합물은 하기 화합물 중에서 선택되는 어느 하나이다. In the exemplary embodiment of the present specification, the compound represented by Formula H is any one selected from the following compounds.
Figure PCTKR2020010123-appb-I000290
Figure PCTKR2020010123-appb-I000290
Figure PCTKR2020010123-appb-I000291
Figure PCTKR2020010123-appb-I000291
Figure PCTKR2020010123-appb-I000292
Figure PCTKR2020010123-appb-I000292
Figure PCTKR2020010123-appb-I000293
Figure PCTKR2020010123-appb-I000293
Figure PCTKR2020010123-appb-I000294
Figure PCTKR2020010123-appb-I000294
Figure PCTKR2020010123-appb-I000295
Figure PCTKR2020010123-appb-I000295
Figure PCTKR2020010123-appb-I000296
Figure PCTKR2020010123-appb-I000296
Figure PCTKR2020010123-appb-I000297
Figure PCTKR2020010123-appb-I000297
Figure PCTKR2020010123-appb-I000298
Figure PCTKR2020010123-appb-I000298
Figure PCTKR2020010123-appb-I000299
Figure PCTKR2020010123-appb-I000299
Figure PCTKR2020010123-appb-I000300
Figure PCTKR2020010123-appb-I000300
Figure PCTKR2020010123-appb-I000301
Figure PCTKR2020010123-appb-I000301
Figure PCTKR2020010123-appb-I000302
Figure PCTKR2020010123-appb-I000302
Figure PCTKR2020010123-appb-I000303
Figure PCTKR2020010123-appb-I000303
Figure PCTKR2020010123-appb-I000304
Figure PCTKR2020010123-appb-I000304
Figure PCTKR2020010123-appb-I000305
Figure PCTKR2020010123-appb-I000305
Figure PCTKR2020010123-appb-I000306
Figure PCTKR2020010123-appb-I000306
Figure PCTKR2020010123-appb-I000307
Figure PCTKR2020010123-appb-I000307
Figure PCTKR2020010123-appb-I000308
Figure PCTKR2020010123-appb-I000308
Figure PCTKR2020010123-appb-I000309
Figure PCTKR2020010123-appb-I000309
Figure PCTKR2020010123-appb-I000310
Figure PCTKR2020010123-appb-I000310
Figure PCTKR2020010123-appb-I000311
Figure PCTKR2020010123-appb-I000311
Figure PCTKR2020010123-appb-I000312
Figure PCTKR2020010123-appb-I000312
본 명세서의 일 실시상태에 있어서, 상기 발광층은 전술한 다환 화합물을 발광층의 도펀트로 포함하고, 상기 화학식 H로 표시되는 화합물을 발광층의 호스트로 포함한다.In the exemplary embodiment of the present specification, the emission layer includes the polycyclic compound described above as a dopant of the emission layer, and the compound represented by Formula H as a host of the emission layer.
본 명세서의 일 실시상태에 있어서, 상기 발광층이 호스트 및 도펀트를 포함할 경우, 도펀트의 함량은 발광층의 100 중량부를 기준으로 0.01 내지 10 중량부의 범위에서 선택될 수 있으며, 이에 한정되지 않는다.In the exemplary embodiment of the present specification, when the emission layer includes a host and a dopant, the content of the dopant may be selected from 0.01 to 10 parts by weight based on 100 parts by weight of the emission layer, but is not limited thereto.
본 명세서의 일 실시상태에 있어서, 상기 발광층이 호스트 및 도펀트를 포함하고, 상기 호스트 및 도펀트는 99: 1 내지 1:99 중량비, 바람직하게는 99: 1 내지 70: 30 중량비, 더욱더 바람직하게는 99:1 내지 90: 10의 중량비로 포함한다.In the exemplary embodiment of the present specification, the emission layer includes a host and a dopant, and the host and the dopant are 99:1 to 1:99 weight ratio, preferably 99:1 to 70:30 weight ratio, even more preferably 99 It includes in a weight ratio of :1 to 90:10.
상기 발광층은 호스트 재료를 더 포함할 수 있고, 상기 호스트는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 카바졸 유도체, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 또는 트리아진 유도체 등이 있으며, 이들의 2 종 이상의 혼합물일 수 있으나, 이에 한정되지 않는다. The light emitting layer may further include a host material, and the host may include a condensed aromatic ring derivative or a heterocyclic compound. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, and fluoranthene compounds, and heterocycle-containing compounds include carbazole derivatives, dibenzofuran derivatives, ladder type Furan compounds, pyrimidine derivatives, triazine derivatives, and the like, and may be a mixture of two or more thereof, but are not limited thereto.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 1 종 이상의 도펀트, 및 호스트를 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes at least one dopant and a host.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 2종 이상의 혼합 도펀트 및 호스트를 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes two or more mixed dopants and a host.
본 명세서의 일 실시상태에 따르면, 상기 2종 이상의 혼합 도펀트 중 1 이상은 상기 화학식 1을 포함하고, 상기 호스트는 상기 화학식 H로 표시되는 화합물을 포함한다. 상기 2종 이상의 혼합 도펀트 중 1 이상은 상기 화학식 1을 포함하고, 나머지는 종래에 알려진 도펀트 물질을 사용할 수 있으나, 이에만 한정되는 것은 아니다.According to an exemplary embodiment of the present specification, at least one of the two or more mixed dopants includes Formula 1, and the host includes a compound represented by Formula H. At least one of the two or more mixed dopants includes Formula 1, and the other may use a conventionally known dopant material, but is not limited thereto.
본 명세서의 일 실시상태에 따르면, 상기 2종 이상의 혼합 도펀트 중 1 이상은 상기 화학식 1을 포함하고, 나머지는 상기 화학식 1과 상이한 보론계 화합물, 파이렌계 화합물 및 지연형광계 화합물 중 1 이상을 사용할 수 있으나, 이에만 한정되는 것은 아니다.According to an exemplary embodiment of the present specification, at least one of the two or more mixed dopants includes the formula 1, and the rest of the boron-based compounds, pyrene-based compounds, and delayed fluorescent compounds different from those of the formula 1 are used. However, it is not limited thereto.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 1 종 이상의 호스트를 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes one or more types of hosts.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 2종 이상의 혼합 호스트를 포함한다. According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes two or more mixed hosts.
본 명세서의 일 실시상태에 따르면, 상기 2 종 이상의 혼합 호스트 중 1 이상은 상기 화학식 H로 표시되는 화합물이다.According to an exemplary embodiment of the present specification, at least one of the two or more mixed hosts is a compound represented by Formula H.
본 명세서의 일 실시상태에 따르면, 상기 2 종 이상의 혼합 호스트는 서로 상이하고, 각각 독립적으로, 상기 화학식 H로 표시되는 화합물이다.According to an exemplary embodiment of the present specification, the two or more kinds of mixed hosts are different from each other, and each independently, is a compound represented by Formula H.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 2종의 혼합 호스트를 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes two kinds of mixed hosts.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층 2 종의 혼합 호스트를 포함하고, 상기 2 종의 혼합 호스트는 서로 상이하며, 상기 2 종의 호스트는 상기 화학식 H로 표시되는 화합물이다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, the emission layer includes a mixed host of two types, the two types of mixed hosts are different from each other, and the two types of hosts are represented by Formula H. It is a compound that becomes.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 화학식 H로 표시되는 제1 호스트; 및 상기 화학식 H로 표시되는 제2 호스트를 포함하고, 상기 제1 호스트 및 제2 호스트는 서로 상이하다.According to an exemplary embodiment of the present specification, the organic material layer includes a first host including an emission layer and represented by Chemical Formula H; And a second host represented by Formula H, wherein the first host and the second host are different from each other.
본 명세서의 일 실시상태에 따르면, 상기 제1 호스트: 제2 호스트는 95:5 내지 5:95의 중량비로 포함되고, 바람직하게는 70: 30 내지 30: 70의 중량비로 포합된다.According to an exemplary embodiment of the present specification, the first host: the second host is included in a weight ratio of 95:5 to 5:95, and preferably is included in a weight ratio of 70:30 to 30:70.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 1 종 이상의 호스트, 및 도펀트를 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes at least one host and a dopant.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 1 종 이상의 호스트, 및 도펀트를 포함하고, 상기 호스트는 상기 화학식 H로 표시되는 화합물을 포함하고, 상기 도펀트는 상기 화학식 1로 표시되는 화합물을 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, the emission layer includes at least one host and a dopant, the host includes a compound represented by Formula H, and the dopant is the formula It includes the compound represented by 1.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 2 종 이상의 혼합 호스트, 및 도펀트를 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes two or more mixed hosts and a dopant.
본 명세서의 일 실시상태에 따르면, 상기 2종 이상의 혼합 호스트 중 1 이상은 상기 화학식 H로 표시되는 화합물을 포함하고, 도펀트는 상기 화학식 1로 표시되는 화합물을 포함한다.According to an exemplary embodiment of the present specification, at least one of the two or more mixed hosts includes the compound represented by Formula H, and the dopant includes the compound represented by Formula 1 above.
본 명세서에서 상기 2종 이상의 혼합 호스트는 서로 상이하다.In the present specification, the two or more kinds of mixed hosts are different from each other.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 2 종의 혼합 호스트, 및 도펀트를 포함한다.According to an exemplary embodiment of the present specification, the organic material layer includes an emission layer, and the emission layer includes two kinds of mixed hosts and a dopant.
본 명세서의 일 실시상태에 따르면, 상기 2 종의 혼합 호스트는 서로 상이하고, 각각 독립적으로, 상기 화학식 H로 표시되는 화합물을 포함하고, 상기 도펀트는 상기 화학식 1로 표시되는 화합물을 포함한다.According to an exemplary embodiment of the present specification, the two kinds of mixed hosts are different from each other, and each independently includes a compound represented by Chemical Formula H, and the dopant includes a compound represented by Chemical Formula 1.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 발광층을 포함하고, 상기 화학식 H로 표시되는 제1 호스트; 상기 화학식 H로 표시되는 제2 호스트; 및 상기 화학식 1로 표시되는 도펀트를 포함하고, 상기 제1 호스트 및 제2 호스트는 서로 상이하다.According to an exemplary embodiment of the present specification, the organic material layer includes a first host including an emission layer and represented by Chemical Formula H; A second host represented by Formula H; And a dopant represented by Formula 1, wherein the first host and the second host are different from each other.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 1 종 이상의 호스트, 및 1 종 이상의 도펀트를 사용하고, 상기 1 종 이상의 호스트는 상기 화학식 H로 표시되는 화합물을 포함하고, 상기 1 종 이상의 도펀트는 상기 화학식 1로 표시되는 화합물을 포함한다.According to an exemplary embodiment of the present specification, the organic material layer uses at least one host and at least one dopant, the at least one host comprises a compound represented by Formula H, and the at least one dopant is the It includes a compound represented by Formula 1.
본 명세서의 일 실시상태에 따르면, 상기 유기물층은 2 종 이상의 혼합 호스트, 및 2 종 이상의 혼합 도펀트를 사용하고, 상기 2 종 이상의 혼합 호스트는 전술한 바와 동일한 재료를 사용할 수 있으며, 상기 2 종 이상의 혼합 도펀트는 전술한 바와 동일한 재료를 사용할 수 있다.According to an exemplary embodiment of the present specification, the organic material layer may use two or more types of mixed hosts and two or more types of mixed dopants, and the two or more types of mixed hosts may use the same material as described above, and the two or more types of mixed host may be used. The dopant may use the same material as described above.
본 명세서의 일 실시상태에 있어서, 상기 화학식 100으로 표시되는 다환 화합물을 포함하는 발광층의 최대 발광 피크는 380 nm 내지 500 nm이다. 즉, 전술한 다환 화합물을 포함하는 발광층은 청색 발광층이다.In the exemplary embodiment of the present specification, the maximum emission peak of the emission layer including the polycyclic compound represented by Chemical Formula 100 is 380 nm to 500 nm. That is, the light emitting layer containing the polycyclic compound described above is a blue light emitting layer.
본 명세서의 일 실시상태에 있어서, 상기 제1 전극은 양극이고, 제2 전극은 음극이다.In the exemplary embodiment of the present specification, the first electrode is an anode, and the second electrode is a cathode.
또 하나의 일 실시상태에 따르면, 상기 제1 전극은 음극이고, 제2 전극은 양극이다.According to another exemplary embodiment, the first electrode is a cathode, and the second electrode is an anode.
본 발명의 유기 발광 소자의 구조는 하기 (1) 내지 (18) 과 같은 구조를 가질 수 있으나, 이에만 한정되는 것은 아니다.The structure of the organic light-emitting device of the present invention may have the following structures (1) to (18), but is not limited thereto.
(1) 양극/정공수송층/발광층/음극(1) Anode/Hole Transport Layer/Light-Emitting Layer/Anode
(2) 양극/정공주입층/정공수송층/발광층/음극(2) Anode/Hole Injection Layer/Hole Transport Layer/Light-Emitting Layer/Anode
(3) 양극/정공주입층/정공버퍼층/정공수송층/발광층/음극(3) Anode/Hole injection layer/Hole buffer layer/Hole transport layer/Light emitting layer/Anode
(4) 양극/정공수송층/발광층/전자수송층/음극(4) Anode/hole transport layer/light-emitting layer/electron transport layer/cathode
(5) 양극/정공수송층/발광층/전자수송층/전자주입층/음극(5) Anode/hole transport layer/light-emitting layer/electron transport layer/electron injection layer/cathode
(6) 양극/정공주입층/정공수송층/발광층/전자수송층/음극(6) Anode/hole injection layer/hole transport layer/light-emitting layer/electron transport layer/cathode
(7) 양극/정공주입층/정공수송층/발광층/전자수송층/전자주입층/음극(7) Anode/hole injection layer/hole transport layer/light-emitting layer/electron transport layer/electron injection layer/cathode
(8) 양극/정공주입층/정공버퍼층/정공수송층/발광층/전자수송층/음극(8) Anode/Hole injection layer/Hole buffer layer/Hole transport layer/Light emitting layer/Electron transport layer/Anode
(9) 양극/정공주입층/정공버퍼층/정공수송층/발광층/전자수송층/전자주입층 /음극(9) Anode/Hole injection layer/Hole buffer layer/Hole transport layer/Light emitting layer/Electron transport layer/Electron injection layer/Anode
(10) 양극/ 정공수송층/전자차단층/발광층/전자수송층/음극(10) Anode/hole transport layer/electron blocking layer/light emitting layer/electron transport layer/cathode
(11) 양극/ 정공수송층/전자차단층/발광층/전자수송층/전자주입층/음극(11) Anode/hole transport layer/electron blocking layer/light emitting layer/electron transport layer/electron injection layer/cathode
(12) 양극/정공주입층/정공수송층/전자차단층/발광층/전자수송층/음극(12) Anode/hole injection layer/hole transport layer/electron blocking layer/light emitting layer/electron transport layer/cathode
(13)양극/정공주입층/정공수송층/전자차단층/발광층/전자수송층/전자주입 층/음극(13) Anode/hole injection layer/hole transport layer/electron blocking layer/light emitting layer/electron transport layer/electron injection layer/cathode
(14) 양극/정공수송층/발광층/정공차단층/전자수송층/음극(14) Anode/Hole Transport Layer/Light-Emitting Layer/Hole Blocking Layer/Electron Transport Layer/Anode
(15) 양극/정공수송층/발광층/ 정공차단층/전자수송층/전자주입층/음극(15) Anode/Hole transport layer/Light-emitting layer/Hole blocking layer/Electron transport layer/Electron injection layer/Anode
(16) 양극/정공주입층/정공수송층/발광층/정공차단층/전자수송층/음극(16) Anode/hole injection layer/hole transport layer/light-emitting layer/hole blocking layer/electron transport layer/cathode
(17)양극/정공주입층/정공수송층/발광층/정공차단층/전자수송층/전자주입 층/음극(17) Anode/Hole injection layer/Hole transport layer/Light emitting layer/Hole blocking layer/Electron transport layer/Electron injection layer/Anode
(18)양극/정공주입층/정공수송층/전자차단층/발광층/정공저지층/전자주입및 수송층/음극(18) Anode/Hole injection layer/Hole transport layer/Electron blocking layer/Light emitting layer/Hole blocking layer/Electron injection and transport layer/Anode
본 발명의 유기 발광 소자의 구조는 도 1 및 2에 나타낸 것과 같은 구조를 가질 수 있으나, 이에만 한정되는 것은 아니다.The structure of the organic light-emitting device of the present invention may have a structure as shown in FIGS. 1 and 2, but is not limited thereto.
도 1에는 기판(1), 양극(2) 위에 발광층(3) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층(3) 에 포함될 수 있다.1 illustrates a structure of an organic light-emitting device in which a light emitting layer 3 and a cathode 4 are sequentially stacked on a substrate 1 and an anode 2. In such a structure, the compound represented by Formula 1 may be included in the emission layer 3.
도 2에는 기판(1), 양극(2) 위에 제1 정공주입층(5), 제2 정공주입층(6), 정공수송층(7), 전자차단층(8), 발광층(3), 제1 전자수송층(9), 제2 전자수송층(10), 전자주입층(11) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층(3) 에 포함될 수 있다.2, a first hole injection layer 5, a second hole injection layer 6, a hole transport layer 7, an electron blocking layer 8, a light emitting layer 3, and a second hole injection layer 6 on the substrate 1 and the anode 2 The structure of an organic light-emitting device in which the first electron transport layer 9, the second electron transport layer 10, the electron injection layer 11, and the cathode 4 are sequentially stacked is illustrated. In such a structure, the compound represented by Formula 1 may be included in the emission layer 3.
예컨대, 본 발명에 따른 유기 발광 소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공주입층, 정공수송층, 정공수송 및 정공주입을 동시에 하는 층, 발광층, 전자수송층, 전자주입층, 및 전자수송 및 전자주입을 동시에하는 층으로 이루어진 군으로부터 선택된 1층 이상을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 만들 수도 있다.For example, the organic light-emitting device according to the present invention uses a PVD (physical vapor deposition) method such as sputtering or e-beam evaporation, and uses a metal or conductive metal oxide or alloy thereof on a substrate. Is deposited to form an anode, and on it After forming an organic material layer including one or more selected layers, it can be prepared by depositing a material that can be used as a cathode thereon. In addition to this method, an organic light-emitting device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.
상기 유기물층은 정공주입층, 정공수송층, 발광층 및 전자수송층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 용매 공정(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다.The organic material layer may have a multilayer structure including a hole injection layer, a hole transport layer, an emission layer, an electron transport layer, etc., but is not limited thereto and may have a single layer structure. In addition, the organic material layer is made of a variety of polymer materials, and is used in a smaller number of solvent processes, such as spin coating, dip coating, doctor blading, screen printing, inkjet printing, or thermal transfer. It can be made in layers.
상기 양극은 정공을 주입하는 전극으로, 양극 물질로는 통상 유기물층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO, Indium Tin Oxide), 인듐아연 산화물(IZO, Indium Zinc Oxide)과 같은 금속 산화물; ZnO : Al 또는 SnO2 : Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.The anode is an electrode for injecting holes, and a material having a large work function is preferably used as the anode material to facilitate hole injection into an organic material layer. Specific examples of the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), conductive polymers such as polypyrrole and polyaniline, and the like, but are not limited thereto.
상기 음극은 전자를 주입하는 전극으로, 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.The cathode is an electrode for injecting electrons, and the cathode material is usually a material having a small work function to facilitate electron injection into the organic material layer. Specific examples of the negative electrode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; There are multilayered materials such as LiF/Al or LiO 2 /Al, but are not limited thereto.
상기 정공주입층은 양극으로부터 발광층으로 정공의 주입을 원활하게 하는 역할을 하는 층이며, 단층 또는 다층구조일 수 있다, 정공 주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입 받을 수 있는 물질로서, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴헥사아자트리페닐렌 계열의 유기물, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. 정공주입층의 두께는 1 내지 150nm일 수 있다. 상기 정공주입층의 두께가 1nm 이상이면, 정공 주입 특성이 저하되는 것을 방지할 수 있는 이점이 있고, 150nm 이하이면, 정공주입층의 두께가 너무 두꺼워 정공의 이동을 향상시키기 위해 구동전압이 상승되는것을 방지할 수 있는 이점이 있다. 본 명세서의 일 실시상태에 있어서, 정공주입층은 2층 이상의 다층 구조이다.The hole injection layer is a layer that facilitates injection of holes from the anode to the light emitting layer, and may have a single-layer or multi-layer structure. The hole injection material is a material capable of injecting holes well from the anode at a low voltage, It is preferable that the HOMO (highest occupied molecular orbital) of the hole injection material is between the work function of the positive electrode material and the HOMO of the surrounding organic material layer. Specific examples of hole injection materials include metal porphyrine, oligothiophene, arylamine-based organic substances, hexanitrile hexaazatriphenylene-based organic substances, quinacridone-based organic substances, and perylene-based organic substances. Organic substances, anthraquinone, polyaniline, and polythiophene-based conductive polymers, etc., but are not limited thereto. The thickness of the hole injection layer may be 1 to 150 nm. When the thickness of the hole injection layer is 1 nm or more, there is an advantage of preventing deterioration of the hole injection characteristics, and when the thickness of the hole injection layer is 150 nm or less, the thickness of the hole injection layer is too thick to increase the driving voltage to improve the movement of holes. There is an advantage that can prevent it. In one embodiment of the present specification, the hole injection layer has a multilayer structure of two or more layers.
상기 정공수송층은 정공의 수송을 원활하게 하는 역할을 할 수 있다. 정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다. The hole transport layer may serve to facilitate transport of holes. As the hole transport material, a material capable of transporting holes from the anode or the hole injection layer and transferring them to the emission layer, and a material having high mobility for holes is suitable. Specific examples include an arylamine-based organic material, a conductive polymer, and a block copolymer including a conjugated portion and a non-conjugated portion, but are not limited thereto.
정공주입층과 정공수송층 사이에 추가로 정공버퍼층이 구비될 있으며, 당 기술분야에 알려져 있는 정공주입 또는 수송재료를 포함할 수 있다. A hole buffer layer may be additionally provided between the hole injection layer and the hole transport layer, and may include a hole injection or transport material known in the art.
정공수송층과 발광층 사이에 전자차단층이 구비될 수 있다. 상기 전자차단층은 전술한 스피로 화합물 또는 당 기술분야에 알려져 있는 재료가 사용될 수 있다.An electron blocking layer may be provided between the hole transport layer and the light emitting layer. As the electron blocking layer, the aforementioned spiro compound or a material known in the art may be used.
상기 발광층은 적색, 녹색 또는 청색을 발광할 수 있으며, 인광 물질 또는 형광 물질로 이루어질 수 있다. 상기 발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자 효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3); 카르바졸 계열 화합물; 이량체화 스티릴(dimerized styryl) 화합물; BAlq; 10-히드록시벤조 퀴놀린-금속 화합물; 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물; 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자; 스피로(spiro) 화합물; 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The emission layer may emit red, green, or blue light, and may be made of a phosphorescent material or a fluorescent material. The light-emitting material is a material capable of emitting light in a visible light region by transporting and bonding holes and electrons from the hole transport layer and the electron transport layer, respectively, and a material having good quantum efficiency for fluorescence or phosphorescence is preferable. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ); Carbazole-based compounds; Dimerized styryl compounds; BAlq; 10-hydroxybenzo quinoline-metal compound; Benzoxazole, benzthiazole, and benzimidazole-based compounds; Poly(p-phenylenevinylene) (PPV)-based polymer; Spiro compounds; Polyfluorene, rubrene, and the like, but are not limited thereto.
발광층의 호스트 재료로는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 카바졸 유도체, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되지 않는다.Examples of the host material for the light emitting layer include a condensed aromatic ring derivative or a heterocyclic compound. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, and fluoranthene compounds, and heterocycle-containing compounds include carbazole derivatives, dibenzofuran derivatives, ladder type Furan compounds, pyrimidine derivatives, and the like, but are not limited thereto.
발광층이 적색 발광을 하는 경우, 발광 도펀트로는 PIQIr(acac)(bis(1-phenylisoquinoline)acetylacetonateiridium), PQIr(acac)(bis(1-phenylquinoline)acetylacetonate iridium), PQIr(tris(1-phenylquinoline)iridium), PtOEP(octaethylporphyrin platinum)와 같은 인광 물질이나, Alq3(tris(8-hydroxyquinolino)aluminum)와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다. 발광층이 녹색 발광을 하는 경우, 발광 도펀트로는 Ir(ppy)3(fac tris(2-phenylpyridine)iridium)와 같은 인광물질이나, Alq3(tris(8-hydroxyquinolino)aluminum)와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다. 발광층이 청색 발광을 하는 경우, 발광 도펀트로는 (4,6-F2ppy)2Irpic와 같은 인광 물질이나, spiro-DPVBi, spiro-6P, 디스틸벤젠(DSB), 디스트릴아릴렌(DSA), PFO계 고분자, PPV계 고분자와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다.When the emission layer emits red light, the emission dopants include PIQIr(acac)(bis(1-phenylisoquinoline)acetylacetonateiridium), PQIr(acac)(bis(1-phenylquinoline)acetylacetonate iridium), PQIr(tris(1-phenylquinoline)iridium). ), a phosphorescent material such as octaethylporphyrin platinum (PtOEP), or a fluorescent material such as Alq 3 (tris(8-hydroxyquinolino)aluminum), but is not limited thereto. When the emission layer emits green light, a phosphor such as Ir(ppy) 3 (fac tris(2-phenylpyridine)iridium) or a fluorescent material such as Alq3 (tris(8-hydroxyquinolino)aluminum) may be used as the emission dopant. However, it is not limited thereto. When the light emitting layer emits blue light, the light emitting dopant is a phosphorescent material such as (4,6-F2ppy) 2 Irpic, spiro-DPVBi, spiro-6P, distillbenzene (DSB), distrylarylene (DSA), A fluorescent material such as a PFO-based polymer or a PPV-based polymer may be used, but is not limited thereto.
전자수송층과 발광층 사이에 정공차단층이 구비될 수 있으며, 당 기술분야에 알려져 있는 재료가 사용될 수 있다.A hole blocking layer may be provided between the electron transport layer and the light emitting layer, and materials known in the art may be used.
상기 전자수송층은 전자의 수송을 원활하게 하는 역할을 하는 것으로, 단층 또는 다층구조일 수 있다. 전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다. 전자수송층의 두께는 1 내지 50nm일 수 있다. 전자수송층의 두께가 1nm 이상이면, 전자 수송 특성이 저하되는 것을 방지할 수 있는 이점이 있고, 50nm 이하이면, 전자수송층의 두께가 너무 두꺼워 전자의 이동을 향상시키기 위해 구동전압이 상승되는 것을 방지할 수 있는 이점이 있다. 본 명세서의 일 실시상태에 있어서, 전자수송층은 2층 이상의 다층 구조이며, 음극에 인접한 전자수송층은 n형 도펀트를 포함한다.The electron transport layer serves to facilitate transport of electrons, and may have a single layer or multilayer structure. As the electron transport material, a material capable of receiving electrons from the cathode and transferring them to the light emitting layer, and a material having high mobility for electrons is suitable. Specific examples include Al complex of 8-hydroxyquinoline; Complexes containing Alq 3 ; Organic radical compounds; Hydroxyflavone-metal complexes and the like, but are not limited thereto. The thickness of the electron transport layer may be 1 to 50 nm. If the thickness of the electron transport layer is 1 nm or more, there is an advantage of preventing deterioration of the electron transport characteristics, and if the thickness of the electron transport layer is 50 nm or less, the thickness of the electron transport layer is too thick to prevent an increase in the driving voltage to improve the movement of electrons. There is an advantage to be able to. In one embodiment of the present specification, the electron transport layer has a multilayer structure of two or more layers, and the electron transport layer adjacent to the cathode includes an n-type dopant.
상기 전자주입층은 전자의 주입을 원활하게 하는 역할을 할 수 있다. 전자 주입 물질로는 전자를 수송하는 능력을 갖고, 음극으로부터의 전자주입 효과, 발광층 또는 발광 재료에 대하여 우수한 전자주입 효과를 가지며, 발광층에서 생성된 여기자의 정공 주입층에의 이동을 방지하고, 또한, 박막형성능력이 우수한 화합물이 바람직하다. 구체적으로는 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 함질소 5원환 유도체 등이 있으나, 이에 한정되지 않는다. The electron injection layer may play a role of smoothly injecting electrons. The electron injection material has the ability to transport electrons, has an electron injection effect from the cathode, an excellent electron injection effect for the light emitting layer or the light emitting material, prevents the movement of excitons generated in the light emitting layer to the hole injection layer, , A compound having excellent thin film forming ability is preferable. Specifically, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylene tetracarboxylic acid, preorenylidene methane, anthrone, etc. Complex compounds and nitrogen-containing 5-membered ring derivatives, but are not limited thereto.
상기 금속 착체 화합물로서는 8-하이드록시퀴놀리나토 리튬, 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되지 않는다.Examples of the metal complex compound include lithium 8-hydroxyquinolinato, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, Tris(8-hydroxyquinolinato)aluminum, tris(2-methyl-8-hydroxyquinolinato)aluminum, tris(8-hydroxyquinolinato)gallium, bis(10-hydroxybenzo[h] Quinolinato)beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)( o-cresolato)gallium, bis(2-methyl-8-quinolinato)(1-naphtholato)aluminum, bis(2-methyl-8-quinolinato)(2-naphtholato)gallium, etc. It is not limited to this.
상기 정공차단층은 정공의 음극 도달을 저지하는 층으로, 일반적으로 정공주입층과 동일한 조건으로 형성될 수 있다. 구체적으로 옥사디아졸 유도체나 트리아졸 유도체, 페난트롤린 유도체, BCP, 알루미늄 착물 (aluminum complex) 등이 있으나, 이에 한정되지 않는다.The hole blocking layer is a layer that prevents holes from reaching the cathode, and may be generally formed under the same conditions as the hole injection layer. Specifically, there are oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, BCP, aluminum complexes, etc., but are not limited thereto.
본 발명에 따른 유기 발광 소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic light emitting device according to the present invention may be a top emission type, a bottom emission type, or a double-sided emission type depending on the material used.
이하, 본 명세서를 구체적으로 설명하기 위해 실시예 및 비교예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 명세서에 따른 실시예 및 비교예는 여러 가지 다른 형태로 변형될 수 있으며, 본 명세서의 범위가 아래에서 상술하는 실시예 및 비교예에 한정되는 것으로 해석되지 않는다. 본 명세서의 실시예 및 비교예는 당업계에서 평균적인 지식을 가진 자에게 본 명세서를 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples and comparative examples will be described in detail to describe the present specification in detail. However, the Examples and Comparative Examples according to the present specification may be modified in various other forms, and the scope of the present specification is not interpreted as being limited to the Examples and Comparative Examples described below. Examples and comparative examples in the present specification are provided to more completely describe the present specification to those of ordinary skill in the art.
합성예 1. 화합물1의 합성Synthesis Example 1. Synthesis of Compound 1
1) 중간체1의 합성1) Synthesis of Intermediate 1
Figure PCTKR2020010123-appb-I000313
Figure PCTKR2020010123-appb-I000313
질소 분위기하에서 1-브로모-3-클로로-5-메틸벤젠 40g, bis(4-(tert-부틸)페닐)아민 54.8g, 소듐-tert-부톡사이드 56.1g, 비스(트리-tert-부틸포스핀)팔라듐(0) 1.0g을 톨루엔 600ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 1을 65g 수득하였다. (수율 82%). MS[M+H]+ = 4071-bromo-3-chloro-5-methylbenzene 40g, bis(4-(tert-butyl)phenyl)amine 54.8g, sodium-tert-butoxide 56.1g, bis(tri-tert-butylphos) under nitrogen atmosphere After adding 1.0 g of pin) palladium (0) to 600 ml of toluene, the mixture was stirred under reflux for 2 hours. After extraction was completed after the reaction was completed, 65 g of Intermediate 1 was obtained through recrystallization. (Yield 82%). MS[M+H]+ = 407
2) 중간체2의 합성2) Synthesis of Intermediate 2
Figure PCTKR2020010123-appb-I000314
Figure PCTKR2020010123-appb-I000314
질소 분위기하에서 중간체 1 30g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 30.5g, 소듐-tert-부톡사이드 14.2g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 450ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 2을 45g 수득하였다. (수율 78%). MS[M+H]+ = 78230 g of intermediate 1 under nitrogen atmosphere, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8,8-tetramethyl-5,6,7, 30.5 g of 8-tetrahydronaphthalen-2-amine, 14.2 g of sodium-tert-butoxide, and 0.4 g of bis (tri-tert-butylphosphine) palladium (0) were added to 450 ml of toluene, followed by reflux stirring for 2 hours. After the reaction was completed, extraction was performed, and 45 g of intermediate 2 was obtained through recrystallization. (Yield 78%). MS[M+H]+ = 782
3) 화합물1의 합성3) Synthesis of compound 1
Figure PCTKR2020010123-appb-I000315
Figure PCTKR2020010123-appb-I000315
질소 분위기하에서 중간체 2 25g, 보론트리아이오다이드 21.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물1을 8g 수득하였다 (수율 32%). MS[M+H]+ = 789In a nitrogen atmosphere, 25 g of intermediate 2 and 21.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and then 8 g of compound 1 was obtained through recrystallization (yield 32%). MS[M+H]+ = 789
합성예 2. 화합물2의 합성Synthesis Example 2. Synthesis of Compound 2
1) 중간체3의 합성1) Synthesis of Intermediate 3
Figure PCTKR2020010123-appb-I000316
Figure PCTKR2020010123-appb-I000316
1-브로모-3-클로로-5-메틸벤젠 대신 1-브로모-3-(tert-부틸)-5-클로로벤젠40g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 3을 60g 수득하였다. (수율 83%). MS[M+H]+ = 449Instead of 1-bromo-3-chloro-5-methylbenzene, 40 g of 1-bromo-3-(tert-butyl)-5-chlorobenzene was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 1 to obtain Intermediate 3 60 g was obtained. (Yield 83%). MS[M+H]+ = 449
2) 중간체4의 합성2) Synthesis of Intermediate 4
Figure PCTKR2020010123-appb-I000317
Figure PCTKR2020010123-appb-I000317
중간체3 30g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 27.5g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 4을 43g 수득하였다. (수율 78%). MS[M+H]+ = 824Intermediate 3 30g, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8,8-tetramethyl-5,6,7,8-tetra 43g of intermediate 4 was obtained through recrystallization of 27.5 g of hydronaphthalen-2-amine using the same material and equivalent as in the synthesis method of intermediate 2. (Yield 78%). MS[M+H]+ = 824
3) 화합물2의 합성3) Synthesis of compound 2
Figure PCTKR2020010123-appb-I000318
Figure PCTKR2020010123-appb-I000318
질소 분위기하에서 중간체 4 25g, 보론트리아이오다이드 20.2g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물2을 8.4g 수득하였다 (수율 33%). MS[M+H]+ = 832In a nitrogen atmosphere, 25 g of intermediate 4 and 20.2 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction was completed after the reaction was completed, 8.4 g of compound 2 was obtained through recrystallization (yield 33%). MS[M+H]+ = 832
합성예 3. 화합물3의 합성Synthesis Example 3. Synthesis of Compound 3
1) 중간체5의 합성1) Synthesis of Intermediate 5
Figure PCTKR2020010123-appb-I000319
Figure PCTKR2020010123-appb-I000319
중간체1 30g, N-(4-(tert-부틸)-2-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)페닐)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 38.6g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 5을 46g 수득하였다. (수율 70%). MS[M+H]+ = 892Intermediate 1 30g, N-(4-(tert-butyl)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl)phenyl)-5, 38.6 g of 5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 2 to obtain 46 g of Intermediate 5. (Yield 70%). MS[M+H]+ = 892
2) 화합물3의 합성2) Synthesis of compound 3
Figure PCTKR2020010123-appb-I000320
Figure PCTKR2020010123-appb-I000320
질소 분위기하에서 중간체 5 25g, 보론트리아이오다이드 20.2g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물3을 8.1g 수득하였다 (수율 31%). MS[M+H]+ = 900In a nitrogen atmosphere, 25 g of intermediate 5 and 20.2 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed and extracted, 8.1 g of compound 3 was obtained through recrystallization (yield 31%). MS[M+H]+ = 900
합성예 4. 화합물4의 합성Synthesis Example 4. Synthesis of Compound 4
1) 중간체6의 합성1) Synthesis of Intermediate 6
Figure PCTKR2020010123-appb-I000321
Figure PCTKR2020010123-appb-I000321
중간체1 30g, bis(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 28.8g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 6을 42g 수득하였다. (수율 75%). MS[M+H]+ = 760Intermediate 1 30g, bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine 28.8g recrystallized using the same material and equivalent as the intermediate 2 synthesis method Through this, 42g of intermediate 6 was obtained. (Yield 75%). MS[M+H]+ = 760
2) 화합물4의 합성2) Synthesis of compound 4
Figure PCTKR2020010123-appb-I000322
Figure PCTKR2020010123-appb-I000322
질소 분위기하에서 중간체 6 25g, 보론트리아이오다이드 21.9g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물4을 7.9g 수득하였다 (수율 31%). MS[M+H]+ = 767In a nitrogen atmosphere, 25 g of intermediate 6 and 21.9 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.9g of compound 4 was obtained through recrystallization (yield 31%). MS[M+H]+ = 767
합성예 5. 화합물5의 합성Synthesis Example 5. Synthesis of Compound 5
1) 중간체7의 합성1) Synthesis of Intermediate 7
Figure PCTKR2020010123-appb-I000323
Figure PCTKR2020010123-appb-I000323
1-브로모-3-클로로-5-메틸벤젠40g, bis(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 75.8g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 7을 72g 수득하였다. (수율 72%). MS[M+H]+ = 5151-bromo-3-chloro-5-methylbenzene 40g, bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine 75.8g Intermediate 1 72 g of Intermediate 7 was obtained through recrystallization using the same material and equivalent as in the synthesis method. (Yield 72%). MS[M+H]+ = 515
2) 중간체8의 합성2) Synthesis of Intermediate 8
Figure PCTKR2020010123-appb-I000324
Figure PCTKR2020010123-appb-I000324
중간체7 30g, 5-(tert-부틸)-N-(3-(tert-부틸)페닐)-[1,1'-바이페닐]-2-아민 30.5g 20.9g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 8을 39g 수득하였다. (수율 80%). MS[M+H]+ = 836Intermediate 7 30g, 5-(tert-butyl)-N-(3-(tert-butyl)phenyl)-[1,1'-biphenyl]-2-amine 30.5g 20.9g the same material as the intermediate 2 synthesis method And 39g of intermediate 8 was obtained through recrystallization using the equivalent. (Yield 80%). MS[M+H]+ = 836
3) 화합물5의 합성3) Synthesis of compound 5
Figure PCTKR2020010123-appb-I000325
Figure PCTKR2020010123-appb-I000325
질소 분위기하에서 중간체 8 25g, 보론트리아이오다이드 19.9g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물5을 8.1g 수득하였다 (수율 32%). MS[M+H]+ = 844In a nitrogen atmosphere, 25 g of intermediate 8 and 19.9 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 8.1 g of compound 5 was obtained through recrystallization (yield 32%). MS[M+H]+ = 844
합성예 6. 화합물6의 합성Synthesis Example 6. Synthesis of Compound 6
1) 중간체9의 합성1) Synthesis of Intermediate 9
Figure PCTKR2020010123-appb-I000326
Figure PCTKR2020010123-appb-I000326
1,3-다이브로모-5-메틸벤젠 40g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 98.8g, 소듐-tert-부톡사이드 92g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.6g을 톨루엔 1000ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정 통하여 중간체 9을 80g 수득하였다. (수율 73%). MS[M+H]+ = 91240 g of 1,3-dibromo-5-methylbenzene, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8,8-tetramethyl- 2 hours after adding 98.8 g of 5,6,7,8-tetrahydronaphthalen-2-amine, 92 g of sodium-tert-butoxide, and 0.6 g of bis (tri-tert-butylphosphine) palladium (0) in 1000 ml of toluene Stir at reflux during. After the reaction was completed, extraction was performed, and 80 g of intermediate 9 was obtained through recrystallization. (73% yield). MS[M+H]+ = 912
2) 화합물6의 합성2) Synthesis of compound 6
Figure PCTKR2020010123-appb-I000327
Figure PCTKR2020010123-appb-I000327
질소 분위기하에서 중간체 9 25g, 보론트리아이오다이드 18.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물6을 7.8g 수득하였다 (수율 31%). MS[M+H]+ = 920In a nitrogen atmosphere, 25 g of intermediate 9 and 18.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.8g of compound 6 was obtained through recrystallization (yield 31%). MS[M+H]+ = 920
합성예 8. 화합물8의 합성Synthesis Example 8. Synthesis of Compound 8
1) 중간체11의 합성1) Synthesis of Intermediate 11
Figure PCTKR2020010123-appb-I000328
Figure PCTKR2020010123-appb-I000328
1-브로모-3-클로로-5-메틸벤젠40g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 80.1g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 11을 77g 수득하였다. (수율 74%). MS[M+H]+ = 5371-bromo-3-chloro-5-methylbenzene 40g, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8,8-tetra 77 g of Intermediate 11 was obtained through recrystallization of 80.1 g of methyl-5,6,7,8-tetrahydronaphthalen-2-amine using the same material and equivalent as in the synthesis method of Intermediate 1. (Yield 74%). MS[M+H]+ = 537
2) 중간체12의 합성2) Synthesis of Intermediate 12
Figure PCTKR2020010123-appb-I000329
Figure PCTKR2020010123-appb-I000329
중간체11 30g, bis(4-(2-페닐프로판-2-yl)페닐)아민 22.7g 을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 12을 33g 수득하였다. (수율 65%). MS[M+H]+ = 90630 g of Intermediate 11 and 22.7 g of bis(4-(2-phenylpropane-2-yl)phenyl)amine were recrystallized using the same material and equivalent as in the synthesis method of Intermediate 2 to obtain 33 g of Intermediate 12. (Yield 65%). MS[M+H]+ = 906
3) 화합물8의 합성3) Synthesis of compound 8
Figure PCTKR2020010123-appb-I000330
Figure PCTKR2020010123-appb-I000330
질소 분위기하에서 중간체 12 25g, 보론트리아이오다이드 18.4g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물8을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 914In a nitrogen atmosphere, 25 g of intermediate 12 and 18.4 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.5g of compound 8 was obtained through recrystallization (yield 30%). MS[M+H]+ = 914
합성예 9. 화합물9의 합성Synthesis Example 9. Synthesis of Compound 9
1) 중간체13의 합성1) Synthesis of Intermediate 13
Figure PCTKR2020010123-appb-I000331
Figure PCTKR2020010123-appb-I000331
중간체7 30g, bis(4-(2-페닐프로판-2-yl)페닐)아민 23.7g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 13을 36g 수득하였다. (수율 70%). MS[M+H]+ = 884Intermediate 7 30g, bis(4-(2-phenylpropane-2-yl)phenyl)amine 23.7g was recrystallized using the same material and equivalent as the intermediate 2 synthesis method to obtain 36g of Intermediate 13. (Yield 70%). MS[M+H]+ = 884
2) 화합물9의 합성2) Synthesis of compound 9
Figure PCTKR2020010123-appb-I000332
Figure PCTKR2020010123-appb-I000332
질소 분위기하에서 중간체 13 25g, 보론트리아이오다이드 18.8g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물9을 7.6g 수득하였다 (수율 30%). MS[M+H]+ = 892In a nitrogen atmosphere, 25 g of intermediate 13 and 18.8 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.6g of compound 9 was obtained through recrystallization (yield 30%). MS[M+H]+ = 892
합성예 10. 화합물10의 합성Synthesis Example 10. Synthesis of Compound 10
1) 중간체14의 합성1) Synthesis of Intermediate 14
Figure PCTKR2020010123-appb-I000333
Figure PCTKR2020010123-appb-I000333
중간체7 30g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 24.7g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 14를 39g 수득하였다. (수율 75%). MS[M+H]+ = 890Intermediate 7 30g, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8,8-tetramethyl-5,6,7,8-tetra 39 g of intermediate 14 was obtained by recrystallization of 24.7 g of hydronaphthalen-2-amine using the same material and equivalent as in the synthesis method of Intermediate 2. (Yield 75%). MS[M+H]+ = 890
2) 화합물10의 합성2) Synthesis of compound 10
Figure PCTKR2020010123-appb-I000334
Figure PCTKR2020010123-appb-I000334
질소 분위기하에서 중간체 14 25g, 보론트리아이오다이드 18.7g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물10을 7.2g 수득하였다 (수율 29%). MS[M+H]+ = 898In a nitrogen atmosphere, 25 g of intermediate 14 and 18.7 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After completion of the reaction, extraction was performed, and 7.2 g of compound 10 was obtained through recrystallization (yield 29%). MS[M+H]+ = 898
합성예 11. 화합물11의 합성Synthesis Example 11. Synthesis of Compound 11
1) 중간체15의 합성1) Synthesis of Intermediate 15
Figure PCTKR2020010123-appb-I000335
Figure PCTKR2020010123-appb-I000335
중간체7 30g, N-(5'-(tert-부틸)-[1,1':3',1''-터페닐]-2'-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 28.5g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 15을 42g 수득하였다. (수율 75%). MS[M+H]+ = 966Intermediate 7 30g, N-(5'-(tert-butyl)-[1,1':3',1''-terphenyl]-2'-yl)-5,5,8,8-tetramethyl- 28.5 g of 5,6,7,8-tetrahydronaphthalen-2-amine was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 2 to obtain 42 g of Intermediate 15. (Yield 75%). MS[M+H]+ = 966
2) 화합물11의 합성2) Synthesis of compound 11
Figure PCTKR2020010123-appb-I000336
Figure PCTKR2020010123-appb-I000336
질소 분위기하에서 중간체 15 25g, 보론트리아이오다이드 17.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물11을 7.6g 수득하였다 (수율 30%). MS[M+H]+ = 974In a nitrogen atmosphere, 25 g of intermediate 15 and 17.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.6g of compound 11 was obtained through recrystallization (yield 30%). MS[M+H]+ = 974
합성예 12. 화합물12의 합성Synthesis Example 12. Synthesis of Compound 12
1) 중간체16의 합성1) Synthesis of Intermediate 16
Figure PCTKR2020010123-appb-I000337
Figure PCTKR2020010123-appb-I000337
중간체7 30g, N-(4-(tert-부틸)-2-메틸페닐)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 20.4g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 16을 33g 수득하였다. (수율 68%). MS[M+H]+ = 828Intermediate 7 30g, N-(4-(tert-butyl)-2-methylphenyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine 20.4g intermediate 2 33g of Intermediate 16 was obtained through recrystallization using the same material and equivalent as in the synthesis method. (Yield 68%). MS[M+H]+ = 828
2) 화합물12의 합성2) Synthesis of compound 12
Figure PCTKR2020010123-appb-I000338
Figure PCTKR2020010123-appb-I000338
질소 분위기하에서 중간체 16 25g, 보론트리아이오다이드 20.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물12을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 836In a nitrogen atmosphere, 25 g of intermediate 16 and 20.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.7g of compound 12 was obtained through recrystallization (yield 31%). MS[M+H]+ = 836
합성예 13. 화합물13의 합성Synthesis Example 13. Synthesis of Compound 13
1) 중간체17의 합성1) Synthesis of Intermediate 17
Figure PCTKR2020010123-appb-I000339
Figure PCTKR2020010123-appb-I000339
중간체7 30g, N-(4-(tert-부틸)페닐)-3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 20.4g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 17을 32g 수득하였다. (수율 66%). MS[M+H]+ = 828Intermediate 7 30g, N-(4-(tert-butyl)phenyl)-3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine 20.4g Intermediate 2 32 g of Intermediate 17 was obtained through recrystallization using the same material and equivalent as in the synthesis method. (Yield 66%). MS[M+H]+ = 828
2) 화합물13의 합성2) Synthesis of compound 13
Figure PCTKR2020010123-appb-I000340
Figure PCTKR2020010123-appb-I000340
질소 분위기하에서 중간체 17 25g, 보론트리아이오다이드 20.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물13을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 836In a nitrogen atmosphere, 25 g of intermediate 17 and 20.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 7.5 g of compound 13 was obtained through recrystallization (yield 30%). MS[M+H]+ = 836
합성예 14. 화합물14의 합성Synthesis Example 14. Synthesis of Compound 14
1) 중간체18의 합성1) Synthesis of Intermediate 18
Figure PCTKR2020010123-appb-I000341
Figure PCTKR2020010123-appb-I000341
1-브로모-3-클로로-5-메틸벤젠40g, 3,5,5,8,8-펜타메틸-N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)-5,6,7,8-테트라하이드로나프탈렌-2-아민 78.6g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 18을 78g 수득하였다. (수율 76%). MS[M+H]+ = 5291-bromo-3-chloro-5- methylbenzene 40g, 3,5,5,8,8-pentamethyl-N-(5,5,8,8-tetramethyl-5,6,7,8- Tetrahydronaphthalene-2-yl)-5,6,7,8-tetrahydronaphthalen-2-amine 78.6g was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 1 to obtain 78g of Intermediate 18. (Yield 76%). MS[M+H]+ = 529
2) 중간체19의 합성2) Synthesis of Intermediate 19
Figure PCTKR2020010123-appb-I000342
Figure PCTKR2020010123-appb-I000342
중간체18 30g, N-(3-(tert-부틸)페닐)-3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 19.9g 을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 19을 32g 수득하였다. (수율 68%). MS[M+H]+ = 828Intermediate 18 30g, N-(3-(tert-butyl)phenyl)-3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine 19.9g of intermediate 2 32g of Intermediate 19 was obtained through recrystallization using the same material and equivalent as in the synthesis method. (Yield 68%). MS[M+H]+ = 828
3) 화합물14의 합성3) Synthesis of compound 14
Figure PCTKR2020010123-appb-I000343
Figure PCTKR2020010123-appb-I000343
질소 분위기하에서 중간체 19 25g, 보론트리아이오다이드 20.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물14을 7.8g 수득하였다 (수율 31%). MS[M+H]+ = 836In a nitrogen atmosphere, 25 g of intermediate 19 and 20.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.8g of compound 14 was obtained through recrystallization (yield 31%). MS[M+H]+ = 836
합성예 15. 화합물15의 합성Synthesis Example 15. Synthesis of Compound 15
1) 중간체20의 합성1) Synthesis of Intermediate 20
Figure PCTKR2020010123-appb-I000344
Figure PCTKR2020010123-appb-I000344
1,3-다이브로모-5-메틸벤젠 30g, 비스(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 93.5g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 20을 77g 수득하였다. (수율 74%). MS[M+H]+ = 8681,3-dibromo-5-methylbenzene 30g, bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl) 93.5g of amine synthesis method of intermediate 2 77 g of Intermediate 20 was obtained through recrystallization using the same material and equivalent. (Yield 74%). MS[M+H]+ = 868
2) 화합물15의 합성2) Synthesis of compound 15
Figure PCTKR2020010123-appb-I000345
Figure PCTKR2020010123-appb-I000345
질소 분위기하에서 중간체 20 25g, 보론트리아이오다이드 19.2g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 15을 7.8g 수득하였다 (수율 31%). MS[M+H]+ = 876In a nitrogen atmosphere, 25 g of intermediate 20 and 19.2 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.8g of compound 15 was obtained through recrystallization (yield 31%). MS[M+H]+ = 876
합성예 16. 화합물16의 합성Synthesis Example 16. Synthesis of Compound 16
1) 중간체21의 합성1) Synthesis of Intermediate 21
Figure PCTKR2020010123-appb-I000346
Figure PCTKR2020010123-appb-I000346
1,3-다이브로모-5-메틸벤젠 30g, 비스(3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 100.2g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 21을 74g 수득하였다. (수율 69%). MS[M+H]+ = 896Intermediate 2 with 30 g of 1,3-dibromo-5-methylbenzene and 100.2 g of bis(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine 74 g of Intermediate 21 was obtained through recrystallization using the same material and equivalent as in the synthesis method. (Yield 69%). MS[M+H]+ = 896
2) 화합물16의 합성2) Synthesis of compound 16
Figure PCTKR2020010123-appb-I000347
Figure PCTKR2020010123-appb-I000347
질소 분위기하에서 중간체 21 25g, 보론트리아이오다이드 18.6g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 16을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 904In a nitrogen atmosphere, 25 g of intermediate 21 and 18.6 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.7 g of compound 16 was obtained through recrystallization (yield 31%). MS[M+H]+ = 904
합성예 17. 화합물17의 합성Synthesis Example 17. Synthesis of Compound 17
1) 중간체22의 합성1) Synthesis of Intermediate 22
Figure PCTKR2020010123-appb-I000348
Figure PCTKR2020010123-appb-I000348
중간체11 40g, 4-(tert-부틸)-2-메틸아닐린 12.2g, 소듐-tert-부톡사이드 21.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 14.3g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 22를 44g 수득하였다. (수율 76%). MS[M+H]+ = 774Intermediate 11 40g, 4-(tert-butyl)-2-methylaniline 12.2g, sodium-tert-butoxide 21.5g, bis(tri-tert-butylphosphine)palladium(0) 0.4g into 600ml of toluene After refluxing for 1 hour and checking whether the reaction proceeds, 14.3 g of 1-bromo-3-chlorobenzene was added during the reflux reaction, and the reflux reaction was further performed for 1 hour. After the reaction was completed, extraction was performed, and then 44 g of intermediate 22 was obtained through recrystallization. (Yield 76%). MS[M+H]+ = 774
2) 중간체23의 합성2) Synthesis of Intermediate 23
Figure PCTKR2020010123-appb-I000349
Figure PCTKR2020010123-appb-I000349
중간체22 25g, 보론트리아이오다이드 21.5g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 23을 7.6g 수득하였다 (수율 30%). MS[M+H]+ = 87625 g of intermediate 22 and 21.5 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.6 g of intermediate 23 was obtained through recrystallization (yield 30%). MS[M+H]+ = 876
3) 화합물17의 합성3) Synthesis of compound 17
Figure PCTKR2020010123-appb-I000350
Figure PCTKR2020010123-appb-I000350
질소 분위기하에서 중간체 23 7g, 다이페닐아민 1.52g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 17을 7g 수득하였다. (수율 85%). MS[M+H]+ = 915In a nitrogen atmosphere, 7 g of intermediate 23, 1.52 g of diphenylamine, 1.7 g of sodium-tert-butoxide, and 0.05 g of bis (tri-tert-butylphosphine) palladium (0) were added to 80 ml of xylene, followed by reflux agitation for 5 hours. I did. After extraction was completed after the reaction was completed, 7 g of compound 17 was obtained through recrystallization. (Yield 85%). MS[M+H]+ = 915
합성예 18. 화합물18의 합성Synthesis Example 18. Synthesis of Compound 18
1) 화합물18의 합성1) Synthesis of compound 18
Figure PCTKR2020010123-appb-I000351
Figure PCTKR2020010123-appb-I000351
질소 분위기하에서 중간체 23 7g, bis(4-(tert-부틸)페닐)아민 1.52g, 소듐-tert-부톡사이드 2.6g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 18을 7.7g 수득하였다. (수율 84%). MS[M+H]+ = 1027In a nitrogen atmosphere, 7 g of intermediate 23, 1.52 g of bis(4-(tert-butyl)phenyl)amine, 2.6 g of sodium-tert-butoxide, and 0.05 g of bis(tri-tert-butylphosphine)palladium(0) were added to xylene. After putting into 80ml, the mixture was stirred under reflux for 5 hours. After extraction after completion of the reaction, 7.7 g of compound 18 was obtained through recrystallization. (Yield 84%). MS[M+H]+ = 1027
합성예 19. 화합물19의 합성Synthesis Example 19. Synthesis of Compound 19
1) 화합물19의 합성1) Synthesis of compound 19
Figure PCTKR2020010123-appb-I000352
Figure PCTKR2020010123-appb-I000352
질소 분위기하에서 중간체 23 7g, bis(4-(tert-부틸)-2-메틸페닐)아민 2.77g, 소듐-tert-부톡사이드 2.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.5g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 19을 7.8g 수득하였다. (수율 83%). MS[M+H]+ = 1055Under nitrogen atmosphere, intermediate 23 7g, bis(4-(tert-butyl)-2-methylphenyl)amine 2.77g, sodium-tert-butoxide 2.7g, bis(tri-tert-butylphosphine)palladium(0) 0.5g Was added to 80 ml of xylene and stirred under reflux for 5 hours. After extraction after completion of the reaction, 7.8g of compound 19 was obtained through recrystallization. (Yield 83%). MS[M+H]+ = 1055
합성예 20. 화합물20의 합성Synthesis Example 20. Synthesis of Compound 20
1) 중간체24의 합성1) Synthesis of Intermediate 24
Figure PCTKR2020010123-appb-I000353
Figure PCTKR2020010123-appb-I000353
1-브로모-3-(tert-부틸)-5-클로로벤젠 40g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 66.5g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 24을 75g 수득하였다. (수율 80%). MS[M+H]+ = 5791-bromo-3-(tert-butyl)-5-chlorobenzene 40g, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8 ,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine 66.5g was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 1 to obtain 75g of Intermediate 24. (Yield 80%). MS[M+H]+ = 579
2) 중간체25의 합성2) Synthesis of Intermediate 25
Figure PCTKR2020010123-appb-I000354
Figure PCTKR2020010123-appb-I000354
중간체24 40g, 4-(tert-부틸)-2-메틸아닐린 11.3g, 소듐-tert-부톡사이드 19.9g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 13.2g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 25을 42g 수득하였다. (수율 74%). MS[M+H]+ = 816After adding 40 g of intermediate 24, 11.3 g of 4-(tert-butyl)-2-methylaniline, 19.9 g of sodium-tert-butoxide, and 0.4 g of bis(tri-tert-butylphosphine) palladium (0) in 600 ml of toluene After refluxing for 1 hour and checking whether the reaction proceeds, 13.2 g of 1-bromo-3-chlorobenzene was added during the reflux reaction, and the reflux reaction was further performed for 1 hour. After the reaction was completed, extraction was performed, and then 42 g of intermediate 25 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 816
3) 중간체26의 합성3) Synthesis of Intermediate 26
Figure PCTKR2020010123-appb-I000355
Figure PCTKR2020010123-appb-I000355
질소 분위기하에서 중간체 25 25g, 보론트리아이오다이드 20.4g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 26을 8.1g 수득하였다 (수율 32%). MS[M+H]+ = 825In a nitrogen atmosphere, 25 g of the intermediate and 20.4 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After completion of the reaction, extraction was performed, and 8.1 g of intermediate 26 was obtained through recrystallization (yield 32%). MS[M+H]+ = 825
4) 화합물20의 합성4) Synthesis of compound 20
Figure PCTKR2020010123-appb-I000356
Figure PCTKR2020010123-appb-I000356
중간체26 7g, 다이페닐아민 1.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 20을 6.5g 수득하였다. (수율 80%). MS[M+H]+ = 9577 g of intermediate 26, 1.5 g of diphenylamine, 1.7 g of sodium-tert-butoxide, and 0.05 g of bis(tri-tert-butylphosphine)palladium(0) were added to 80 ml of xylene, followed by reflux stirring for 5 hours. After the reaction was completed, extraction was performed, and 6.5 g of compound 20 was obtained through recrystallization. (Yield 80%). MS[M+H]+ = 957
합성예 21. 화합물21의 합성Synthesis Example 21. Synthesis of Compound 21
1) 중간체27의 합성1) Synthesis of Intermediate 27
Figure PCTKR2020010123-appb-I000357
Figure PCTKR2020010123-appb-I000357
1-브로모-3-클로로-5-메틸벤젠 40g, N-(4-(tert-부틸)-2-메틸페닐)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 56.5g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 27을 55g 수득하였다. (수율 72%). MS[M+H]+ = 4751-bromo-3-chloro-5-methylbenzene 40g, N-(4-(tert-butyl)-2-methylphenyl)-5,5,8,8-tetramethyl-5,6,7,8- 55 g of Intermediate 27 was obtained by recrystallization of 56.5 g of tetrahydronaphthalen-2-amine using the same material and equivalent as in the synthesis method of Intermediate 1. (Yield 72%). MS[M+H]+ = 475
2) 중간체28의 합성2) Synthesis of Intermediate 28
Figure PCTKR2020010123-appb-I000358
Figure PCTKR2020010123-appb-I000358
중간체27 40g, 4-(tert-부틸)-2-메틸아닐린 13.8g, 소듐-tert-부톡사이드 24.3g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 16.2g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 28을 44g 수득하였다. (수율 73%). MS[M+H]+ = 712Intermediate 27 40g, 4-(tert-butyl)-2-methylaniline 13.8g, sodium-tert-butoxide 24.3g, bis(tri-tert-butylphosphine)palladium(0) 0.4g was added to 600ml of toluene. After refluxing for 1 hour and checking whether the reaction proceeds, 16.2 g of 1-bromo-3-chlorobenzene was added during the reflux reaction, and the reflux reaction was further performed for 1 hour. After the reaction was completed, extraction was performed, and then 44 g of intermediate 28 was obtained through recrystallization. (73% yield). MS[M+H]+ = 712
3) 중간체29의 합성3) Synthesis of Intermediate 29
Figure PCTKR2020010123-appb-I000359
Figure PCTKR2020010123-appb-I000359
질소 분위기하에서 중간체 28 25g, 보론트리아이오다이드 23.4g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 29을 8.2g 수득하였다 (수율 32%). MS[M+H]+ = 720In a nitrogen atmosphere, 25 g of intermediate 28 and 23.4 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 8.2 g of intermediate 29 was obtained through recrystallization (yield 32%). MS[M+H]+ = 720
4) 화합물21의 합성4) Synthesis of compound 21
Figure PCTKR2020010123-appb-I000360
Figure PCTKR2020010123-appb-I000360
중간체29 7g, 다이페닐아민 1.7g, 소듐-tert-부톡사이드 1.8g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 21을 6.6g 수득하였다. (수율 70%). MS[M+H]+ = 9657 g of intermediate 29, 1.7 g of diphenylamine, 1.8 g of sodium-tert-butoxide, and 0.05 g of bis(tri-tert-butylphosphine)palladium(0) were added to 80 ml of xylene, followed by reflux stirring for 5 hours. After extraction after completion of the reaction, 6.6g of compound 21 was obtained through recrystallization. (Yield 70%). MS[M+H]+ = 965
합성예 22. 화합물22의 합성Synthesis Example 22. Synthesis of Compound 22
1) 중간체30의 합성1) Synthesis of Intermediate 30
Figure PCTKR2020010123-appb-I000361
Figure PCTKR2020010123-appb-I000361
중간체7 40g, 5-(tert-부틸)-[1,1'-바이페닐]-2-아민 17.6g, 소듐-tert-부톡사이드 22.4g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 14.9g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 30을 45g 수득하였다. (수율 71%). MS[M+H]+ = 814Intermediate 7 40g, 5-(tert-butyl)-[1,1'-biphenyl]-2-amine 17.6g, sodium-tert-butoxide 22.4g, bis(tri-tert-butylphosphine)palladium (0 ) After adding 0.4 g to 600 ml of toluene, reflux for 1 hour, and after checking whether the reaction proceeds, 14.9 g of 1-bromo-3-chlorobenzene is added during the reflux reaction, and the reflux reaction is further performed for 1 hour. After the reaction was completed, extraction was performed, and then 45 g of intermediate 30 was obtained through recrystallization. (Yield 71%). MS[M+H]+ = 814
2) 중간체31의 합성2) Synthesis of Intermediate 31
Figure PCTKR2020010123-appb-I000362
Figure PCTKR2020010123-appb-I000362
질소 분위기하에서 중간체 30 25g, 보론트리아이오다이드 20.4g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 31을 8.3g 수득하였다 (수율 33%). MS[M+H]+ = 822In a nitrogen atmosphere, 25 g of intermediate 30 and 20.4 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 8.3 g of intermediate 31 was obtained through recrystallization (yield 33%). MS[M+H]+ = 822
3) 화합물22의 합성3) Synthesis of compound 22
Figure PCTKR2020010123-appb-I000363
Figure PCTKR2020010123-appb-I000363
중간체31 7g, bis(4-(tert-부틸)페닐)아민 2.4g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 22을 6.5g 수득하였다. (수율 72%). MS[M+H]+ = 1067Intermediate 31 7g, bis(4-(tert-butyl)phenyl)amine 2.4g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and then 6.5 g of compound 22 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1067
합성예 23. 화합물23의 합성Synthesis Example 23. Synthesis of Compound 23
3) 화합물23의 합성3) Synthesis of compound 23
Figure PCTKR2020010123-appb-I000364
Figure PCTKR2020010123-appb-I000364
중간체31 7g, bis(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 3.4g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 23을 7.4g 수득하였다. (수율 74%). MS[M+H]+ = 1175Intermediate 31 7g, bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine 3.4g, sodium-tert-butoxide 1.7g, bis(tri- After adding 0.05 g of tert-butylphosphine) palladium (0) to 80 ml of xylene, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 7.4 g of compound 23 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 1175
합성예 25. 화합물25의 합성Synthesis Example 25. Synthesis of Compound 25
1) 중간체32의 합성1) Synthesis of Intermediate 32
Figure PCTKR2020010123-appb-I000365
Figure PCTKR2020010123-appb-I000365
1-브로모-3-클로로-5-메틸벤젠 40g, 1,5,5,8,8-펜타메틸-N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)-5,6,7,8-테트라하이드로나프탈렌-2-아민 78.6g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 32을 72g 수득하였다. (수율 70%). MS[M+H]+ = 5291-bromo-3-chloro-5- methylbenzene 40g, 1,5,5,8,8-pentamethyl-N-(5,5,8,8-tetramethyl-5,6,7,8- Tetrahydronaphthalene-2-yl)-5,6,7,8-tetrahydronaphthalen-2-amine 78.6g was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 1 to obtain 72g of Intermediate 32. (Yield 70%). MS[M+H]+ = 529
2) 중간체33의 합성2) Synthesis of Intermediate 33
Figure PCTKR2020010123-appb-I000366
Figure PCTKR2020010123-appb-I000366
중간체32 40g, 3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 16.5g, 소듐-tert-부톡사이드 14.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 14.5g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 33을 46g 수득하였다. (수율 74%). MS[M+H]+ = 820Intermediate 32 40g, 3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine 16.5g, sodium-tert-butoxide 14.5g, bis(tri-tert- After adding 0.4 g of butylphosphine) palladium (0) to 600 ml of toluene, refluxed for 1 hour, and after confirming the progress of the reaction, 14.5 g of 1-bromo-3-chlorobenzene was added during the reflux reaction, followed by refluxing for 1 hour. The reaction proceeds. After the reaction was completed, extraction was performed, and then 46 g of intermediate 33 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 820
3) 중간체34의 합성3) Synthesis of Intermediate 34
Figure PCTKR2020010123-appb-I000367
Figure PCTKR2020010123-appb-I000367
질소 분위기하에서 중간체 33 25g, 보론트리아이오다이드 20.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 34을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 828In a nitrogen atmosphere, 25 g of intermediate 33 and 20.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After completion of the reaction, extraction was performed, and 7.7 g of intermediate 34 was obtained through recrystallization (yield 31%). MS[M+H]+ = 828
4) 화합물25의 합성4) Synthesis of compound 25
Figure PCTKR2020010123-appb-I000368
Figure PCTKR2020010123-appb-I000368
중간체34 7g, bis(4-(tert-부틸)페닐)아민 2.4 g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 25을 6.8g 수득하였다. (수율 75%). MS[M+H]+ = 1073Intermediate 34 7g, bis(4-(tert-butyl)phenyl)amine 2.4g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction after completion of the reaction, 6.8g of compound 25 was obtained through recrystallization. (Yield 75%). MS[M+H]+ = 1073
합성예 26. 화합물26의 합성Synthesis Example 26. Synthesis of Compound 26
1) 중간체35의 합성1) Synthesis of Intermediate 35
Figure PCTKR2020010123-appb-I000369
Figure PCTKR2020010123-appb-I000369
3-브로모-5-클로로페놀 40g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 79.4g을 중간체1 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 35을 70g 수득하였다. (수율 57%). MS[M+H]+ = 53940 g of 3-bromo-5-chlorophenol, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8,8-tetramethyl-5, 79.4 g of 6,7,8-tetrahydronaphthalen-2-amine was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 1 to obtain 70 g of Intermediate 35. (Yield 57%). MS[M+H]+ = 539
2) 중간체36의 합성2) Synthesis of Intermediate 36
Figure PCTKR2020010123-appb-I000370
Figure PCTKR2020010123-appb-I000370
중간체35 40g, 1,1,2,2,3,3,4,4,4-노나플로로부탄-1-설포닐 플로라이드 20ml, 포타슘카보네이트30g을 테트라하이드로퓨란 400ml, 물 200ml 에 넣은 후 3시간 동안 반응후 반응 종료 후 추출한 후에 용액을 제거해 중간체 36을 58g 수득하였다. (수율 97%). MS[M+H]+ = 805Intermediate 35 40g, 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonyl fluoride 20ml, potassium carbonate 30g in tetrahydrofuran 400ml, water 200ml 3 After the reaction was completed for a period of time, extraction was performed, and the solution was removed to obtain 58 g of intermediate 36. (Yield 97%). MS[M+H]+ = 805
3) 중간체37의 합성3) Synthesis of Intermediate 37
Figure PCTKR2020010123-appb-I000371
Figure PCTKR2020010123-appb-I000371
질소 분위기하에서 중간체 36 40g, bis(4-(tert-부틸)페닐)아민 14g, Pd(dba)2 0.85g, Xphos 1.42g, 세슘카보네이트 48.6g을 자일렌 500ml에 넣은후 24시간 동안 환류 교반 하였다. 반응 종료 후 추출한뒤, 재결정을 통하여 중간체 37을 31g 수득하였다 (수율 78%). MS[M+H]+ = 802In a nitrogen atmosphere, 40 g of intermediate 36, 14 g of bis(4-(tert-butyl)phenyl)amine, 0.85 g of Pd(dba) 2 , 1.42 g of Xphos, and 48.6 g of cesium carbonate were added to 500 ml of xylene and stirred under reflux for 24 hours. . After extraction after completion of the reaction, 31g of intermediate 37 was obtained through recrystallization (yield 78%). MS[M+H]+ = 802
4) 중간체38의 합성4) Synthesis of Intermediate 38
Figure PCTKR2020010123-appb-I000372
Figure PCTKR2020010123-appb-I000372
중간체37 25g, 보론트리아이오다이드 20.8g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 38을 7.9g 수득하였다 (수율 31%). MS[M+H]+ = 81025 g of intermediate 37 and 20.8 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.9 g of intermediate 38 was obtained through recrystallization (yield 31%). MS[M+H]+ = 810
5) 화합물26의 합성5) Synthesis of compound 26
Figure PCTKR2020010123-appb-I000373
Figure PCTKR2020010123-appb-I000373
중간체38 7g, 다이페닐아민 1.46g, 소듐-tert-부톡사이드 2.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 26을 6.2g 수득하였다. (수율 76%). MS[M+H]+ = 9437 g of intermediate 38, 1.46 g of diphenylamine, 2.5 g of sodium-tert-butoxide, and 0.05 g of bis (tri-tert-butylphosphine) palladium (0) were added to 80 ml of xylene, followed by reflux stirring for 5 hours. After extraction was completed after the reaction was completed, 6.2 g of compound 26 was obtained through recrystallization. (Yield 76%). MS[M+H]+ = 943
합성예 27. 화합물27의 합성Synthesis Example 27. Synthesis of Compound 27
1) 화합물27의 합성1) Synthesis of compound 27
Figure PCTKR2020010123-appb-I000374
Figure PCTKR2020010123-appb-I000374
중간체38 7g, bis(4-(tert-부틸)페닐)아민 2.43g, 소듐-tert-부톡사이드 2.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 27을 6.7g 수득하였다. (수율 73%). MS[M+H]+ = 1055Intermediate 38 7g, bis(4-(tert-butyl)phenyl)amine 2.43g, sodium-tert-butoxide 2.5g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.7 g of compound 27 was obtained through recrystallization. (73% yield). MS[M+H]+ = 1055
합성예 29. 화합물29의 합성Synthesis Example 29. Synthesis of Compound 29
1) 중간체41의 합성1) Synthesis of Intermediate 41
Figure PCTKR2020010123-appb-I000375
Figure PCTKR2020010123-appb-I000375
질소 분위기하 1,3-다이브로모-5-클로로벤젠 40g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 121.8g, 소듐-tert-부톡사이드 56.9g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.8g을 톨루엔 1200ml에 넣은 후 1시간 동안 환류 하고 반응 종료 후 추출한 후에 재결정 통하여 중간체 41을 99g 수득하였다. (수율 72%). MS[M+H]+ = 93240 g of 1,3-dibromo-5-chlorobenzene under nitrogen atmosphere, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-5,5,8,8- Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine 121.8 g, sodium-tert-butoxide 56.9 g, bis (tri-tert-butylphosphine) palladium (0) 0.8 g to 1200 ml of toluene After the addition, the mixture was refluxed for 1 hour, extracted after completion of the reaction, and recrystallized to obtain 99 g of intermediate 41. (Yield 72%). MS[M+H]+ = 932
2) 중간체42의 합성2) Synthesis of Intermediate 42
Figure PCTKR2020010123-appb-I000376
Figure PCTKR2020010123-appb-I000376
질소 분위기하에서 중간체 41 25g, 보론트리아이오다이드 17.9g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 42을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 940In a nitrogen atmosphere, 25 g of intermediate 41 and 17.9 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.7 g of intermediate 42 was obtained through recrystallization (yield 31%). MS[M+H]+ = 940
3) 화합물29의 합성3) Synthesis of compound 29
Figure PCTKR2020010123-appb-I000377
Figure PCTKR2020010123-appb-I000377
중간체42 7g, bis(4-(tert-부틸)페닐)아민 2.1g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.04g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 29을 6.4g 수득하였다. (수율 72%). MS[M+H]+ = 1185Intermediate 42 7g, bis(4-(tert-butyl)phenyl)amine 2.1g, sodium-tert-butoxide 1.5g, bis(tri-tert-butylphosphine)palladium(0) 0.04g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.4 g of compound 29 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1185
합성예 30. 화합물30의 합성Synthesis Example 30. Synthesis of Compound 30
1) 중간체43의 합성1) Synthesis of Intermediate 43
Figure PCTKR2020010123-appb-I000378
Figure PCTKR2020010123-appb-I000378
질소 분위기하 중간체36 40g, N-(4-(tert-부틸)-2-메틸페닐)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 17.4g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 43을 35g 수득하였다. (수율 81%). MS[M+H]+ = 87040 g of intermediate 36 under nitrogen atmosphere, N-(4-(tert-butyl)-2-methylphenyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine 17.4 35g of Intermediate 43 was obtained through recrystallization of g using the same material and equivalent weight as the synthesis method of Intermediate 37. (Yield 81%). MS[M+H]+ = 870
2) 중간체44의 합성2) Synthesis of Intermediate 44
Figure PCTKR2020010123-appb-I000379
Figure PCTKR2020010123-appb-I000379
질소 분위기하에서 중간체 43 25g, 보론트리아이오다이드 19.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 44을 7.8수득하였다 (수율 31%). MS[M+H]+ = 878In a nitrogen atmosphere, 25 g of intermediate 43 and 19.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 7.8 intermediate 44 was obtained through recrystallization (yield 31%). MS[M+H]+ = 878
3) 화합물30의 합성3) Synthesis of compound 30
Figure PCTKR2020010123-appb-I000380
Figure PCTKR2020010123-appb-I000380
중간체44 7g, bis(4-(tert-부틸)페닐)아민 2.2g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.04g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 30을 6.6g 수득하였다. (수율 74%). MS[M+H]+ = 1123Intermediate 44 7g, bis(4-(tert-butyl)phenyl)amine 2.2g, sodium-tert-butoxide 1.5g, bis(tri-tert-butylphosphine)palladium(0) 0.04g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction after completion of the reaction, 6.6g of compound 30 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 1123
합성예 31. 화합물31의 합성Synthesis Example 31. Synthesis of Compound 31
1) 중간체45의 합성1) Synthesis of Intermediate 45
Figure PCTKR2020010123-appb-I000381
Figure PCTKR2020010123-appb-I000381
3-브로모-5-클로로페놀 40g, bis(5,5,8,8-테트라메틸-5,6,7,8-테트라히이드로나프탈렌-2-yl)아민 75.2g을 중간체35 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 45을 70g 수득하였다. (수율 70%). MS[M+H]+ = 51740 g of 3-bromo-5-chlorophenol and 75.2 g of bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine were added to the intermediate 35 synthesis method and Using the same material and equivalent, 70g of Intermediate 45 was obtained through recrystallization. (Yield 70%). MS[M+H]+ = 517
2) 중간체46의 합성2) Synthesis of Intermediate 46
Figure PCTKR2020010123-appb-I000382
Figure PCTKR2020010123-appb-I000382
중간체45 40g을 중간체36 합성방법과 동일한 물질 및 당량을 사용하여 중간체 46을 56g 수득하였다. (수율 92%). MS[M+H]+ = 78340 g of Intermediate 45 was obtained by using the same material and equivalent weight as the synthesis method of Intermediate 36 to obtain 56 g of Intermediate 46. (Yield 92%). MS[M+H]+ = 783
3) 중간체47의 합성3) Synthesis of Intermediate 47
Figure PCTKR2020010123-appb-I000383
Figure PCTKR2020010123-appb-I000383
질소 분위기하에서 중간체 46 40g, di([1,1'-바이페닐]-4-yl)아민 16.4g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정을 통하여 중간체 47을 34g 수득하였다 (수율 81%). MS[M+H]+ = 820In a nitrogen atmosphere, 40 g of Intermediate 46 and 16.4 g of di([1,1'-biphenyl]-4-yl)amine were recrystallized using the same material and equivalent as the synthesis method of Intermediate 37 to obtain 34 g of Intermediate 47 ( Yield 81%). MS[M+H]+ = 820
4) 중간체48의 합성4) Synthesis of Intermediate 48
Figure PCTKR2020010123-appb-I000384
Figure PCTKR2020010123-appb-I000384
중간체47 25g, 중간체 38의 합성방법과 동일한 물질 및 당량을 사용하여 재결정을 통하여 중간체 48을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 82825 g of Intermediate 47 and 7.5 g of Intermediate 48 were obtained through recrystallization using the same materials and equivalents as in the synthesis method of Intermediate 38 (yield 30%). MS[M+H]+ = 828
5) 화합물31의 합성5) Synthesis of compound 31
Figure PCTKR2020010123-appb-I000385
Figure PCTKR2020010123-appb-I000385
중간체48 7g, bis(4-(tert-부틸)페닐)아민 1.46g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 31을 6.7g 수득하였다. (수율 78%). MS[M+H]+ = 1073Intermediate 48 7g, bis(4-(tert-butyl)phenyl)amine 1.46g, sodium-tert-butoxide 1.5g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction after completion of the reaction, 6.7 g of compound 31 was obtained through recrystallization. (Yield 78%). MS[M+H]+ = 1073
합성예 32. 화합물32의 합성Synthesis Example 32. Synthesis of Compound 32
1) 중간체49의 합성1) Synthesis of Intermediate 49
Figure PCTKR2020010123-appb-I000386
Figure PCTKR2020010123-appb-I000386
질소 분위기하 중간체46 40g, bis(4-(tert-부틸)페닐)아민 14g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 49을 32g 수득하였다. (수율 83%). MS[M+H]+ = 780In a nitrogen atmosphere, 40 g of Intermediate 46 and 14 g of bis(4-(tert-butyl)phenyl)amine were recrystallized using the same materials and equivalents as those of the synthesis method of Intermediate 37 to obtain 32 g of Intermediate 49. (Yield 83%). MS[M+H]+ = 780
2) 중간체50의 합성2) Synthesis of Intermediate 50
Figure PCTKR2020010123-appb-I000387
Figure PCTKR2020010123-appb-I000387
질소 분위기하에서 중간체 49 25g, 보론트리아이오다이드 21.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 50을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 788In a nitrogen atmosphere, 25 g of intermediate 49 and 21.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.5 g of intermediate 50 was obtained through recrystallization (yield 30%). MS[M+H]+ = 788
3) 화합물32의 합성3) Synthesis of compound 32
Figure PCTKR2020010123-appb-I000388
Figure PCTKR2020010123-appb-I000388
중간체50 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 32을 6.5g 수득하였다. (수율 71%). MS[M+H]+ = 1033Intermediate 50 7g, bis(4-(tert-butyl)phenyl)amine 2.5g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and then 6.5 g of compound 32 was obtained through recrystallization. (Yield 71%). MS[M+H]+ = 1033
합성예 33. 화합물33의 합성Synthesis Example 33. Synthesis of Compound 33
1) 중간체51의 합성1) Synthesis of Intermediate 51
Figure PCTKR2020010123-appb-I000389
Figure PCTKR2020010123-appb-I000389
질소 분위기하 중간체46 40g, bis(3-(tert-부틸)페닐)아민 14g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 51을 30g 수득하였다. (수율 81%). MS[M+H]+ = 780In a nitrogen atmosphere, 40 g of Intermediate 46 and 14 g of bis(3-(tert-butyl)phenyl)amine were recrystallized using the same materials and equivalents as in the synthesis method of Intermediate 37 to obtain 30 g of Intermediate 51. (Yield 81%). MS[M+H]+ = 780
2) 중간체52의 합성2) Synthesis of Intermediate 52
Figure PCTKR2020010123-appb-I000390
Figure PCTKR2020010123-appb-I000390
질소 분위기하에서 중간체 51 25g, 보론트리아이오다이드 21.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 52를 7.4g 수득하였다 (수율 30%). MS[M+H]+ = 788In a nitrogen atmosphere, 25 g of intermediate 51 and 21.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After completion of the reaction, extraction was performed, and 7.4 g of intermediate 52 was obtained through recrystallization (yield 30%). MS[M+H]+ = 788
3) 화합물33의 합성3) Synthesis of compound 33
Figure PCTKR2020010123-appb-I000391
Figure PCTKR2020010123-appb-I000391
중간체52 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 33을 6.6g 수득하였다. (수율 72%). MS[M+H]+ = 1033Intermediate 52 7g, bis(4-(tert-butyl)phenyl)amine 2.5g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.6 g of compound 33 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1033
합성예 34. 화합물34의 합성Synthesis Example 34. Synthesis of Compound 34
1) 중간체53의 합성1) Synthesis of Intermediate 53
Figure PCTKR2020010123-appb-I000392
Figure PCTKR2020010123-appb-I000392
질소 분위기하 중간체35 40g, N-(4-(tert-부틸)phenyl)-3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 17.4g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 53을 34g 수득하였다. (수율 79%). MS[M+H]+ = 87040 g of intermediate 35 under nitrogen atmosphere, 17.4 g of N-(4-(tert-butyl)phenyl)-3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine Intermediate 53 was obtained by recrystallization using the same material and equivalent weight as in the synthesis method of Intermediate 37. (79% yield). MS[M+H]+ = 870
2) 중간체54의 합성2) Synthesis of Intermediate 54
Figure PCTKR2020010123-appb-I000393
Figure PCTKR2020010123-appb-I000393
질소 분위기하에서 중간체 53 25g, 보론트리아이오다이드 19.2g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 54을 7.1g 수득하였다 (수율 28%). MS[M+H]+ = 878In a nitrogen atmosphere, 25 g of intermediate 53 and 19.2 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed and extracted, 7.1 g of intermediate 54 was obtained through recrystallization (yield 28%). MS[M+H]+ = 878
3) 화합물34의 합성3) Synthesis of compound 34
Figure PCTKR2020010123-appb-I000394
Figure PCTKR2020010123-appb-I000394
중간체54 7g, bis(4-(tert-부틸)페닐)아민 2.3g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 34을 6.6g 수득하였다. (수율 74%). MS[M+H]+ = 1123Intermediate 54 7g, bis(4-(tert-butyl)phenyl)amine 2.3g, sodium-tert-butoxide 1.5g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.6 g of compound 34 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 1123
합성예 35. 화합물35의 합성Synthesis Example 35. Synthesis of Compound 35
1) 중간체55의 합성1) Synthesis of Intermediate 55
Figure PCTKR2020010123-appb-I000395
Figure PCTKR2020010123-appb-I000395
질소 분위기하 중간체35 40g, bis(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 19.4g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 55을 35g 수득하였다. (수율 77%). MS[M+H]+ = 910In a nitrogen atmosphere, 40 g of intermediate 35 and 19.4 g of bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine were the same material and equivalent as the synthesis method of intermediate 37. 35g of the intermediate 55 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 910
2) 중간체56의 합성2) Synthesis of Intermediate 56
Figure PCTKR2020010123-appb-I000396
Figure PCTKR2020010123-appb-I000396
질소 분위기하에서 중간체 55 25g, 보론트리아이오다이드 18.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 56을 7.4g 수득하였다 (수율 29%). MS[M+H]+ = 918In a nitrogen atmosphere, 25 g of the intermediate 55 and 18.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 7.4 g of intermediate 56 was obtained through recrystallization (29% yield). MS[M+H]+ = 918
3) 화합물35의 합성3) Synthesis of compound 35
Figure PCTKR2020010123-appb-I000397
Figure PCTKR2020010123-appb-I000397
중간체56 7g, bis(4-(tert-부틸)페닐)아민 2.1g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 35을 6.5g 수득하였다. (수율 73%). MS[M+H]+ = 1163Intermediate 56 7g, bis(4-(tert-butyl)phenyl)amine 2.1g, sodium-tert-butoxide 1.5g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and then 6.5 g of compound 35 was obtained through recrystallization. (73% yield). MS[M+H]+ = 1163
합성예 36. 화합물36의 합성Synthesis Example 36. Synthesis of Compound 36
1) 중간체57의 합성1) Synthesis of Intermediate 57
Figure PCTKR2020010123-appb-I000398
Figure PCTKR2020010123-appb-I000398
질소 분위기하 1,3-다이브로모-5-클로로벤젠 40g, bis(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 115.3g을 중간체 41의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 57을 99g 수득하였다. (수율 75%). MS[M+H]+ = 88840 g of 1,3-dibromo-5-chlorobenzene, and 115.3 g of bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine under nitrogen atmosphere as an intermediate 99g of intermediate 57 was obtained through recrystallization using the same material and equivalent as in the synthesis method of 41. (Yield 75%). MS[M+H]+ = 888
2) 중간체58의 합성2) Synthesis of Intermediate 58
Figure PCTKR2020010123-appb-I000399
Figure PCTKR2020010123-appb-I000399
질소 분위기하에서 중간체 57 25g, 보론트리아이오다이드 18.7g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 58을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 896In a nitrogen atmosphere, 25 g of intermediate 57 and 18.7 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction was completed after the reaction was completed, 7.7 g of intermediate 58 was obtained through recrystallization (yield 31%). MS[M+H]+ = 896
3) 화합물36의 합성3) Synthesis of compound 36
Figure PCTKR2020010123-appb-I000400
Figure PCTKR2020010123-appb-I000400
중간체58 7g, 다이페닐아민 1.4g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 36을 6.3g 수득하였다. (수율 78%). MS[M+H]+ = 10297 g of intermediate 58, 1.4 g of diphenylamine, 1.5 g of sodium-tert-butoxide, and 0.05 g of bis (tri-tert-butylphosphine) palladium (0) were added to 80 ml of xylene, followed by reflux stirring for 5 hours. After the reaction was completed, extraction was performed, and 6.3 g of compound 36 was obtained through recrystallization. (Yield 78%). MS[M+H]+ = 1029
합성예 37. 화합물37의 합성Synthesis Example 37. Synthesis of Compound 37
1) 화합물37의 합성1) Synthesis of compound 37
Figure PCTKR2020010123-appb-I000401
Figure PCTKR2020010123-appb-I000401
중간체58 7g, bis(4-(tert-부틸)페닐)아민 2.2g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 37을 6.5g 수득하였다. (수율 73%). MS[M+H]+ = 1141Intermediate 58 7g, bis(4-(tert-butyl)phenyl)amine 2.2g, sodium-tert-butoxide 1.5g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and then 6.5 g of compound 37 was obtained through recrystallization. (73% yield). MS[M+H]+ = 1141
합성예 38. 화합물38의 합성Synthesis Example 38. Synthesis of Compound 38
1) 중간체59의 합성1) Synthesis of Intermediate 59
Figure PCTKR2020010123-appb-I000402
Figure PCTKR2020010123-appb-I000402
중간체7 40g, 다이벤조[b,d]퓨란-1-아민 14.3g, 소듐-tert-부톡사이드 22.4g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 6-브로모-1,1,4,4-테트라메틸-1,2,3,4-테트라하이드로나프탈렌 20.8g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 59을 54g 수득하였다. (수율 82%). MS[M+H]+ = 848Intermediate 7 40g, dibenzo[b,d]furan-1-amine 14.3g, sodium-tert-butoxide 22.4g, bis(tri-tert-butylphosphine)palladium(0) 0.4g in 600ml of toluene After refluxing for 1 hour and checking whether the reaction proceeds, 20.8 g of 6-bromo-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthalene was added during the reflux reaction, and for 1 hour Further reflux reaction proceeds. After the reaction was completed, extraction was performed, and then 54 g of intermediate 59 was obtained through recrystallization. (Yield 82%). MS[M+H]+ = 848
2) 화합물38의 합성2) Synthesis of compound 38
Figure PCTKR2020010123-appb-I000403
Figure PCTKR2020010123-appb-I000403
질소 분위기하에서 중간체 59 25g, 보론트리아이오다이드 19.7g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 38을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 856In a nitrogen atmosphere, 25 g of intermediate 59 and 19.7 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.5g of compound 38 was obtained through recrystallization (yield 30%). MS[M+H]+ = 856
합성예 39. 화합물39의 합성Synthesis Example 39. Synthesis of Compound 39
1) 중간체60의 합성1) Synthesis of Intermediate 60
Figure PCTKR2020010123-appb-I000404
Figure PCTKR2020010123-appb-I000404
중간체7 40g, 다이벤조[b,d]싸이오펜-1-아민 15.5g을 중간체59의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 60을 52g 수득하였다. (수율 77%). MS[M+H]+ = 86440 g of Intermediate 7 and 15.5 g of dibenzo[b,d]thiophen-1-amine were recrystallized using the same substances and equivalents as in the synthesis method of Intermediate 59 to obtain 52 g of Intermediate 60. (Yield 77%). MS[M+H]+ = 864
2) 화합물39의 합성2) Synthesis of compound 39
Figure PCTKR2020010123-appb-I000405
Figure PCTKR2020010123-appb-I000405
질소 분위기하에서 중간체 60 25g, 보론트리아이오다이드 19.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 39을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 872In a nitrogen atmosphere, 25 g of intermediate 60 and 19.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.7 g of compound 39 was obtained through recrystallization (yield 31%). MS[M+H]+ = 872
합성예 40. 화합물40의 합성Synthesis Example 40. Synthesis of Compound 40
1) 중간체61의 합성1) Synthesis of Intermediate 61
Figure PCTKR2020010123-appb-I000406
Figure PCTKR2020010123-appb-I000406
중간체7 40g, 9,9-다이메틸-9H-플로렌-4-아민 16.3g을 중간체59의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 61을 54g 수득하였다. (수율 79%). MS[M+H]+ = 87440 g of Intermediate 7 and 16.3 g of 9,9-dimethyl-9H-floren-4-amine were recrystallized using the same substances and equivalents as the synthesis method of Intermediate 59 to obtain 54 g of Intermediate 61. (79% yield). MS[M+H]+ = 874
2) 화합물40의 합성2) Synthesis of compound 40
Figure PCTKR2020010123-appb-I000407
Figure PCTKR2020010123-appb-I000407
질소 분위기하에서 중간체 61 25g, 보론트리아이오다이드 19.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 40을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 882In a nitrogen atmosphere, 25 g of intermediate 61 and 19.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.5g of compound 40 was obtained through recrystallization (yield 30%). MS[M+H]+ = 882
합성예 41. 화합물41의 합성Synthesis Example 41. Synthesis of Compound 41
1) 중간체62의 합성1) Synthesis of Intermediate 62
Figure PCTKR2020010123-appb-I000408
Figure PCTKR2020010123-appb-I000408
중간체7 40g, 다이벤조[b,d]퓨란-4-아민 14.3g을 중간체59의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 62을 53g 수득하였다. (수율 77%). MS[M+H]+ = 84840 g of Intermediate 7 and 14.3 g of dibenzo[b,d]furan-4-amine were recrystallized using the same substances and equivalents as the synthesis method of Intermediate 59 to obtain 53 g of Intermediate 62. (Yield 77%). MS[M+H]+ = 848
2) 화합물41의 합성2) Synthesis of Compound 41
Figure PCTKR2020010123-appb-I000409
Figure PCTKR2020010123-appb-I000409
질소 분위기하에서 중간체 62 25g, 보론트리아이오다이드 19.7g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 41을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 856In a nitrogen atmosphere, 25 g of intermediate 62 and 19.7 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed and extracted, 7.7 g of compound 41 was obtained through recrystallization (yield 31%). MS[M+H]+ = 856
합성예 42. 화합물42의 합성Synthesis Example 42. Synthesis of Compound 42
1) 중간체63의 합성1) Synthesis of Intermediate 63
Figure PCTKR2020010123-appb-I000410
Figure PCTKR2020010123-appb-I000410
중간체7 40g, 다이벤조[b,d]싸이오펜-4-아민 15.5g을 중간체59의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 63을 54g 수득하였다. (수율 78%). MS[M+H]+ = 864Intermediate 7 40g and dibenzo[b,d]thiophen-4-amine 15.5g were recrystallized using the same substances and equivalents as the synthesis method of Intermediate 59 to obtain 54g of Intermediate 63. (Yield 78%). MS[M+H]+ = 864
2) 화합물42의 합성2) Synthesis of compound 42
Figure PCTKR2020010123-appb-I000411
Figure PCTKR2020010123-appb-I000411
질소 분위기하에서 중간체 63 25g, 보론트리아이오다이드 19.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 42을 7.6g 수득하였다 (수율 31%). MS[M+H]+ = 872In a nitrogen atmosphere, 25 g of the intermediate 63 and 19.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.6 g of compound 42 was obtained through recrystallization (yield 31%). MS[M+H]+ = 872
합성예 43. 화합물43의 합성Synthesis Example 43. Synthesis of Compound 43
1) 중간체64의 합성1) Synthesis of Intermediate 64
Figure PCTKR2020010123-appb-I000412
Figure PCTKR2020010123-appb-I000412
중간체7 40g, 9,9-다이메틸-9H-플로렌-1-아민 16.3g을 중간체59의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 64을 51g 수득하였다. (수율 77%). MS[M+H]+ = 87440 g of Intermediate 7 and 16.3 g of 9,9-dimethyl-9H-floren-1-amine were recrystallized using the same substances and equivalents as in the synthesis method of Intermediate 59 to obtain 51 g of Intermediate 64. (Yield 77%). MS[M+H]+ = 874
2) 화합물43의 합성2) Synthesis of compound 43
Figure PCTKR2020010123-appb-I000413
Figure PCTKR2020010123-appb-I000413
질소 분위기하에서 중간체 64 25g, 보론트리아이오다이드 19.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 43을 7.2g 수득하였다 (수율 28%). MS[M+H]+ = 882In a nitrogen atmosphere, 25 g of intermediate 64 and 19.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After completion of the reaction, extraction was performed, and 7.2 g of compound 43 was obtained through recrystallization (yield 28%). MS[M+H]+ = 882
합성예 44. 화합물44의 합성Synthesis Example 44. Synthesis of Compound 44
1) 중간체65의 합성1) Synthesis of Intermediate 65
Figure PCTKR2020010123-appb-I000414
Figure PCTKR2020010123-appb-I000414
중간체7 40g, 다이벤조[b,d]퓨란-4-아민 14.3g, 1-브로모-3-(tert-부틸)벤젠 16.6g을 중간체59의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 65을 47g 수득하였다. (수율 76%). MS[M+H]+ = 794Intermediate 7 40g, dibenzo[b,d]furan-4-amine 14.3g, 1-bromo-3-(tert-butyl)benzene 16.6g through recrystallization using the same material and equivalent as the synthesis method of Intermediate 59 47 g of intermediate 65 was obtained. (Yield 76%). MS[M+H]+ = 794
2) 화합물44의 합성2) Synthesis of compound 44
Figure PCTKR2020010123-appb-I000415
Figure PCTKR2020010123-appb-I000415
질소 분위기하에서 중간체 65 25g, 보론트리아이오다이드 21g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 44을 7.8g 수득하였다 (수율 31%). MS[M+H]+ = 801In a nitrogen atmosphere, 25 g of intermediate 65 and 21 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.8g of compound 44 was obtained through recrystallization (yield 31%). MS[M+H]+ = 801
합성예 45. 화합물45의 합성Synthesis Example 45. Synthesis of Compound 45
1) 중간체66의 합성1) Synthesis of Intermediate 66
Figure PCTKR2020010123-appb-I000416
Figure PCTKR2020010123-appb-I000416
중간체7 40g, 다이벤조[b,d]퓨란-1-아민 14.3g, 소듐-tert-부톡사이드 22.4g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 14.9g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 66을 46g 수득하였다. (수율 77%). MS[M+H]+ = 771Intermediate 7 40g, dibenzo[b,d]furan-1-amine 14.3g, sodium-tert-butoxide 22.4g, bis(tri-tert-butylphosphine)palladium(0) 0.4g in 600ml of toluene After refluxing for 1 hour and checking whether the reaction proceeds, 14.9 g of 1-bromo-3-chlorobenzene was added during the reflux reaction, and the reflux reaction was further performed for 1 hour. After the reaction was completed, extraction was performed, and then 46 g of intermediate 66 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 771
2) 중간체67의 합성2) Synthesis of Intermediate 67
Figure PCTKR2020010123-appb-I000417
Figure PCTKR2020010123-appb-I000417
질소 분위기하에서 중간체 66 25g, 보론트리아이오다이드 21.6g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 67을 7.8g 수득하였다 (수율 31%). MS[M+H]+ = 780In a nitrogen atmosphere, 25 g of intermediate 66 and 21.6 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.8 g of intermediate 67 was obtained through recrystallization (31% yield). MS[M+H]+ = 780
3) 화합물45의 합성3) Synthesis of compound 45
Figure PCTKR2020010123-appb-I000418
Figure PCTKR2020010123-appb-I000418
중간체67 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 45을 6.6g 수득하였다. (수율 72%). MS[M+H]+ = 1025Intermediate 67 7g, bis(4-(tert-butyl)phenyl)amine 2.5g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed and extracted, 6.6g of compound 45 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1025
합성예 46. 화합물46의 합성Synthesis Example 46. Synthesis of Compound 46
1) 중간체68의 합성1) Synthesis of Intermediate 68
Figure PCTKR2020010123-appb-I000419
Figure PCTKR2020010123-appb-I000419
N-(3-클로로-5-메틸페닐)-N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)다이벤조[b,d]퓨란-1-아민 40g, 3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 16.6g, 소듐-tert-부톡사이드 23.3g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 15.5g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 68을 47g 수득하였다. (수율 74%). MS[M+H]+ = 786N-(3-chloro-5-methylphenyl)-N-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl)dibenzo[b,d]furan -1- amine 40g, 3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine 16.6g, sodium-tert-butoxide 23.3g, bis(tri- After adding 0.4 g of tert-butylphosphine) palladium (0) to 600 ml of toluene, refluxed for 1 hour, and after confirming the progress of the reaction, 15.5 g of 1-bromo-3-chlorobenzene was added during the reflux reaction and for 1 hour. Further reflux reaction proceeds. After the reaction was completed, extraction was performed, and then 47 g of intermediate 68 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 786
2) 중간체69의 합성2) Synthesis of Intermediate 69
Figure PCTKR2020010123-appb-I000420
Figure PCTKR2020010123-appb-I000420
질소 분위기하에서 중간체 68 25g, 보론트리아이오다이드 21.2g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 69을 7.7g 수득하였다 (수율 30%). MS[M+H]+ = 794In a nitrogen atmosphere, 25 g of intermediate 68 and 21.2 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.7 g of intermediate 69 was obtained through recrystallization (yield 30%). MS[M+H]+ = 794
3) 화합물46의 합성3) Synthesis of compound 46
Figure PCTKR2020010123-appb-I000421
Figure PCTKR2020010123-appb-I000421
중간체69 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 46을 6.8g 수득하였다. (수율 74%). MS[M+H]+ = 1039Intermediate 69 7g, bis(4-(tert-butyl)phenyl)amine 2.5g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction after completion of the reaction, 6.8g of compound 46 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 1039
합성예 47. 화합물47의 합성Synthesis Example 47. Synthesis of Compound 47
1) 중간체70의 합성1) Synthesis of Intermediate 70
Figure PCTKR2020010123-appb-I000422
Figure PCTKR2020010123-appb-I000422
중간체46 40g, N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)다이벤조[b,d]퓨란-1-아민 18.9g, 중간체 47의 합성방법과 동일한 물질 및 당량을 사용하여 반응 종료 후 추출한 후에 재결정 통하여 중간체 70을 34g 수득하였다. (수율 77%). MS[M+H]+ = 868Intermediate 46 40g, N-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl)dibenzo[b,d]furan-1-amine 18.9g, intermediate After the reaction was completed and extracted using the same material and equivalent as in the synthesis method of 47, 34 g of intermediate 70 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 868
2) 중간체71의 합성2) Synthesis of Intermediate 71
Figure PCTKR2020010123-appb-I000423
Figure PCTKR2020010123-appb-I000423
질소 분위기하에서 중간체 70 25g, 보론트리아이오다이드 19.2g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 71을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 876In a nitrogen atmosphere, 25 g of intermediate 70 and 19.2 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.5 g of intermediate 71 was obtained through recrystallization (yield 30%). MS[M+H]+ = 876
3) 화합물47의 합성3) Synthesis of compound 47
Figure PCTKR2020010123-appb-I000424
Figure PCTKR2020010123-appb-I000424
중간체71 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 47을 6.9g 수득하였다. (수율 70%). MS[M+H]+ = 11207 g of intermediate 71, 2.5 g of bis(4-(tert-butyl)phenyl)amine, 1.7 g of sodium-tert-butoxide, and 0.05 g of bis(tri-tert-butylphosphine)palladium(0) were added to 80 ml of xylene. Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.9 g of compound 47 was obtained through recrystallization. (Yield 70%). MS[M+H]+ = 1120
합성예 48. 화합물48의 합성Synthesis Example 48. Synthesis of Compound 48
1) 중간체72의 합성1) Synthesis of Intermediate 72
Figure PCTKR2020010123-appb-I000425
Figure PCTKR2020010123-appb-I000425
N-(3-클로로-5-(메틸-d3)페닐)-5,5,8,8-테트라메틸-N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)-5,6,7,8-테트라하이드로나프탈렌-2-아민 30g, N-(4-(tert-부틸)페닐)-3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 20.4g을 중간체2 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 72을 33g 수득하였다. (수율 69%). MS[M+H]+ = 831N-(3-chloro-5-(methyl-d3)phenyl)-5,5,8,8-tetramethyl-N-(5,5,8,8-tetramethyl-5,6,7,8- Tetrahydronaphthalene-2-yl)-5,6,7,8-tetrahydronaphthalen-2-amine 30g, N-(4-(tert-butyl)phenyl)-3,5,5,8,8-penta 20.4 g of methyl-5,6,7,8-tetrahydronaphthalen-2-amine was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 2 to obtain 33 g of Intermediate 72. (Yield 69%). MS[M+H]+ = 831
2) 화합물48의 합성2) Synthesis of compound 48
Figure PCTKR2020010123-appb-I000426
Figure PCTKR2020010123-appb-I000426
질소 분위기하에서 중간체 72 25g, 보론트리아이오다이드 20.4g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물48을 7.4g 수득하였다 (수율 29%). MS[M+H]+ = 839In a nitrogen atmosphere, 25 g of intermediate 72 and 20.4 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 7.4 g of compound 48 was obtained through recrystallization (yield 29%). MS[M+H]+ = 839
합성예 49. 화합물49의 합성Synthesis Example 49. Synthesis of Compound 49
1) 중간체73의 합성1) Synthesis of Intermediate 73
Figure PCTKR2020010123-appb-I000427
Figure PCTKR2020010123-appb-I000427
1,3-다이브로모-5-(tert-부틸)벤젠 30g, 3,5,5,8,8-펜타메틸-N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)-5,6,7,8-테트라하이드로나프탈렌-2-아민 83g을 중간체20 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 73을 66g 수득하였다. (수율 69%). MS[M+H]+ = 93830 g of 1,3-dibromo-5-(tert-butyl)benzene, 3,5,5,8,8-pentamethyl-N-(5,5,8,8-tetramethyl-5,6,7, 83 g of 8-tetrahydronaphthalene-2-yl)-5,6,7,8-tetrahydronaphthalen-2-amine was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 20 to obtain 66 g of Intermediate 73. (Yield 69%). MS[M+H]+ = 938
2) 화합물49의 합성2) Synthesis of Compound 49
Figure PCTKR2020010123-appb-I000428
Figure PCTKR2020010123-appb-I000428
질소 분위기하에서 중간체 73 25g, 보론트리아이오다이드 17.7g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물49을 7.6g 수득하였다 (수율 30%). MS[M+H]+ = 946In a nitrogen atmosphere, 25 g of intermediate 73 and 17.7 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.6g of compound 49 was obtained through recrystallization (yield 30%). MS[M+H]+ = 946
합성예 50. 화합물50의 합성Synthesis Example 50. Synthesis of Compound 50
1) 중간체74의 합성1) Synthesis of Intermediate 74
Figure PCTKR2020010123-appb-I000429
Figure PCTKR2020010123-appb-I000429
N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-N-(3-클로로-5-(메틸-d3)페닐)-5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 40g, 4-(tert-부틸)-2-메틸아닐린 12.1g, 소듐-tert-부톡사이드 21.4g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 14.2g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 74을 42g 수득하였다. (수율 73%). MS[M+H]+ = 777N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-N-(3-chloro-5-(methyl-d3)phenyl)-5,5,8,8 -Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine 40g, 4-(tert-butyl)-2-methylaniline 12.1g, sodium-tert-butoxide 21.4g, bis(tri-tert -After adding 0.4 g of butylphosphine)palladium (0) to 600 ml of toluene, refluxed for 1 hour, and after confirming the progress of the reaction, 14.2 g of 1-bromo-3-chlorobenzene was added during the reflux reaction, and further for 1 hour. The reflux reaction proceeds. After the reaction was completed, extraction was performed, and then 42 g of intermediate 74 was obtained through recrystallization. (73% yield). MS[M+H]+ = 777
2) 중간체75의 합성2) Synthesis of Intermediate 75
Figure PCTKR2020010123-appb-I000430
Figure PCTKR2020010123-appb-I000430
질소 분위기하에서 중간체 74 25g, 보론트리아이오다이드 21.4g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 75을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 785In a nitrogen atmosphere, 25 g of intermediate 74 and 21.4 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After completion of the reaction, extraction was performed, and 7.5 g of intermediate 75 was obtained through recrystallization (yield 30%). MS[M+H]+ = 785
3) 화합물50의 합성3) Synthesis of compound 50
Figure PCTKR2020010123-appb-I000431
Figure PCTKR2020010123-appb-I000431
중간체75 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 50을 7.1g 수득하였다. (수율 77%). MS[M+H]+ = 1030Intermediate 75 7g, bis(4-(tert-butyl)phenyl)amine 2.5g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 7.1 g of compound 50 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 1030
합성예 51. 화합물51의 합성Synthesis Example 51. Synthesis of Compound 51
1) 중간체76의 합성1) Synthesis of Intermediate 76
Figure PCTKR2020010123-appb-I000432
Figure PCTKR2020010123-appb-I000432
N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-N-(3-클로로-5-메틸페닐)-1,1,3,3-테트라메틸-2,3-다이하이드로-1H-인덴-5-아민 40g, 4-(tert-부틸)-2-메틸아닐린 12.1g, 소듐-tert-부톡사이드 22.1g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 14.6g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 76을 43g 수득하였다. (수율 74%). MS[M+H]+ = 760N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-N-(3-chloro-5-methylphenyl)-1,1,3,3-tetramethyl-2 ,3-dihydro-1H-inden-5-amine 40g, 4-(tert-butyl)-2-methylaniline 12.1g, sodium-tert-butoxide 22.1g, bis(tri-tert-butylphosphine)palladium (0) 0.4g was added to 600ml of toluene, refluxed for 1 hour, and after checking whether the reaction proceeded, 14.6g of 1-bromo-3-chlorobenzene was added during the reflux reaction, and the reflux reaction was further performed for 1 hour. After the reaction was completed, extraction was performed, and then 43 g of intermediate 76 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 760
2) 중간체77의 합성2) Synthesis of Intermediate 77
Figure PCTKR2020010123-appb-I000433
Figure PCTKR2020010123-appb-I000433
질소 분위기하에서 중간체 76 25g, 보론트리아이오다이드 21.9g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 77을 7.1g 수득하였다 (수율 28%). MS[M+H]+ = 768In a nitrogen atmosphere, 25 g of intermediate 76 and 21.9 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.1 g of intermediate 77 was obtained through recrystallization (yield 28%). MS[M+H]+ = 768
3) 화합물51의 합성3) Synthesis of compound 51
Figure PCTKR2020010123-appb-I000434
Figure PCTKR2020010123-appb-I000434
중간체77 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 51을 6.5g 수득하였다. (수율 72%). MS[M+H]+ = 1013Intermediate 77 7g, bis(4-(tert-butyl)phenyl)amine 2.5g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction was completed after the reaction was completed, 6.5 g of compound 51 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1013
합성예 52. 화합물52의 합성Synthesis Example 52. Synthesis of Compound 52
1) 중간체78의 합성1) Synthesis of Intermediate 78
Figure PCTKR2020010123-appb-I000435
Figure PCTKR2020010123-appb-I000435
N-(3-클로로-5-(메틸-d3)페닐)-1,1,3,3-테트라메틸-N-(1,1,3,3-테트라메틸-2,3-다이하이드로-1H-인덴-5-yl)-2,3-다이하이드로-1H-인덴-5-아민 30g, N-(4-(tert-부틸)페닐)-1,1,3,3,6-펜타메틸-2,3-다이하이드로-1H-인덴-5-아민 27.4g을 중간체2의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 78을 33g 수득하였다. (수율 78%). MS[M+H]+ = 789N-(3-chloro-5-(methyl-d3)phenyl)-1,1,3,3-tetramethyl-N-(1,1,3,3-tetramethyl-2,3-dihydro-1H -Inden-5-yl)-2,3-dihydro-1H-inden-5-amine 30g, N-(4-(tert-butyl)phenyl)-1,1,3,3,6-pentamethyl- 27.4 g of 2,3-dihydro-1H-inden-5-amine was recrystallized using the same material and equivalent as in the synthesis method of Intermediate 2 to obtain 33 g of Intermediate 78. (Yield 78%). MS[M+H]+ = 789
2) 화합물52의 합성2) Synthesis of compound 52
Figure PCTKR2020010123-appb-I000436
Figure PCTKR2020010123-appb-I000436
질소 분위기하에서 중간체 78 25g, 보론트리아이오다이드 21.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물52을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 797In a nitrogen atmosphere, 25 g of intermediate 78 and 21.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction was completed after the reaction was completed, 7.5 g of compound 52 was obtained through recrystallization (yield 30%). MS[M+H]+ = 797
합성예 53. 화합물53의 합성Synthesis Example 53. Synthesis of Compound 53
1) 중간체79의 합성1) Synthesis of Intermediate 79
Figure PCTKR2020010123-appb-I000437
Figure PCTKR2020010123-appb-I000437
1,3-다이브로모-5-메틸벤젠 30g, 1,1,3,3,6-펜타메틸-N-(1,1,3,3-테트라메틸-2,3-다이하이드로-1H-인덴-5-yl)-2,3-다이하이드로-1H-인덴-5-아민 90.1g을 중간체20의 합성방법과 동일한 물질 및 당량을 사용하여 재결정 통하여 중간체 79을 66g 수득하였다. (수율 66%). MS[M+H]+ = 8401,3-dibromo-5- methylbenzene 30g, 1,1,3,3,6-pentamethyl-N-(1,1,3,3-tetramethyl-2,3-dihydro-1H-indene 66 g of Intermediate 79 was obtained by recrystallization of 90.1 g of -5-yl)-2,3-dihydro-1H-inden-5-amine using the same material and equivalent as in the synthesis method of Intermediate 20. (Yield 66%). MS[M+H]+ = 840
2) 화합물53의 합성2) Synthesis of compound 53
Figure PCTKR2020010123-appb-I000438
Figure PCTKR2020010123-appb-I000438
질소 분위기하에서 중간체 79 25g, 보론트리아이오다이드 19.8g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물53을 7.3g 수득하였다 (수율 29%). MS[M+H]+ = 848In a nitrogen atmosphere, 25 g of the intermediate 79 and 19.8 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.3g of compound 53 was obtained through recrystallization (yield 29%). MS[M+H]+ = 848
합성예 54. 화합물54의 합성Synthesis Example 54. Synthesis of Compound 54
1) 중간체80의 합성1) Synthesis of Intermediate 80
Figure PCTKR2020010123-appb-I000439
Figure PCTKR2020010123-appb-I000439
N-(3-클로로-5-(메틸-d3)페닐)-5,5,8,8-테트라메틸-N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)-5,6,7,8-테트라하이드로나프탈렌-2-아민 40g, 다이벤조[b,d]퓨란-1-아민 14.2g, 소듐-tert-부톡사이드 22.3g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 14.1g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 80을 41g 수득하였다. (수율 68%). MS[M+H]+ = 775N-(3-chloro-5-(methyl-d3)phenyl)-5,5,8,8-tetramethyl-N-(5,5,8,8-tetramethyl-5,6,7,8- Tetrahydronaphthalene-2-yl)-5,6,7,8-tetrahydronaphthalen-2-amine 40g, dibenzo[b,d]furan-1-amine 14.2g, sodium-tert-butoxide 22.3g, After adding 0.4 g of bis(tri-tert-butylphosphine)palladium(0) to 600 ml of toluene, refluxed for 1 hour, and after confirming the progress of the reaction, 14.1 g of 1-bromo-3-chlorobenzene was added during the reflux reaction. And further reflux reaction for 1 hour. After the reaction was completed, extraction was performed, and 41 g of intermediate 80 was obtained through recrystallization. (Yield 68%). MS[M+H]+ = 775
2) 중간체81의 합성2) Synthesis of Intermediate 81
Figure PCTKR2020010123-appb-I000440
Figure PCTKR2020010123-appb-I000440
질소 분위기하에서 중간체 80 25g, 보론트리아이오다이드 21.5g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 81을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 783In a nitrogen atmosphere, 25 g of the intermediate 80 and 21.5 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.5 g of intermediate 81 was obtained through recrystallization (yield 30%). MS[M+H]+ = 783
3) 화합물54의 합성3) Synthesis of compound 54
Figure PCTKR2020010123-appb-I000441
Figure PCTKR2020010123-appb-I000441
중간체81 7g, bis(4-(tert-부틸)페닐)아민 2.5g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 54을 6.6g 수득하였다. (수율 72%). MS[M+H]+ = 1028Intermediate 81 7g, bis(4-(tert-butyl)phenyl)amine 2.5g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.6g of compound 54 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1028
합성예 55. 화합물55의 합성Synthesis Example 55. Synthesis of Compound 55
1) 중간체82의 합성1) Synthesis of Intermediate 82
Figure PCTKR2020010123-appb-I000442
Figure PCTKR2020010123-appb-I000442
중간체46 40g, N-(4-(다이벤조[b,d]퓨란-1-yl)페닐)-3-메틸-[1,1'-바이페닐]-4-아민 31g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정을 통하여 중간체 82을 55g 수득하였다. (수율 78%). MS[M+H]+ = 924Intermediate 46 40g, N-(4-(dibenzo[b,d]furan-1-yl)phenyl)-3-methyl-[1,1'-biphenyl]-4-amine 31g Synthesis of Intermediate 37 55 g of Intermediate 82 was obtained through recrystallization using the same material and equivalent weight as. (Yield 78%). MS[M+H]+ = 924
2) 중간체83의 합성2) Synthesis of Intermediate 83
Figure PCTKR2020010123-appb-I000443
Figure PCTKR2020010123-appb-I000443
질소 분위기하에서 중간체 82 25g, 보론트리아이오다이드 18g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 83을 7.2g 수득하였다 (수율 29%). MS[M+H]+ = 932In a nitrogen atmosphere, 25 g of intermediate 82 and 18 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.2 g of intermediate 83 was obtained through recrystallization (29% yield). MS[M+H]+ = 932
3) 화합물55의 합성3) Synthesis of compound 55
Figure PCTKR2020010123-appb-I000444
Figure PCTKR2020010123-appb-I000444
중간체83 7g, bis(4-(tert-부틸)페닐)아민 2.1g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 55을 6.4g 수득하였다. (수율 72%). MS[M+H]+ = 1177Intermediate 83 7g, bis(4-(tert-butyl)phenyl)amine 2.1g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.4 g of compound 55 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1177
합성예 56. 화합물56의 합성Synthesis Example 56. Synthesis of Compound 56
1) 중간체84의 합성1) Synthesis of Intermediate 84
Figure PCTKR2020010123-appb-I000445
Figure PCTKR2020010123-appb-I000445
중간체46 40g, N-(4-(다이벤조[b,d]싸이오펜-2-yl)페닐)-3-메틸-[1,1'-바이페닐]-4-아민 34g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정을 통하여 중간체 84을 54g 수득하였다. (수율 74%). MS[M+H]+ = 940Intermediate 46 40g, N-(4-(dibenzo[b,d]thiophene-2-yl)phenyl)-3-methyl-[1,1'-biphenyl]-4-amine 34g Synthesis of Intermediate 37 54 g of intermediate 84 was obtained through recrystallization using the same material and equivalent as in the method. (Yield 74%). MS[M+H]+ = 940
2) 중간체85의 합성2) Synthesis of Intermediate 85
Figure PCTKR2020010123-appb-I000446
Figure PCTKR2020010123-appb-I000446
질소 분위기하에서 중간체 84 25g, 보론트리아이오다이드 17.7g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 85을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 948In a nitrogen atmosphere, 25 g of intermediate 84 and 17.7 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.5 g of intermediate 85 was obtained through recrystallization (yield 30%). MS[M+H]+ = 948
3) 화합물56의 합성3) Synthesis of compound 56
Figure PCTKR2020010123-appb-I000447
Figure PCTKR2020010123-appb-I000447
중간체85 7g, bis(4-(tert-부틸)페닐)아민 2.1g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 56을 6.6g 수득하였다. (수율 72%). MS[M+H]+ = 1235Intermediate 85 7g, bis(4-(tert-butyl)phenyl)amine 2.1g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction was completed after the reaction was completed, 6.6 g of compound 56 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1235
합성예 57. 화합물57의 합성Synthesis Example 57. Synthesis of Compound 57
1) 중간체86의 합성1) Synthesis of Intermediate 86
Figure PCTKR2020010123-appb-I000448
Figure PCTKR2020010123-appb-I000448
중간체46 40g, N-(4-(9,9-다이메틸-9H-플로렌-1-yl)페닐)-3-메틸-[1,1'-바이페닐]-4-아민 35g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정을 통하여 중간체 86을 53g 수득하였다. (수율 72%). MS[M+H]+ = 950Intermediate 46 40g, N-(4-(9,9-dimethyl-9H-floren-1-yl)phenyl)-3-methyl-[1,1'-biphenyl]-4-amine 35g, intermediate 37 53 g of intermediate 86 was obtained through recrystallization using the same material and equivalent as the synthesis method of. (Yield 72%). MS[M+H]+ = 950
2) 중간체87의 합성2) Synthesis of Intermediate 87
Figure PCTKR2020010123-appb-I000449
Figure PCTKR2020010123-appb-I000449
질소 분위기하에서 중간체 86 25g, 보론트리아이오다이드 17.5g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 87을 7.7g 수득하였다 (수율 31%). MS[M+H]+ = 958In a nitrogen atmosphere, 25 g of intermediate 86 and 17.5 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.7 g of intermediate 87 was obtained through recrystallization (yield 31%). MS[M+H]+ = 958
3) 화합물57의 합성3) Synthesis of compound 57
Figure PCTKR2020010123-appb-I000450
Figure PCTKR2020010123-appb-I000450
중간체87 7g, bis(4-(tert-부틸)페닐)아민 2.1g, 소듐-tert-부톡사이드 1.7g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 57을 6.8g 수득하였다. (수율 75%). MS[M+H]+ = 1245Intermediate 87 7g, bis(4-(tert-butyl)phenyl)amine 2.1g, sodium-tert-butoxide 1.7g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction after completion of the reaction, 6.8g of compound 57 was obtained through recrystallization. (Yield 75%). MS[M+H]+ = 1245
합성예 58. 화합물58의 합성Synthesis Example 58. Synthesis of Compound 58
1) 중간체88의 합성1) Synthesis of Intermediate 88
Figure PCTKR2020010123-appb-I000451
Figure PCTKR2020010123-appb-I000451
중간체46 40g, 4-(tert-부틸)-N-(3-클로로페닐)-2-메틸아닐린 15g을 중간체 37의 합성방법과 동일한 물질 및 당량을 사용하여 재결정을 통하여 중간체 88을 31g 수득하였다. (수율 79%). MS[M+H]+ = 772Intermediate 46 40g, 4-(tert-butyl)-N-(3-chlorophenyl)-2-methylaniline 15g was recrystallized using the same material and equivalent as the synthesis method of Intermediate 37 to obtain 31g of Intermediate 88. (79% yield). MS[M+H]+ = 772
2) 중간체89의 합성2) Synthesis of Intermediate 89
Figure PCTKR2020010123-appb-I000452
Figure PCTKR2020010123-appb-I000452
질소 분위기하에서 중간체 88 25g, 보론트리아이오다이드 21.6g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 89을 7.6g 수득하였다 (수율 30%). MS[M+H]+ = 780In a nitrogen atmosphere, 25 g of the intermediate 88 and 21.6 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.6 g of intermediate 89 was obtained through recrystallization (yield 30%). MS[M+H]+ = 780
3) 화합물58의 합성3) Synthesis of compound 58
Figure PCTKR2020010123-appb-I000453
Figure PCTKR2020010123-appb-I000453
중간체89 7g, bis(4-(tert-부틸)페닐)아민 4.3g, 소듐-tert-부톡사이드 2.1g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 58을 7.2g 수득하였다. (수율 78%). MS[M+H]+ = 1270Intermediate 89 7g, bis(4-(tert-butyl)phenyl)amine 4.3g, sodium-tert-butoxide 2.1g, bis(tri-tert-butylphosphine)palladium(0) 0.05g in 80ml xylene Then, the mixture was stirred under reflux for 5 hours. After extraction was completed after the reaction was completed, 7.2 g of compound 58 was obtained through recrystallization. (Yield 78%). MS[M+H]+ = 1270
합성예 59. 화합물59의 합성Synthesis Example 59. Synthesis of Compound 59
1) 화합물59의 합성1) Synthesis of compound 59
Figure PCTKR2020010123-appb-I000454
Figure PCTKR2020010123-appb-I000454
중간체58 7g, bis(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)아민 3g, 소듐-tert-부톡사이드 1.5g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.04g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 59을 7.1g 수득하였다. (수율 73%). MS[M+H]+ = 1249Intermediate 58 7g, bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amine 3g, sodium-tert-butoxide 1.5g, bis(tri-tert -Butylphosphine)Palladium (0) 0.04g was added to 80ml of xylene and stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 7.1 g of compound 59 was obtained through recrystallization. (73% yield). MS[M+H]+ = 1249
합성예 60. 화합물60의 합성Synthesis Example 60. Synthesis of Compound 60
1) 중간체90의 합성1) Synthesis of Intermediate 90
Figure PCTKR2020010123-appb-I000455
Figure PCTKR2020010123-appb-I000455
질소 분위기하에서 1-브로모-3-클로로-5-메틸벤젠 40g, N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-9,9,10,10-테트라메틸-9,10-다이하이드로안트라센-2-아민 89.5g, 소듐-tert-부톡사이드 56.1g, 비스(트리-tert-부틸포스핀)팔라듐(0) 1.0g을 톨루엔 600ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 90을 88g 수득하였다. (수율 77%). MS[M+H]+ = 5851-bromo-3-chloro-5-methylbenzene 40g under nitrogen atmosphere, N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-9,9,10, After adding 89.5 g of 10-tetramethyl-9,10-dihydroanthracene-2-amine, 56.1 g of sodium-tert-butoxide, and 1.0 g of bis (tri-tert-butylphosphine) palladium (0) in 600 ml of toluene Stir at reflux for 2 hours. After extraction was completed after the reaction was completed, 88 g of intermediate 90 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 585
2) 중간체91의 합성2) Synthesis of Intermediate 91
Figure PCTKR2020010123-appb-I000456
Figure PCTKR2020010123-appb-I000456
질소 분위기하에서 중간체 90 30g, bis(4-(tert-부틸)페닐)아민 14.5g, 소듐-tert-부톡사이드 9.9g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.3g을 톨루엔 450ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 91을 34g 수득하였다. (수율 80%). MS[M+H]+ = 830In a nitrogen atmosphere, 30 g of intermediate 90, 14.5 g of bis(4-(tert-butyl)phenyl)amine, 9.9 g of sodium-tert-butoxide, 0.3 g of bis(tri-tert-butylphosphine)palladium(0), 450 ml of toluene After putting in, the mixture was stirred under reflux for 2 hours. After the reaction was completed, extraction was performed, and 34 g of intermediate 91 was obtained through recrystallization. (Yield 80%). MS[M+H]+ = 830
3) 화합물60의 합성3) Synthesis of compound 60
Figure PCTKR2020010123-appb-I000457
Figure PCTKR2020010123-appb-I000457
질소 분위기하에서 중간체 91 25g, 보론트리아이오다이드 20.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물60을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 838In a nitrogen atmosphere, 25 g of intermediate 91 and 20.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 7.5 g of compound 60 was obtained through recrystallization (yield 30%). MS[M+H]+ = 838
합성예 61. 화합물61의 합성Synthesis Example 61. Synthesis of Compound 61
1) 중간체92의 합성1) Synthesis of Intermediate 92
Figure PCTKR2020010123-appb-I000458
Figure PCTKR2020010123-appb-I000458
질소 분위기하에서 중간체 90 30g, 9,9,10,10-테트라메틸-N-(3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)-9,10-다이하이드로안트라센-2-아민 23.2g, 소듐-tert-부톡사이드 9.9g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.3g을 톨루엔 450ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 92을 38g 수득하였다. (수율 74%). MS[M+H]+ = 1000Intermediate 90 30g, 9,9,10,10-tetramethyl-N-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalene-2-yl) under nitrogen atmosphere 23.2 g of -9,10-dihydroanthracene-2-amine, 9.9 g of sodium-tert-butoxide, 0.3 g of bis (tri-tert-butylphosphine) palladium (0) were added to 450 ml of toluene and refluxed for 2 hours. Stirred. After the reaction was completed, extraction was performed, and 38 g of intermediate 92 was obtained through recrystallization. (Yield 74%). MS[M+H]+ = 1000
2) 화합물61의 합성2) Synthesis of Compound 61
Figure PCTKR2020010123-appb-I000459
Figure PCTKR2020010123-appb-I000459
질소 분위기하에서 중간체 92 25g, 보론트리아이오다이드 20.1g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물61을 7.6g 수득하였다 (수율 30%). MS[M+H]+ = 1008In a nitrogen atmosphere, 25 g of intermediate 92 and 20.1 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.6g of compound 61 was obtained through recrystallization (yield 30%). MS[M+H]+ = 1008
합성예 62. 화합물62의 합성Synthesis Example 62. Synthesis of Compound 62
1) 중간체93의 합성1) Synthesis of Intermediate 93
Figure PCTKR2020010123-appb-I000460
Figure PCTKR2020010123-appb-I000460
질소 분위기하에서 중간체90 30g, 3,5,5,8,8-펜탐메틸-5,6,7,8-테트라하이드로나프탈렌-2-아민 14.9g, 소듐-tert-부톡사이드 19.8g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.4g을 톨루엔 600ml에 넣은 후 1시간 동안 환류 하고, 반응 진행 여부를 확인 후에 환류 반응 중 1-브로모-3-클로로벤젠 13.1g을 투입하고 1시간 동안 더 환류반응을 진행한다. 반응 종료 후 추출한 후에 재결정 통하여 중간체 93을 44g 수득하였다. (수율 73%). MS[M+H]+ = 876Intermediate 90 30g, 3,5,5,8,8-pentammethyl-5,6,7,8-tetrahydronaphthalen-2-amine 14.9g, sodium-tert-butoxide 19.8g, bis(tri After adding 0.4 g of -tert-butylphosphine) palladium (0) to 600 ml of toluene, refluxed for 1 hour, and after confirming the progress of the reaction, 13.1 g of 1-bromo-3-chlorobenzene was added during the reflux reaction for 1 hour. During further reflux reaction proceeds. After the reaction was completed, extraction was performed, and then 44 g of intermediate 93 was obtained through recrystallization. (73% yield). MS[M+H]+ = 876
(수율 77%). MS[M+H]+ = 585 (Yield 77%). MS[M+H]+ = 585
2) 중간체94의 합성2) Synthesis of Intermediate 94
Figure PCTKR2020010123-appb-I000461
Figure PCTKR2020010123-appb-I000461
질소 분위기하에서 중간체 93 25g, 보론트리아이오다이드 19g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체94을 8.0g 수득하였다 (수율 32%). MS[M+H]+ = 884In a nitrogen atmosphere, 25 g of intermediate 93 and 19 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After completion of the reaction, extraction was performed, and 8.0 g of intermediate 94 was obtained through recrystallization (yield 32%). MS[M+H]+ = 884
3) 화합물62의 합성3) Synthesis of compound 62
Figure PCTKR2020010123-appb-I000462
Figure PCTKR2020010123-appb-I000462
질소 분위기하에서 중간체 94 7g, bis(4-(tert-부틸)페닐)아민 14.5g, 소듐-tert-부톡사이드 9.9g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.3g을 톨루엔 150ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 62을 6.9g 수득하였다. (수율 77%). MS[M+H]+ = 1129In a nitrogen atmosphere, 7 g of intermediate 94, 14.5 g of bis(4-(tert-butyl)phenyl)amine, 9.9 g of sodium-tert-butoxide, 0.3 g of bis(tri-tert-butylphosphine)palladium(0), 150 ml of toluene After putting in, the mixture was stirred under reflux for 2 hours. After extraction after completion of the reaction, 6.9g of compound 62 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 1129
합성예 63. 화합물63의 합성Synthesis Example 63. Synthesis of Compound 63
1) 중간체95의 합성1) Synthesis of Intermediate 95
Figure PCTKR2020010123-appb-I000463
Figure PCTKR2020010123-appb-I000463
질소 분위기하에서 1,3-다이브로모-5-메틸벤젠 30g, 9,9,10,10-테트라메틸-N-(3,5,5,8,8-펜타메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)-9,10-다이하이드로안트라센-2-아민 108g, 소듐-tert-부톡사이드 70g, 비스(트리-tert-부틸포스핀)팔라듐(0) 1.2g을 톨루엔 600ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 95을 88g 수득하였다. (수율 72%). MS[M+H]+ = 10121,3-dibromo-5- methylbenzene 30g, 9,9,10,10-tetramethyl-N-(3,5,5,8,8-pentamethyl-5,6,7,8 under nitrogen atmosphere -Tetrahydronaphthalene-2-yl)-9,10-dihydroanthracene-2-amine 108 g, sodium-tert-butoxide 70 g, bis (tri-tert-butylphosphine) palladium (0) 1.2 g toluene 600 ml After putting in, the mixture was stirred under reflux for 2 hours. After extraction was completed after the reaction was completed, 88 g of intermediate 95 was obtained through recrystallization. (Yield 72%). MS[M+H]+ = 1012
2) 중간체96의 합성2) Synthesis of Intermediate 96
Figure PCTKR2020010123-appb-I000464
Figure PCTKR2020010123-appb-I000464
질소 분위기하에서 중간체 95 25g, 보론트리아이오다이드 16.4g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체96을 7.9g 수득하였다 (수율 31%). MS[M+H]+ = 1020In a nitrogen atmosphere, 25 g of the intermediate 95 and 16.4 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.9 g of intermediate 96 was obtained through recrystallization (yield 31%). MS[M+H]+ = 1020
3) 화합물63의 합성3) Synthesis of compound 63
Figure PCTKR2020010123-appb-I000465
Figure PCTKR2020010123-appb-I000465
질소 분위기하에서 중간체 96 7g, bis(4-(tert-부틸)페닐)아민 1.93g, 소듐-tert-부톡사이드 1.32g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.03g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 63을 6.9g 수득하였다. (수율 79%). MS[M+H]+ = 1265In a nitrogen atmosphere, 7 g of intermediate 96, 1.93 g of bis(4-(tert-butyl)phenyl)amine, 1.32 g of sodium-tert-butoxide, and 0.03 g of bis(tri-tert-butylphosphine)palladium(0) were added to xylene. The mixture was added to 80ml and stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.9g of compound 63 was obtained through recrystallization. (79% yield). MS[M+H]+ = 1265
합성예 64. 화합물64의 합성Synthesis Example 64. Synthesis of Compound 64
1) 화합물64의 합성1) Synthesis of compound 64
Figure PCTKR2020010123-appb-I000466
Figure PCTKR2020010123-appb-I000466
질소 분위기하에서 중간체 58 7g, 4a,9a-다이메틸-2,3,4,4a,9,9a-헥사하이드로-1H-카바졸 1.93g, 소듐-tert-부톡사이드 1.52g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.04g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 64을 6.5g 수득하였다. (수율 78%). MS[M+H]+ = 1061Intermediate 58 7g, 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole 1.93g, sodium-tert-butoxide 1.52g, bis(tri-tert) under nitrogen atmosphere -Butylphosphine)Palladium (0) 0.04 g was added to 80 ml of xylene and stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.5 g of compound 64 was obtained through recrystallization. (Yield 78%). MS[M+H]+ = 1061
합성예 65. 화합물65의 합성Synthesis Example 65. Synthesis of Compound 65
1) 화합물65의 합성1) Synthesis of compound 65
Figure PCTKR2020010123-appb-I000467
Figure PCTKR2020010123-appb-I000467
질소 분위기하에서 중간체 58 7g, 6-(tert-부틸)-4a,9a-다이메틸-2,3,4,4a,9,9a-헥사하이드로-1H-카바졸 2.05g, 소듐-tert-부톡사이드 1.52g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.04g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 65을 6.7g 수득하였다. (수율 77%). MS[M+H]+ = 1117Intermediate 58 7g, 6-(tert-butyl)-4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole 2.05g, sodium-tert-butoxide under nitrogen atmosphere 1.52 g, bis (tri-tert-butylphosphine) palladium (0) 0.04 g was added to 80 ml of xylene and stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.7 g of compound 65 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 1117
합성예 66. 화합물66의 합성Synthesis Example 66. Synthesis of Compound 66
1) 화합물66의 합성1) Synthesis of compound 66
Figure PCTKR2020010123-appb-I000468
Figure PCTKR2020010123-appb-I000468
질소 분위기하에서 중간체 71 7g, 6-(tert-부틸)-4a,9a-다이메틸-2,3,4,4a,9,9a-헥사하이드로-1H-카바졸 2.06g, 소듐-tert-부톡사이드 1.55g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.04g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 66을 6.9g 수득하였다. (수율 79%). MS[M+H]+ = 10977 g of intermediate 71, 6-(tert-butyl)-4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole 2.06 g, sodium-tert-butoxide under nitrogen atmosphere 1.55 g, bis (tri-tert-butylphosphine) palladium (0) 0.04 g was added to 80 ml of xylene and stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 6.9 g of compound 66 was obtained through recrystallization. (79% yield). MS[M+H]+ = 1097
합성예 67. 화합물67의 합성Synthesis Example 67. Synthesis of Compound 67
1) 중간체97의 합성1) Synthesis of Intermediate 97
Figure PCTKR2020010123-appb-I000469
Figure PCTKR2020010123-appb-I000469
질소 분위기하에서 1,3-다이브로모-5-클로로벤젠 30g, N-(5,5,8,8-테트라메틸-5,6,7,8-테트라하이드로나프탈렌-2-yl)다이벤조[b,d]퓨란-4-아민 82g, 소듐-tert-부톡사이드 64g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.6g을 톨루엔 600ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 97을 69g 수득하였다. (수율 73%). MS[M+H]+ = 8481,3-dibromo-5-chlorobenzene 30g, N-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl)dibenzo[b] under a nitrogen atmosphere ,d] 82 g of furan-4-amine, 64 g of sodium-tert-butoxide, and 0.6 g of bis (tri-tert-butylphosphine) palladium (0) were added to 600 ml of toluene, followed by reflux stirring for 2 hours. After extraction after completion of the reaction, 69g of intermediate 97 was obtained through recrystallization. (73% yield). MS[M+H]+ = 848
2) 중간체98의 합성2) Synthesis of Intermediate 98
Figure PCTKR2020010123-appb-I000470
Figure PCTKR2020010123-appb-I000470
질소 분위기하에서 중간체 97 25g, 보론트리아이오다이드 19.6g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체98을 7.2g 수득하였다 (수율 29%). MS[M+H]+ = 856In a nitrogen atmosphere, 25 g of the intermediate 97 and 19.6 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.2 g of intermediate 98 was obtained through recrystallization (29% yield). MS[M+H]+ = 856
3) 화합물67의 합성3) Synthesis of compound 67
Figure PCTKR2020010123-appb-I000471
Figure PCTKR2020010123-appb-I000471
질소 분위기하에서 중간체 98 7g, 6-(tert-부틸)-4a,9a-다이메틸-2,3,4,4a,9,9a-헥사하이드로-1H-카바졸 2.1g, 소듐-tert-부톡사이드 1.6g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.04g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 67을 7.0g 수득하였다. (수율 79%). MS[M+H]+ = 10777 g of intermediate 98 under nitrogen atmosphere, 6-(tert-butyl)-4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole 2.1 g, sodium-tert-butoxide 1.6 g, bis (tri-tert-butylphosphine) palladium (0) 0.04 g was added to 80 ml of xylene and stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 7.0 g of compound 67 was obtained through recrystallization. (79% yield). MS[M+H]+ = 1077
합성예 68. 화합물68의 합성Synthesis Example 68. Synthesis of Compound 68
1) 화합물68의 합성1) Synthesis of compound 68
Figure PCTKR2020010123-appb-I000472
Figure PCTKR2020010123-appb-I000472
질소 분위기하에서 중간체 67 7g, 6-(tert-부틸)-4a,9a-다이메틸-2,3,4,4a,9,9a-헥사하이드로-1H-카바졸 2.31g, 소듐-tert-부톡사이드 1.8g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.05g을 자일렌 80ml에 넣은 후 5시간 동안 환류 교반하였다 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물 68을 7.1g 수득하였다. (수율 79%). MS[M+H]+ = 1001Intermediate 67 7g, 6-(tert-butyl)-4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole 2.31g, sodium-tert-butoxide under nitrogen atmosphere 1.8 g, bis (tri-tert-butylphosphine) palladium (0) 0.05 g was added to 80 ml of xylene and stirred under reflux for 5 hours. After the reaction was completed, extraction was performed, and 7.1 g of compound 68 was obtained through recrystallization. (79% yield). MS[M+H]+ = 1001
합성예 71. 화합물71의 합성Synthesis Example 71. Synthesis of Compound 71
1) 중간체99의 합성1) Synthesis of Intermediate 99
Figure PCTKR2020010123-appb-I000473
Figure PCTKR2020010123-appb-I000473
질소 분위기하에서 N-(5-(tert-부틸)-[1,1'-바이페닐]-2-yl)-N-(3-클로로-5-메틸페닐)-1,1,3,3-테트라메틸-2,3-다이하이드로-1H-인덴-5-아민 30g, bis(4-(tert-butyl)phenyl)amine 16.5g, 소듐-tert-부톡사이드 11.1g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.3g을 톨루엔 450ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 99을 34g 수득하였다. (수율 77%). MS[M+H]+ = 768N-(5-(tert-butyl)-[1,1'-biphenyl]-2-yl)-N-(3-chloro-5-methylphenyl)-1,1,3,3-tetra under nitrogen atmosphere Methyl-2,3-dihydro-1H-inden-5-amine 30g, bis(4-(tert-butyl)phenyl)amine 16.5g, sodium-tert-butoxide 11.1g, bis(tri-tert-butylphos) Pin) Palladium (0) 0.3g was added to 450ml of toluene and stirred under reflux for 2 hours. After the reaction was completed, extraction was performed, and 34 g of intermediate 99 was obtained through recrystallization. (Yield 77%). MS[M+H]+ = 768
2) 화합물71의 합성2) Synthesis of Compound 71
Figure PCTKR2020010123-appb-I000474
Figure PCTKR2020010123-appb-I000474
질소 분위기하에서 중간체 99 25g, 보론트리아이오다이드 21.7g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물71을 7.3g 수득하였다 (수율 29%). MS[M+H]+ = 776In a nitrogen atmosphere, 25 g of intermediate 99 and 21.7 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After extraction after completion of the reaction, 7.3g of compound 71 was obtained through recrystallization (29% yield). MS[M+H]+ = 776
합성예 72. 화합물72의 합성Synthesis Example 72. Synthesis of Compound 72
1) 중간체 100의 합성1) Synthesis of Intermediate 100
Figure PCTKR2020010123-appb-I000475
Figure PCTKR2020010123-appb-I000475
질소 분위기하에서 중간체 1 30g, 3-(tert-butyl)-N-(4-(tert-butyl)phenyl)aniline 15.7g, 소듐-tert-부톡사이드 10.8g, 비스(트리-tert-부틸포스핀)팔라듐(0) 0.3g을 톨루엔 450ml에 넣은 후 2시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 중간체 100을 33g 수득하였다. (수율 76%). MS[M+H]+ = 782Intermediate 1 30g, 3-(tert-butyl)-N-(4-(tert-butyl)phenyl)aniline 15.7g, sodium-tert-butoxide 10.8g, bis(tri-tert-butylphosphine) under nitrogen atmosphere After adding 0.3 g of palladium (0) to 450 ml of toluene, the mixture was stirred under reflux for 2 hours. After the reaction was completed, extraction was performed, and 33 g of the intermediate 100 was obtained through recrystallization. (Yield 76%). MS[M+H]+ = 782
2) 화합물 72의 합성2) Synthesis of compound 72
Figure PCTKR2020010123-appb-I000476
Figure PCTKR2020010123-appb-I000476
질소 분위기하에서 중간체 100 25g, 보론트리아이오다이드 21.3g을 1,2-다이클로로벤젠 250ml에 넣은 후 160OC 4시간 교반하였다. 반응 종료 후 추출한 뒤, 재결정을 통하여 화합물72을 7.5g 수득하였다 (수율 30%). MS[M+H]+ = 790In a nitrogen atmosphere, 25 g of the intermediate 100 and 21.3 g of boron triiodide were added to 250 ml of 1,2-dichlorobenzene, followed by stirring at 160 O C for 4 hours. After the reaction was completed, extraction was performed, and 7.5 g of compound 72 was obtained through recrystallization (yield 30%). MS[M+H]+ = 790
전술한 합성예와 같은 방법을 이용하여 다양한 치환기를 도입함으로써, 전술한 화합물 외에도, 상기 화학식 100으로 표시되는 화합물을 합성할 수 있다.By introducing various substituents using the same method as in the above synthesis example, in addition to the above compound, a compound represented by Chemical Formula 100 may be synthesized.
<실험예 1> 소자예<Experimental Example 1> Device Example
실시예 1-1Example 1-1
ITO(indium tin oxide)가 1,400Å의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척 하였다. 이 때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀리포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용하였다. ITO를 30분간 세척한 후, 증류수로 2회 반복하여 초음파 세척을 10분간 진행하였다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 메탄올의 용제로 초음파 세척을 하고 건조시킨 후, 플라즈마 세정기로 수송시켰다. 또한, 산소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다.A glass substrate coated with a thin film of ITO (indium tin oxide) to a thickness of 1,400Å was put in distilled water dissolved in a detergent and washed with ultrasonic waves. In this case, Fischer Co. product was used as a detergent, and distilled water secondarily filtered with a filter made by Millipore Co. was used as distilled water. After washing the ITO for 30 minutes, ultrasonic washing was performed for 10 minutes by repeating twice with distilled water. After washing with distilled water, ultrasonic cleaning was performed with a solvent of isopropyl alcohol, acetone, and methanol, dried, and then transported to a plasma cleaner. In addition, after cleaning the substrate for 5 minutes using oxygen plasma, the substrate was transported to a vacuum evaporator.
상기와 같이 준비된 ITO 투명 전극 위에 하기 HI-A와 HAT-CN을 각각 650 Å, 50 Å의 두께로 열 진공증착하여 제1 및 제2 정공주입층을 형성하였다. 상기 정공 주입층 위에 하기 HT-A를 600 Å의 두께로 진공 증착하여 정공수송층을 형성하였다. 상기 정공수송층 위에 하기 HT-B를 50 Å의 두께로 진공 증착하여 전자차단층을 형성하였다. 이어서, 상기 전자차단층 위에 청색 발광 도펀트로 본 발명의 화합물 1을 발광층 100 중량부 기준으로 4 중량부, 호스트로 하기 BH 를 200Å의 두께로 진공 증착하여 발광층을 형성하였다. 그 다음에 상기 발광층 위에 제1 전자수송층으로 하기 화합물 ET-A 50Å을 진공 증착하고, 연이어 하기 ET-B 및 LiQ 를 1:1 중량비로 진공증착하여 360Å의 두께로 제2 전자수송층을 형성하였다. 상기 제2 전자수송층 위에 LiQ를 진공 증착하여 5Å의 두께로 진공증착하여 전자주입층을 형성하였다. 상기 전자주입층 위에 220Å 두께로 알루미늄과 은을 10:1의 중량비로 증착하고 그 위에 알루미늄을 1000Å 두께로 증착하여 음극을 형성하였다.First and second hole injection layers were formed by thermal vacuum deposition of the following HI-A and HAT-CN to a thickness of 650 Å and 50 Å, respectively, on the ITO transparent electrode prepared as described above. On the hole injection layer, the following HT-A was vacuum deposited to a thickness of 600 Å to form a hole transport layer. On the hole transport layer, the following HT-B was vacuum deposited to a thickness of 50 Å to form an electron blocking layer. Subsequently, a light emitting layer was formed by vacuum depositing 4 parts by weight of Compound 1 of the present invention as a blue light emitting dopant on the electron blocking layer to a thickness of 200 Å as a host and 4 parts by weight of the compound 1 based on 100 parts by weight of the emission layer. Then, 50 Å of the following compound ET-A was vacuum-deposited on the light-emitting layer as a first electron transport layer, and subsequently ET-B and LiQ were vacuum-deposited at a 1:1 weight ratio to form a second electron transport layer having a thickness of 360 Å. LiQ was vacuum deposited on the second electron transport layer to form an electron injection layer by vacuum deposition to a thickness of 5 Å. A cathode was formed by depositing aluminum and silver at a thickness of 220 Å on the electron injection layer at a weight ratio of 10:1, and depositing aluminum to a thickness of 1000 Å thereon.
상기의 과정에서 유기물의 증착속도는 0.4 ~ 0.9 Å/sec를 유지하였고, 음극의 알루미늄은 2 Å/sec의 증착 속도를 유지하였으며, 증착시 진공도는 1 Х 10-7 ~ 5 Х 10-8 torr를 유지하여, 유기 발광 소자를 제작하였다In the above process, the deposition rate of organic materials was maintained at 0.4 ~ 0.9 Å/sec, and the deposition rate of aluminum at the cathode was maintained at 2 Å/sec, and the vacuum degree during deposition was 1 Х 10 -7 ~ 5 Х 10 -8 torr. To prepare an organic light emitting device
Figure PCTKR2020010123-appb-I000477
Figure PCTKR2020010123-appb-I000477
실시예 1-2 내지 1-6, 1-8 내지 1-23, 1-25 내지 1-27 및 1-29 내지 1-68Examples 1-2 to 1-6, 1-8 to 1-23, 1-25 to 1-27 and 1-29 to 1-68
상기 실시예 1-1에서 발광층의 도펀트를 하기 표 1에 기재된 화합물로 한 것을 제외하고 실시예 1-1와 동일한 방법으로 소자를 제작하였다.A device was fabricated in the same manner as in Example 1-1, except that the dopant of the light emitting layer in Example 1-1 was used as the compound shown in Table 1 below.
Figure PCTKR2020010123-appb-I000478
Figure PCTKR2020010123-appb-I000478
Figure PCTKR2020010123-appb-I000479
Figure PCTKR2020010123-appb-I000479
Figure PCTKR2020010123-appb-I000480
Figure PCTKR2020010123-appb-I000480
Figure PCTKR2020010123-appb-I000481
Figure PCTKR2020010123-appb-I000481
비교예 1-1 및 1-2Comparative Examples 1-1 and 1-2
상기 실시예 1-1에서 발광층의 도펀트를 하기 표 1에 기재된 화합물로 한 것을 제외하고 실시예 1-1와 동일한 방법으로 소자를 제작하였다.A device was fabricated in the same manner as in Example 1-1, except that the dopant of the light emitting layer in Example 1-1 was used as the compound shown in Table 1 below.
Figure PCTKR2020010123-appb-I000482
Figure PCTKR2020010123-appb-I000482
상기 실시예 및 비교예에서 제작한 유기 발광 소자의 10 mA/㎠의 전류밀도에서의 효율, 수명 및 색좌표(1931 CIE color coordinate 기준)를 측정하여, 그 결과를 하기 표 1에 나타내었다. The efficiency, lifetime, and color coordinates (based on 1931 CIE color coordinates) at a current density of 10 mA/cm 2 of the organic light emitting devices fabricated in the above Examples and Comparative Examples were measured, and the results are shown in Table 1 below.
도펀트 물질Dopant material 효율(cd/A)Efficiency (cd/A) 색좌표Color coordinates 수명life span
CIE (x)CIE (x) CIE (y)CIE (y) T95(hr)T95(hr)
실시예 1-1 Example 1-1 화합물 1Compound 1 9.129.12 0.150.15 0.050.05 271271
실시예 1-2 Example 1-2 화합물 2Compound 2 9.129.12 0.150.15 0.050.05 272272
실시예 1-3 Example 1-3 화합물 3Compound 3 9.249.24 0.140.14 0.050.05 283283
실시예 1-4 Example 1-4 화합물 4Compound 4 9.289.28 0.150.15 0.050.05 285285
실시예 1-5 Example 1-5 화합물 5Compound 5 9.299.29 0.150.15 0.050.05 282282
실시예 1-6 Example 1-6 화합물 6Compound 6 9.299.29 0.150.15 0.050.05 284284
실시예 1-8 Example 1-8 화합물 8Compound 8 9.149.14 0.140.14 0.050.05 273273
실시예 1-9 Example 1-9 화합물 9Compound 9 9.269.26 0.140.14 0.050.05 284284
실시예 1-10 Example 1-10 화합물 10Compound 10 9.459.45 0.150.15 0.060.06 291291
실시예 1-11 Example 1-11 화합물 11Compound 11 9.449.44 0.150.15 0.060.06 292292
실시예 1-12 Example 1-12 화합물 12Compound 12 9.459.45 0.150.15 0.060.06 289289
실시예 1-13 Example 1-13 화합물 13Compound 13 9.459.45 0.150.15 0.050.05 291291
실시예 1-14 Example 1-14 화합물 14Compound 14 9.49.4 0.150.15 0.050.05 292292
실시예 1-15 Example 1-15 화합물 15Compound 15 9.779.77 0.140.14 0.050.05 294294
실시예 1-16 Example 1-16 화합물 16Compound 16 9.779.77 0.140.14 0.050.05 292292
실시예 1-17 Example 1-17 화합물 17Compound 17 9.159.15 0.150.15 0.060.06 274274
실시예 1-18 Example 1-18 화합물 18Compound 18 9.159.15 0.150.15 0.060.06 272272
실시예 1-19 Example 1-19 화합물 19Compound 19 9.169.16 0.150.15 0.060.06 273273
실시예 1-20 Example 1-20 화합물 20Compound 20 9.159.15 0.150.15 0.060.06 275275
실시예 1-21 Example 1-21 화합물 21Compound 21 9.159.15 0.150.15 0.060.06 276276
실시예 1-22 Example 1-22 화합물 22Compound 22 9.299.29 0.150.15 0.060.06 283283
실시예 1-23 Example 1-23 화합물 23Compound 23 9.519.51 0.150.15 0.060.06 289289
실시예 1-25 Example 1-25 화합물 25Compound 25 9.489.48 0.150.15 0.060.06 291291
실시예 1-26 Example 1-26 화합물 26Compound 26 9.199.19 0.140.14 0.050.05 277277
실시예 1-27 Example 1-27 화합물 27Compound 27 9.29.2 0.140.14 0.050.05 280280
실시예 1-29 Example 1-29 화합물 29Compound 29 9.349.34 0.140.14 0.050.05 281281
실시예 1-30 Example 1-30 화합물 30Compound 30 9.339.33 0.140.14 0.050.05 283283
실시예 1-31 Example 1-31 화합물 31Compound 31 9.319.31 0.150.15 0.060.06 281281
실시예 1-32 Example 1-32 화합물 32Compound 32 9.339.33 0.140.14 0.050.05 280280
실시예 1-33 Example 1-33 화합물 33Compound 33 9.339.33 0.140.14 0.050.05 281281
실시예 1-34 Example 1-34 화합물 34Compound 34 9.329.32 0.140.14 0.050.05 280280
실시예 1-35 Example 1-35 화합물 35Compound 35 9.489.48 0.150.15 0.050.05 290290
실시예 1-36 Example 1-36 화합물 36Compound 36 9.819.81 0.150.15 0.050.05 290290
실시예 1-37 Example 1-37 화합물 37Compound 37 9.839.83 0.150.15 0.050.05 289289
실시예 1-38 Example 1-38 화합물 38Compound 38 9.59.5 0.150.15 0.060.06 285285
실시예 1-39 Example 1-39 화합물 39Compound 39 9.499.49 0.150.15 0.060.06 287287
실시예 1-40 Example 1-40 화합물 40Compound 40 9.59.5 0.150.15 0.060.06 285285
실시예 1-41 Example 1-41 화합물 41Compound 41 9.59.5 0.150.15 0.060.06 286286
실시예 1-42 Example 1-42 화합물 42Compound 42 9.59.5 0.150.15 0.060.06 282282
실시예 1-43 Example 1-43 화합물 43Compound 43 9.59.5 0.150.15 0.060.06 284284
실시예 1-44 Example 1-44 화합물 44Compound 44 9.319.31 0.150.15 0.060.06 280280
실시예 1-45 Example 1-45 화합물 45Compound 45 9.299.29 0.150.15 0.050.05 281281
실시예 1-46 Example 1-46 화합물 46Compound 46 9.39.3 0.150.15 0.050.05 280280
실시예 1-47 Example 1-47 화합물 47Compound 47 9.469.46 0.150.15 0.050.05 288288
실시예 1-48 Example 1-48 화합물 48Compound 48 9.459.45 0.150.15 0.050.05 286286
실시예 1-49 Example 1-49 화합물 49Compound 49 9.789.78 0.140.14 0.050.05 290290
실시예 1-50 Example 1-50 화합물 50Compound 50 9.169.16 0.150.15 0.060.06 274274
실시예 1-51 Example 1-51 화합물 51Compound 51 9.149.14 0.150.15 0.060.06 275275
실시예 1-52 Example 1-52 화합물 52Compound 52 9.439.43 0.150.15 0.050.05 284284
실시예 1-53 Example 1-53 화합물 53Compound 53 9.759.75 0.140.14 0.050.05 293293
실시예 1-54 Example 1-54 화합물 54Compound 54 9.39.3 0.150.15 0.050.05 283283
실시예 1-55 Example 1-55 화합물 55Compound 55 9.319.31 0.150.15 0.060.06 285285
실시예 1-56 Example 1-56 화합물 56Compound 56 9.39.3 0.150.15 0.060.06 284284
실시예 1-57 Example 1-57 화합물 57Compound 57 9.319.31 0.150.15 0.060.06 284284
실시예 1-58 Example 1-58 화합물 58Compound 58 9.339.33 0.150.15 0.050.05 283283
실시예 1-59 Example 1-59 화합물 59Compound 59 9.899.89 0.150.15 0.050.05 290290
실시예 1-60 Examples 1-60 화합물 60Compound 60 9.159.15 0.150.15 0.050.05 274274
실시예 1-61 Example 1-61 화합물 61Compound 61 9.479.47 0.150.15 0.060.06 290290
실시예 1-62 Example 1-62 화합물 62Compound 62 9.319.31 0.150.15 0.060.06 285285
실시예 1-63 Example 1-63 화합물 63Compound 63 9.869.86 0.150.15 0.050.05 289289
실시예 1-64Example 1-64 화합물 64Compound 64 9.859.85 0.150.15 0.050.05 295295
실시예 1-65Example 1-65 화합물 65Compound 65 9.889.88 0.150.15 0.050.05 294294
실시예 1-66Example 1-66 화합물 66Compound 66 9.489.48 0.150.15 0.050.05 291291
실시예 1-67Example 1-67 화합물 67Compound 67 9.399.39 0.140.14 0.050.05 290290
실시예 1-68Example 1-68 화합물 68Compound 68 9.349.34 0.150.15 0.050.05 288288
비교예 1-1Comparative Example 1-1 화합물 BD1Compound BD1 7.547.54 0.150.15 0.050.05 240240
비교예 1-2Comparative Example 1-2 화합물 BD2Compound BD2 7.837.83 0.150.15 0.050.05 245245
상기 표 1에서 확인할 수 있듯이, 화학식 100으로 표시되는 화합물을 유기 발광 소자의 발광층 도펀트로 사용하는 경우, 소자의 효율 및 수명이 상승하는 것을 알 수 있다.As can be seen in Table 1, when the compound represented by Chemical Formula 100 is used as a dopant for an emission layer of an organic light-emitting device, it can be seen that the efficiency and lifetime of the device are increased.
<실험예 2> MD 계산 (Host-dopant system에서의 분자간의 거리계산)<Experimental Example 2> MD calculation (Calculation of distance between molecules in Host-dopant system)
실시예 2-1Example 2-1
화합물 1(도펀트) 및 화합물 BH(호스트)가 5 : 95 중량비로 포함된 시스템을 구현하였다. 구체적으로, OPLS3e force field를 이용하여 분자 300개(호스트 95%, 도펀트 5%의 비율), 온도 300K, 시뮬레이션 시간(simulation time) 3ns으로 설정하고, NVT 및 NPT 계산을 통해 Molecular Dynamics(분자동역학) 계산하여 도핑되어 있는 소자의 환경을 계산화학적으로 구현하였다. A system containing compound 1 (dopant) and compound BH (host) in a weight ratio of 5:95 was implemented. Specifically, using the OPLS3e force field, set 300 molecules (host 95%, dopant 5% ratio), temperature 300K, simulation time 3ns, and calculate NVT and NPT as Molecular Dynamics. By calculation, the environment of the doped device was calculated and chemically implemented.
실시예 2-2 내지 2-5Examples 2-2 to 2-5
상기 실시예 2-1에서 화합물 1 대신 하기 표 2에 기재된 도펀트를 사용한 것을 제외하고는 실시예 2-1과 동일한 방법으로 분자 시스템을 계산하였다.A molecular system was calculated in the same manner as in Example 2-1, except that the dopant shown in Table 2 below was used instead of Compound 1 in Example 2-1.
Figure PCTKR2020010123-appb-I000483
Figure PCTKR2020010123-appb-I000483
비교예 2-1 및 2-2Comparative Examples 2-1 and 2-2
상기 실시예 1에서 화합물 1 대신 하기 표 2에 기재된 도펀트를 사용한 것을 제외하고는 실시예 2-1과 동일한 방법으로 분자 시스템을 계산하였다.A molecular system was calculated in the same manner as in Example 2-1, except that the dopant shown in Table 2 below was used instead of Compound 1 in Example 1.
Figure PCTKR2020010123-appb-I000484
Figure PCTKR2020010123-appb-I000484
구현된 분자 모형은 도 3 내지 도 9에 나타내었다. 도 3 내지 7은 각각 실시예 2-1 내지 2-5의 시스템을 도시한 것이며, 도 8 및 9는 비교예 2-1 및 2-2의 시스템을 도시한 것이다. 이 때의 전체 밀도 및 서로 다른 분자 간의 평균 거리를 계산한 값을 하기 표 2에 나타내었다.The implemented molecular model is shown in FIGS. 3 to 9. 3 to 7 show the systems of Examples 2-1 to 2-5, respectively, and FIGS. 8 and 9 show the systems of Comparative Examples 2-1 and 2-2. The values obtained by calculating the total density and the average distance between different molecules at this time are shown in Table 2 below.
도펀트 Dopant 전체 밀도Density(g/cm3)Overall Density(g/cm 3 ) 분자간 평균 거리Radial(Å)Average distance between molecules Radial (Å)
실시예 2-1Example 2-1 화합물 1 Compound 1 1.0931.093 15.2015.20
실시예 2-2Example 2-2 화합물 10 Compound 10 1.0901.090 15.4715.47
실시예 2-3Example 2-3 화합물 59Compound 59 1.071.07 15.7715.77
실시예 2-4Example 2-4 화합물 71Compound 71 1.0861.086 15.2415.24
실시예 2-5Example 2-5 화합물 72Compound 72 1.0921.092 15.3215.32
비교예 2-1Comparative Example 2-1 화합물 BD1Compound BD1 1.121.12 14.714.7
비교예 2-2Comparative Example 2-2 화합물 BD2Compound BD2 1.0941.094 15.115.1
상기 표 2 및 도 3 내지 9를 보면, 지방족 탄화수소고리가 메틸기로 치환될수록 호스트와 도펀트 사이의 거리가 더 멀어지는걸 확인할 수 있고, 전체적인 밀도가 감소하는 것을 확인할 수 있다. 한 공간내 물질이 밀집될 시 분자간 덱스터 전이가 일어나게 되어 효율이 줄어든다. 본 발명의 실시예 2-1 내지 2-5와 같이, 메틸기로 치환된 지방족 탄화수소고리를 포함하는 경우, 분자간 거리가 멀어지고, 밀집도가 줄어들게 되면서 소자의 효율이 상승하고, 불필요한 전자 및 정공의 주입이 줄어들어 소자의 수명 또한 향상된다.Referring to Table 2 and FIGS. 3 to 9, it can be seen that as the aliphatic hydrocarbon ring is substituted with a methyl group, the distance between the host and the dopant increases, and the overall density decreases. When substances in a space are concentrated, dexter transfer between molecules occurs, reducing efficiency. In the case of including an aliphatic hydrocarbon ring substituted with a methyl group, as in Examples 2-1 to 2-5 of the present invention, the distance between molecules increases and the density decreases, increasing the efficiency of the device, and injection of unnecessary electrons and holes This decreases, thus improving the life of the device.

Claims (12)

  1. 하기 화학식 100으로 표시되는 다환 화합물:Polycyclic compound represented by the following formula 100:
    [화학식 100][Chemical Formula 100]
    Figure PCTKR2020010123-appb-I000485
    Figure PCTKR2020010123-appb-I000485
    상기 화학식 100에 있어서, In Formula 100,
    R1 및 R301은 서로 같거나 상이하고, 각각 독립적으로, 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R1 and R301 are the same as or different from each other, and each independently deuterium; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    x101은 1 또는 2이고,x101 is 1 or 2,
    Cy3 및 Cy4는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 방향족 탄화수소고리; 치환 또는 비치환된 지방족 탄화수소고리; 및 치환 또는 비치환된 방향족 헤테로고리로 이루어진 군에서 선택된 하나이거나, 상기 군에서 선택된 2 이상의 고리가 축합된 고리이고,Cy3 and Cy4 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
    R302은 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R302 is hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    n1는 1 내지 3의 정수이고, n301는 1 내지 4의 정수이고, n302는 0 내지 10의 정수이고,n1 is an integer of 1 to 3, n301 is an integer of 1 to 4, n302 is an integer of 0 to 10,
    n1, n301 및 n302가 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하고,When n1, n301 and n302 are each 2 or more, the substituents in parentheses are the same as or different from each other,
    상기 Cy3 및 Cy4 중 적어도 하나는 하기 화학식 A-1 내지 A-3에서 선택된 하나이고,At least one of Cy3 and Cy4 is one selected from Formulas A-1 to A-3,
    Figure PCTKR2020010123-appb-I000486
    Figure PCTKR2020010123-appb-I000486
    상기 화학식 A-1 내지 A-3에 있어서,In the formulas A-1 to A-3,
    점선은 화학식 100에 연결되는 위치이며,The dotted line is the position connected to Formula 100,
    Q1은 O; S; 또는 C(R118)(R119)이고,Q1 is O; S; Or C(R118)(R119),
    R101 내지 R104, R118 및 R119는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R101 to R104, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    x11은 1 또는 2이고, x11 is 1 or 2,
    n101은 0 내지 7의 정수이고, n102는 0 내지 11의 정수이고, n103은 0 내지 4의 정수이고, n104는 0 내지 5의 정수이고,n101 is an integer from 0 to 7, n102 is an integer from 0 to 11, n103 is an integer from 0 to 4, n104 is an integer from 0 to 5,
    n101 내지 n104이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하고,When n101 to n104 are each 2 or more, the substituents in parentheses are the same as or different from each other,
    상기 화학식 100에 포함된 지방족 고리 중 1 이상은 하기 구조에서 선택되고,At least one of the aliphatic rings contained in Formula 100 is selected from the following structures,
    Figure PCTKR2020010123-appb-I000487
    Figure PCTKR2020010123-appb-I000487
    상기 구조에 있어서,In the above structure,
    점선 이중선은 축합되는 위치이고, The dotted double line is the condensed position,
    R105 내지 R114는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 알킬기이고,R105 to R114 are the same as or different from each other, and each independently, a substituted or unsubstituted alkyl group,
    R115 내지 R117는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R115 to R117 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    n115은 0 내지 2의 정수이고, n116 및 n117은 각각 0 내지 4의 정수이고, n115 is an integer of 0 to 2, n116 and n117 are each an integer of 0 to 4,
    n115 내지 n117이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n115 to n117 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  2. 청구항 1에 있어서, 상기 화학식 100은 하기 화학식 1 내지 3 중 어느 하나로 표시되는 다환 화합물:The method of claim 1, wherein the formula 100 is a polycyclic compound represented by any one of the following formulas 1 to 3:
    [화학식 1][Formula 1]
    Figure PCTKR2020010123-appb-I000488
    Figure PCTKR2020010123-appb-I000488
    [화학식 2][Formula 2]
    Figure PCTKR2020010123-appb-I000489
    Figure PCTKR2020010123-appb-I000489
    [화학식 3][Formula 3]
    Figure PCTKR2020010123-appb-I000490
    Figure PCTKR2020010123-appb-I000490
    상기 화학식 1 내지 3에 있어서,In Formulas 1 to 3,
    R1, Cy3, Cy4 및 n1은 상기 화학식 100에서 정의한 바와 같고,R1, Cy3, Cy4 and n1 are as defined in Chemical Formula 100,
    R3 및 R4는 서로 같거나 상이하고, 각각 독립적으로, 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R3 and R4 are the same as or different from each other, and each independently, deuterium; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    R2, R5, R6, 및 R8은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R2, R5, R6, and R8 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    n3 및 n4는 각각 1 내지 4의 정수이고, n2, n5 및 n6은 각각 0 내지 10의 정수이고, n8은 0 내지 8의 정수이고,n3 and n4 are each an integer of 1 to 4, n2, n5 and n6 are each an integer of 0 to 10, n8 is an integer of 0 to 8,
    n2 내지 n6 및 n8이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n2 to n6 and n8 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  3. 청구항 1에 있어서, Cy3 및 Cy4는 서로 같거나 상이하고, 각각 독립적으로, 하기 그룹 A-11 내지 A-14에서 선택되고, Cy3 및 Cy4 중 적어도 하나는 하기 그룹 A-11 내지 A-13 에서 선택된 것인 다환 화합물:The method according to claim 1, Cy3 and Cy4 are the same as or different from each other, each independently, is selected from the following groups A-11 to A-14, At least one of Cy3 and Cy4 is selected from the following groups A-11 to A-13 Polycyclic compound:
    [그룹 A-11][Group A-11]
    Figure PCTKR2020010123-appb-I000491
    Figure PCTKR2020010123-appb-I000491
    [그룹 A-12][Group A-12]
    Figure PCTKR2020010123-appb-I000492
    Figure PCTKR2020010123-appb-I000492
    [그룹 A-13][Group A-13]
    Figure PCTKR2020010123-appb-I000493
    Figure PCTKR2020010123-appb-I000493
    [그룹 A-14][Group A-14]
    Figure PCTKR2020010123-appb-I000494
    Figure PCTKR2020010123-appb-I000494
    상기 그룹 A-11 내지 A-14에 있어서,In the above groups A-11 to A-14,
    점선은 화학식 100에 연결되는 위치이며,The dotted line is the position connected to Formula 100,
    Q1은 O; S; 또는 C(R118)(R119)이고,Q1 is O; S; Or C(R118)(R119),
    R41 내지 R44, R46 내지 R50, R53 내지 R55, R118 및 R119는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R41 to R44, R46 to R50, R53 to R55, R118 and R119 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    R45, R51 및 R52는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 또는 치환 또는 비치환된 알킬기이고,R45, R51 and R52 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group,
    n41, n43 및 n44는 각각 0 내지 7의 정수이고, n42, n49 및 n50은 각각 0 내지 5의 정수이고, n41, n43 and n44 are each an integer of 0 to 7, n42, n49 and n50 are each an integer of 0 to 5,
    n41 내지 n44, n49 및 n50이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n41 to n44, n49 and n50 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  4. 청구항 1에 있어서, The method according to claim 1,
    상기 화학식 100은 하기 화학식 101 내지 109 중 어느 하나로 표시되는 것인 다환 화합물:Formula 100 is a polycyclic compound represented by any one of the following Formulas 101 to 109:
    [화학식 101][Formula 101]
    Figure PCTKR2020010123-appb-I000495
    Figure PCTKR2020010123-appb-I000495
    [화학식 102][Formula 102]
    Figure PCTKR2020010123-appb-I000496
    Figure PCTKR2020010123-appb-I000496
    [화학식 103][Chemical Formula 103]
    Figure PCTKR2020010123-appb-I000497
    Figure PCTKR2020010123-appb-I000497
    [화학식 104][Formula 104]
    Figure PCTKR2020010123-appb-I000498
    Figure PCTKR2020010123-appb-I000498
    [화학식 105][Chemical Formula 105]
    Figure PCTKR2020010123-appb-I000499
    Figure PCTKR2020010123-appb-I000499
    [화학식 106][Chemical Formula 106]
    Figure PCTKR2020010123-appb-I000500
    Figure PCTKR2020010123-appb-I000500
    [화학식 107][Chemical Formula 107]
    Figure PCTKR2020010123-appb-I000501
    Figure PCTKR2020010123-appb-I000501
    [화학식 108][Formula 108]
    Figure PCTKR2020010123-appb-I000502
    Figure PCTKR2020010123-appb-I000502
    [화학식 109][Formula 109]
    Figure PCTKR2020010123-appb-I000503
    Figure PCTKR2020010123-appb-I000503
    상기 화학식 101 내지 109에 있어서,In Formulas 101 to 109,
    Cy3 및 Cy4는 상기 화학식 100에서 정의한 바와 같고,Cy3 and Cy4 are as defined in Chemical Formula 100,
    R22, R31, G1, G2 및 Y1 내지 Y6은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R22, R31, G1, G2 and Y1 to Y6 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    R21은 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
    G1 및 G2 중 적어도 하나는 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,At least one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
    n22 및 n31은 각각 0 내지 2의 정수이고, y1 및 y5은 각각 0 내지 4의 정수이고, y2 내지 y4 및 y6은 각각 0 내지 6의 정수이고,n22 and n31 are each an integer of 0 to 2, y1 and y5 are each an integer of 0 to 4, y2 to y4 and y6 are each an integer of 0 to 6,
    n22, n31 및 y1 내지 y6가 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하다.When n22, n31 and y1 to y6 are each 2 or more, the substituents in parentheses are the same as or different from each other.
  5. 청구항 1에 있어서, The method according to claim 1,
    상기 화학식 100은 하기 화학식 201 내지 209 중 어느 하나로 표시되는 것인 다환 화합물:Formula 100 is a polycyclic compound represented by any one of the following Formulas 201 to 209:
    [화학식 201][Formula 201]
    Figure PCTKR2020010123-appb-I000504
    Figure PCTKR2020010123-appb-I000504
    [화학식 202][Formula 202]
    Figure PCTKR2020010123-appb-I000505
    Figure PCTKR2020010123-appb-I000505
    [화학식 203][Formula 203]
    Figure PCTKR2020010123-appb-I000506
    Figure PCTKR2020010123-appb-I000506
    [화학식 204][Formula 204]
    Figure PCTKR2020010123-appb-I000507
    Figure PCTKR2020010123-appb-I000507
    [화학식 205][Formula 205]
    Figure PCTKR2020010123-appb-I000508
    Figure PCTKR2020010123-appb-I000508
    [화학식 206][Formula 206]
    Figure PCTKR2020010123-appb-I000509
    Figure PCTKR2020010123-appb-I000509
    [화학식 207][Formula 207]
    Figure PCTKR2020010123-appb-I000510
    Figure PCTKR2020010123-appb-I000510
    [화학식 208][Chemical Formula 208]
    Figure PCTKR2020010123-appb-I000511
    Figure PCTKR2020010123-appb-I000511
    [화학식 209][Chemical Formula 209]
    Figure PCTKR2020010123-appb-I000512
    Figure PCTKR2020010123-appb-I000512
    상기 화학식 201 내지 209에 있어서,In Formulas 201 to 209,
    Q1는 상기 화학식 100에서 정의한 바와 같고,Q1 is as defined in Chemical Formula 100,
    Cy5 내지 Cy7은 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 방향족 탄화수소고리; 치환 또는 비치환된 지방족 탄화수소고리; 및 치환 또는 비치환된 방향족 헤테로고리로 이루어진 군에서 선택된 하나이거나, 상기 군에서 선택된 2 이상의 고리가 축합된 고리이고,Cy5 to Cy7 are the same as or different from each other, and each independently, a substituted or unsubstituted aromatic hydrocarbon ring; A substituted or unsubstituted aliphatic hydrocarbon ring; And one selected from the group consisting of a substituted or unsubstituted aromatic heterocycle, or a ring in which two or more rings selected from the group are fused,
    R22, R31 내지 R38, G1 및 G2는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 니트릴기; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고, R22, R31 to R38, G1 and G2 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Nitrile group; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted silyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    R21은 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,R21 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
    G1 및 G2 중 적어도 하나는 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이고,At least one of G1 and G2 is a substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; A substituted or unsubstituted heterocyclic group; Or a substituted or unsubstituted amine group,
    x1 내지 x3은 각각 1 또는 2이고,x1 to x3 are each 1 or 2,
    n22, n31, n36 및 n37은 각각 0 내지 2의 정수이고, n32 및 n35는 각각 0 내지 4의 정수이고, n33은 0 내지 5의 정수이고, n34 및 n38은 각각 0 내지 3의 정수이고,n22, n31, n36 and n37 are each an integer of 0 to 2, n32 and n35 are each an integer of 0 to 4, n33 is an integer of 0 to 5, n34 and n38 are each an integer of 0 to 3,
    n22 및 n31 내지 n38이 각각 2 이상일 때, 괄호 내의 치환기는 서로 같거나 상이하고,When n22 and n31 to n38 are each 2 or more, the substituents in parentheses are the same as or different from each other,
    Cy11 내지 Cy13은 서로 같거나 상이하고, 각각 독립적으로, 하기 구조에서 선택되고,Cy11 to Cy13 are the same as or different from each other, and each independently, is selected from the following structures,
    Figure PCTKR2020010123-appb-I000513
    Figure PCTKR2020010123-appb-I000513
    상기 구조에 있어서,In the above structure,
    점선 이중선은 축합되는 위치이고,The dotted double line is the condensed position,
    R121 내지 R123은 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하고,R121 to R123 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; A substituted or unsubstituted alkyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group, or bonded to each other with an adjacent substituent to form a substituted or unsubstituted ring,
    n121은 0 내지 2의 정수이고, n122 및 n123은 각각 0 내지 4의 정수이고, n121 내지 n123이 각각 2 이상일 때. 괄호 내의 치환기는 서로 같거나 상이하다.n121 is an integer of 0 to 2, n122 and n123 are each an integer of 0 to 4, when n121 to n123 are each 2 or more. The substituents in parentheses are the same as or different from each other.
  6. 청구항 1에 있어서, The method according to claim 1,
    R1은 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴아민기; 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 60의 아릴헤테로아릴아민기; 또는 하기 화학식 Het1인 것인 다환 화합물:R1 is an alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Arylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Arylheteroarylamine group having 6 to 60 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group; Or a polycyclic compound of the formula Het1:
    [화학식 Het1][Chemical Formula Het1]
    Figure PCTKR2020010123-appb-I000514
    Figure PCTKR2020010123-appb-I000514
    상기 화학식 Het1에 있어서,In the formula Het1,
    점선은 화학식 100에 연결되는 위치이고,The dotted line is the position connected to Chemical Formula 100,
    R203 내지 R205는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 중수소 및 탄소수 1 내지 10의 알킬기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이고,R203 to R205 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; An alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Or an aryl group having 6 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of deuterium and an alkyl group having 1 to 10 carbon atoms or a substituent connected with two or more groups selected from the group,
    n205는 0 내지 12의 정수이고, n205가 2 이상일 때 R205는 서로 같거나 상이하다.n205 is an integer from 0 to 12, and when n205 is 2 or more, R205 is the same as or different from each other.
  7. 청구항 4에 있어서, The method of claim 4,
    G1 및 G2 중 어느 하나는 중수소 또는 탄소수 6 내지 20의 아릴기로 치환 또는 비치환된 탄소수 1 내지 6의 알킬기; 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기; 탄소수 1 내지 6의 알킬기, 탄소수 6 내지 20의 아릴기 또는 탄소수 7 내지 30의 알킬아릴기로 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기; 또는 -N(R211)(R121)이고, 다른 하나는 수소 또는 중수소이고,Any one of G1 and G2 is an alkyl group having 1 to 6 carbon atoms unsubstituted or substituted with deuterium or an aryl group having 6 to 20 carbon atoms; An aryl group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms; A C6-C20 heterocyclic group substituted or unsubstituted with a C1-C6 alkyl group, a C6-C20 aryl group, or a C7-C30 alkylaryl group; Or -N(R211)(R121), and the other is hydrogen or deuterium,
    Cy3 및 Cy4 중 적어도 하나는 상기 화학식 A-1 내지 A-3에서 선택되고, 나머지는 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 6 내지 30의 방향족 탄화수소고리이고,At least one of Cy3 and Cy4 is selected from Formulas A-1 to A-3, and the rest are at least one substituent selected from the group consisting of deuterium, an alkyl group having 1 to 10 carbon atoms, and an aryl group having 6 to 30 carbon atoms or selected from the group. It is an aromatic hydrocarbon ring having 6 to 30 carbon atoms substituted or unsubstituted with a substituent connected to two or more groups,
    R21은 중수소로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 중수소, 탄소수 1 내지 10의 알킬기 및 탄소수 6 내지 30의 아릴기로 이루어진 군에서 선택된 1 이상의 치환기 또는 상기 군에서 선택된 2 이상의 기가 연결된 치환기로 치환 또는 비치환된 탄소수 2 내지 30의 N함유 헤테로고리기; 또는 -N(R211)(R121)이고,R21 is an alkyl group having 1 to 10 carbon atoms unsubstituted or substituted with deuterium; Deuterium, an N-containing heterocyclic group having 2 to 30 carbon atoms substituted or unsubstituted with one or more substituents selected from the group consisting of an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 30 carbon atoms or a substituent connected with two or more groups selected from the group; Or -N(R211)(R121),
    R211 및 R212는 서로 같거나 상이하고, 각각 독립적으로 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환되고, 탄소수 5 또는 6의 지방족 탄화수소고리가 축합 또는 비축합된, 탄소수 6 내지 20의 아릴기; 또는 중수소 또는 탄소수 1 내지 6의 알킬기로 치환 또는 비치환된 탄소수 6 내지 20의 헤테로고리기인 것인 다환 화합물.R211 and R212 are the same as or different from each other, each independently substituted or unsubstituted with deuterium or an alkyl group having 1 to 6 carbon atoms, and an aryl group having 6 to 20 carbon atoms in which an aliphatic hydrocarbon ring having 5 or 6 carbon atoms is condensed or uncondensed ; Or a polycyclic compound that is a heterocyclic group having 6 to 20 carbon atoms unsubstituted or substituted with deuterium or an alkyl group having 1 to 6 carbon atoms.
  8. 청구항 1에 있어서, The method according to claim 1,
    상기 화학식 100은 하기 화합물들 중 어느 하나로 표시되는 다환 화합물: Formula 100 is a polycyclic compound represented by any one of the following compounds:
    Figure PCTKR2020010123-appb-I000515
    Figure PCTKR2020010123-appb-I000515
    Figure PCTKR2020010123-appb-I000516
    Figure PCTKR2020010123-appb-I000516
    Figure PCTKR2020010123-appb-I000517
    Figure PCTKR2020010123-appb-I000517
    Figure PCTKR2020010123-appb-I000518
    Figure PCTKR2020010123-appb-I000518
    Figure PCTKR2020010123-appb-I000519
    Figure PCTKR2020010123-appb-I000519
    Figure PCTKR2020010123-appb-I000520
    Figure PCTKR2020010123-appb-I000520
    Figure PCTKR2020010123-appb-I000521
    Figure PCTKR2020010123-appb-I000521
    Figure PCTKR2020010123-appb-I000522
    Figure PCTKR2020010123-appb-I000522
    Figure PCTKR2020010123-appb-I000523
    Figure PCTKR2020010123-appb-I000523
    Figure PCTKR2020010123-appb-I000524
    Figure PCTKR2020010123-appb-I000524
    Figure PCTKR2020010123-appb-I000525
    Figure PCTKR2020010123-appb-I000525
    Figure PCTKR2020010123-appb-I000526
    Figure PCTKR2020010123-appb-I000526
    Figure PCTKR2020010123-appb-I000527
    Figure PCTKR2020010123-appb-I000527
    Figure PCTKR2020010123-appb-I000528
    Figure PCTKR2020010123-appb-I000528
    Figure PCTKR2020010123-appb-I000529
    Figure PCTKR2020010123-appb-I000529
    Figure PCTKR2020010123-appb-I000530
    Figure PCTKR2020010123-appb-I000530
    Figure PCTKR2020010123-appb-I000531
    Figure PCTKR2020010123-appb-I000531
    Figure PCTKR2020010123-appb-I000532
    Figure PCTKR2020010123-appb-I000532
    Figure PCTKR2020010123-appb-I000533
    Figure PCTKR2020010123-appb-I000533
    Figure PCTKR2020010123-appb-I000534
    Figure PCTKR2020010123-appb-I000534
    Figure PCTKR2020010123-appb-I000535
    Figure PCTKR2020010123-appb-I000535
    Figure PCTKR2020010123-appb-I000536
    Figure PCTKR2020010123-appb-I000536
    Figure PCTKR2020010123-appb-I000537
    Figure PCTKR2020010123-appb-I000537
    Figure PCTKR2020010123-appb-I000538
    Figure PCTKR2020010123-appb-I000538
    Figure PCTKR2020010123-appb-I000539
    Figure PCTKR2020010123-appb-I000539
    Figure PCTKR2020010123-appb-I000540
    Figure PCTKR2020010123-appb-I000540
    Figure PCTKR2020010123-appb-I000541
    Figure PCTKR2020010123-appb-I000541
    Figure PCTKR2020010123-appb-I000542
    Figure PCTKR2020010123-appb-I000542
    Figure PCTKR2020010123-appb-I000543
    Figure PCTKR2020010123-appb-I000543
    Figure PCTKR2020010123-appb-I000544
    Figure PCTKR2020010123-appb-I000544
    Figure PCTKR2020010123-appb-I000545
    Figure PCTKR2020010123-appb-I000545
    Figure PCTKR2020010123-appb-I000546
    Figure PCTKR2020010123-appb-I000546
    Figure PCTKR2020010123-appb-I000547
    Figure PCTKR2020010123-appb-I000547
    Figure PCTKR2020010123-appb-I000548
    Figure PCTKR2020010123-appb-I000548
    Figure PCTKR2020010123-appb-I000549
    Figure PCTKR2020010123-appb-I000549
    Figure PCTKR2020010123-appb-I000550
    Figure PCTKR2020010123-appb-I000550
    Figure PCTKR2020010123-appb-I000551
    Figure PCTKR2020010123-appb-I000551
    Figure PCTKR2020010123-appb-I000552
    Figure PCTKR2020010123-appb-I000552
    Figure PCTKR2020010123-appb-I000553
    Figure PCTKR2020010123-appb-I000553
    Figure PCTKR2020010123-appb-I000554
    Figure PCTKR2020010123-appb-I000554
    Figure PCTKR2020010123-appb-I000555
    Figure PCTKR2020010123-appb-I000555
    Figure PCTKR2020010123-appb-I000556
    Figure PCTKR2020010123-appb-I000556
    Figure PCTKR2020010123-appb-I000557
    Figure PCTKR2020010123-appb-I000557
    Figure PCTKR2020010123-appb-I000558
    Figure PCTKR2020010123-appb-I000558
    Figure PCTKR2020010123-appb-I000559
    Figure PCTKR2020010123-appb-I000559
    Figure PCTKR2020010123-appb-I000560
    Figure PCTKR2020010123-appb-I000560
    Figure PCTKR2020010123-appb-I000561
    Figure PCTKR2020010123-appb-I000561
    Figure PCTKR2020010123-appb-I000562
    Figure PCTKR2020010123-appb-I000562
    Figure PCTKR2020010123-appb-I000563
    Figure PCTKR2020010123-appb-I000563
    Figure PCTKR2020010123-appb-I000564
    Figure PCTKR2020010123-appb-I000564
    Figure PCTKR2020010123-appb-I000565
    Figure PCTKR2020010123-appb-I000565
    Figure PCTKR2020010123-appb-I000566
    Figure PCTKR2020010123-appb-I000566
    Figure PCTKR2020010123-appb-I000567
    Figure PCTKR2020010123-appb-I000567
    Figure PCTKR2020010123-appb-I000568
    Figure PCTKR2020010123-appb-I000568
    Figure PCTKR2020010123-appb-I000569
    Figure PCTKR2020010123-appb-I000569
    Figure PCTKR2020010123-appb-I000570
    Figure PCTKR2020010123-appb-I000570
    Figure PCTKR2020010123-appb-I000571
    Figure PCTKR2020010123-appb-I000571
    Figure PCTKR2020010123-appb-I000572
    Figure PCTKR2020010123-appb-I000572
    Figure PCTKR2020010123-appb-I000573
    Figure PCTKR2020010123-appb-I000573
    Figure PCTKR2020010123-appb-I000574
    Figure PCTKR2020010123-appb-I000574
    Figure PCTKR2020010123-appb-I000575
    Figure PCTKR2020010123-appb-I000575
    Figure PCTKR2020010123-appb-I000576
    Figure PCTKR2020010123-appb-I000576
    Figure PCTKR2020010123-appb-I000577
    Figure PCTKR2020010123-appb-I000577
    Figure PCTKR2020010123-appb-I000578
    Figure PCTKR2020010123-appb-I000578
    Figure PCTKR2020010123-appb-I000579
    Figure PCTKR2020010123-appb-I000579
    Figure PCTKR2020010123-appb-I000580
    Figure PCTKR2020010123-appb-I000580
    Figure PCTKR2020010123-appb-I000581
    Figure PCTKR2020010123-appb-I000581
    Figure PCTKR2020010123-appb-I000582
    Figure PCTKR2020010123-appb-I000582
    Figure PCTKR2020010123-appb-I000583
    Figure PCTKR2020010123-appb-I000583
    Figure PCTKR2020010123-appb-I000584
    Figure PCTKR2020010123-appb-I000584
    Figure PCTKR2020010123-appb-I000585
    Figure PCTKR2020010123-appb-I000585
    Figure PCTKR2020010123-appb-I000586
    Figure PCTKR2020010123-appb-I000586
    Figure PCTKR2020010123-appb-I000587
    Figure PCTKR2020010123-appb-I000587
    Figure PCTKR2020010123-appb-I000588
    Figure PCTKR2020010123-appb-I000588
    Figure PCTKR2020010123-appb-I000589
    Figure PCTKR2020010123-appb-I000589
    Figure PCTKR2020010123-appb-I000590
    Figure PCTKR2020010123-appb-I000590
    Figure PCTKR2020010123-appb-I000591
    Figure PCTKR2020010123-appb-I000591
    Figure PCTKR2020010123-appb-I000592
    Figure PCTKR2020010123-appb-I000592
    Figure PCTKR2020010123-appb-I000593
    Figure PCTKR2020010123-appb-I000593
    Figure PCTKR2020010123-appb-I000594
    Figure PCTKR2020010123-appb-I000594
    Figure PCTKR2020010123-appb-I000595
    Figure PCTKR2020010123-appb-I000595
    Figure PCTKR2020010123-appb-I000596
    Figure PCTKR2020010123-appb-I000596
    Figure PCTKR2020010123-appb-I000597
    Figure PCTKR2020010123-appb-I000597
    Figure PCTKR2020010123-appb-I000598
    Figure PCTKR2020010123-appb-I000598
    Figure PCTKR2020010123-appb-I000599
    Figure PCTKR2020010123-appb-I000599
    Figure PCTKR2020010123-appb-I000600
    Figure PCTKR2020010123-appb-I000600
    Figure PCTKR2020010123-appb-I000601
    Figure PCTKR2020010123-appb-I000601
    Figure PCTKR2020010123-appb-I000602
    Figure PCTKR2020010123-appb-I000602
    Figure PCTKR2020010123-appb-I000603
    Figure PCTKR2020010123-appb-I000603
    Figure PCTKR2020010123-appb-I000604
    Figure PCTKR2020010123-appb-I000604
    Figure PCTKR2020010123-appb-I000605
    Figure PCTKR2020010123-appb-I000605
    Figure PCTKR2020010123-appb-I000606
    Figure PCTKR2020010123-appb-I000606
    Figure PCTKR2020010123-appb-I000607
    Figure PCTKR2020010123-appb-I000607
    Figure PCTKR2020010123-appb-I000608
    Figure PCTKR2020010123-appb-I000608
    Figure PCTKR2020010123-appb-I000609
    Figure PCTKR2020010123-appb-I000609
    Figure PCTKR2020010123-appb-I000610
    Figure PCTKR2020010123-appb-I000610
    Figure PCTKR2020010123-appb-I000611
    Figure PCTKR2020010123-appb-I000611
    Figure PCTKR2020010123-appb-I000612
    Figure PCTKR2020010123-appb-I000612
    Figure PCTKR2020010123-appb-I000613
    Figure PCTKR2020010123-appb-I000613
    Figure PCTKR2020010123-appb-I000614
    Figure PCTKR2020010123-appb-I000614
    Figure PCTKR2020010123-appb-I000615
    Figure PCTKR2020010123-appb-I000615
    Figure PCTKR2020010123-appb-I000616
    Figure PCTKR2020010123-appb-I000616
    Figure PCTKR2020010123-appb-I000617
    Figure PCTKR2020010123-appb-I000617
    Figure PCTKR2020010123-appb-I000618
    Figure PCTKR2020010123-appb-I000618
    Figure PCTKR2020010123-appb-I000619
    Figure PCTKR2020010123-appb-I000619
    Figure PCTKR2020010123-appb-I000620
    Figure PCTKR2020010123-appb-I000620
    Figure PCTKR2020010123-appb-I000621
    Figure PCTKR2020010123-appb-I000621
    Figure PCTKR2020010123-appb-I000622
    Figure PCTKR2020010123-appb-I000622
    Figure PCTKR2020010123-appb-I000623
    Figure PCTKR2020010123-appb-I000623
    Figure PCTKR2020010123-appb-I000624
    Figure PCTKR2020010123-appb-I000624
    Figure PCTKR2020010123-appb-I000625
    Figure PCTKR2020010123-appb-I000625
    Figure PCTKR2020010123-appb-I000626
    Figure PCTKR2020010123-appb-I000626
    Figure PCTKR2020010123-appb-I000627
    Figure PCTKR2020010123-appb-I000627
    Figure PCTKR2020010123-appb-I000628
    Figure PCTKR2020010123-appb-I000628
    Figure PCTKR2020010123-appb-I000629
    Figure PCTKR2020010123-appb-I000629
    Figure PCTKR2020010123-appb-I000630
    Figure PCTKR2020010123-appb-I000630
    Figure PCTKR2020010123-appb-I000631
    Figure PCTKR2020010123-appb-I000631
    Figure PCTKR2020010123-appb-I000632
    Figure PCTKR2020010123-appb-I000632
    Figure PCTKR2020010123-appb-I000633
    Figure PCTKR2020010123-appb-I000633
    Figure PCTKR2020010123-appb-I000634
    Figure PCTKR2020010123-appb-I000634
    Figure PCTKR2020010123-appb-I000635
    Figure PCTKR2020010123-appb-I000635
    Figure PCTKR2020010123-appb-I000636
    Figure PCTKR2020010123-appb-I000636
    Figure PCTKR2020010123-appb-I000637
    Figure PCTKR2020010123-appb-I000637
    Figure PCTKR2020010123-appb-I000638
    Figure PCTKR2020010123-appb-I000638
    Figure PCTKR2020010123-appb-I000639
    Figure PCTKR2020010123-appb-I000639
    Figure PCTKR2020010123-appb-I000640
    Figure PCTKR2020010123-appb-I000640
    Figure PCTKR2020010123-appb-I000641
    Figure PCTKR2020010123-appb-I000641
    Figure PCTKR2020010123-appb-I000642
    Figure PCTKR2020010123-appb-I000642
    Figure PCTKR2020010123-appb-I000643
    Figure PCTKR2020010123-appb-I000643
    Figure PCTKR2020010123-appb-I000644
    Figure PCTKR2020010123-appb-I000644
    Figure PCTKR2020010123-appb-I000645
    Figure PCTKR2020010123-appb-I000645
    Figure PCTKR2020010123-appb-I000646
    Figure PCTKR2020010123-appb-I000646
    Figure PCTKR2020010123-appb-I000647
    Figure PCTKR2020010123-appb-I000647
    Figure PCTKR2020010123-appb-I000648
    Figure PCTKR2020010123-appb-I000648
    Figure PCTKR2020010123-appb-I000649
    Figure PCTKR2020010123-appb-I000649
    Figure PCTKR2020010123-appb-I000650
    Figure PCTKR2020010123-appb-I000650
    Figure PCTKR2020010123-appb-I000651
    Figure PCTKR2020010123-appb-I000651
    Figure PCTKR2020010123-appb-I000652
    Figure PCTKR2020010123-appb-I000652
    Figure PCTKR2020010123-appb-I000653
    Figure PCTKR2020010123-appb-I000653
    Figure PCTKR2020010123-appb-I000654
    Figure PCTKR2020010123-appb-I000654
    Figure PCTKR2020010123-appb-I000655
    Figure PCTKR2020010123-appb-I000655
    Figure PCTKR2020010123-appb-I000656
    Figure PCTKR2020010123-appb-I000656
    Figure PCTKR2020010123-appb-I000657
    Figure PCTKR2020010123-appb-I000657
    Figure PCTKR2020010123-appb-I000658
    Figure PCTKR2020010123-appb-I000658
    Figure PCTKR2020010123-appb-I000659
    Figure PCTKR2020010123-appb-I000659
    Figure PCTKR2020010123-appb-I000660
    Figure PCTKR2020010123-appb-I000660
    Figure PCTKR2020010123-appb-I000661
    Figure PCTKR2020010123-appb-I000661
    Figure PCTKR2020010123-appb-I000662
    Figure PCTKR2020010123-appb-I000662
    Figure PCTKR2020010123-appb-I000663
    Figure PCTKR2020010123-appb-I000663
    Figure PCTKR2020010123-appb-I000664
    Figure PCTKR2020010123-appb-I000664
    Figure PCTKR2020010123-appb-I000665
    Figure PCTKR2020010123-appb-I000665
    Figure PCTKR2020010123-appb-I000666
    Figure PCTKR2020010123-appb-I000666
    Figure PCTKR2020010123-appb-I000667
    Figure PCTKR2020010123-appb-I000667
    Figure PCTKR2020010123-appb-I000668
    Figure PCTKR2020010123-appb-I000668
    Figure PCTKR2020010123-appb-I000669
    Figure PCTKR2020010123-appb-I000669
    Figure PCTKR2020010123-appb-I000670
    Figure PCTKR2020010123-appb-I000670
    Figure PCTKR2020010123-appb-I000671
    Figure PCTKR2020010123-appb-I000671
    Figure PCTKR2020010123-appb-I000672
    Figure PCTKR2020010123-appb-I000672
    Figure PCTKR2020010123-appb-I000673
    Figure PCTKR2020010123-appb-I000673
    Figure PCTKR2020010123-appb-I000674
    Figure PCTKR2020010123-appb-I000674
    Figure PCTKR2020010123-appb-I000675
    Figure PCTKR2020010123-appb-I000675
    Figure PCTKR2020010123-appb-I000676
    Figure PCTKR2020010123-appb-I000676
    Figure PCTKR2020010123-appb-I000677
    Figure PCTKR2020010123-appb-I000677
    Figure PCTKR2020010123-appb-I000678
    Figure PCTKR2020010123-appb-I000678
    Figure PCTKR2020010123-appb-I000679
    Figure PCTKR2020010123-appb-I000679
    Figure PCTKR2020010123-appb-I000680
    Figure PCTKR2020010123-appb-I000680
    Figure PCTKR2020010123-appb-I000681
    Figure PCTKR2020010123-appb-I000681
    Figure PCTKR2020010123-appb-I000682
    Figure PCTKR2020010123-appb-I000682
    Figure PCTKR2020010123-appb-I000683
    Figure PCTKR2020010123-appb-I000683
    Figure PCTKR2020010123-appb-I000684
    Figure PCTKR2020010123-appb-I000684
    Figure PCTKR2020010123-appb-I000685
    Figure PCTKR2020010123-appb-I000685
    Figure PCTKR2020010123-appb-I000686
    Figure PCTKR2020010123-appb-I000686
    Figure PCTKR2020010123-appb-I000687
    Figure PCTKR2020010123-appb-I000687
    Figure PCTKR2020010123-appb-I000688
    Figure PCTKR2020010123-appb-I000688
    Figure PCTKR2020010123-appb-I000689
    Figure PCTKR2020010123-appb-I000689
    Figure PCTKR2020010123-appb-I000690
    Figure PCTKR2020010123-appb-I000690
    Figure PCTKR2020010123-appb-I000691
    Figure PCTKR2020010123-appb-I000691
    Figure PCTKR2020010123-appb-I000692
    Figure PCTKR2020010123-appb-I000692
    Figure PCTKR2020010123-appb-I000693
    Figure PCTKR2020010123-appb-I000693
    Figure PCTKR2020010123-appb-I000694
    Figure PCTKR2020010123-appb-I000694
    Figure PCTKR2020010123-appb-I000695
    Figure PCTKR2020010123-appb-I000695
    Figure PCTKR2020010123-appb-I000696
    Figure PCTKR2020010123-appb-I000696
    Figure PCTKR2020010123-appb-I000697
    Figure PCTKR2020010123-appb-I000697
    Figure PCTKR2020010123-appb-I000698
    Figure PCTKR2020010123-appb-I000698
    Figure PCTKR2020010123-appb-I000699
    Figure PCTKR2020010123-appb-I000699
    Figure PCTKR2020010123-appb-I000700
    Figure PCTKR2020010123-appb-I000700
    Figure PCTKR2020010123-appb-I000701
    Figure PCTKR2020010123-appb-I000701
    Figure PCTKR2020010123-appb-I000702
    Figure PCTKR2020010123-appb-I000702
    Figure PCTKR2020010123-appb-I000703
    Figure PCTKR2020010123-appb-I000703
    Figure PCTKR2020010123-appb-I000704
    Figure PCTKR2020010123-appb-I000704
    Figure PCTKR2020010123-appb-I000705
    Figure PCTKR2020010123-appb-I000705
    Figure PCTKR2020010123-appb-I000706
    Figure PCTKR2020010123-appb-I000706
    Figure PCTKR2020010123-appb-I000707
    Figure PCTKR2020010123-appb-I000707
    Figure PCTKR2020010123-appb-I000708
    Figure PCTKR2020010123-appb-I000708
    Figure PCTKR2020010123-appb-I000709
    Figure PCTKR2020010123-appb-I000709
    Figure PCTKR2020010123-appb-I000710
    Figure PCTKR2020010123-appb-I000710
    Figure PCTKR2020010123-appb-I000711
    Figure PCTKR2020010123-appb-I000711
    Figure PCTKR2020010123-appb-I000712
    Figure PCTKR2020010123-appb-I000712
    Figure PCTKR2020010123-appb-I000713
    Figure PCTKR2020010123-appb-I000713
    Figure PCTKR2020010123-appb-I000714
    Figure PCTKR2020010123-appb-I000714
    Figure PCTKR2020010123-appb-I000715
    Figure PCTKR2020010123-appb-I000715
    Figure PCTKR2020010123-appb-I000716
    Figure PCTKR2020010123-appb-I000716
    Figure PCTKR2020010123-appb-I000717
    Figure PCTKR2020010123-appb-I000717
    Figure PCTKR2020010123-appb-I000718
    Figure PCTKR2020010123-appb-I000718
    Figure PCTKR2020010123-appb-I000719
    Figure PCTKR2020010123-appb-I000719
    Figure PCTKR2020010123-appb-I000720
    Figure PCTKR2020010123-appb-I000720
    Figure PCTKR2020010123-appb-I000721
    Figure PCTKR2020010123-appb-I000721
    Figure PCTKR2020010123-appb-I000722
    Figure PCTKR2020010123-appb-I000722
    Figure PCTKR2020010123-appb-I000723
    Figure PCTKR2020010123-appb-I000723
    Figure PCTKR2020010123-appb-I000724
    Figure PCTKR2020010123-appb-I000724
    Figure PCTKR2020010123-appb-I000725
    Figure PCTKR2020010123-appb-I000725
    Figure PCTKR2020010123-appb-I000726
    Figure PCTKR2020010123-appb-I000726
    Figure PCTKR2020010123-appb-I000727
    Figure PCTKR2020010123-appb-I000727
    Figure PCTKR2020010123-appb-I000728
    Figure PCTKR2020010123-appb-I000728
    Figure PCTKR2020010123-appb-I000729
    Figure PCTKR2020010123-appb-I000729
    Figure PCTKR2020010123-appb-I000730
    Figure PCTKR2020010123-appb-I000730
    Figure PCTKR2020010123-appb-I000731
    Figure PCTKR2020010123-appb-I000731
    Figure PCTKR2020010123-appb-I000732
    Figure PCTKR2020010123-appb-I000732
    Figure PCTKR2020010123-appb-I000733
    Figure PCTKR2020010123-appb-I000733
    Figure PCTKR2020010123-appb-I000734
    Figure PCTKR2020010123-appb-I000734
    Figure PCTKR2020010123-appb-I000735
    Figure PCTKR2020010123-appb-I000735
    Figure PCTKR2020010123-appb-I000736
    Figure PCTKR2020010123-appb-I000736
    Figure PCTKR2020010123-appb-I000737
    Figure PCTKR2020010123-appb-I000737
    Figure PCTKR2020010123-appb-I000738
    Figure PCTKR2020010123-appb-I000738
    Figure PCTKR2020010123-appb-I000739
    Figure PCTKR2020010123-appb-I000739
    Figure PCTKR2020010123-appb-I000740
    Figure PCTKR2020010123-appb-I000740
    Figure PCTKR2020010123-appb-I000741
    Figure PCTKR2020010123-appb-I000741
    Figure PCTKR2020010123-appb-I000742
    Figure PCTKR2020010123-appb-I000742
    Figure PCTKR2020010123-appb-I000743
    Figure PCTKR2020010123-appb-I000743
    Figure PCTKR2020010123-appb-I000744
    Figure PCTKR2020010123-appb-I000744
    Figure PCTKR2020010123-appb-I000745
    Figure PCTKR2020010123-appb-I000745
    Figure PCTKR2020010123-appb-I000746
    Figure PCTKR2020010123-appb-I000746
    Figure PCTKR2020010123-appb-I000747
    Figure PCTKR2020010123-appb-I000747
    Figure PCTKR2020010123-appb-I000748
    Figure PCTKR2020010123-appb-I000748
    Figure PCTKR2020010123-appb-I000749
    Figure PCTKR2020010123-appb-I000749
    Figure PCTKR2020010123-appb-I000750
    Figure PCTKR2020010123-appb-I000750
    Figure PCTKR2020010123-appb-I000751
    Figure PCTKR2020010123-appb-I000751
    Figure PCTKR2020010123-appb-I000752
    .
    Figure PCTKR2020010123-appb-I000752
    .
  9. 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상이 청구항 1 내지 8 중 어느 한 항에 따른 다환 화합물을 포함하는 유기 발광 소자.A first electrode; A second electrode provided to face the first electrode; And one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers comprises the polycyclic compound according to any one of claims 1 to 8. device.
  10. 청구항 9에 있어서,The method of claim 9,
    상기 유기물층은 발광층을 포함하고, 상기 발광층은 상기 다환 화합물을 포함하는 유기 발광 소자.The organic material layer includes an emission layer, and the emission layer includes the polycyclic compound.
  11. 청구항 9에 있어서,The method of claim 9,
    상기 유기물층은 발광층을 포함하고, The organic material layer includes a light emitting layer,
    상기 발광층은 상기 다환 화합물을 발광층의 도펀트로 포함하고, 하기 화학식 H로 표시되는 화합물을 발광층의 호스트로 포함하는 유기 발광 소자:The emission layer includes the polycyclic compound as a dopant of the emission layer, and an organic light-emitting device comprising a compound represented by Formula H as a host of the emission layer:
    [화학식 H][Formula H]
    Figure PCTKR2020010123-appb-I000753
    Figure PCTKR2020010123-appb-I000753
    상기 화학식 H에 있어서,In the formula H,
    L21 및 L22는 서로 같거나 상이하고, 각각 독립적으로, 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 헤테로아릴렌기이고,L21 and L22 are the same as or different from each other, and each independently, a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group,
    Ar21 및 Ar22는 서로 같거나 상이하고, 각각 독립적으로, 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고, Ar21 and Ar22 are the same as or different from each other, and each independently a substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
    R201 및 R202는 서로 같거나 상이하고, 각각 독립적으로, 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로고리기이고,R201 and R202 are the same as or different from each other, and each independently hydrogen; heavy hydrogen; Halogen group; A substituted or unsubstituted alkyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heterocyclic group,
    n202는 0 내지 7의 정수이고, n202가 2 이상일 때 R202는 서로 같거나 상이하다.n202 is an integer from 0 to 7, and when n202 is 2 or more, R202 is the same as or different from each other.
  12. 청구항 9에 있어서, 상기 유기물층은 발광층, 정공 주입층, 정공수송층, 전자 주입층, 전자 수송층, 전자 차단층 및 정공 차단층으로 이루어진 군에서 선택되는 1층 또는 2층 이상을 더 포함하는 것인 유기 발광 소자. The organic material of claim 9, wherein the organic material layer further comprises one or two or more layers selected from the group consisting of a light-emitting layer, a hole injection layer, a hole transport layer, an electron injection layer, an electron transport layer, an electron blocking layer, and a hole blocking layer. Light-emitting element.
PCT/KR2020/010123 2019-07-31 2020-07-31 Polycyclic compound and organic light-emitting element comprising same WO2021020928A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP20847289.4A EP3901158A4 (en) 2019-07-31 2020-07-31 Polycyclic compound and organic light-emitting element comprising same
US17/423,185 US20230077439A1 (en) 2019-07-31 2020-07-31 Polycyclic compound and organic light-emitting element comprising same
JP2021540053A JP7248229B2 (en) 2019-07-31 2020-07-31 Polycyclic compound and organic light-emitting device containing the same
CN202080010225.9A CN113396151B (en) 2019-07-31 2020-07-31 Polycyclic compound and organic light-emitting element including the same

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR20190093157 2019-07-31
KR10-2019-0093157 2019-07-31
KR20190156836 2019-11-29
KR10-2019-0156836 2019-11-29
KR1020200065269A KR102239440B1 (en) 2019-07-31 2020-05-29 Multicyclic compound and organic light emitting device comprising the same
KR10-2020-0065269 2020-05-29

Publications (2)

Publication Number Publication Date
WO2021020928A2 true WO2021020928A2 (en) 2021-02-04
WO2021020928A3 WO2021020928A3 (en) 2021-03-25

Family

ID=74228758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/010123 WO2021020928A2 (en) 2019-07-31 2020-07-31 Polycyclic compound and organic light-emitting element comprising same

Country Status (1)

Country Link
WO (1) WO2021020928A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022042737A1 (en) * 2020-08-31 2022-03-03 北京鼎材科技有限公司 Organic compound for organic electroluminescent device and organic electroluminescent device
CN115724869A (en) * 2022-11-15 2023-03-03 深圳市华星光电半导体显示技术有限公司 Organic compound, light-emitting element, and display panel
EP4151697A1 (en) * 2021-09-17 2023-03-22 Idemitsu Kosan Co., Ltd. Compound and an organic electroluminescence device comprising the compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017126443A1 (en) 2016-01-21 2017-07-27 学校法人関西学院 Polycyclic aromatic compound
KR20190093157A (en) 2018-01-31 2019-08-08 세이코 엡슨 가부시키가이샤 Print head
KR20200065269A (en) 2018-11-30 2020-06-09 주식회사 포스코 High strength hot-rolled steel sheet and cold rolled steel sheet having excellent surface property and continuous productivity, and manufacturing method for the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10686141B2 (en) * 2016-09-07 2020-06-16 Kwansei Gakuin Educational Foundation Polycyclic aromatic compound
KR101876763B1 (en) * 2017-05-22 2018-07-11 머티어리얼사이언스 주식회사 Organic compound and organic electroluminescent device comprising the same
KR102134523B1 (en) * 2017-12-26 2020-07-16 주식회사 엘지화학 Compound and organic light emitting device comprising the same
WO2020054676A1 (en) * 2018-09-10 2020-03-19 学校法人関西学院 Organic electroluminescent element

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017126443A1 (en) 2016-01-21 2017-07-27 学校法人関西学院 Polycyclic aromatic compound
KR20190093157A (en) 2018-01-31 2019-08-08 세이코 엡슨 가부시키가이샤 Print head
KR20200065269A (en) 2018-11-30 2020-06-09 주식회사 포스코 High strength hot-rolled steel sheet and cold rolled steel sheet having excellent surface property and continuous productivity, and manufacturing method for the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022042737A1 (en) * 2020-08-31 2022-03-03 北京鼎材科技有限公司 Organic compound for organic electroluminescent device and organic electroluminescent device
EP4151697A1 (en) * 2021-09-17 2023-03-22 Idemitsu Kosan Co., Ltd. Compound and an organic electroluminescence device comprising the compound
WO2023042574A1 (en) * 2021-09-17 2023-03-23 Idemitsu Kosan Co., Ltd. Compound and an organic electroluminescence device comprising the compound
CN115724869A (en) * 2022-11-15 2023-03-03 深圳市华星光电半导体显示技术有限公司 Organic compound, light-emitting element, and display panel

Also Published As

Publication number Publication date
WO2021020928A3 (en) 2021-03-25

Similar Documents

Publication Publication Date Title
WO2021107737A1 (en) Organic light-emitting element
WO2021020942A1 (en) Organic light-emitting element
WO2020009467A1 (en) Polycyclic compound and organic light emitting diode comprising same
WO2019221545A1 (en) Organic light emitting diode
WO2019240464A1 (en) Organic light-emitting device
WO2013183851A1 (en) Novel organic electroluminescent element compound and organic electroluminescent element comprising same
WO2019212287A9 (en) Compound and organic light emitting diode comprising same
WO2012039534A1 (en) Compound for an organic photoelectric device, and organic photoelectric device including same
WO2022139525A1 (en) Organic light-emitting device including organic compound
WO2021020946A1 (en) Organic light-emitting element
WO2021020948A1 (en) Organic light emitting device
WO2017131483A1 (en) Spiro-structured compound and organic electronic device comprising same
WO2021020929A1 (en) Compound and organic light emitting device comprising same
WO2021020928A2 (en) Polycyclic compound and organic light-emitting element comprising same
WO2020096357A1 (en) Organic light-emitting device
WO2021107711A1 (en) Polycyclic compound and organic light-emitting element comprising same
WO2021049843A1 (en) Compound and organic light emitting device comprising same
WO2020096358A1 (en) Organic light-emitting device
WO2021020931A1 (en) Compound and organic light emitting device comprising same
WO2022019536A1 (en) Compound and organic light-emitting device comprising same
WO2021020947A1 (en) Organic light-emitting device
WO2023085860A1 (en) Compound and organic light-emitting device comprising same
WO2024025353A1 (en) Organic compound and organic light-emitting device comprising same
WO2022216018A1 (en) Organic light-emitting device
WO2022240267A1 (en) Organic light emitting device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20847289

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2021540053

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2020847289

Country of ref document: EP

Effective date: 20210721

NENP Non-entry into the national phase

Ref country code: DE